TW387888B - Novel quinolone-or naphthylidone-carboxylic acid derivatives or their salts - Google Patents

Novel quinolone-or naphthylidone-carboxylic acid derivatives or their salts Download PDF

Info

Publication number
TW387888B
TW387888B TW84108286A TW84108286A TW387888B TW 387888 B TW387888 B TW 387888B TW 84108286 A TW84108286 A TW 84108286A TW 84108286 A TW84108286 A TW 84108286A TW 387888 B TW387888 B TW 387888B
Authority
TW
Taiwan
Prior art keywords
carboxylic acid
group
fluoro
dihydro
methyl
Prior art date
Application number
TW84108286A
Other languages
Chinese (zh)
Inventor
Yozo Todo
Kazuya Hayashi
Masahiro Takahata
Yasuo Watanabe
Hirokazu Narita
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to TW84108286A priority Critical patent/TW387888B/en
Application granted granted Critical
Publication of TW387888B publication Critical patent/TW387888B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

C;' !:' O'wi i. ^ -r 大勝桿菌NIHJJ02 ! I 71 I m g T3 5 室 m m D> 萏 0.012 0.025 0.006 0.012 03 4 靈 0.0121 ρ mmk 0.012 0.05 00 >-Cf〇 o § <0.006 0.05 <0.006 0.012 00 I \ \ <0.006 ρ 0.012 0.025 00 s 1.56 〇 p 00 fttVcooh ΗΝ〇Γϊί ^ M· CHjCHaF 0.05 0.39 0.05 0.05 00 0 F-y^A^COOH 0.025 ο r〇 0.051 0.0251 CO o ^xr$; #C; '!:' O'wi i. ^ -R victorius NIHJJ02! I 71 I mg T3 5 chamber mm D > 萏 0.012 0.025 0.006 0.012 03 4 Ling 0.0121 ρ mmk 0.012 0.05 00 > -Cf〇o § < 0.006 0.05 < 0.006 0.012 00 I \ \ < 0.006 ρ 0.012 0.025 00 s 1.56 〇p 00 fttVcooh ΗΝ〇Γϊί ^ M · CHjCHaF 0.05 0.39 0.05 0.05 00 0 Fy ^ A ^ COOH 0.025 ο r〇0.051 0.0251 CO o ^ xr $; #

:¾騰#菌 NIHJJC~2 I 1 1 w I T 1 1 T1 § Ό 1 fr 蓉' 0.003 0.025 0.006 0.006 00 卜Q。 0 0 0.012 <0.006 <0.006 <0.006 00 i \ 0 § 1 0.05 <0.012 <0.012 <0.012 CO ffv^Vcooh ΗΝ〇φτΧ^ F 0.05 〇 ho p p CO 々1。 1 <0.006! 0.025 <0.006 ( 0.012 00 OMe^ 0.025 0.05 0.025 0.025 00 〇 Me 0.051 0.051 0.051 0.051 CO 1大腸桿菌NIHJJ02 1 1 1 雪 71 莒 % 1 τι g 1 m 缂 化合物 1 3.13 1,56 ο fo ' 0.39: σ> fXjCVc〇〇h NH 丨 3.13 0.012 0.012 0.012 i § 0.006 ο fo 0.012 0.012 00 i § 0.025 0.78 0.025 0.05 CO k 0 丨 0.006 ο FO 0.025 0.012 00 % o § . <0.006 0.05 <0,006 <0.006 CO O § 99a 經濟部中央標準局員工消費合作社印製 A7 B7___ 五、發明説明(,) 技術領域 本發明僳W於對革酺氏明性«及革蘭氏陰性豳,待别 MRS A具有择力抗«活性之通式〔I〕表示之新潁轾咻酮_ 或萊啶酮-羧酸衍生物。 背景技術 作為授啉酮合成抗菌劑,至今為止_床上廣泛使用那 芙洛辛(Norfloxacin),赛普洛笑洛辛(Ciprofloxacin) ,»芙洛辛(Ofloxacin)等,但對革黼氏鵑性0特別MRSA 並未具足夠之活性β因此希望明發對此等細®有效且具 有91泛抗醣範_之合成抗菌爾β 發明掲示 此種情況下,發明人進行撤底研究而發現通式〔I〕 表示之丨f啉酮-或萊啶酮-羧酸衍生物或其鹽具有绝佳抗 篇活性: 5: ¾ 腾 # 菌 NIHJJC ~ 2 I 1 1 w I T 1 1 T1 § Ό 1 fr Rong '0.003 0.025 0.006 0.006 00 BU Q. 0 0 0.012 < 0.006 < 0.006 < 0.006 00 i \ 0 § 1 0.05 < 0.012 < 0.012 < 0.012 CO ffv ^ Vcooh ΗΝ〇φτχ ^ F 0.05 〇 ho p p CO 々1. 1 < 0.006! 0.025 < 0.006 (0.012 00 OMe ^ 0.025 0.05 0.025 0.025 00 〇Me 0.051 0.051 0.051 0.051 CO 1 E. coli NIHJJ02 1 1 1 snow 71 莒% 1 τι g 1 m 缂 compound 1 3.13 1,56 ο fo '0.39: σ > fXjCVc〇〇h NH 丨 3.13 0.012 0.012 0.012 i § 0.006 ο fo 0.012 0.012 00 i § 0.025 0.78 0.025 0.05 CO k 0 丨 0.006 ο FO 0.025 0.012 00% o §. < 0.006 0.05 < 0,006 < 0.006 CO O § 99a Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7___ V. Description of the invention (,) TECHNICAL FIELD The present invention is not limited to Gram's clarity «and Gram-negative 别MRS A has neopentanone or erythridone-carboxylic acid derivative represented by the general formula [I] with selective anti- «activity. BACKGROUND ART As a synthetic antibacterial agent for linolinone, hitherto has been widely used on beds Norfloxacin, Ciprofloxacin, »Ofloxacin, etc., but MRSA does not have sufficient activity for the Rhododendron genus 0, especially MRSA, so I hope that this kind of details ® Synthetic Antibacterial Beta with Effective Pan-Anti-Glycemic Formula 91 Presentation of the invention In this case, the inventor carried out a bottom-out study and found that the folinone- or erythridone-carboxylic acid derivative or its salt represented by the general formula [I] has excellent antibacterial activity: 5

RR

R 2 ο 其中R1表示氫原子或羧基保謹基;R2表示經取代或未 經取代之烷基,烯基,琢烷基,芳基或雜璨条基;R3 表示邐自下列之至少一者:氫原子,鹵原子,經取代或 未經取代之烷基,烯基,璨烷基,芳基,烷氣基或烷硫 基,硝基,氡基,醯基,經保護或未經保護之羥基,經 本紙張尺度適用中國國家梯準( CNS ) A4規格(210X297公釐) ---------* 裝------1T--Μ----「線 (請先閲讀背面之注意事項再填寫本頁) 五、發明説明(> ) A7 B7 保護或未經保護之羰烷基,經保護或未經保謹之胺基, 經保護或未經保謭之烷胺基,二烷胺基,經保護或未經 保護之胺疼基,經保護或未經保譜之烷胺烷基及二烷胺 烷基;R4表示襄自下列之至少一者:氫原子,鹵原子 經取代或未經取代之烷基,烯基,環烷基,芳烷基,芳 基,烷氣基或烷碱基,經保謾或未經保護之羥基,經保 護或未經保謹之羥烷基,經保護或未經保護之胺基,經 保謹或未經保護之烷按基,二烷胺基,經保護或未經保 護之胺烷基,經保護或未經保護之烷胺烷基,二烷胺烷 基,亞烷基,氧基,亞胺基及與R4鍵结之磺原子生成 璨烷環之基;Rs表示氫原子,經取代或未經取代之烷 基,環烷基,烷磺醯基,芳磺酵基,醯基或芳基,經保 護或未經保護之胺烷基,經保護或未經保護之烷胺烷基 ,二烷胺基烷基或經保護或未锤保護之羥烷基;Re表示 氳原子,鹵原子,經取代或未經取代之烷基,烷基或烷 碱基,保護或未經保鼸之羥基,經保護或未經保護之胺 基或硝基 \ / % A表示R 2 ο wherein R1 represents a hydrogen atom or a carboxyl carboxyl group; R2 represents a substituted or unsubstituted alkyl, alkenyl, alkylene, aryl, or heterocyclic group; R3 represents at least one of : Hydrogen atom, halogen atom, substituted or unsubstituted alkyl group, alkenyl group, alkenyl group, aryl group, alkane group or alkylthio group, nitro group, fluorenyl group, fluorenyl group, protected or unprotected The hydroxyl group of this paper is applicable to China National Standard (CNS) A4 specification (210X297 mm) according to this paper standard --------- * Packing ----- 1T--M ---- "line (please Please read the notes on the back before filling out this page) 5. Description of the invention (>) A7 B7 Protected or unprotected carbonylalkyl, protected or unreserved amine, protected or unreserved Alkylamino, dialkylamino, protected or unprotected amidyl, protected or unspectrumed alkylamine alkyl and dialkylamine alkyl; R4 represents at least one of the following: hydrogen Atoms, halogen atoms substituted or unsubstituted alkyl, alkenyl, cycloalkyl, aralkyl, aryl, alkanoyl or alkane bases, protected or unprotected hydroxyl groups, protected Unreserved hydroxyalkyl, protected or unprotected amine, protected or unprotected alkane, dialkylamino, protected or unprotected amine alkyl, protected or Unprotected alkylamine alkyl, dialkylamine alkyl, alkylene, oxy, imine and sulfonium atoms bonded to R4 to form a sane ring; Rs represents a hydrogen atom, substituted or unsubstituted Substituted alkyl, cycloalkyl, alkylsulfonyl, arylsulfonyl, fluorenyl or aryl, protected or unprotected amine alkyl, protected or unprotected alkylamine alkyl, dioxane Aminoalkyl or hydroxyalkyl protected or unprotected; Re means fluorene atom, halogen atom, substituted or unsubstituted alkyl, alkyl or alkyl group, protected or unprotected hydroxy group, Protected or unprotected amine or nitro

或V 其中Y表示氳原子 ---------(,—裝------訂-->----(線 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局負工消費合作社印製 齓原子,經取代或未經取代之烷基,烷《基或烷破基或經 保護或未經保護之羥基或輿R2生成下式表示之基:丨 B 其中R7表示理自下列之至少一者:氫原子,烷基,鹵 烷基,經保護或未經保護之羥烷基,亞烷基及與87鍵Or V, where Y represents a plutonium atom --------- (, — install ------ order-> ---- (line (please read the precautions on the back before filling this page) The Central Standards Bureau of the Ministry of Economic Affairs prints a rubidium atom, a substituted or unsubstituted alkyl group, an alkyl group or an alkyl group, or a protected or unprotected hydroxyl group or R2 to form a base represented by the following formula:丨 B where R7 represents at least one of the following: hydrogen atom, alkyl group, haloalkyl group, protected or unprotected hydroxyalkyl group, alkylene group and bond with 87

R7 本紙張尺度適用中國國家標準(_CNS ) A4规格(210X297公釐) 經濟部中央標準局員工消費合作社印装 A7 B7 五、發明説明(4 ) 結之硪原子生成琛烷琛之基,及B表示翥原子,硫原子 或可由烷基取代之亞胺基;及X表示氳原子或鹵原子, 因而完成 > 發明。 本發明詳細說明如下β 說明軎中除非S行規定,否則"鹵原子"一詞表示氟原 子,氯原子,溴原子或碘原子;"烷基"一詞表示直鏈或 支鐽Ci - 1〇烷基如甲基,乙基,正丙基,異丙基,正丁 基,異丁基,第二丁基,第三丁基,戊基,己基,庚基 ,辛基等;"低硪烷基"一詞表示直鏞或支《 C 1 - 5烷 基例如甲基,乙基,正丙基,異丙基,正丁基,異丁基 ,第二丁基,第三丁基,戊基等;"烷《基"一詞表示直 鏈或支鏈〇1- 10垸氣基如甲氣基,乙《基,正丙氣基 ,異丙氣基,正丁氡基,異丁氧基,第二丁氣基,第三 丁氧基,戊氣基,己«基,庚氣基,辛氣基等;"低硪 烷《基"一詞表示直鐽或支鍵(31_ 5烷《基如甲氣基, 乙«基,正丙氣基,異丙氧基,正-丁氣基,異丁氣基 ,第二丁氧基,第三丁氣基,戊氧基等;"烷硫基"一詞 表示直鏈或支«Ci- !〇烷硫基如甲硫基,乙硫基,正 丙硫基,異丙硫基,正丁«基,異丁硫基,第二丁硫基 ,第三丁硫基,戊硫基,己硫基,庚砘基,辛硫基等; 低确烷昧基"一詞表示直鍵或支鍵Ci- 5烷硫基如甲 硫基,己硫基,正丙碱基,異丙硫基,正丁碕基,異丁 硫基,第二丁碕基,第三丁硫基,戊硫基等;"醯基••一 詞表示甲酵基,直鏈或支鏈c2- S烷醯基如乙醯基, 本紙張尺度適用中國國家標準(0NS ) A4规格(210X297公釐) -----------^ <裝------訂—-^----f 線 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標隼局員工消費合作杜印製 A7 __ B7_ 五、發明説明(4 ) 乙基羧基等或芳醯基如苯甲醯基,萊歎基等;"低硝烷 氣羰基"一詞表示直鏈或支鍵Ci- s烷m羰基如甲氣欺 基,乙氧轶基,正丙《羰基,異丙*嫌基,正丁《羰基 ,異丁氣羰基,第二丁氣羰基,第三丁氣黢基,戊氣羰 基等;"烷胺基"一詞表示直鍵或支鍵^^- ω烷胺基如 甲胺基,乙胺基,丙胺基,丁胺基,戊胺基,己胺基, 庚胺基,辛胺基等;”低硪烷胺基"一詞表示直鍵或支鍵 Ci- s烷胺基如甲胺基-乙胺基,丙胺基等;”二烷胺 基''一詞表示二直鰱或支鍵Ci - 1D烷胺基如二甲胺基 ,二乙胺基,甲乙胺基,二丙胺基,二丁胺基,二戊按 基,二己胺基,二庚胺基,二辛按基等;"二低硪烷胺 基'· 一詞表示二直«或支餹Ci- s烷按基如二甲胺基, 二乙胺基,甲乙胺基等;胺烷基"一諝表示胺基直鍵或 支鍵Cl - 30院基如按甲基,肢乙基,按丙基,胺丁基 ,胺戊基,胺己基,胺庚基,胺辛基等;"胺低硪烷基" 一詞表示胺基直鏈或支鏈Ci- 5烷基如胺甲基,胺乙 基,胺丙基等;"烷胺烷基H—飼表示直鍵或支鰱C 1 -烷胺基-直鍵或支鐽Cl - !〇烷基如甲胺基甲基,甲胺基 乙基,乙胺基甲基,甲按基丙基,丙胺基乙基,甲胺基 丁基,丁胺基己基,戊胺基甲基,甲按基己基,庚按基 丙基,丁胺基辛基等;"低碩烷胺基-低磺烷基"一詞表 示直鍵或支鍵Ci - 5烷胺基-直鍵或支鍵Ci - s烷基 如甲胺基甲基,甲胺基乙基,乙胺基甲基,甲胺基丙基 ,丙胺基乙基等;"二烷胺基烷基"一詞表示二直鏈或分 本紙張尺度逋用中國國家榇準(CNS ) A4規格(210X297公釐) --------AI 裝-- (請先.閲讀背面之注意事項再填寫本頁) 訂 線 A7 B7 經濟部中夬標準局負工消費合作杜印製 五、發明説明(, 支鍵Cl - 10烷胺基一直鏈或支鐽Cl - 10烷基如二甲胺 基甲基,二乙胺基甲基,二乙肢基丙基,二甲胺基丁 己胺基甲基,二戊胺基庚基,二辛胺基己基等;"二-低 磺烷胺基-低硪烷基"一詞表示二直鐽或支鐽Ci- 5烷 胺基-直鰱或支鏈Cl - s烷基如二甲胺基甲基,二乙胺 基甲基,二乙胺基乙基,二甲胺基丙基等;"羥烷基"一 詞表示羥基-直鐽或支鰱Cl - ω烷基如羥甲基,羥乙基 ,羥丙基,羥丁基,羥戊基,羥己基,羥戊基,羥辛基 等;"羥基-低硪烷基"一詞表示羥基-直鍵或支鍵Ci -烷基如羥甲基,羥乙基,羥丙基等;"鹵烷基"一詞表示 鹵-直鍵或支鐽Ci- 10烷基如氟甲基,氰甲基,溴甲 基,二氛甲基,三氟甲基,三氯甲基,氨乙基,二氣乙 基,三氨乙基,《丙基,《 丁基,氛戊基,《己基,氰 庚基,氣辛基等;"鹵-低硪烷基"一詞表示鹵直鏈或支鐽 Ci- s烷基如氣甲基,氰甲基,溴甲基,二«甲基,三氟 甲基,三氰甲基,«乙基,二氯乙基,三氢乙基,氯丙 基等;"烯基"一詞表示直鐽或支鍵C2- !〇烯基如乙烯 基,烯丙基,異丙烯基,丁烯基,戊烯基,己烯基, 庚烯基,辛烯基等;"低硪烯基"一詞表示直鏈或支鰱 c2- s烯基如乙烯基,烯丙基等;"亞烷基"一飼表示 直鏈或支鍵Cl _ 10亞烷基如亞甲基,亞乙基,亞丙基, 亞異丙基,亞丁基,亞己基,亞辛基等;”低碩亞烷基" 一詞表示直鐽或支鏈Ci- S亞烷基如亞甲基,亞乙基, 本紙張尺度適用中國國家標準(CMS ) A4规格(21.0X297公釐) --------《I裝-- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央樣準扃員工消费合作社印製 A7 B7___ 五、發明説明(fr ) 亞丙基,亞異丙基等;"瓌烷基"一詞表示β琛烷 基如琛丙基,環丁基,琛戊基,琢己基等;"琛烷環"一 鋪表示C 3 - s璨烷環如瓌丙烷,琛丁烷,琢己烷等; "琛基襄醯基Ν —詞表示直鍵或支鏟Ci- 10烷基裹匿基 如甲基磺醯基,乙基磺醒基,正-丙基嫌醯基,異丙基 磺醣基,正丁基磷醯基,異丁基礙醒基,第二丁基磺醣 基,第三丁基磺醒基,戊基雄醒基,己基磁醒基,庚基 磺醯基,辛基磺醒基等;"低硪烷基幾醣基” 一詞表示直 鍵或支鐽Ci- s烷基磺醻基如甲基磺醯基,乙基職醭 基,正丙基磺醒基,異丙基職醯基,正丁基裹醯基•異 丁基磺醯基,第二丁基磺釀基,第三丁基磯醯基,戊基 磺醯基等;H芳基”一豳表示苯基或萊基等;"芳基磺醯 基"一詞表示苯基礎醣基或萊基磯醯基等;”芳烷基"一 飼表示苄基或苯乙基等;及"雜瑷条基"一詞表示含有至 少一餡選自氣原子,氰原子及碱原子之雜原子作為生成 環之雜原子之4-貝,5-貝或6-貝琛条基或其樨合瑷条基 如一氣肆園基,一昧肆園基,一氮肆園基,呋喃基,批 咯基,咩吩基,枵唑基,異枵唑基,眯唑基,瞎唑基, 異咩唑基,吡咯啶基,苯駢呋喃基,苯駢咩睡基,吡疲 基,授啉基,嘧啶基或嗎啉基。 R2中經取代或未經取代之低«烷基,垸基•低》嫌 基,烯基,琢烷基,芳基或雑環糸基之取代基;R3中 經取代或未經取代之低硪烷基,烷基,低硪烯基,嫌基 ,環烷基,芳基,低硪烷氣基,烷《基,低硪烷硫基或 本紙张尺度適用中國國家橾隼(CNS〉A4规格(210X297公釐〉 I------At 裝—----訂—-^----Γ 線 (請先閲讀背面之注意事項再填寫本頁) Α7 Β7 五、發明説明(7) 烷硫基之取代基;R4中經取代或未經取代之低硪烷基 ,烷基,低硪烯基,烯基,珊烷基,芳烷基,芳基,低 磺烷氣基/烷氣基,低磺烷磷基或烷硫基之取代基;R 5 中經取代或未經取代之低碩烷基,烷基,琛烷基,低硪 烷基裹釀基,烷基雇醯基,芳基_醸基,醴基或芳基之 取代基;Re中經取代或未經取代之低磺烷基,烷基, 低硪烷氣基,烷氧基,低硪烷硫基或垸硫基之取代基; 及Y中經取代或未經取代之低碩烷基,烷基,低硪烷氣 基,烷氣基,低磺烷硫基或烷硫基之取代基包含鹵原子 ,氱基,經保護或未經保護之羧基,經保護或未經保護 之羥基,經保謹或未经保護之胺基,低硪烷基,低磺烷 氧基,低磺烷氣羰基,芳基,琛烷基,低硪烯基,鹵-低硪烷基,經保護或未經保護之低磺烷胺基及二-低硪 烷胺基,且可由此等取代基中之至少一者取代β 經濟部中央標準局w:工消费合作社印製 (請先閲讀背面之注意事項再填寫本頁) 羧基保護基包含全部習知羧基保護基,持別值得一提 者為低磺烷基如甲基,乙基,正丙基,異丙基,1,卜二 甲基丙基,正-丁基,第三-丁基等;芳基如苯基,萊基 等;芳-低硪烷基如苄基,二苯甲基,三苯甲基,對-硝 苄基,對-甲氣苄基,贰(對-甲氧苯基)甲基等;g基-低 碩烷基如乙醏基甲基,苯甲醯基甲基,對-硝苯甲醯基甲 基,對-澳苯甲酵基甲基,對-甲烷磺酵基苯甲匿基甲基 等;含氣雜琛糸基如2-四氳哌喃基,2-四氫呋喃基等; 鹵-低硪烷基如2,2,2-三氯乙基等;低磺烷基矽烷基烷 基如2-(三甲基矽烷基)乙基等;醯氣烷基如乙醏霣甲基 本紙張尺度適用中國國家橾準(bNS〉Α4規格(210Χ297公釐) 經濟部中央標準局貝工消費合作社印製 Α7 Β7 五、發明説明(s ) ,丙醯氣甲基,特戊酯氣甲基等;含氪雜環条低硪烷基 如酴二醯胺基甲基,丁二酵亞胺甲基等;環烷基如琛己 基等;低铒烷氧-低硪烷基如甲氧甲基,甲氧基乙氣甲 基,2-(Ξ甲基矽烷基)乙氣甲基等;芳-低硪烷氣基-低 硪烷基如苄氣甲基等;低磺烷硫基-低硪烷基如甲碕基 甲基,2-甲硫基乙基等;芳硫基-低硪烷基如苯硫基甲 基等;低磺烯基如1,1-二甲基-2-丙烯基,3-甲基-3-丁 烯基,烯丙基等;及經取代之矽烷基如三甲基矽烷基, 三乙基矽烷基,三丙基矽烷基,二乙基異丙基矽烷基, 第三-丁基二甲基矽烷基,第三-丁基二苯基矽烷基,二 苯基甲基矽烷基,第三-丁基甲氧基苯基矽烷基等;等。 又經保護之胺基,低磺烷胺基,烷胺基,胺基-低磺 烷基,胺烷基,低硪烷胺基-低磺烷基或烷胺基烷基三 保護基包含全部習知胺基保護基,特別值得一提者為醣 基如三氯乙氣羰基,三溴乙氣羰基,苄氣羰基,對-硝 苄基羧基,鄰-溴苄氣羰基,(單二-或三氰乙醣基 ,三氟乙酵基,苯基乙醣基,甲醣基,乙醯基,苯甲酵 基,第三-戊氣羰基,第三-丁氣數基,對-甲氣苄氣羰 基,3,4-二甲氣苄氣羰基,4-(苯基馬«)苄氣羰基,2-糠氧羰基,二苯基甲氧羰基,1,1-二甲基丙《羰基,異 丙氣羰基,酞藹基,丁二醯基,丙胺睡基,白胺醢基, 1-金明烷氣羰基,8-授啉氣羧基等;芳-低«烷基如节 基,二苯甲基,三苯甲基等;芳硫基如2-硝基苯硫基, 2,4-二硝基苯碱基等;烷基-及芳基-職醯基如甲烷磺醯 -10- 本紙張尺度適用中國國家橾準(CNS > Α4規格(210X297公釐) (請先閱讀背面之注意Ϋ項再填寫本頁) .ΛI 裝------訂| U----^線 經濟部中央標準局属工消费合作社印製 A7 _B7_五、發明説明(9 ) 基,對-甲苯满醯基等;二-低磺烷胺基-低硪亞垸基如 N,N-二甲胺基亞甲基等;芳-低磺亞烷基如亞苄基,2-羥亞苄基;2-羥-5-氰亞苄基,2-羥-1-萊基亞甲基等; 含氰雑環条亞烷基如3-羥-4-毗啶基亞甲基等;亞琛烷 基如亞環己基,2-乙«羰基亞瑷己基,2-乙«羰基亞環 戊基,2-乙K基亞_己基,3, 3-二甲基-5-氣亞琢己基 等;二芳基及二芳-低W烷基磷S基如二苯基磷醛基, 二苄基辟醯基等;含氧雜琛条烷基如5-甲基-2-氣- 2H-1,3-二氣-烯伍圃-4-基甲基等;經取代之矽烷基如三甲 基矽烷基等;等。 此外,锼保護之羥基,羥基-低硪烷基或羥烷基之保護 基包含全部習知羥基-保護基,特別值得一提者為醣基 如苄氣羧基,4-硝基苄《羰基,3,4-二甲氣苄氧嫌基, 甲*嫌基,.乙氣羰基,第三·丁氧玻基,1,卜二甲基丙 氣羰基,異丙氣羰基,異丁氣羰基,二苯基申氣羰基, 2,2,2-三氯乙氣羰基,2,2,2-三溴乙氧羰基,2-(三甲 基矽烷基)-乙氣羰基,2-(苯基磺醯基)乙氣羰基,2-( 三苯基膦醏基)乙氣羰基,2-槺氣羰基,1-金刚烷氣羰 基,乙烯氣嫌基,烯丙«羰基,S-苄硫羰基,4-乙氧-1-黎氣羰基,8-牲啉氧羰基,乙醯基,甲醯基,氰乙醱基 ,二教乙醴基,三氛乙醯基,三氟乙醯基•甲«乙醯基 ,苯氣乙醣基,待戊醯氧基,苯甲醯基等;低磺烷基如 甲基,第三-丁基,2,2, 2-三氛乙基,2-三甲基矽烷基乙 基等;低磺烯基如烯丙基等;芳低硪烷基,如苄基,對-11- (請先閲讀背面之注意事項再填寫本頁) 人|裝.R7 This paper size applies Chinese National Standard (_CNS) A4 specification (210X297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (4) The base of the erbium atom generates a base of alkane, and B Represents a fluorene atom, a sulfur atom, or an imine group which may be substituted by an alkyl group; and X represents a fluorene atom or a halogen atom, and thus the invention is completed. The present invention is explained in detail in the following β. Explain that unless the S line is specified in the 軎, the term " halogen atom " means a fluorine atom, a chlorine atom, a bromine atom or an iodine atom; the term " alkyl " Ci-10 alkyl such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second butyl, third butyl, pentyl, hexyl, heptyl, octyl, etc. &Quot; Lower alkyl " means straight or branched "C 1-5 alkyl such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second butyl , Third butyl, pentyl, etc .; "Alkyl" refers to a straight or branched chain, such as a methyl group, a methyl group, a methyl group, an n-propyl group, an isopropyl group , N-butylfluorenyl, isobutoxy, second butanyl, third butoxy, pentyl, hexyl, heptyl, octyl, etc .; " lower alkyl " Straight or branched (31-5 alkyl groups such as methylamino, ethyl «, n-propanyl, isopropoxy, n-butanyl, isobutanyl, second butoxy, third butane Gasoyl, pentyloxy, etc .; " Alkylthio > The term quot means a linear or branched «Ci-! 〇 alkylthio group such as methylthio, ethylthio, n-propylthio, isopropylthio, n-butyl«, isobutylthio, second butylthio Group, third butylthio group, pentylthio group, hexylthio group, heptyl group, octylthio group, etc .; the term "lowly alkanoyl" means a straight or branched Ci-5 alkylthio group such as methylthio , Hexylthio, n-propyl base, isopropylthio, n-butylfluorenyl, isobutylthio, second butylsulfanyl, third butylsulfanyl, pentylthio, etc .; " fluorenyl •• means a formyl group , Linear or branched c2-S alkyl fluorenyl group such as ethyl fluorenyl group, this paper size applies the Chinese National Standard (0NS) A4 specification (210X297 mm) ----------- ^ < pack- ----- Order —- ^ ---- f line (please read the notes on the back before filling this page) Printed by A7 __ B7_ of the Consumer Co-operation of the Central Standardization Bureau of the Ministry of Economic Affairs V. Description of the Invention (4) Ethylcarboxyl, etc. or arylfluorenyl, such as benzamyl, lysyl, etc .; " low-nitroalkane carbonyl " means a straight or branched Ci-salkanecarbonyl group, such as methylamino, ethoxy Yiji, n-propyl, carbonyl, isopropyl *, butyl, carbonyl, isobutyl Carbonyl, second butane carbonyl, third butane fluorenyl, pentane carbonyl, etc .; " alkylamino " means a straight or branched bond ^^-ω alkylamino such as methylamino, ethylamino , Propylamino, butylamino, pentamine, hexylamine, heptylamine, octylamine, etc .; "lower alkylamino" means a straight or branched Ci-s alkylamino group such as methylamine -Ethylamino, propylamino, etc .; the term "dialkylamino" means a dimer or branched Ci-1D alkylamino group such as dimethylamino, diethylamino, methylethylamino, dipropylamino , Dibutylamino, dipentylamino, dihexylamino, diheptylamino, dioctylamino, etc .; " Di-oligomeric alkylamino " means the two straight «or branched Ci-s alkane According to groups such as dimethylamino, diethylamino, methylethylamino, etc .; amine alkyl " one 谞 means straight or branched amine group Cl-30, such as methyl, limb ethyl, propyl , Aminebutyl, aminepentyl, aminehexyl, amineheptyl, amineoctyl, etc .; " amine lower alkyl " means an amine linear or branched Ci-5 alkyl group such as aminemethyl, Amine ethyl, amine propyl, etc .; " Alkyl alkyl H-feed means straight or branch C 1 -Alkylamino-straight or branched Cl-! O alkyl such as methylaminomethyl, methylaminoethyl, ethylaminomethyl, methylaminopropyl, propylaminoethyl, methylamine Butylbutyl, butylaminohexyl, pentaminomethyl, methylidylhexyl, heptylpropyl, butylaminooctyl, etc .; " lower alkylamino-low sulfoalkyl " Straight or branched Ci-5 alkylamino-straight or branched Ci-s alkyl such as methylaminomethyl, methylaminoethyl, ethylaminomethyl, methylaminopropyl, propylaminoethyl The term "dialkylaminoalkyl" means two linear or branch paper sizes, using China National Standard (CNS) A4 (210X297 mm) -------- AI equipment -(Please read the precautions on the back before filling out this page) Order A7 B7 Printed by the Ministry of Economic Affairs, China Standards Bureau, Consumer Affairs Cooperation, Du Printed 5. Description of the invention (, branched Cl-10 alkylamino straight chain or Branched Cl-10 alkyl groups such as dimethylaminomethyl, diethylaminomethyl, diethyllimylpropyl, dimethylaminobutylhexylaminomethyl, dipentylaminoheptyl, dioctylamine Hexyl, etc .; " Di-oligosulfanylamino-lower alkyl "; The term means di- or dibranched Ci-5 alkylamino- or straight-chain or branched Cl-s alkyl such as dimethylaminomethyl, diethylaminomethyl, diethylaminoethyl, di "Methylaminopropyl", etc .; "hydroxyalkyl" means hydroxy-ortho or branched Cl-omega alkyl such as hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl, Hydroxyhexyl, hydroxypentyl, hydroxyoctyl, etc .; "hydroxy-lower alkyl" means hydroxy-straight or branched Ci-alkyl such as hydroxymethyl, hydroxyethyl, hydroxypropyl, etc .; The term "haloalkyl" means a halogen-straight or branched Ci-10 alkyl group such as fluoromethyl, cyanomethyl, bromomethyl, dioxanyl, trifluoromethyl, trichloromethyl, Aminoethyl, diaminoethyl, triaminoethyl, "propyl," butyl, pentyl, "hexyl, cyanoheptyl, octyl, etc .; " halo-lower alkyl " Represents halogen straight or branched Ci-s alkyl such as gas methyl, cyanomethyl, bromomethyl, di «methyl, trifluoromethyl, tricyanomethyl,« ethyl, dichloroethyl, tri Hydroethyl, chloropropyl, etc .; " alkenyl " means straight or branched C2-! 〇alkenyl such as Alkenyl, allyl, isopropenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, etc .; " lower alkenyl " means straight-chain or branched c2- s alkenyl such as vinyl, allyl, etc. " alkylene " represents a straight or branched chain Cl-10 alkylene such as methylene, ethylene, propylene, isopropylidene , Butylene, hexylene, octyl, etc .; "low master alkylene" means straight or branched Ci-S alkylene such as methylene, ethylene, this paper size applies Chinese national standards (CMS) A4 specification (21.0X297mm) -------- 《I Pack-(Please read the precautions on the back before filling this page) Order the central sample of the Ministry of Economic Affairs 扃 Printed by the consumer consumer cooperative A7 B7___ V. Description of the invention (fr) propylene, isopropylidene, etc .; " fluorinated alkyl " means β-alkynyl such as chenyl, cyclobutyl, chenpentyl, hexyl, etc .; " "Schenane ring" Yipu means C 3 -s sane ring such as fluorene propane, succinic butane, hexane, etc .; "Schenyl xiang" N — the word indicates a straight bond or branch Ci-10 alkyl coating Methylsulfonyl Ethylsulfonyl, n-propylsulfanyl, isopropylsulfosyl, n-butylphosphonium, isobutyl sulfonyl, second butylsulfonyl, third butylsulfonyl , Amyl androyl, hexyl, magnetic, heptylsulfonyl, octylsulfonyl, etc .; " lower alkylalkylglycosyl " means straight or branched Ci-s alkylsulfonyl Such as methylsulfonyl, ethylsulfanyl, n-propylsulfanyl, isopropylsulfanyl, n-butylsulfonyl • isobutylsulfonyl, second butylsulfonyl, Tributylisopropyl, pentylsulfenyl, etc .; Haryl "means phenyl or lycyl; etc .;" arylsulfonyl "means benzene-based glycosyl or lysylpyridinyl Etc .; "aralkyl" means benzyl or phenethyl, etc .; and "heteropyridyl" means that it contains at least one heteroatom selected from the group consisting of a gas atom, a cyan atom and a base atom. Heterocyclic atoms of 4-, 5-, or 6-Beschen strips or their coupling strips are, for example, a radical radical, a radical radical, a nitrogen radical, a furanyl radical, or a pyrrolyl radical. , Fluorenyl, oxazolyl, isoxazolyl, oxazolyl Group, oxazolyl, isoxazolyl, pyrrolidinyl, benzofuranyl, benzosulfanyl, pyrhexyl, pyrinyl, pyrimidinyl or morpholinyl. Substituted or unsubstituted low «alkyl, fluorenyl·low" alkyl, alkenyl, oxyalkyl, aryl or fluorenyl fluorenyl substituents in R2; substituted or unsubstituted low in R3 Alkyl, alkyl, alkalenyl, alkyl, cycloalkyl, aryl, alkane, alkane, alkanyl, alkanethio, or this paper is applicable to Chinese national rhenium (CNS> A4) Specifications (210X297mm) I ------ At Packing ------ Order --- ^ ---- Γ Line (Please read the precautions on the back before filling this page) Α7 Β7 V. Description of the invention ( 7) Substituents of alkylthio groups; substituted or unsubstituted lower alkyl groups, alkyl groups, lower alkylene groups, alkenyl groups, alkenyl groups, aralkyl groups, aryl groups, and low sulfonyl alkyl groups in R4 / Alkyl, sulfoalkylphosphino or alkylthio substituents; substituted or unsubstituted lower alkyl groups, alkyl groups, alkenyl groups, lower alkyl groups, alkyl groups in R 5 Alkyl, aryl-fluorenyl, fluorenyl or aryl substituents; substituted or unsubstituted lower sulfoalkyl, alkyl, lower alkane, alkoxy, lower alkanethio in Re Or a thiol substituent; and substituted or unsubstituted in Y Substituted lower alkyl, alkyl, lower alkane, alkane, sulfoalkylthio or alkylthio substituents containing halogen atoms, fluorenyl groups, protected or unprotected carboxyl groups, protected Or unprotected hydroxy, well-protected or unprotected amine, lower alkyl, lower sulfoalkoxy, lower sulfoalkane carbonyl, aryl, octyl, lower alkyl, halo-low Fluorenyl, protected or unprotected sulfoalkylamino and di-oligomeric amine, and may be substituted by at least one of these substituents β Central Bureau of Standards, Ministry of Economic Affairs w: printed by Industrial and Consumer Cooperatives (Please read the notes on the back before filling out this page.) The carboxy protecting group includes all the conventional carboxy protecting groups. It is worth mentioning that it is a low sulfoalkyl group such as methyl, ethyl, n-propyl, isopropyl, 1, dimethyl propyl, n-butyl, tertiary butyl, etc .; aryl groups such as phenyl, legyl, etc .; aryl-lower alkyl groups such as benzyl, benzyl, trityl , P-nitrobenzyl, p-methylbenzyl, fluoren (p-methoxyphenyl) methyl, etc .; g-lower alkyl such as ethenylmethyl, benzamylmethyl, p- Nifedipine Methyl, p-o-benzyl methyl, p-methanesulfonyl benzyl methyl, etc .; gas-containing heterobenzyl groups such as 2-tetrahydropiperanyl, 2-tetrahydrofuranyl, etc .; halogen -Lower alkyl groups such as 2,2,2-trichloroethyl, etc .; lower sulfoalkylsilyl groups such as 2- (trimethylsilyl) ethyl; etc. Paper size is applicable to China National Standard (bNS> A4 (210 × 297 mm)) Printed by Shellfish Consumer Cooperative of Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (s), propane gas methyl, tamyl gas methyl Etc .; fluorene-containing heterocyclic oligoalkyl groups such as fluorenediamidomethyl, succinimidomethyl, etc .; cycloalkyl groups such as oxohexyl, etc .; oligomeric alkoxy-lower alkyl groups such as methoxymethyl Methyl, methoxyethoxymethyl, 2- (fluorenylsilyl) ethoxymethyl and the like; aryl-lower alkylthio-lower alkyl such as benzylmethyl and the like; Lower alkyl groups such as methylmethyl, 2-methylthioethyl, etc .; arylthio-lower alkyl groups such as phenylthiomethyl, etc .; lower sulfenyl groups such as 1,1-dimethyl-2 -Propenyl, 3-methyl-3-butenyl, allyl, etc .; and substituted silyl groups Such as trimethylsilyl, triethylsilyl, tripropylsilyl, diethylisopropylsilyl, third-butyldimethylsilyl, third-butyldiphenylsilyl, Diphenylmethylsilyl, tert-butylmethoxyphenylsilyl, etc .; etc. Protected amines, oligosulphonylamino, alkylamino, amine-oligosulfanyl, aminealkyl, oligoalkylamino-oligosulfoalkyl or alkylaminoalkyl triprotective groups all Known amine protecting groups, especially worth mentioning are sugar groups such as trichloroethane carbonyl, tribromoethane carbonyl, benzyl carbonyl, p-nitrobenzyl carboxyl, o-bromobenzyl carbonyl, (monodi- Or tricyanoglycosyl, trifluoroethionyl, phenylethylglycosyl, methylosyl, acetamyl, benzoyl, third-pentylcarbonyl, third-butylene, p-methylene Benzylcarbonyl, 3,4-Dimethylbenzylcarbonyl, 4- (phenylmethyl «) benzylcarbonyl, 2-furyloxycarbonyl, diphenylmethoxycarbonyl, 1,1-dimethylpropanecarbonyl , Isopropylcarbonyl, phthalofluorenyl, succinimidyl, propylamine, leukoamino, 1-adaminyl carbonyl, 8-phosphinoyl carboxyl, etc .; aryl-lower alkyl such as benzyl, di Benzyl, trityl, etc .; arylthio groups such as 2-nitrophenylthio, 2,4-dinitrophenyl bases, etc .; alkyl- and aryl-alkyl groups such as methanesulfonyl-10 -This paper size applies to China National Standard (CNS > Α4 size (210X297mm) ( (Please read the note on the back before filling this page). ΛI Packing ------ Order | U ---- ^ Printed by the Industrial and Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 _B7_ V. Description of Invention (9 ) Group, p-tolyl fluorenyl and the like; bis-oligosulfanylamino-lower fluorenylene such as N, N-dimethylaminomethylene and the like; aryl-low sulfoalkylene such as benzylene, 2-Hydroxybenzylidene; 2-Hydroxy-5-cyanobenzylidene, 2-Hydroxy-1-lylmethylene, etc .; Cyanofluorene-containing ring alkylenes such as 3-hydroxy-4-pyridinylidene Methyl, etc .; aachen alkyl such as cyclohexylene, 2-ethyl «carbonylhexylene, 2-ethyl« carbonylcyclopentylene, 2-ethyl K-hexylene, 3,3-dimethyl-5 -Hexylene, etc .; diaryl and diaryl-lower W alkyl phosphorus S groups such as diphenylphosphonal, dibenzylpyridinyl and the like; oxalanyl alkyl groups such as 5-methyl- 2-Gas-2H-1,3-Digas-ene-Wu-4-ylmethyl, etc .; substituted silyl groups such as trimethylsilyl, etc .; etc. In addition, the hydroxyl groups protected by hydrazone, hydroxy-lower Alkyl or hydroxyalkyl protecting groups include all conventional hydroxy-protecting groups, especially notable are sugars such as benzyl carboxy, 4-nitrobenzyl, carbonyl, 3,4-dimethylbenzyloxy Methyl group, methyl group, ethyl carbonyl group, tert-butoxy glass group, 1, dimethyl dimethyl carbonyl group, isopropyl carbonyl group, isobutyl carbonyl group, diphenyl carbonyl group, 2,2 , 2-trichloroethoxycarbonyl, 2,2,2-tribromoethoxycarbonyl, 2- (trimethylsilyl) -ethoxycarbonyl, 2- (phenylsulfonyl) ethoxycarbonyl, 2- (Triphenylphosphinofluorenyl) ethane carbonyl, 2-fluorene carbonyl, 1-adamantane carbonyl, ethylene carbamoyl, allyl «carbonyl, S-benzylthiocarbonyl, 4-ethoxy-1-phenylene Carbonyl, 8-carboline oxycarbonyl, ethanoyl, formamyl, cyanoethanoyl, diethylethyl, trifluoroethyl, trifluoroethylethyl, methyl acetyl, ethylbenzene Group, pentamyloxy, benzamidine and the like; lower sulfoalkyl such as methyl, tertiary-butyl, 2,2,2-trifluoroethyl, 2-trimethylsilylethyl, etc .; Low sulfoalkenyl such as allyl; aralkylene such as benzyl, for -11- (Please read the precautions on the back before filling this page)

If 線 本紙浪尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央橾準局貞工消費合作社印製 A7 B7 五、發明説明(,。) -甲氧苄基,3,4-二甲氣苄基,二苯基甲基,三苯甲基 等;含氧及含碱雜琢糸基如四氫呋_,四氫哌喃基,四 氫硫醱晡華等;低硪烷氣-及低硪烷硫-低磺烷基如甲氣 甲基,甲硫甲基,苄軀甲基,2-甲氣乙氣甲基,2,2,2-三«乙氧甲基,2-(三甲基矽烷碁 > 乙翥甲基,1-乙氣乙 基等;烷基-及芳基-礙醒基如甲烷磺菌基,對-甲苯磺 醣基等;經取代之矽烷基如三甲基矽烷基,三乙基矽烷 基,三異丙基矽烷基,二乙基異丙基矽烷基,第三丁基 二甲基矽烷基,第三丁基二苯基矽烷基,二苯甲基矽烷 基,第三丁基甲氣苯基矽烷基等;等。 通式〔I〕表示之化合物之鹽包含通常為於_性基如 胺基等之已知邇及於酸性基如羥基,羧基等之鹽。於鹼 性基之鹽包含例如蘧與無機‘酸如氢氱酸,氳溴酸,硫酸 等生成之鹽;與有櫥羧酸如酒石酸,甲酸,掙櫬酸,三 氯乙酸,三氰乙酸等生成之鹽;及舆雄酸如甲烷磺酸 ,苯磺酸,對-甲苯磺酸,2,4,6-三甲苯職酸,萊磺酸 等生成之鹽;及於酸性基之H包含例如輿鱷金屬如銷, 鉀等生成之鹽;與齡土金饜如鈣,鎂等生成之*;銨鹽 ;含氮有機鐮如三甲胺,三乙胺,三丁胺,吡啶,Ν,Ν-二甲基苯胺,Ν -甲基六氫毗啶,Ν -甲基二乙胺, 二環己胺,普洛卡因(procaine),二苄胺,Ν-苄基-彡-苯乙胺,1-依凡那朗(ephenamine), Ν,ΙΓ·二苄基伸乙 基二胺等;等》通式〔1]表示之鹽中以《藥表可接受性鹽 為佳β -1 2- 本紙張尺度逋用中國國家橾準(CNS > Α4规格(210X297公釐) ---------^ I 裝------1Τ--^----「線 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央揉準局貝工消費合作社印裝 A7 B7 五、發明説明(d) 本發明化合物中,較佳者為下述通式〔1〕化合物, 其中R2表示經取代或未經取代之低硪烷基,低硪烯基 ,環烷基,,芳基或雜琢基;R3表示選自下列之至少一 基:氳原子,鹵原子經取代或未經取代之低硪烷基,低 硪烯基,琢烷基,芳基,低硪烷氣基或低磺烷硫基,硝 基,氱基,醯基,經保護或未經保護之羥基,經保護或 未經保護之羥-低磺烷基,經保護或未經保護之胺基, 經保護或未經保護之低硪烷胺基,二-低碩烷基胺基, 經保護或未經保護之胺基-低磺烷基,經保護或未經保 護之低磺烷胺基-低碩烷基及二-低硪烷胺基-低硪烷基 ;R 4表示選自下列之至少一基:氲原子,鹵原子,經 取代或未經取代之低硪烷基,低硪烯基,環烷基,芳烷 基,芳基,低硪烷氱基或低硪烷硫基,經保護或未經保 護之羥基,經保護或未經保護之羥基-低磺烷基,經保 護或未經保護之胺基,經保護或未經保隳之低碩烷胺基 ,二-低硪烷胺基,經保護或未經保護之胺基-低碩烷基 ,經保護或未經保護之烷胺基-低硪烷基,二-低硪烷基 胺基-低硪烷基·,低硪亞烷基,氧基,亞抜基及與R4鍵 结之磺原子生成琢烷環之基;RS表示氬原子,經取代 或未經取代之低磺烷基,琛烷基,低硪烷基磺醒基,芳 基磔醯基,酵基或芳基,經保護或未經保護之胺基-低硪 烷基,經保護或未經保護之低磺烷胺基-低碩烷基,二-低碩烷胺基-低硪烷基或經保護或未經保護之羥基-低硪 烷基;R6表示蠹原子,鹵原子,經取代或未經取代之 -1 3- 本紙張尺度適用中國國家標準(CNS ) Μ規格(210X297公釐) ---------^ I裝------訂丨^.----f線 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央橾準局負工消费合作杜印製 A7 B7 五、發明説明(ι>) 低硪烷基,低硪烷《基或低磺烷硫基,經保護或未經保 饉之羥基,經保護或未經保護之胺基或硝基;Na/表示If the size of the paper wave is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) Printed by A7 B7 of the Zhengong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (,... -Dimethylbenzyl, diphenylmethyl, trityl, etc .; oxygen-containing and alkali-containing heterocyclic groups such as tetrahydrofuran, tetrahydropiperanyl, tetrahydrothiosulfa, etc .; Alkane- and oxane-sulfo-lower sulfoalkyl groups such as methyl methyl, methylthiomethyl, benzyl methyl, 2-methyl ethyl methyl, 2,2,2-triethoxymethyl , 2- (trimethylsilane 碁) > Acetylmethyl, 1-ethoxyethyl, etc .; Alkyl- and aryl-hexyl groups such as methanesulfonyl, p-toluenesulfonyl, etc .; substituted Silyl groups such as trimethylsilyl, triethylsilyl, triisopropylsilyl, diethylisopropylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilane Group, benzylsilyl group, tert-butylmethylphenylsilyl group, etc .; etc. The salt of the compound represented by the general formula [I] contains a known group usually having a basic group such as an amino group and an acid group. Such as hydroxy, carboxyl and other salts. Basic group salts include, for example, salts produced by amidine and inorganic 'acids such as hydrofluoric acid, ammonium bromide, sulfuric acid, and the like; and formed with carboxylic acids such as tartaric acid, formic acid, picolinic acid, trichloroacetic acid, and tricyanoacetic acid. Salts; and salts produced from maleic acids such as methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, 2,4,6-trimethylbenzene acid, lysenesulfonic acid, and the like; Salts produced by crocodile metals such as pins, potassium, etc .; with age soils such as calcium, magnesium, etc .; ammonium salts; nitrogen-containing organic sickles such as trimethylamine, triethylamine, tributylamine, pyridine, Ν, Ν- Dimethylaniline, N-methylhexahydropyridine, N-methyldiethylamine, dicyclohexylamine, procaine, dibenzylamine, N-benzyl-fluorene-phenylethylamine, 1-Evanamine (ephenamine), Ν, ΙΓ, dibenzyl ethylene diamine, etc .; etc. Among the salts represented by the general formula [1], the "acceptable salt of the drug table is preferred β 1-2"- Paper size: China National Standard (CNS > Α4 size (210X297mm) --------- ^ I pack ------ 1T-^ ---- "line (please first (Please read the notes on the back and fill in this page.) Printed by A7 B7 V. Description of the invention (d) Among the compounds of the present invention, the compounds of the following formula [1] are preferred, wherein R2 represents a substituted or unsubstituted lower alkylene group, a lower alkylene group, Cycloalkyl, aryl, or heterocarbo; R3 represents at least one group selected from the group consisting of fluorene, halogenated or unsubstituted lower alkyl, haloalkenyl, alkyl, aryl , Low alkyloxanyl or sulfoalkylthio, nitro, fluorenyl, fluorenyl, protected or unprotected hydroxy, protected or unprotected hydroxy-low sulfoalkyl, protected or unprotected Protected or unprotected oligoalkylamine, di-lower alkylamine, protected or unprotected amine-oligosulfonyl, protected or unprotected Sulfoalkylamino-lower alkyl and di-lower alkylamino-lower alkyl; R 4 represents at least one group selected from the group consisting of a halogen atom, a halogen atom, substituted or unsubstituted lower alkyl Group, oligoalkenyl, cycloalkyl, aralkyl, aryl, oligomeric alkyl or oligoalkylthio, protected or unprotected hydroxy, protected or unprotected Protected hydroxy-low sulfoalkyl, protected or unprotected amine, protected or unprotected lower alkylamine, di-lower alkylamine, protected or unprotected amine -Lower alkyl, protected or unprotected alkylamino-lower alkyl, di-lower alkylamino-lower alkyl ·, lower alkylene, oxy, fluorenyl and The sulfonic atom bonded to R4 forms a alkane ring group; RS represents an argon atom, a substituted or unsubstituted lower sulfoalkyl group, an octyl group, a lower alkylsulfonyl group, an arylfluorenyl group, and a ferment Or aryl, protected or unprotected amine-lower alkyl, protected or unprotected low sulfoalkylamino-lower alkyl, di-lower alkylamino-lower alkyl Or protected or unprotected hydroxy-lower alkyl; R6 represents a fluorene atom, a halogen atom, substituted or unsubstituted 1-3 3- This paper size applies to Chinese National Standard (CNS) M specifications (210X297 mm) ) --------- ^ I install ------ order 丨 ^ .---- f line (please read the precautions on the back before filling this page) Consumption cooperation Du printed A7 B7 V. Invention theory (Ι >) Wo lower alkyl, lower alkyl Wo "sulfo group or lower alkylthio group, a hydroxyl group protected with or without the security Jin, the nitro group or the protected or unprotected; Na / represents

或\/其中Y表示氫原子,谢原子,經取代或未經取 IOr / / where Y represents a hydrogen atom, Xie atom, substituted or unselected I

Y 代之低硪烷基,低磺烷氣基或低硪烷硫基或經保護或未 經保護之羥基或與R2生成下式表示之基;Y is substituted with lower alkyl, lower sulfoalkane or lower alkylthio, or protected or unprotected hydroxyl group or a group represented by the following formula with R2

其中R7表示衋自下列之至少一基:氳原子,低磺烷基, 鹵-低磺烷基,經保護或未經保謹之羥-低硪烷基,低硪 亞烷基及輿R7鍵結之硪庳子生成璨烷顧之基,及B表 示氣原子,硫原子或亞胺基,其可由低硪烷基取代及X 表示曲原子。更佳者為上述之化合物,但R3表示選自 下列之至少一者:*原子,曲原子,經取代或未經取代 之低硪烷基,低磺烷氣基或低硪烷昧基,硝基,氱基, 經保護或未經保護之羥基及經保護或未經保護之胺基》 特佳者為前述化合物,但R4為S自下列之至少一基: 氳原子,經取代或未經取代之低硪烷基,低硪亞烷基及 與R4鍵結之硪原子生成之琛烷環。待佳為前述化合物 但R5表示氫原子或經取代或未經取代之低磺烷基或琛 烷基》 本發明化合物中,代表性化合物如下: •卜琢丙基-6-氟- 7- (異吲呤-基卜8_甲基_1,4_ 一 «-4-氧基吱啉-3-羧基 .1-乙基-6-氟- 7- (異吲》朵啉-卜基)_8_甲基_1,4_二氮 -4-翥基H啉-3-羧酸 "14- 本紙張尺度逋用中國國家橾隼(CNS > ΛΑ规格(210X297公釐) --------f -裝------τίί----ΙΓ 線 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 A7 B7_ 五、發明説明(Μ ) • 1-(2,4-二氟苯基)-6-氟-7-(異吲呤啉-5-基)-8-甲基 -1,4-二氫-4-氣基S啉-3-羧酸 • 6-氟-1: (4-羥苯基>-7-(異吲哚啉-5-基)-8-甲基-1,4 -二氫-4-氣基睹啉-3-羧酸 • 6-氟-1-(4-氟苯基>-7-(異吲呤囀-5-基)-8-甲基-1,4 -二氫-4-氣基技啉-3-羧酸 • 6-氟- l-〔(lR,2S)-2-氟琛丙基〕-7-(異吲呤啉-5-基) -8-甲基-1 , 4-二餛-4-氧基1¾啉-3-羧酸 • 1-環丙基-6-氟-8-甲基- 7-(2-甲基-異吲I朵_-5-基) -1,4-二篇-4-氣基睹淋-3-搂酸 • 1-乙基-6-氟-8-甲基- 7- (2 -甲基異1¾呤啉-5-基)-1, 4-二氫-4-氣基睡啉-3-羧酸 • 1-(2,4 -二氟苯基)-6 -氟-8-甲基- 7- (2 -甲基異吲呤啉 -5-基)-1,4-二氫-4-氣基授啉-3-羧酸 .6-氟-卜(4-羥苯基>-8-甲基- 7-(2-甲基異吲呤啉- 5-基)-1,4-二氫-4-氣基睡啉-3-羧酸 • 6-氟-1- (4-氟苯基> -8-甲基-7- (2-甲基異吲呤啉- 5-基)-1,4-二氫-4-氣基理啉-3-羧酸 • 6-氟-l-〔(lR,2S)-2-氟琛丙基〕-8-甲基-7-(2-甲基 異吲呤啉-5-基)-1,4 -二氫-4-氣基喹咻-3-羧酸 • 1-琢丙基-6-氟- 7- (異吲丨朵啉-5-基)-1,4 -二氫-4-氣 基1¾啉-3 -羧酸 _ 1-乙基-6-氣- 7-(異吲呤啉-5-基)-1,4-二氫-4-氣基 »奎W -3-羧酸 -1 5- 本紙張尺度適用中國國家標準(tNS ) A4規格(2丨OXW7公釐) --------f 1裝-- (請先閱讀背面之注意事項再填寫本頁) 訂 U1. •Γ線 經濟部中央標準局員工消費合作社印製 A7 B7__ 五、發明説明(以) • 1-(2,4-二氟苯基)-6-氬- 7-(異吲呤淋-5-基>-1,4-二 氬-4-«基If啉-3-羧酸 • 6-氣-1 了(4-翔苯基)-7-(異时丨時 # - 5-基)-1,4 -二 fi - 4 -氣基R _ -3-羧酸 • 6-氟-1-(4-氟苯基)-7-(異吲呤囀-5-基)-1,4-二氫-4 -氣基睹啉-3-羧酸 • 6-氟-1-〔(1R.2S)-2-氟環丙基〕-7-(異吲哚啉-5-基) -1,4 -二氧-4-氣基if解-3-矮酸 • 1-琛丙基- β-氟 - 7-(2-甲基-異吲呤啉-5-基)-1,4-二氫 -4-氧基喹咻-3-羧酸 •卜乙基-6 -氟-7 - ( 2 -甲基異吲呤啉-5 -基)-1 , 4 -二氫-4 -氣基授啉-3-羧酸 • 1-(2, 4-二氟苯基)-6-氟- 7-(2-甲基異吲H朵林-5-基)-1 , 4-二氳-4-氣基》啉-3-羧酸 • 6-氟-1-(4-羥苯基>-7-(2-甲基異吲I朵啉-5-基)-1,4-二氳-4-氣基技啉-3-羧酸 • 6-觎-1- (4-氟苯基)-7- (2-甲基異吲哚啉-5-基)-1 , 4-二氫-4-氧基眭啉-3-羧酸 .8-氰-1 -〔( 1 R · 2 S ) - 2-氰琛丙基〕-7 - ( 2 -甲基異吲H朵 啉-5-基)-1,4-二氫-4-氣基if啉-3-羧酸 • 1-琛丙基-6-氰- 7- (異吲哚啉-5-基>-8 -甲氧基-1,4-二氫-4-氣基B啉-3-羧酸 • 1-乙基-6-氟- 7- (異吲II朵啉-5-基)-8 -甲氣基-1,4 -二 氳-4-氣基技啉-3-羧酸 -1 6 本紙張尺度適用不國國家標準(&NS ) A4規格( 210X297公釐) --------f 裝.------訪 r---f 線 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標隼局員工消費合作杜印裂 A 7 B7 五'發明説明(κ) • 1-(2,4-二氟苯基)-6-藥- 7-(異吲呤_ - 5-基)-8-甲氧 基-1,4 -二氳-4-氣基H琳-3-袋酸 .6 -氟-1,- ( 4 -羥苯基)-7 -(異吲哚啉-5 -基)-8 -甲氧基-1 ,4-二氫-4-氣基挂_ -3-羧酸 • 6-氟-1-(4-氟苯基)-7-(異吲I朵啉-5-基>-8-甲氣基-1 ,4 -二氳-4 -氧基β啉-3 -羧酸 • 6-氰-1-〔(1R,2S )-2-氟琛丙基〕-7-(異吲呤啉-5-基) -8-甲氣基-1,4-二氳-4-氣基PfW:-3-羧酸 • 1-琛丙基-6-幫-8-甲基- 7- (2 -甲基-異13丨時林-5-基)-1 ,4-二氬-4-氣基丨i啉-3-羧酸 •卜乙基-6-氟-8-甲氣基- 7- (2 -甲基異吲呤啉-5-基)-1 ,4-二氫-4-氣基挂财-3-竣酸 • 1-(2,4-二氟苯基)-6-氟-8-甲氣基- 7-(2-甲基異吲呤 啉-5」基)-1,4-二氫-4-氧基理W-3-羧酸 • 6-概-1- (4-羥苯基> -8-甲氣基-7- (2-甲基異吲呤啉-5 -基)-1,4-二氫-4-氣基丨f啉-3-羧酸 • 6-氟-卜(4-氟苯基)-8-甲氣基-7- (2-甲基異吲ί朵啉-5 -基)-1,4-二氳-4-氧基丨奎啭-3-羧酸 • 6-氟- l-〔(lR,2S)-2-氟琛丙基〕-8-甲氣基- 7-(2-甲 基異吲哚啉-5-基)-1,4 -二氫-4-氣基技啉-3-羧酸 • 8-氨-卜琛丙基-6-氟- 7-(異吲哚_-5-基)-1,4-二氳-4-氧基β啉-3-羧酸 • 8 -氱-1-乙基-6-氣- 7- (異_3丨丨$淋-5-基)-1,4 -二氫- 4-氣基丨f啉-3 -羧酸 -1 7 - 本紙張尺度適用中國國家標车(CNS ) A4規格(210X297公釐) --------^、批衣-- (請先閲讀背面之注意事項再填寫本頁)Wherein R7 represents at least one of the following groups: fluorene atom, lower sulfoalkyl group, halo-lower sulfoalkyl group, protected or unprotected hydroxy-lower alkyl group, lower fluorene group and R7 bond The resulting gardenia produces a alkane group, and B represents a gas atom, a sulfur atom, or an imine group, which may be substituted by a lower alkyl group and X represents a curved atom. More preferred are the above-mentioned compounds, but R3 represents at least one selected from the group consisting of: * atom, curved atom, substituted or unsubstituted lower alkyl group, lower sulfoalkyl group or lower alkyl group, nitrate Phenyl group, fluorenyl group, protected or unprotected hydroxyl group and protected or unprotected amine group. Particularly preferred are the aforementioned compounds, but R4 is at least one group of S from: fluorene atom, substituted or unprotected Substituted lower alkylene, lower alkylene and alkylene ring formed by the halogen atom bonded to R4. Desirable are the aforementioned compounds but R5 represents a hydrogen atom or a substituted or unsubstituted low sulfoalkyl or octyl group. "Among the compounds of the present invention, the representative compounds are as follows: Isoindin-kib 8-methyl_1,4_ mono «-4-oxysuccinol-3-carboxyl. 1-ethyl-6-fluoro-7- (isoindolino-porphyrin-boxy) _8 _Methyl_1,4_diaza-4-fluorenyl Holin-3-carboxylic acid " 14- This paper uses China National Standard (CNS > ΛΑ Specifications (210X297 mm) ---- ---- f -install ------ τίί ---- IΓ line (please read the notes on the back before filling this page) Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7_ V. Description of the invention ( Μ) • 1- (2,4-difluorophenyl) -6-fluoro-7- (isoindolinolin-5-yl) -8-methyl-1,4-dihydro-4-amino group S Phenyl-3-carboxylic acid • 6-fluoro-1: (4-hydroxyphenyl) -7- (isoindololin-5-yl) -8-methyl-1,4-dihydro-4-gas Metholin-3-carboxylic acid6-fluoro-1- (4-fluorophenyl) -7- (isoindolinamidin-5-yl) -8-methyl-1,4-dihydro-4 -Gastoline-3-carboxylic acid • 6-fluoro- l-[(lR, 2S) -2-fluorosynyl] -7- (isoindolinolin-5-yl) -8-methyl- 1, 4-Difluorene-4-oxo 1¾line-3-carboxylic acid • 1-cyclopropyl-6-fluoro-8-methyl-7- (2-methyl-isoindo Idol_-5-yl) -1,4-bihan-4 -Aminomethyl-3-amino acid • 1-ethyl-6-fluoro-8-methyl-7- (2-methyliso1¾olinolin-5-yl) -1, 4-dihydro-4 -Aminopyridin-3-carboxylic acid • 1- (2,4-difluorophenyl) -6-fluoro-8-methyl-7- (2-methylisoindolinolin-5-yl)- 1,4-dihydro-4-amino-phenanthroline-3-carboxylic acid. 6-fluoro-bu (4-hydroxyphenyl) -8-methyl-7- (2-methylisoindolinline- 5-yl) -1,4-dihydro-4-aminopyridin-3-carboxylic acid • 6-fluoro-1- (4-fluorophenyl) -8-methyl-7- (2-formyl) Isoindolinline- 5-yl) -1,4-dihydro-4-yloxyline-3-carboxylic acid • 6-fluoro-l-[(lR, 2S) -2-fluorochenyl] -8-Methyl-7- (2-methylisoinolinolin-5-yl) -1,4-dihydro-4-aminoquinoline-3-carboxylic acid Fluoro-7- (isoindoline-5-yl) -1,4-dihydro-4-amino 1¾line-3-carboxylic acid_1-ethyl-6-gas-7- (isoindolin Porphyrin-5-yl) -1,4-dihydro-4-amino group »Quydroxy-3-3-carboxylic acid-1 5- This paper size applies to Chinese national standard (tNS) A4 specification (2 丨 OXW7 mm)- ------- f 1 pack-(Please read the notes on the back before filling this page) Order U1. • Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economics A7 B7__ 5. Description of the invention (to) • 1- (2,4-difluorophenyl) -6-argon-7- (isoindolin- 5-yl > -1,4-diargon-4- «yl Ifline-3-carboxylic acid • 6-gas-1 (4-xiangphenyl) -7- (isochronous 丨 time #-5- Radical) -1,4-difi-4-4-amino radical R_-3-carboxylic acid • 6-fluoro-1- (4-fluorophenyl) -7- (isoindolinamidine-5-yl) -1 , 4-Dihydro-4 -aminoaminoline-3-carboxylic acid • 6-fluoro-1-[(1R.2S) -2-fluorocyclopropyl] -7- (isoindolinline-5-yl ) -1,4-dioxo-4-airyl if hydrolysate-3-dwarf acid • 1-chenpropyl-β-fluoro-7- (2-methyl-isoindolinolin-5-yl) -1 , 4-dihydro-4-oxyquinoline-3-carboxylic acid • ethyl-6-fluoro-7- (2-methylisoinolinolin-5-yl) -1, 4-dihydro-4- Pyroline-3-carboxylic acid • 1- (2, 4-difluorophenyl) -6-fluoro-7- (2-methylisoindoHdolin-5-yl) -1, 4-di氲 -4-Amino group> Phenyl-3-carboxylic acid • 6-fluoro-1- (4-hydroxyphenyl > -7- (2-methylisoindol Idololin-5-yl) -1,4 -Dipyridin-4-yloxyline-3-carboxylic acid • 6-fluorene-1- (4-fluorophenyl) -7- (2-methylisoindolin-5-yl) -1, 4 -Dihydro-4-oxyphospholine-3-carboxylic acid. 8-cyano-1-[( 1 R · 2 S)-2-cyanopropyl] -7-(2 -methylisoindole H dorolin-5-yl) -1,4-dihydro-4-amino ifolin-3-carboxy Acid 1-Ceryl-6-cyano-7- (isoindolinyl-5-yl) -8-methoxy-1,4-dihydro-4-amino-Bolin-3-carboxylic acid • 1-Ethyl-6-fluoro-7- (isoindolinylidolin-5-yl) -8-methylamino-1,4-difluoren-4-yloxy-3-carboxylic acid-1 6 The size of this paper is applicable to the national standard (& NS) A4 specification (210X297mm) -------- f installed .-------- visit r --- f line (please read the back first Please pay attention to this page, please fill in this page) Employees ’cooperation with the Central Bureau of Standards, Ministry of Economic Affairs, Du Yincha A 7 B7 Five 'Invention Description (κ) • 1- (2,4-difluorophenyl) -6-drug-7- (Isoindin_-5-yl) -8-methoxy-1,4-difluoren-4-yl-Hlyin-3-bagic acid. 6-fluoro-1,-(4-hydroxyphenyl) -7-(Isoindoline-5 -yl) -8 -methoxy-1,4-dihydro-4-aminoyl-3-carboxylic acid-6-fluoro-1- (4-fluorobenzene ) -7- (isoindolinylidolin-5-yl> -8-methylamino-1,4-difluorene-4 -oxybetaline-3 -carboxylic acid • 6-cyano-1- [ (1R, 2S) -2-fluorosynyl] -7- (isoindolinolin-5-yl) -8-methylamino-1,4-difluoren-4-yl PfW: -3-carboxy Acid • 1-chen Propyl-6-gang-8-methyl-7- (2-methyl-iso13 丨 hryn-5-yl) -1,4-diargon-4-yl group i-line-3-carboxylic acid • Ethyl-6-fluoro-8-methylamino- 7- (2-methylisoindolinolin-5-yl) -1,4-dihydro-4-aminoyl 3-caproic acid • 1 -(2,4-difluorophenyl) -6-fluoro-8-methylamino- 7- (2-methylisoindolinline-5 "yl) -1,4-dihydro-4-oxy W-3-carboxylic acid • 6-Homo-1- (4-hydroxyphenyl) -8-methylamino-7- (2-methylisoindolinline-5 -yl) -1,4- Dihydro-4-amino group f-line-3-carboxylic acid • 6-fluoro-bu (4-fluorophenyl) -8-methylamino group 7- (2-methylisoindolinyl-5- ) -1,4-Difluoren-4-oxy 丨 Quylen-3-carboxylic acid • 6-Fluoro-l-[(lR, 2S) -2-fluorosynyl] -8-methylamino- 7- (2-methylisoindololin-5-yl) -1,4-dihydro-4-amino-based morpholine-3-carboxylic acid • 8-Amino-Phenyl-6-fluoro-7 -(Isoindol_-5-yl) -1,4-bisfluoren-4-oxyβline-3-carboxylic acid • 8-fluoren-1-ethyl-6-gas-7- (iso_3丨 丨 $ -5--5-)-1,4 -dihydro- 4-gas-based folin-3 -carboxylic acid-1 7-This paper size applies to China National Standard Car (CNS) A4 specification (210X297 mm ) -------- ^, batch of clothing-(Please read the precautions on the back first (Fill in this page)

1T -f線 ' 41 · 經濟部中央標準局負工消費合作社印製 A7 B7__ 五、發明説明('b ) • 8 -氛-1 - ( 2,4 -二氟苯基)-.6 -氟-7 -(異吲1$啉-5-基)-1 ,4-二氫-4-氣基技啉-3-羧酸 • 8-氯-6Γ氟-1- (4-羥苯基)-7-(異吲昤ft - 5-基)-1 , 4-二氫-4-氣基BfW-3 -袋酸 • 8-氯-6-氟-1- (4-氟苯基)-7 -(異吲呤_ - 5-基)-1,4-二氫-4-«基If啉-3-羧酸 • 8-氰-6-氟-1-〔(1R,2S )-2-氟環丙基〕-7-(異吲丨朵淋 -5-基)-1,4-二氫-4-氧基HW-3-羧酸 .8-*-卜琛丙基-6-氟- 7-(2-甲基-異吲呤啉-5-基)-1, 4-二氫-4-氣基ΙΪ啉-3-羧酸 • 8-氰-1-乙基-6-氟-7-(2-甲基異吲I朵啉-5-基)-1,4-二氫-4-氣基睡啉-3-羧酸 • 8-氰-1-(2,4-二氟苯基)-6-氟- 7-(2-甲基異吲呤W-5 -基)-1,4 -二篇-4-氣基枝淋-3-搂酸 • 8-氮-6-氟-1-(4-羥苯基)-7-(2-甲基異吲呤啉-5-基) -1,4-二氫-4-氣基if啉-3-羧酸 • 8-氯-6-氟-卜(4-氟苯基)-7-(2-甲基異吲呤啉-5-基) -1,4-二氫-4-氧基技明:-3-羧酸 •8-氯-6-氟-1-〔(111,23)-2-氟琛丙基〕-7-(2-甲基異 吲昤啉-5-基)-1,4-二氫-4-氧基挂啉-3-羧酸 • 1-環丙基-6 ,8-二氰- 7-(異吲呤啉-5-基)-1,4-二氳- 4-氣基授啉-3-羧酸 • 1-乙基-6,8 -二氟- 7- (異吲呤啉-5-基&gt;-1,4 -二氫-4-氣 基技啉-3-羧酸 _ 1 8 _ 本紙張尺度適用中國國家橾準(CNS ) A4規格(210X297公釐) --------^ —裝------訂--„----「線 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝 A7 B7 五、發明説明(^ ) • 6,8 -二氟 1-(2,4 -二氟苯基)-7-(異吲《淋-5-基)-1,4 -二氫-4-氧基桂啉-3-羧酸 • 6,8-二疼-卜(4-羥苯基)-7-(異吲哚啉-5-基)-1,4-二 氫-4-氧基挂啉-3-羧酸 • 6,8-二氟-1-(4-氟苯基)-7-(異吲哚啉-5-基)-1,4-二 氳-4-氧基桂啉-3-羧酸 • 6, 8-二氟-1-〔(1R,2S)-2-氟環丙基〕-7-(異吲呤啉 -5 -基)-1,4 -二篇-4-氣基丨f # - 3-袋酸 • 1-環丙基-6, 8-二氟- 7-(2-甲基-異吲呤啉-5-基)-1, 4-二氫-4-氣基枝啉-3-羧酸 •卜乙基-6,8 -二氟- 7- (2 -甲基異吲U朵啉-5-基&gt;-1,4 -二 氳-4-氣基B1啉-3-羧酸 • 6,8-二氟-1-(2 ,4-二氟苯基)-7-(2-甲基異吲呤啉- 5-基)-1,4-二氳-4-氣基IH啉-3-羧酸 • 6,8 -二氟-1-(4 -羥苯基)-7-(2 -甲基異吲呤啉-5-基&gt;-1,4-二氫-4-«基(f咻-3-羧酸 • 6 , 8-二氟1- (4-氟苯基)-7- (2-甲基異13丨哚啉-5-基)-1 ,4-二氫-4-氧基技啉-3-羧酸 • 6,8-二氟-1-〔(lR,2S)-2-氟瑷丙基〕-7-(2-甲基異 吲昤啉-5-基)-1,4-二氫-4-氣基授啉-3-羧酸 • 1-琛丙基-6-氟- 7-(異吲呤琳-5-基)-1,4-二氫-4-氧 基-1 , 8-策啶-3-羧酸 • 1-乙基-6-氟- 7- (異吲H朵啉-5-基)-1,4 -二氬-4-氣基 -1,8-萊啶-3-羧酸 -1 9- 本紙張尺度遑用中國國家標準(CNS ) A4規格(210X297公嫠) ---------^ Ί裝------訂-------「線 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明Μ ) • 1-(2 ,4-二氟苯基)-6-氟- 7-(異吲呤啉-5-基)-1,4-二 氲-4-氣基-1,8-萊啶-3-羧酸 • 6-氟-1:( 4-羥苯基)-7-(異吲呤琳-5-基)-1,4-二氳-4 -氣基-1 ,8-萊啶-3-羧酸 • 6-氟-1-(4-氟苯基)-7-(異吲哚啉-5-基&gt;-1,4-二氫-4 -氣基-1 ,8-萊啶-3-羧酸 • 6-氟-1- [ (1R,2S )-2-氟環丙基〕-7-(異吲哚啉-5-基) -1,4-二氳-4-氧基-1,8-萊啶-3-羧酸 .1-琢丙基-6-氟- 7-(2-甲基-異吲呤W-5-基)-1·4-二氬 -4-氧基-1,8-萊啶-3-羧酸 • 1-乙基-6-氟- 7-(2-甲基異吲哚啉-5-基&gt;-1,4-二氲- 4-«基-1 ,8-萊啶-3-羧酸 • 1-(2,4-二氟苯基)-6-氟-7-( 2-甲基異吲哚_ - 5-基)-1 ,4-二氫-4-氣基-1,8-萊啶-3-羧酸 • 6-氟-1-(4-羥苯基&gt;-7-(2-甲基異吲哚啉-5-基)-1,4-二氫-4-氣基-1,8-萊啶-3-羧酸 • 6-氟-1-(4-氟苯基)-7-(2-甲基異吲哚I» -5-基)-1,4-二氳-4-氣基-1,8-策啶-3-羧酸 • 6-氟-卜〔(1R,2S)-2-氟琛丙基〕-7-(2-甲基異吲哚啉 -5-基)-1,4 -二'氫-4-氣基-1,8-萊淀-3-竣酸 • -9-氟-10-(異吲呤啉-5-基)-3-甲# -7-氧基-2 , 3-二氳 -7-吡啶駢〔1,2,3-de〕 〔1,4〕苯駢丨§阱-6-羧酸 • (S)-9-氟-10-(異吲J朵啉-5-基}-3-甲基-7-氣基- 2,3- 二氳-7-毗啶駢〔1,2, 3-de〕 〔1,4]苯駢丨§哄-6-羧酸 -20- ---------f —裝------訂|_.----(線 (請先閱讀背面之注意事項再填寫本頁) 本紙浪尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作杜印製 A7 _B7_ 五、發明説明) • 9-氟-3-甲基-10-(2-甲基異吲I采啉-5-基)-7-氣基-2, 3- 二氫-7-吡啶駢〔1,2,3-de〕 〔1,4〕苯駢垮阱-6-羧酸 _( S ) - 9 -第-3 -甲基-1 0 - ( 2 -甲基異吲哚啉-5 -基)-7 -氣 基-2,3-二氫-7-吡啶駢〔1,2,3-(16〕 [1,4〕苯駢垮阱 -6-羧酸 .1-琢丙基-5 ,6,8-三氟- 7-(異吲呤啉-5-基&gt;-1,4-二氫 -4-氧基B啉-3-羧酸 • 1-琢丙基-5 ,6,8-三氟-7-(2-甲基異吲昤_ - 5-基)-1, 4- 二氫-4-氣基睡啉-3-羧酸 • 1-環丙基-5, 6 ,8-三氟-7-(異吲呤咻-5-基)-1,4-二氳 -4-氣基B啉-3-羧酸 • 5 -胺基-1-環丙基-6,8 -二氣-7-(異丨f琳-5-基)-1,4-二氫-4-氣基β啉-5-羧酸 • 5-胺基-1-琢丙基-6,8-二氟- 7-(2-甲基異I引1朵_-5-基)-1,4-二氫-4-氣基桎啉-3-羧酸 • 1-璨丙S-6-氟- 7-(7-氟異吲呤啉-5-基)-1,4-二氫-4 -氣基桂啉-3-羧酸 • 1-琛丙基-6-氟- 7-(7-甲基異吲呤W-5-基&gt;-1,4-二氳 -4-氣基睡啉-3-羧酸 • 1-琢丙基-6-氣- 7- (4,6 ,7-三覩異丨§丨吟淋-5-基)-1,4-二氳-4-氣基授啉-3-羧酸 • 1-瑁丙基-6-氟- 7-(3-甲基異吲哚¢1:-5-基)-1,4-二氫 -4 -氣基挂囀-3-羧酸 • 1-琢丙基- 7-(1 ,3-二甲基異吲呤_ - 5-基)-6-氟-1,4- -2 1- 本紙乐尺度適用中國國家標準(CNS) A4規格(210X297公釐) T^n n^i i—· mi Kn 1 &quot;wv m vvn — n ^^^1 Μ 身 i ^ Λ&amp;. (請先閱讀背面之注意事項再填寫本頁) 〆 /V 明説 明 發五 - - 金 3 7 B : [0 稱麵 I 3 睡6 I a!睹, -丙 4 13 . 瑪 Ϊ ϊ - 氣 *1 I ·4二·- 酸 羧1T -f line '41 · Printed by A7 B7__ of the Central Laboratories of the Ministry of Economic Affairs and Consumer Cooperatives V. Description of the invention (' b) -7-(Isoin1 $ line-5-yl) -1,4-dihydro-4-airylline-3-carboxylic acid -7- (isoindioftft-5-yl) -1,4-dihydro-4-airyl BfW-3 -bagic acid • 8-chloro-6-fluoro-1- (4-fluorophenyl)- 7-(isoindolin_-5-yl) -1,4-dihydro-4- «yl If chloro-3-carboxylic acid • 8-cyano-6-fluoro-1-[(1R, 2S) -2 -Fluorocyclopropyl] -7- (isoindolinone-5-yl) -1,4-dihydro-4-oxyHW-3-carboxylic acid. 8-*-Buchenpropyl-6- Fluoro-7- (2-methyl-isoindolinolin-5-yl) -1,4-dihydro-4-aminoylpyridin-3-carboxylic acid • 8-cyano-1-ethyl-6- Fluoro-7- (2-methylisoindolinol-5-yl) -1,4-dihydro-4-aminopyroline-3-carboxylic acid • 8-cyano-1- (2,4- Difluorophenyl) -6-fluoro-7- (2-methylisoindin W-5 -yl) -1,4 -biphenyl-4-amino branched-leaching-3-carboxylic acid • 8-nitrogen- 6-Fluoro-1- (4-hydroxyphenyl) -7- (2-methylisoinolinolin-5-yl) -1,4-dihydro-4-amino ifolin-3-carboxylic acid • 8-chloro-6-fluoro-bu (4-fluorophenyl) -7- (2-methylisoinolinolin-5-yl) -1,4-dihydro-4 -Oxygen technology: -3-carboxylic acid • 8-chloro-6-fluoro-1-[(111,23) -2-fluorochenpropyl] -7- (2-methylisoindolinline-5 -Yl) -1,4-dihydro-4-oxoporphyrin-3-carboxylic acid • 1-cyclopropyl-6,8-dicyano-7- (isoindolinolin-5-yl) -1 1,4-Difluorene- 4-aminopyridin-3-carboxylic acid • 1-ethyl-6,8-difluoro-7- (isoindolinolin-5-yl)> -1,4-dihydro -4-Gastoline-3-carboxylic acid _ 1 8 _ This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) -------- ^ — 装 ----- -Order-„----" Line (Please read the precautions on the back before filling out this page) Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (^) • 6,8 -difluoro 1- (2,4-difluorophenyl) -7- (isoindole <5-5-yl) -1,4-dihydro-4-oxycinolin-3-carboxylic acid • 6,8-di Pa- (4-hydroxyphenyl) -7- (isoindololin-5-yl) -1,4-dihydro-4-oxoporphyrin-3-carboxylic acid • 6,8-difluoro- 1- (4-fluorophenyl) -7- (isoindololin-5-yl) -1,4-difluoren-4-oxylaurin-3-carboxylic acid • 6, 8-difluoro-1 -[(1R, 2S) -2-fluorocyclopropyl] -7- (isoindolinline-5 -yl) -1,4 -two articles-4-amino group f #-3-bagic acid • 1 -Cyclopropyl-6, 8-difluoro-7- (2-methyl-isoinolinolin-5-yl) -1,4-dihydro-4-aminodenoline-3-carboxylic acid • ethyl -6,8-difluoro-7- (2-methylisoindiolidene-5-yl &gt; &gt; -1,4-difluoren-4-ylamino B1line-3-carboxylic acid Difluoro-1- (2,4-difluorophenyl) -7- (2-methylisoindolinolin-5-yl) -1,4-difluoren-4-amino IH phthaloline-3-carboxy Acid • 6,8-difluoro-1- (4-hydroxyphenyl) -7- (2-methylisoindolinline-5-yl> -1,4-dihydro-4- «yl (f咻 -3-carboxylic acid • 6, 8-difluoro1- (4-fluorophenyl) -7- (2-methyliso13 丨 inolin-5-yl) -1,4-dihydro-4- Oxyline-3-carboxylic acid • 6,8-difluoro-1-[(lR, 2S) -2-fluoroamidinopropyl] -7- (2-methylisoindinoline-5-yl) -1,4-dihydro-4-aminohydantoline-3-carboxylic acid • 1-chenpropyl-6-fluoro-7- (isoindolinline-5-yl) -1,4-dihydro- 4-oxy-1, 8-Ceridine-3-carboxylic acid • 1-ethyl-6-fluoro-7- (isoindohordolin-5-yl) -1,4-diargon-4-gas -1,8-Radiidine-3-carboxylic acid-1 9- This paper uses Chinese National Standard (CNS) A4 (210X297) for paper size --------- ^ Outfit --- --- Order ------- "Line (Please read the notes on the back before filling this page) Central of the Ministry of Economy A7 B7 printed by the Consumer Cooperatives of the quasi bureau 5. Description of the invention M) • 1- (2,4-difluorophenyl) -6-fluoro-7- (isoindolinolin-5-yl) -1,4- Difluoren-4-yl-1,8-eryridin-3-carboxylic acid • 6-fluoro-1: (4-hydroxyphenyl) -7- (isoindolinline-5-yl) -1,4 -Diamidine-4 -Gasyl-1,8-lyridin-3-carboxylic acid • 6-fluoro-1- (4-fluorophenyl) -7- (isoindolinyl-5-yl &gt; -1 , 4-Dihydro-4 -amino-1,8-radidine-3-carboxylic acid • 6-fluoro-1- [(1R, 2S) -2-fluorocyclopropyl] -7- (isoindole Phenyl-5-yl) -1,4-bisfluoren-4-oxy-1,8-eryridine-3-carboxylic acid. 1-Chloropropyl-6-fluoro-7- (2-methyl-iso Indolin W-5-yl) -1 · 4-Diargon-4-oxy-1,8-Radiidine-3-carboxylic acid • 1-Ethyl-6-fluoro-7- (2-methyliso Indoline-5-yl &gt; -1,4-difluorene-4- «yl-1,8-eryridin-3-carboxylic acid • 1- (2,4-difluorophenyl) -6-fluoro -7- (2-methylisoindole_-5-yl) -1,4-dihydro-4-carbyl-1,8-eryridine-3-carboxylic acid 6-fluoro-1- (4 -Hydroxyphenyl &gt; -7- (2-methylisoindolin-5-yl) -1,4-dihydro-4-amino-1,8-eryridine-3-carboxylic acid • 6- Fluoro-1- (4-fluorophenyl) -7- (2-methylisoindole I »-5-yl) -1,4-difluoren-4-yl-1,8-ceridine-3 -Carboxylic acid • 6-fluoro-bu [(1R, 2S) -2- Fluoropropyl] -7- (2-methylisoindololin-5-yl) -1,4-di'hydro-4-carbyl-1,8-Lyodo-3-unsaturated acid • -9 -Fluoro-10- (isoindolinolin-5-yl) -3-methyl # -7-oxy-2, 3-difluorene-7-pyridine [1,2,3-de] [1,4 ] Benzene 骈 丨 §Trap-6-carboxylic acid • (S) -9-Fluoro-10- (isoindiolidene-5-yl) -3-methyl-7-airyl-2,3-difluorene -7-pyridine hydrazine [1,2, 3-de] 〔1,4] Benzene 骈 §-6-carboxylic acid-20- --------- f —pack -------- -Order | _.---- (line (please read the precautions on the back before filling this page) This paper wave scale is applicable to China National Standard (CNS) A4 specifications (210X297 mm) Printing A7 _B7_ V. Explanation of the invention) • 9-fluoro-3-methyl-10- (2-methylisoindolinium-5-yl) -7-amino-2, 3-dihydro-7 -Pyridine hydrazine [1,2,3-de] [1,4] benzene sulfonium-6-carboxylic acid_ (S)-9 -th -3 -methyl-1 0-(2 -methylisoindole Indolin-5 -yl) -7-amino-2,3-dihydro-7-pyridine hydrazine [1,2,3- (16] [1,4] benzene hydrazone-6-carboxylic acid.1 -Cyclopropyl-5,6,8-trifluoro-7- (isoinolinolin-5-yl)-1,4-dihydro-4-oxyB-line-3-carboxylic acid Propyl-5,6,8-trifluoro-7 -(2-methylisoindionium_- 5-yl) -1,4-dihydro-4-aminopyroline-3-carboxylic acid • 1-cyclopropyl-5, 6, 8-trifluoro- 7- (isoindolinamidine-5-yl) -1,4-diamidino-4-amino-Bolinyl-3-carboxylic acid • 5-amino-1-cyclopropyl-6,8-digas- 7- (iso 丨 flin-5-yl) -1,4-dihydro-4-airyl β-line-5-carboxylic acid • 5-amino-1-carbopropyl-6,8-difluoro- 7- (2-methylisopropyl 1--5-yl) -1,4-dihydro-4-aminopyridin-3-carboxylic acid • 1-Chrysanyl S-6-fluoro-7- (7-Fluoroisoinolinolin-5-yl) -1,4-dihydro-4 -aminocyanoline-3-carboxylic acid • 1-chenpropyl-6-fluoro-7- (7-methyl Isoinline W-5-yl &gt; -1,4-diamidino-4-aminopyroline-3-carboxylic acid1-propylpropyl-6-gas-7- (4,6,7-tris覩 iso 丨 § 丨 Glycol-5-yl) -1,4-Difluorene-4-ylaminophenyl-3-carboxylic acid • 1-Homopropyl-6-fluoro-7- (3-methyliso Indole ¢ 1: -5-yl) -1,4-dihydro-4 -aminopyridine-3-carboxylic acid • 1-Cyclopropyl-7- (1,3-dimethylisoindolin_ -5-based) -6-fluoro-1,4- -2 1- This paper scale is applicable to Chinese National Standard (CNS) A4 (210X297 mm) T ^ nn ^ ii— · mi Kn 1 &quot; wv m vvn — N ^^^ 1 Μ Body i ^ Λ &amp;. (Please read the notes on the back before filling in this ) 〆 / V Out the five confessed - - Gold 3 7 B: [0, said sleeping surface I 3 6 I a see - propan 413 Mar Ϊ ϊ - gas * 1 I · 4 · two - carboxylic acid!.

7 7 A B 基 - 5 I 啉 «31 異 基 甲 氫 二 甲酸甲 二羧二 _ _ 13 3 1 g 3 ( W ( 7 B 7 -£ -sEls UT*集弓 戸 I 尹 琛-4琛 1-氫1-•二· 氟 I 6 I 基 - 5 - 啉 2? ,31 0 - 6 曙 基 I 5 I 咻 引 Mr 酸 羧 - 3 I 啉0 基 氣 I 4 - 氳 二7 7 AB based-5 I phthaloline «31 Isomethyldicarboxylic acid dicarboxylic acid _ _ 13 3 1 g 3 (W (7 B 7-£ -sEls UT * 集 戸 I Yin Chen-4 Chen 1- Hydrogen 1- • di · fluoro I 6 I group-5-phthaloline 2?, 3 1 0-6 Eosin I 5 I hydration Mr acid carboxyl-3 I morpholine 0 base gas I 4-hydrazone

甲 氟 I 8 晒0 - 6 I 基 丙 琛 - 1A 基 I 5 啉 2? P3I 異 酸 羧 - 3 - Vi 基 氧 - 4 两 氲 二 甲 氟 - 8 - 氰 - 6 攀 基 乙 羧 I 3 - 啉 Ilf 基 氣 I 4 - 氳 二 «酸 基 - 5 - 囀 1¾ »3| 異 .^^ϋ. 1--— ί mu ml ·- -1 nn —i ml (請先閱讀背面之注意事項再填寫本頁) 基 8 1- 啉 * ^ tB T基 I)氧 基- 苯T氟«; 二二 I I 4 4 基 氣 甲 氟 I# 131 異 酸 羧 基 苯酸 羥羧 I - 4 3 ^' -1-啉基睡 Ξ基 氣ί l·-*氟-48-氫 R-一一 0 - 4 6 , 基 - 5 I 啉 朵 I ,j{ 異Methyl Fluoride I 8 Sun 0-6 I Phenyl-1A I 5 Porphyrin 2 P3I Isoacid Carboxylic Acid 3-Vi Hydoxy Oxygen 4 Methionyl Dimethyl Fluoride 8-Cyanide 6 Phenyl Ethyl Carboxyl I 3- Isoline Ilf base gas I 4-氲 bis «Acid-5-啭 1¾» 3 | iso. ^^ ϋ. 1 --— ί mu ml ·--1 nn —i ml (Please read the precautions on the back first Fill in this page) Group 8 1-Pholine * ^ tB T group I) Oxy-benzene Tfluoro 1-Porphyrinyl hydrazone, l ·-* fluoro-48-hydrogen R-one-0-4 6, radical-5 I phosphono I, j {iso

*1T* 1T

基 苯酸氟羧 - * 4 3 /IV | 1-啉 基枝 ^ 0 氣S 巾-«氟T 8-氫 mV 基 I 5 I 啉 ,jl 異 線 1 基 I I 氟-5 6w •»* 經濟部中央揉準局負工消費合作社印袈 3啉 *111 丙技 ^ 0 環ί R氧 0 一 4 2 I )-氫 S -2 二 * I R 4 枉 8 i- 2 氟氣 - I 6 4 I I 基氬 丙二 琢4- 甲0 啉 - 羧 氣3- 酸 氧 甲氟 酸 羧 異 基 - 5 1 啉 ϊ?, 異 I 基 甲 基 - 5 - 啉 Ϊ*異基 甲 - 2 /1 - 7 - 氣 甲氟 I 8 垂氟 - 6 I基乙 - 4 £2, 二-( 啉 授 基 氧 基苯0 二 氣 甲氟酸? 竣 Jm 2? HI異基 甲 本紙張尺度適用中國國家標準(CNS &gt; A4規格(210X297公釐) 經濟部中央標準局員工消費合作杜印袈 A7 B7_ 五、發明説明(Η ) 啉-5-基)-1,4-二氫-4-氧基睹啉-3-羧酸 • 6-氟-8-氰甲氣-1-(4-羥苯基)-7-(2-甲基異吲呤啉- 5-基)-l,4-p氫-4-氣基P1啉-3-羧酸 • 6-氟-8-氟甲氧-1-(4-氟苯基)-7-(2-甲基異吲呤啉- 5-基)-1,4-二氬-4-氣基睡啉-3-羧酸 •6-氰-卜〔(111,23)-2-氟琛丙基〕-8-氟甲氣-7-(2-甲 基異丨3丨找淋-5-基)-1,4-二氫-4-氣基睡淋-3-竣酸 •卜環丙基-8-二氟甲氣-6-氟- 7-(異吲I荣啉-5-基)-1,4 -二氳-4-«基β啉-3-羧敢 • 8-二氟甲氧-卜乙基-6-氟-7-(異吲呤啉-5-基)-1,4-二氳-4-氣基喹咻-3-羧酸 • 8-二氟甲氣-1-(2,4-二氟苯基)-β-氟- 7-(異吲哚咻-5-基)-1,4-二氫-4-氣基牲啉-3-羧酸 • 8-二氟甲氣-6-氟-1-(4-羥苯基)-7-(異吲哚啉-5-基) -1,4-二氫-4-氣基ϋ啉-3-羧酸 • 8-二氟甲《-6-氟-1-(4-氟苯基)-7-(異I引I荣啉-5-基) -1,4-二氫-4-氧基理啉-3-羧酸 .8-二氟甲氣-6-氟-l-〔(lR,2S)-2-氰琛丙基〕-7-(異 吲呤啉-5-基)-1,4-二氫-4-氣基桂咻-3-羧酸 • 1-環丙基-8-二氟甲氧-6-氟- 7-(2-甲基-異吲ί朵啉-5-基)-1,4 -二氫-4-氣基桂啉-3-羧酸 • 8-二氟甲氣-1-乙基-6-瓤- 7-(2-甲基異吲呤啉-5-基) -1,4-二氫-4-氣基II啉-3-羧酸 • 8-二氟甲氧-1-(2,4-二氟苯基)-6-籌- 7-(2-甲基異吲 -23- 本紙張尺度適用中國國家揉準(CNS ) A4規格(210X297公釐) I-------ζ 1等------訂--:----(線 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作杜印製 A7 B7_ 五、發明説明(0) 呤啉-5-基)-1,4-二氳-4-氣基11啉-3-羧酸 • 8 -二氟甲氣-6-氰-1-(4 -羥苯基)-7-(2 -甲基異吲呤啉 -5-基)-1,4-二氫-4-氣基β啉-3-羧酸 • 8-二氟甲氣-6-氟-1-(4-氟苯基)-7-(2-甲基異吲呤啉 -5-基)-1,4-二氲- 4-«基丨f啉-3-羧酸 •8-二氟甲氣-6-氟-卜〔(11?,28卜2-氟環丙基]-7-(2-甲基異吲呤啉-5-基)-1,4-二氫-4-氣基技淋-3-羧酸 •卜琛丙基-6-氟-8-羥- 7-(異吲丨朵咻-5-基卜1,4-二氫-4-氣基ϋ啉-3-羧酸 • 1_乙基-6-氣-8-翔- 7- (異丨引丨朵IS - 5-基)-1,4 -二氳- 4-氧基技啉-3-羧酸 .1-(2,4-二氟苯基)-6-氟-8-羥- 7-(異吲呤啉-5-基&gt;-1 ,4-二氫-4-氣基丨奎淋-3-羧酸 • 6-氣-8-理-1-(4-理苯基)-7-(異丨3丨找淋-5-基)-1,4-二氳-4-氣基桂林-3-羧酸 • 6-氟-1-(4-氟苯基&gt;-8-羥- 7-(異吲丨朵啉-5-基)-1,4-二氫-4-氣基挂啉-3-羧酸 • 6-氰-卜〔(lR,2S)-2-氟琛丙基〕-8-羥- 7-(異吲呤啉 -5-基)-1,4-二氳-4-氣基if啉-3-羧酸 • 6-氟-1-(2-氰乙基〕-7-(異吲呤1»-5-基)-8-甲基-1, 4-二氫-4-氧基《啉-3-羧酸 • 6-氟-1-(2-氟乙基)-8-甲基-7-(2-甲基異吲I朵啉- 5-基)-1,4-二氫-4-氣基睡啉-3-羧酸 • 6 -氟-卜(2 -氟乙基〕-7 -(異吲呤啉-5 -基)-1,4 -二氳 -24- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------f ' —裝------訂„----「線 (請先閱讀背面之注意事項再填寫本页) 經濟部争央標準局員工消費合作杜印製 A7 £7__ 五、發明説明(“) -4-氣基睡林-3-箱酸 • 6-氟-卜(2-氟乙基)-7-(2-甲基異吲H朵淋-5-基)-1,4 -二氫-4-铒基桂W -3-羧酸 • 6-氟-1-(2-氟乙基〕-7-(異吲昤啉-5-基)-8-甲氣-1 ,4-二氫-4-氣基β啉-3-羧酸 • 6-氟-1-(2-氟乙基)-7-(2-甲基異吲H荣啉-5-基)-8-甲 氣-1,4-二氫-4-氧基技啉-3-羧酸 • 8-氰-6-氟-1-(2-氟乙基〕-7-(異吲哚啉-5-基)-1,4-二氫-4-氣基睡啉-3-羧酸 • 8-氯6-氟-1-(2-氟乙基)-7-(2-甲基異吲I朵啉-5-基)-1,4-二氳-4-氧基技咻-3-羧酸 • 6 ,8 -二氣-1-(2-戴乙基〕-7-(異丨3丨時淋-5-基)-1,4-二氳-4-«基H啉-3-羧酸 • 6, 8-二氟-1-(2-氟乙基〕-7-(2-甲基異吲呤ft - 5-基) -1,4-二氳-4-氣基枝啉-3-羧酸 • 6-氟-1-(2-氟乙基〕-7-(異吲呤啉-5-基)-1,4-二氫 -4-氣基-1 ,8-萊啶-3-羧酸 • 6-氟-卜(2-氟乙基〕-7 - (2-甲基異吲呤啉-5-基)-1 , 4-二氫-4-氣基-1,8-萊啶-3-羧酸 • 6 -氟- 7- (異13丨呤啉-5-基&gt;-8 -甲基-1-( 一氧肆園-3-基) -1,4-二氫-4-氣基睹啉-3-羧酸 • 6-氟-7 -(異吲哚啉-5-基)-1-(一氣肆蘭-3-基)-1,4-二氫-4-氣基技啉-3-羧酸 .6-觎- 7- (異吲I朵啉-5-基)-8 -甲氣-1-( 一氣肆鼷-3-基) -2 5 * 本紙張Λ度適用中國國家標準(CNS ) A4規格(210X297公釐) --------^—裝------ir-----「線 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 A 7 B7_ 五、發明説明(4) -1,4-二氳-4-氣基K啉-3-羧酸 • 8-氯-6-氟- 7-(異吲丨朵啉-5-基)-1-(一氧肆圃-3-基) -1,4-二氬-4-氣基技林-3-羧酸 •6,8-二氟-7-(異吲哚咻-5-基)-1-(—氣肆圔-3-基)-1,4-二氳-4-氣基桂啉-3-羧酸 • 6-氟-7-(異吲_朵啉-5-基)-1-(一氱肆園-3-基)-1 · 4-二氫-4-氣基-1,8-萊啶-3-羧酸 • 6 -氟-7 -(異吲呤啉-5 -基)-1 -(異啐唑-3 -基)-8 -甲基 -1,4-二氫-4-氣基理啉-3-羧酸 • 6-氟-7-(異吲丨朵啉-5-基)-1-(異枵唑-3-基)-1,4-二 氫-4-氣基眭啉-3-羧酸 • 6 -氟-7 -(異I引跺啉-5 -基)-1 -(異枵唑-3 -基)-8 -甲氣 -1,4-二氫-4-氧基丨S啉-3-羧酸 • 8-« - 6-氟- 7-(異吲丨朵啉-5-基)-1-(異丨§唑-3-基)-1 ,4-二氫-4-氧基睹啉-3-羧酸 • 6 , 8 -二氟-7 -(異吲呤啉-5 -基)-卜(異啤唑-3 -基)-1, 4-二氫-4-氣基晻啉-3-羧酸 • 6 -氟-7 -(異吲呤啉-5 -基)-1 -(異枵唑-3 -基)-1,4 -二 氫-4-氣基-1,8-桊啶-3-羧酸 • 1-琛丙基-6-氟-8-甲氣- 7- (3 -甲基異吲哚啉-5-基)-1 ,4-二氫-4-氣基睹啉-3-羧酸 _ 1-琛丙基- 7-(1,3-二甲基異吲呤啉-5-基)-6-氟-8-甲 氣-1,4-二氲-4-氣基挂啉-3-羧酸 •卜琛丙基-6-氟-8-甲氣- 7- (1-甲基異吲I朵啉-5-基)-1 -2 6 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------f 1裝------訂--„----f線 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(J) ,4-二氫-4-氱基技啉-3-羧酸 •卜琛丙基-6-氟-8-甲《-7-〔螺〔異吲呤啉- Ι,Ι1-琛丙 烷〕-5-基,)-1,4-二氫-4-氧基丨宝啉-3-羧酸 • 1-琛丙基-6-氟- 7-(1-亞胺基異吲呤啉-5-基)-8-甲氣 -1,4 -二氫-4-氣基BE _ - 3-竣酸 • 1-璨丙基- 7- U,7-二氟異吲I朵啉-5-基)-6-氧-8-甲氣 -1 , 4-二氫-4-氧基技咻-3-羧酸 • 5-胺基-1-環丙基-6-氟- 7-(異吲呤啉-5-基)-8-甲氣-1,4-二氳-4-氣基技啉-3-羧酸 .1-琛丙基-6-氟-7.-(4-氰異吲呤啉-5-基)-8-甲氧-1,4 -二氫-4-氣基If W - 3-錢酸 •卜琛丙基-8-二氟甲氣-6-氟- 7-(3-甲基異吲哚啉- 5-基)-1,4-二氫-4-氧基瞍啉-3-羧酸 •卜琛丙基-8-二氟甲氣- 7-(1,3-二甲基異吲哚啉-5-基) -6-氰-1,4-二氫-4-氧基Hf啉-3-羧酸 •卜琛丙基-8-二氣甲氣-6-氣- 7-(1-甲基異吲哚啉- 5-基)-1,4 -二氣-4-氧基if麻-3-矮酸 • 1-琛丙基-8-二氟甲氧-6-氟-7-〔蠼〔異吲H朵啉-1,1' -琛丙烷〕-5-基)-1,4-二氳-4-氣基技啉-3-羧酸 •卜琛丙基-8-二氟甲氣-6-戴- 7-(1-亞胺基異吲ί呆啉-5 -基)-1,4-二氪-4-氣基丨f啉-3-羧酸 • 1-琛丙基- 7- (4,7 -二氰異吲呤啉-5-基)-8 -二氟甲氧-6 -氟-1,4 -二氫-4-氧基Kf啉-3-羧酸 • 5-胺基-1-琛丙基-8 -二氟甲氧-6-氟- 7- (異吲呤啉- 5- -2 7 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) —-------^—裝*------許--^ 「線 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央樣準局員工消費合作社印製 A7 _B7_ 五、發明説明(讣) 基)-1,4-二氳-4-氣基睹啉-3-羧酸 .1-琛丙基-8-二氟甲氧-6-氟- 7-(4-氟-異吲哚啉-5-基) -1,4-二鏢-4 -氣基ίϊ啉-3-羧酸 •1-琛丙基-6-氟- 7-(4-氟異吲哚啭-5-基)-1,4-二氫- 4-氣基睡啉-3-羧酸 • 1-琛丙基-7-(4, 7-二氟異吲丨$啉-5-基)-6-氟-1,4-二 氳-4-氣基睹啉-3-羧酸 •卜琛丙基-6-氟-8-氟甲基- 7-(異吲I#啉-5-基)-1,4-二氫-4-氧基if啉-3-羧酸 • 1-環丙基-6-氟-8-«甲基-7-(2-甲基異吲呤啉-5-基) -1 ,4 -二氳-4-氧基丨f啉-3-羧酸 • 1-琢丙基-7-(1,3-二甲基異吲1朵琳-5-基)-6-氟-8-氟 甲基-1,4 -二氫-4-氣基β啉-3-羧酸 • 1-環丙基-8-二氟甲基-6-氟- 7-(異吲呤啉-5-基)-1,4-二氢-4-氧基_f啉-3-羧酸 • 1-璟丙基-8-二氟甲基-6-氟-7-(2-甲基異吲I榮啉-5-基) -1,4 -二氫-4-氣基睡_ - 3-矮酸 •卜琛丙基-8-二氟甲基- 7- (1 ,3 -二甲基異吲哚啉-5-基) -6-氟-1,4-二氳-4-氧基I®啉-3-羧酸 • 1-琛丙基-6-氰- 7-(異吲ί朵啉-5-基&gt;-8-三籌甲基-1,4-二氫-4-氣基晻啉-3-羧酸, •卜環丙基-6-氟- 7-(2-甲基異吲呤啉-5-基)-8-三氟甲 基-1,4 -二氫-4-氣基異丨f啉-3-羧酸 • 1-琛丙基- 7-(1,3-二甲基異吲I朵_-5-基)-6-氟-8-三 -2 8 ~ 本紙張尺度適用中國國家標準(CMS ) A4規格(210X297公釐) ---------^ Ί 裝-- (請先閱讀背面之注意事項再填寫本頁) 訂 -2 A7 B7 _ 五、發明説明(&gt;9 ) 氟甲基-1,4-二氫-4-氧基ϋ啉-3-羧酸 •卜琛丙基-6-氟- 7-(異吲呤啉-5-基)-5,8-二甲基-1,4 -二氫-4-氧基β啉-3-羧酸 •卜琛丙基-6-氟-5,8-二甲基- 7-(2-甲基異吲呤啉- 5-基)-1,4 -二氫-4-氧基ϋ淋-3-搂酸 •卜琢丙基-6-氟-5,8-二甲基- 7-(1 ,3-二甲基異吲丨荣啉 -5-基)-1,4-二氳-4-氧基喹啉-3-羧酸 • 8-氯-1-環丙基- 7-(異吲昤啉-5-基)-1,4-二氫-4-氣基 授啉-3-羧酸 • 1-琛丙基-8-氟-7-(異吲哚啉-5-基)-1,4-二氫-4-氧基 技啉-3-羧酸 •卜環丙基- 7-(異I引呤W-5-基)-8-甲基-1,4-二氰-4-氣 基牲啉-3-羧酸 當通式〔I〕化合物或其鹽具有異構物(例如光學異構 物,幾何異構物,互變異構物等)時,本發明包含此等 異構物,又化合物或其鹽可呈溶劑合物或水合物或多種 结晶形。 本發明化合物之製法說明如下。 本發明化合物可根據例如,下迷方法合成。 ---------f -裝,------IT—一r---f 線 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標隼局員工消費合作社印裝 -29- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) A7 B7 五、發明説明(4 〔製法1〕 R6 0Benzoic acid fluorocarboxyl-* 4 3 / IV | 1-Phenyl group ^ 0 Gas S towel-«Fluoro T 8-Hydrogen mV I 5 I morpholine, jl isoline 1 radical II Fluoro-5 6w •» * Economy Ministry of Work, Central Bureau, Work Bureau, Consumer Cooperatives, Indole 3, Pyridoxine * 111, Propionate ^ 0 Ring, R, Oxygen, 0, 4 2 I) -Hydrogen S -2, 2 * IR 4 枉 8, i- 2 Fluorine-I 6 4 II Argon diisocyanate 4-methyl0 morpholine-carboxy gas 3-acid oxymethanefluoric acid carboxyiso- 5 1 phosphonium hydrazone ?, iso-I-methyl-5-phosphonium hydrazone * isopropylmethyl-2/1-7 -Gas methyl fluoride I 8 Fluoride-6 I based ethyl-4 £ 2, Di- (phosphinoyloxybenzene 0 Dimethyl methofluoric acid? End Jm 2? HI isopropyl methyl This paper standard applies to Chinese national standards ( CNS &gt; A4 specification (210X297 mm) Consumer cooperation of the Central Standards Bureau of the Ministry of Economic Affairs Du Yin 袈 A7 B7_ V. Description of the invention -3-carboxylic acid • 6-fluoro-8-cyanomethyl-1- (4-hydroxyphenyl) -7- (2-methylisoinolinolin-5-yl) -l, 4-p hydrogen- 4-Gas P1 phthaloline-3-carboxylic acid • 6-fluoro-8-fluoromethoxy-1- (4-fluorophenyl) -7- (2-methylisoindolinline-5-yl) -1 , 4-Diargon-4-aminopyroline-3-carboxylic acid • 6-cyano-bu [(111,23) -2-fluorosine Group] -8-fluoromethyl gas-7- (2-methyliso 丨 3 丨 Lymph-5-yl) -1,4-dihydro-4-airyl 8-difluoromethane-6-fluoro-7- (isoindolinium-5-yl) -1,4-bisfluoren-4- «ylβline-3-carboxyl Methoxy-buethyl-6-fluoro-7- (isoindolinolin-5-yl) -1,4-difluoren-4-aminoquinoline-3-carboxylic acid • 8-difluoromethyl-1- (2,4-difluorophenyl) -β-fluoro-7- (isoindolyl-5-yl) -1,4-dihydro-4-aminozoline-3-carboxylic acid • 8-di Fluoromethyl-6-fluoro-1- (4-hydroxyphenyl) -7- (isoindolinline-5-yl) -1,4-dihydro-4-aminopyridin-3-carboxylic acid • 8-Difluoromethane "-6-fluoro-1- (4-fluorophenyl) -7- (isopropylimide rongolin-5-yl) -1,4-dihydro-4-oxoline- 3-carboxylic acid. 8-difluoromethane-6-fluoro-l-[(lR, 2S) -2-cyanopropyl] -7- (isoindolinolin-5-yl) -1,4- Dihydro-4-amino cinnamo-3-carboxylic acid • 1-cyclopropyl-8-difluoromethoxy-6-fluoro-7- (2-methyl-isoindolinyl-5-yl) -1,4 -dihydro-4-amino cyanoline-3-carboxylic acid8-difluoromethyl-1-ethyl-6-fluorene-7- (2-methylisoindolinoline-5- Group) -1,4-dihydro-4-amino-II-line-3-carboxylic acid • 8-difluoromethoxy-1- (2,4-difluorophenyl) -6-chip-7- (2 -Methyliso -23- The size of this paper is applicable to China National Standard (CNS) A4 (210X297 mm) I ------- ζ 1 etc .------ Order-: ---- (line (please Please read the notes on the back before filling this page) Consumption Cooperation by Employees of the Central Bureau of Standards, Ministry of Economic Affairs, Printed A7 B7_ V. Description of the Invention (0) Porphyrin-5-yl) -1,4-Difluorene-4-yl 11-Phenolin-3-carboxylic acid • 8-Difluoromethane-6-cyano-1- (4-hydroxyphenyl) -7- (2-methylisoindolinolin-5-yl) -1,4- Dihydro-4-amino β-line-3-carboxylic acid • 8-difluoromethane-6-fluoro-1- (4-fluorophenyl) -7- (2-methylisoindolinline-5- ) -1,4-Difluorene- 4- «yl 丨 folin-3-carboxylic acid • 8-difluoromethane-6-fluoro-bu [(11?, 28bu 2-fluorocyclopropyl]- 7- (2-methylisoinolinolin-5-yl) -1,4-dihydro-4-air-based lysine-3-carboxylic acid • Phenyl-6-fluoro-8-hydroxy-7 -(Isoindone) Doryl-5-kib 1,4-dihydro-4-aminopyridin-3-carboxylic acid • 1-ethyl-6-gas-8-xiang- 7- (iso丨 Duo IS-5-yl) -1,4-difluorene-4-oxoline-3-carboxylic acid. 1- (2,4-difluorophenyl) -6-fluoro-8-hydroxy-7 -(Isoinolinolin-5-yl &gt; -1,4-dihydro-4-amino group KuiLin-3-carboxylic acid • 6-Ga-8-Li-1- (4-Liphenyl) -7- (Different 丨 3 丨 Lin -5-yl) -1,4-difluoren-4-yl-guilin-3-carboxylic acid • 6-fluoro-1- (4-fluorophenyl) &gt; -8-hydroxy-7- (isoindole) Phenyl-5-yl) -1,4-dihydro-4-aminopyridin-3-carboxylic acid • 6-cyano-bu [(lR, 2S) -2-fluorosynyl] -8-hydroxy- 7- (Isoinolinolin-5-yl) -1,4-diamidino-4-amino ifolin-3-carboxylic acid • 6-fluoro-1- (2-cyanoethyl) -7- (iso Indolin 1 »-5-yl) -8-methyl-1,4-dihydro-4-oxy" Porphyrin-3-carboxylic acid • 6-fluoro-1- (2-fluoroethyl) -8- Methyl-7- (2-methylisoindolinol-5-yl) -1,4-dihydro-4-aminopyridin-3-carboxylic acid • 6-fluoro-bu (2-fluoroethyl Base] -7-(isoindolinline-5 -yl) -1,4 -difluorene-24- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -------- -f '—install ------ order „----“ line (please read the precautions on the back before filling this page) employee cooperation of the Central Bureau of Standards, Ministry of Economic Affairs, printed A7 £ 7__ V. Invention Explanation (") 4-Aminopyrimin-3-boxic acid • 6-fluoro-bu (2-fluoroethyl) -7- (2-methylisoindole D-do-5-yl) -1, 4 -dihydro-4-fluorenyl laurate W-3-carboxylic acid • 6-fluoro-1- (2-fluoroethyl] -7- (isoindioline-5-yl) -8-methyl-1 , 4-two -4-Gasyl β-line-3-carboxylic acid • 6-fluoro-1- (2-fluoroethyl) -7- (2-methylisoindoleH-rongolin-5-yl) -8-methyl- 1,4-dihydro-4-oxoline-3-carboxylic acid • 8-cyano-6-fluoro-1- (2-fluoroethyl] -7- (isoindololin-5-yl)- 1,4-dihydro-4-aminopyroline-3-carboxylic acid • 8-chloro 6-fluoro-1- (2-fluoroethyl) -7- (2-methylisoindolin I-doline-5 -Yl) -1,4-difluoren-4-oxypyridine-3-carboxylic acid • 6,8-digas-1- (2-daithyl) -7- (iso 丨 3 丨 hrhen-5- ) -1,4-Difluoren-4- «ylHolin-3-carboxylic acid • 6, 8-difluoro-1- (2-fluoroethyl] -7- (2-methylisoindolin ft -5-yl) -1,4-bisfluoren-4-ylidinoline-3-carboxylic acid • 6-fluoro-1- (2-fluoroethyl] -7- (isoindolinolin-5-yl ) -1,4-dihydro-4-airyl-1,8-eryridine-3-carboxylic acid • 6-fluoro-bu (2-fluoroethyl) -7-(2-methylisoindolinoline -5-yl) -1,4-dihydro-4-airyl-1,8-eryridin-3-carboxylic acid • 6-fluoro-7- (iso13 丨 Porinolin-5-yl> -8 -Methyl-1- (monooxo-3-yl) -1,4-dihydro-4-ylamino-4-line-3-carboxylic acid • 6-fluoro-7-(isoindoleline-5- Yl) -1- (monomethylsilanyl-3-yl) -1,4-dihydro-4-ylpyridin-3-carboxylic acid. 6-fluorene-7- (isoindolindol-5-yl ) -8-Mechanical-1- (Yiqi鼷 -3-based) -2 5 * The paper Λ degree applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) -------- ^ — packing ------ ir ---- -"Line (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A 7 B7_ V. Description of the Invention (4) -1,4-Difluorene-4-Gasyl-K -3-carboxylic acid • 8-chloro-6-fluoro-7- (isoindolinone-5-yl) -1- (monooxo-3-yl) -1,4-diargon-4- Gas-Based Technol-3-carboxylic Acid • 6,8-Difluoro-7- (Isoindolyl-5-yl) -1-(— Gasidine-3-yl) -1,4-Difluorene- 4-Gauryl cinolin-3-carboxylic acid • 6-fluoro-7- (isoindole_dorolin-5-yl) -1- (monomethylbenzo-3-yl) -1 · 4-dihydro- 4-Amino-1,8-eryridine-3-carboxylic acid • 6-fluoro-7-(isoindolinline-5 -yl) -1-(isoxazol-3 -yl) -8 -methyl -1,4-dihydro-4-yloxyline-3-carboxylic acid • 6-fluoro-7- (isoindolinodol-5-yl) -1- (isoxazol-3-yl)- 1,4-dihydro-4-aminopyridin-3-carboxylic acid • 6-fluoro-7-(iso-isopyridin-5 -yl) -1-(isoxazole-3 -yl) -8 -Methane-1,4-dihydro-4-oxy 丨 S-Phenyl-3-carboxylic acid • 8- «-6-Fluoro-7- (isoindole 丨 dololin-5-yl) -1- (iso丨 §azole-3-yl) -1,4- Hydroxy-4-oxoquinoline-3-carboxylic acid • 6, 8-difluoro-7- (isoindolinline-5-yl) -bu (isopropazol-3-yl) -1,4-di Hydrogen-4-amino dark phthaloline-3-carboxylic acid • 6-fluoro-7-(isoindolinline-5 -yl) -1-(isoxazol-3 -yl) -1,4 -dihydro- 4-amino-1,8-pyridin-3-carboxylic acid • 1-chenpropyl-6-fluoro-8-methylazine-7- (3-methylisoindolin-5-yl) -1 , 4-Dihydro-4-aminoyl phenanthroline-3-carboxylic acid_ 1-chenpropyl-7- (1,3-dimethylisoindolinolin-5-yl) -6-fluoro-8- Methane-1,4-bisfluoren-4-ylpyridin-3-carboxylic acid • Phenyl-6-fluoro-8-methane-6- (1-methylisoindolinol-5 -Base) -1 -2 6-This paper size is applicable to China National Standard (CNS) A4 specification (210X297mm) --------- f 1 pack -------- Order --―-- --f-line (Please read the notes on the back before filling this page) Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (J), 4-Dihydro-4-fluorenyl-3 -Carboxylic acid · Phenyl-6-fluoro-8-methyl "-7- [spiro [isoindolinline-1,11-chenpropane] -5-yl,)-1,4-dihydro-4 -Oxy 丨 Poroline-3-carboxylic acid • 1-Ceryl-6-fluoro-7- (1-iminoisoinolinolin-5-yl) -8 -Methane-1,4 -dihydro-4-airyl BE _ -3-unsaturated acid • 1-gallyl-7-U, 7-difluoroisoindolinium-Idolline-5-yl) -6- Oxy-8-methyl-1, 4-dihydro-4-oxypyridine-3-carboxylic acid • 5-amino-1-cyclopropyl-6-fluoro-7- (isoindolinline-5 -Yl) -8-methyl-1,4-bisfluoren-4-yl-pyridin-3-carboxylic acid. 1-benzyl-6-fluoro-7 .- (4-cyanoindoline- 5-yl) -8-methoxy-1,4-dihydro-4-carbyl group If W -3-Canoic acid • Phenylpropyl-8-difluoromethane-6-fluoro-7- (3- Methyl isoindolino-5-yl) -1,4-dihydro-4-oxyfluoroline-3-carboxylic acid • Phenylpropyl-8-difluoromethane-7- (1,3- Dimethylisoindolin-5-yl) -6-cyano-1,4-dihydro-4-oxyHfline-3-carboxylic acid • Phenyl-8-digasmethyl-6- GAS- 7- (1-methylisoindolinol-5-yl) -1,4 -digas-4-oxy if hemp-3-dwarf acid • 1-chenpropyl-8-difluoromethoxy -6-Fluoro-7- [蠼 [Iso [IndoH-doline-1,1'-Chenpropane] -5-yl) -1,4-difluoren-4-aminopyridin-3-carboxylic acid Ethylpropyl-8-difluoromethane-6-daily 7- (1-iminoisoindolinyl-5 -yl) -1,4-difluoren-4-yl 丨 folin-3 -Carboxylic acid 1-chenpropyl-7- (4,7-dicyanoisoinolinolin-5-yl) -8-difluoromethoxy-6-fluoro-1,4- Hydroxy-4-oxy Kfline-3-carboxylic acid • 5-Amino-1-chenpropyl-8-difluoromethoxy-6-fluoro-7- (isoindolinoline 5- -2 7- This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) —------- ^ — packing * ------ Xu-^ "line (please read the precautions on the back first) Refill this page) Printed by A7 _B7_ of the Consumer Cooperatives of the Central Procurement Bureau of the Ministry of Economy Propyl-8-difluoromethoxy-6-fluoro-7- (4-fluoro-isoindolline-5-yl) -1,4-bisarthr-4-aminoylfluorin-3-carboxylic acid • 1-Ceryl-6-fluoro-7- (4-fluoroisoindolyl-5-yl) -1,4-dihydro-4-aminopyridin-3-carboxylic acid • 1-chenpropyl -7- (4, 7-difluoroisoindolinium $ -5-yl) -6-fluoro-1,4-difluoren-4-ylamino-3-phenylcarboxylic acid • Phenyl-6 -Fluoro-8-fluoromethyl-7- (isoindole I # line-5-yl) -1,4-dihydro-4-oxyifline-3-carboxylic acid • 1-cyclopropyl-6- Fluoro-8- «methyl-7- (2-methylisoinolinolin-5-yl) -1,4-difluoren-4-oxy 丨 folin-3-carboxylic acid -7- (1,3-dimethylisoindolin-1dolin-5-yl) -6-fluoro-8-fluoromethyl-1,4-dihydro-4-airyl β-line-3-carboxylic acid • 1-cyclopropyl-8-difluoromethyl-6-fluoro-7- (isoinolinolin-5-yl) -1,4-dihydro-4-oxy_fline-3-carboxylic acid • 1-Hydroxypropyl-8-difluoromethyl-6-fluoro-7- (2-methylisoindolinium Ironyl-5-yl) -1,4-dihydro-4-amino group _-3 -Dwarf acid • Phenyl-8-difluoromethyl-7- (1,3-dimethylisoindolin-5-yl) -6-fluoro-1,4-difluoren-4-oxo I-Porphyrin-3-carboxylic acid • 1-Ceryl-6-cyano-7- (isoindoleline-5-yl> -8-trimethyl-1,4-dihydro-4 -Amino cyanoline-3-carboxylic acid, • cyclopropyl-6-fluoro-7- (2-methylisoindinolin-5-yl) -8-trifluoromethyl-1,4-di Hydrogen-4-amino-iso-folin-3-carboxylic acid • 1-Ceryl-7- (1,3-dimethylisoindolinol_-5-yl) -6-fluoro-8-tri -2 8 ~ This paper size applies Chinese National Standard (CMS) A4 specification (210X297mm) --------- ^ Ί Equipment-(Please read the precautions on the back before filling this page) Order- 2 A7 B7 _ V. Description of the invention (&gt; 9) Fluoromethyl-1,4-dihydro-4-oxyfluoroline-3-carboxylic acid • Buchenpropyl-6-fluoro-7- (isoindole (Purinolin-5-yl) -5,8-dimethyl-1,4-dihydro-4-oxyβ phthaloline-3-carboxylic acid • Phenyl-6-fluoro-5,8-dimethyl -7- (2-methylisoindolinline-5 -Yl) -1,4-dihydro-4-oxypyrene-3-aranoic acid • Butoxypropyl-6-fluoro-5,8-dimethyl-7- (1,3-dimethyl Isoindole-5-rongolin-5-yl) -1,4-bisfluoren-4-oxyquinoline-3-carboxylic acid • 8-chloro-1-cyclopropyl-7- (isoindioline-5- Yl) -1,4-dihydro-4-ylaminopyridin-3-carboxylic acid • 1-chenpropyl-8-fluoro-7- (isoindololin-5-yl) -1,4-di Hydroxy-4-oxoline-3-carboxylic acid • cyclopropyl-7- (iso-I-tertrin W-5-yl) -8-methyl-1,4-dicyano-4-amino When the compound of general formula [I] or its salt has isomers (such as optical isomers, geometric isomers, tautomers, etc.), the present invention includes these isomers, and The compound or its salt may be in a solvate or hydrate or multiple crystalline forms. The production method of the compound of the present invention is explained below. The compound of the present invention can be synthesized according to, for example, the following method. --------- f -install, ------ IT—a r --- f line (please read the precautions on the back before filling this page) Employees' Cooperatives of Central Bureau of Standards, Ministry of Economic Affairs Printing -29- This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) A7 B7 V. Description of invention (4 [Manufacturing method 1] R6 0

R6 〇R6 〇

【4]或其鹽 【2】或其鹽[4] or a salt thereof [2] or a salt thereof

Sn(Alk)3 催化劑 R6 〇Sn (Alk) 3 catalyst R6 〇

CO2R1CO2R1

【5]或其鹽 I-------Λ I裝------訂丨-----f線 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局負工消費合作杜印製 如上通式[1],[2], [3], [4】及[51 中,R1 ,R2 , R 4,R s , R s 及X之定義如上;χι表示氣原子, 溴原子或碘原子;及Alfc表示含1至6値碩原子之直鏈 或支鏈烷基β -30- 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 經濟部中央橾準局貝工消費合作杜印製 A7 B7 五、發明説明(0) 通式[2], [3],[4]及[5]之化合物之鹽包含與通式[1] 化合物相同之鹽。 通式[1】化合物或其《可經由使用把铕合物催化爾於 有或無儀化銀存在下輿通式[2】化合物或其鹽及通式[3] 有機錫化合物或其鹽或通式U]有檐鍚化合物或其鹽及 通式[5]化合物或其》進行禺合反應而得β此反醱使用 之溶劑可為任何溶劑,只要對反應不會産生不良彩響。 至於溶涮值得一提者有例如芳族《妬苯,甲苯,二甲苯 等;醚如二丨I烷,四氬呋喃,苯基甲基醚,二乙二酵二 乙醚,二甲基溶雄素等;請如乙請等;醒按如Ν,Ν-二甲 基甲睡胺,Ν,Ν-二甲基乙醸胺等;亞明如二甲亞隳等, 而此等溶《I可單獨或混合兩種或兩種以上使用。 此種反應使用之把錯合SI包含例如PdCl2(PPh3)2, Pd(PPh3)«,[5] or its salt I ------- Λ I equipment -------- Order 丨 ----- f line (Please read the precautions on the back before filling this page) Central Bureau of Standards, Ministry of Economic Affairs The work-consumption cooperation is printed as the general formulas [1], [2], [3], [4] and [51 above, where R1, R2, R4, Rs, Rs, and X are defined as above; Gas atom, bromine atom or iodine atom; and Alfc represents a linear or branched alkyl group containing 1 to 6 値 atoms β -30- This paper size applies to the Chinese National Standard (CNS) A4 specification (2 丨 0X297 mm) DuPont A7 B7 printed by Shellfish Consumer Cooperation of the Central Bureau of Standards, Ministry of Economic Affairs 5. Description of the invention (0) Salts of compounds of the general formulas [2], [3], [4] and [5] contain the general formula [1] Compounds are the same salts. A compound of the general formula [1] or its "can be used to catalyze the adduct in the presence or absence of silver, or a compound of the general formula [2] or its salt and an organic tin compound or its salt or The general formula U] has an eaves compound or a salt thereof and a compound of the general formula [5] or a compound thereof to obtain β. The solvent used in this reaction may be any solvent, as long as the reaction does not produce a bad color. As for solvents, it is worth mentioning, for example, aromatic benzene, toluene, xylene, etc .; ethers such as dioxane, tetrahydrofuran, phenyl methyl ether, dioxane diethyl ether, dimethyl lysate Please wait, please wait, please wait; wake up, such as Ν, Ν-dimethyl mesitamine, Ν, Ν-dimethylacetamide, etc .; Yaming, such as dimethylarsine, etc., and these soluble "I They can be used alone or as a mixture of two or more. This reaction uses a complex SI that contains, for example, PdCl2 (PPh3) 2, Pd (PPh3) «,

PdCl2[P(〇-t〇lyl)3】2, PdCl2+2P(OEt)3 及 PdCl2(PhCN)2 其中Pli表示苯基。 通式[3]有檐錫化合物或其鹽之用置相對於每莫耳通 遇[2]化合物或其鹽至少為1莫耳,較佳1.0荃2.0莫耳 ,及通式[5]化合物或其鹽用Μ相對於每莫耳通式[4]有 機錫化合物或其鹽用量至少為1契耳,較佳1.G至5.0莫 耳β 此種偁合反應通常係於惰性氣鼸(例如氬、氮)氣氛下 於50至17Q*C溫度進行1分鐘至24小時時間而完成。 如此所得通式[1]化合物或其鹽可經由将前者進行己 知反應例如氣化,邇原,重排,取代,鹵化,脱水,水 -3 1- 本紙張尺度逋用中國國家揉準(CNS ) A4規格(210X297公釐〉 --------Λ-装------訂.丨-Γ,---Γ線 (請先閱讀背面之注意事項再填寫本頁) A7 _B7__ 五、發明説明(v) 解等或進行此等反«之適當組合而轉成另一種通式[1] 化合物或其鹽。 若前述製法之通式12】,[31,[4]及【5]之化合物或其 鹽具有異構物(例如光學異構物,幾何異構物,互變異 構物等 &gt; 則此等量構物可經取代。又前述化合物或其麵 可以溶劑合物或水合物或多種结晶形使用。 當通式[1 ] , [ 2 ] , [ 3 ] , . [ 4 ]及[5 ]之化合物或其81含 有按基,羥基或羧基時可事先使用習知保謹基保護該基 並於反應後以己知方式去除保護基。 其次通式[21,[31, [4】及[5]化合物或其鹽(本發明 化合物之生産時之起始物料)之裂法説明如下•通式[3] 及[4]之有機錫化合物或其《為新顬化合物。 首先通式[21化合物或其*及通式[4]有機錫化合物或 其鹽可根據下述製法合成。 --------Λ I裝-- (請先閱讀背面之注意事項再填寫本頁) *tr 線 經濟部中央橾準局另工消費合作社印衷 -32- 本紙張尺度適用中國國家梂準(CNS ) Α4^格(210X297公釐) A7 B7 五、發明説明(〜) R6 R6PdCl2 [P (0-tolyl) 3] 2, PdCl2 + 2P (OEt) 3 and PdCl2 (PhCN) 2, where Pli represents a phenyl group. The use of the eaves tin compound or its salt of the general formula [3] is at least 1 mole, preferably 1.0 to 2.0 moles per mole of the compound [2] or its salt, and the compound of the general formula [5] The amount of M or its salt is at least 1 mole, preferably 1. G to 5.0 moles per mole of the organic tin compound of the general formula [4] or its salt. Such a coupling reaction is usually in an inert gas ( For example, argon, nitrogen) in the atmosphere at 50 to 17Q * C temperature for 1 minute to 24 hours to complete. The compound of the general formula [1] or a salt thereof thus obtained can be subjected to a known reaction such as gasification, primogenation, rearrangement, substitution, halogenation, dehydration, and water-3 by the former. CNS) A4 specification (210X297mm) -------- Λ-installation ------ order. 丨 -Γ, --- Γ line (please read the precautions on the back before filling this page) A7 _B7__ 5. Explanation of the invention (v) The solution or the appropriate combination of these anti- «will be converted into another compound of the general formula [1] or its salt. If the general formula 12 of the aforementioned production method], [31, [4] And the compound of [5] or its salt has isomers (such as optical isomers, geometric isomers, tautomers, etc.), then these equivalent structures may be substituted. Moreover, the aforementioned compound or its surface may be a solvent Hydrates or hydrates or various crystalline forms. When the compounds of the general formulas [1], [2], [3],. [4] and [5] or their 81 contains an amino group, a hydroxyl group or a carboxyl group can be used in advance The conventional spleen protects this group and removes the protecting group in a known manner after the reaction. Next, the compound of the general formula [21, [31, [4] and [5] or a salt thereof (starting from the production of the compound of the present invention) The method of cracking is described as follows: • Organic tin compounds of the general formulas [3] and [4] or their "is a new compound. First of all, the compounds of the general formula [21 or * and the organic tin compounds of the general formula [4] or their salts. It can be synthesized according to the following method. -------- Λ I Pack-(Please read the precautions on the back before filling out this page) * tr Central Ministry of Economic Affairs, Central Bureau of Standards, Another Industry Consumer Cooperative Cooperative Indigo -32 -This paper size applies to China National Standards (CNS) A4 ^ grid (210X297 mm) A7 B7 V. Description of the invention (~) R6 R6

nn ml ml &gt;n^— I ^1· (請先閲讀背面之注意事項再填寫本頁) 、-'° .Γ線 經濟部中央標隼局員工消費合作社印裝nn ml ml &gt; n ^ — I ^ 1 · (Please read the precautions on the back before filling out this page),-'° .Γ line, printed by the staff consumer cooperative of the Central Bureau of Standards, Ministry of Economic Affairs

C02R1 本紙張尺度適用中國國家揉準(CNS ) A4規格(210X297公釐) •33· 經濟部中央標準局貝工消費合作社印袈 Α7 Β7 五、發明説明(p ) 如上通式[2], [4], [61, [7], [81, [9】, [10], [11] \ / 及[12]中,R1 ,R2,Re, A ,X ,Χ1 及 Aik 之定義如 上;R14·表示如同R1之羧基保護基;R 24表示如同R2 之經取代或未經取代之焼16,**基,琛院基,芳基或雜 琛基;〆為下式表示之基:'N〆或夂C〆 T a 其中Ya表示氫原子,齒原子,經取代或未經取代之烷 基,烷《基或烷硫基•或經保護或未經保護之羥基;而 X2表不®原子。 通式[6 ], [ 7 ], [8] , [9], [10] , [ 1 II 及[1 2 ]之化合 物之鹽包括如通式[1]化合物所逑之相同鼸。 各步驟說明如下》 (U通式[Ή化合物或其鹽或通式[1Π化合物或其邇通 常俱經由通式[61化合物或其或通式[1〇]化合物或其 鹽分別進行業界已知之酮基酯化反窸而得》 (a)例如根據 Angewant C h e n i e , I n t e r n a t i ο n a 1 Edition in English,vol.18, page 72( 1 979)所述方法,通式[6] 化合物或其鹽之羧基或通式[1〇】化合物或其鹽之羧基舆 例如Ν,!Γ -羰基二咪唑反廳而將化合物轉成活性酸醯胺, 及随後活性酸醯胺與丙二酸單®之鎂鹽反鼴而得通式【7! 化合物或其鹽或通式【11]化合物或其活性酸酹胺與 丙二酸單酯鎂鼸之反應中使用的溶_只要不負面彩響反 醮可為任何溶劑且包含例如芳族煙如苯,甲苯,二甲苯 等;醚如二枵烷,四氫呋喃,二乙醚等;鹵化烴如二氰 -3 4 - 本紙張尺度適用中國國家橾準(CNS ) Α4規格(2丨0Χ297公釐) --------f -裝------訏I-r---f線 (請先聞讀背面之注意事項再填寫本頁) 經濟部中央樣準局貝工消費合作杜印製 A7 B7 _ 五、發明説明(“) 甲烷,氰仿,二《乙烷等;及醒胺如N,Η-二甲基甲B胺 ,Ν,Ν-二甲基乙醒胺等。此等溶爾可單獼或混合兩種或 兩種以上俾用· H,(T-羰基二味唑及丙二酸單酯之鎂鹽 之用量分別相對於毎莫耳之通式[6】或【10】化合物^其 鹽至少為1莫耳,較佳1至2莫耳。反應通常僳於0-100*0,較佳10-80eC之溫度遒行5分鐘至30小時。 (b)至於另一種方法,通式[6】化合物或其*之羧基或 通式U〇]化合物或其鹽之羧基輿曲化_如氯化硫醣基反 匾而轉成酸鹵化物及隨後酸鹵化物舆丙二酸二酯之金屬 鹽如丙二酸二酯之銷或乙《鎂》等反應,》後反應混合 物於水合溶莆中使用對甲苯議酸或三《乙酸進行羧基保 護基之部分去除及脱羧化反應,因而分別獲得通式[Ή 化合物或其》或通式[Π]化合物或其》。酸鹵化物與丙二· 酸二酯金羼鹽反應使用的溶繭只要對反應不會産生不良 影響可為任何溶劑,且待別包含前述U)(a)相同的溶_ β丙二酸二酯金屬鹽之用量相對於每某耳通式[61或【1〇1 化合物或其鹽至少為1其耳,較佳1至3荚耳。此種反 應通常僳於-50至10(TC之溫度進行5分鏟至30小時時間。 (2) (a&gt;通式[9]化合物或其鹽或通式[12】化合物或其 鹽分別可經由通式[71化合物或其鹽或通式丨11】化合物 或其邇與原酸酯如原甲酸甲酯,原甲酸乙酯等於乙酸醉 中反應,然後與通式[8】化合物或其《反應而得。此等 反醮使用的溶_只要對反應不會産生不良的影想可為任 何溶包含例如芳族煙如苯,甲苯,二甲苯等;_如 -35- 本紙張尺度適用中國國家揉準(CNS ) A4規格(210X297公釐} I-------丨装,------訂--i----A 線 (请先閱讀背面之注意事項再填离本莨) 經濟部中央橾準局貝工消費合作社印製 A7 B7__ 五、發明説明(4 ) 二丨等烷,四氫呋_,苯基甲基«,二乙二酵二乙«,二 甲基溶繼素等;酵如甲酵,乙酵,丙酵等;鹵化埂如二 «甲烷,氰仿,二氰乙烷等;醻胺如N,N-二甲基甲醯胺 ,Ν,Ν -二甲基乙匿胺等;亞W如二甲亞«等;等。此等 溶舅可單玀或混合兩種或兩種以上使用。原酸醣之用量 相對於毎莫耳通式[Ή或[11]化合物或其蠢至少為1其 耳,較佳1至10莫耳。反應通常僳於〇-15(TC,較佳50-1 5 0 °C之溫度進行2 0分鐘至5 0小時時間❶ 鼸後與通式U]化合物或其《之反應中,通式[8]化合 物或其鹽之用Μ相對於每其耳通式[Ή或[11]化合物或 其鹽至少為1莫耳,此等反應通常侏於O-iWC,較佳 10-60 ·0之湛度進行20分鐮至30小時時間。 (b)至於另一方法,通式(Ή化合物或其鼸或通式【11】 化合物或其《與縮醛如Ν,Ν-二甲基甲醣按二甲基缩醛,η ,Ν -二甲基甲醱胺二乙编醛等,於有或無醆酐如乙酸酐等 存在下反應,然後舆通式[8]或其鹽反應而分別轉成通式 [9]化合物或其鹽,或通式[12丨化合物或其鹽。前述反應 使用的溶_只要對反應不會産生不良彩響可為任何溶劑, 且待別包含前述(2)&lt;a)之相同溶两·缠^用量相對於毎 莫耳通式【7】或[11】化合物或其鹽至少為1莫耳,較隹 為約1至5契耳。與编S之反應通常你於0-100 eC,較佳 20-85°〇之溫度進行20分鏞至50小時時間· 讁後與通式[81化合物或其衋之反驩中,通式[8]化合 物或其蘧之用量相對於毎英耳通式[7]或之化合物或 其豔至少為1莫耳,及此等反慝通常傜於較佳 1 0 - 6 D eC之溫度進行2 0分鐘至3 0小時時間。 (3)通式[21 化合物或其鹽或通式【41化合物或其鹽可 分別經由通式[9】化合物或其鱷或通式[12]化合物或其鹽於 有或無氟化物鹽或齡存在下進行明瑷反應而得。反醮中 使用之溶_只要對反應不會産生不良彩響可為任何溶劑 包含例如醣胺如Ν,Ν-二甲基甲醯胺,Ν,Ν-二甲基乙醯胺 胺等;醚如二丨等烷,苯基甲基醚,二乙二酵二甲醚,二 甲基溶鑛素等;亞硪如二甲亞硯等;等。此等溶剤可單 钿或兩種或兩種以上混合使用。可視霈要使用的氟化物 -3 6 - 本紙張尺度適用中國國家揉準(CNS ) Α4规格(210Χ297公釐) ---------f 1 裝------訂----f 線 (請先閲讀背面之注意Ϋ項再填寫本萸) 經濟部中央標準局貝工消費合作社印裝 A7 _ _ _B7___ 五、發明説明(β) 麵包含如氟化納,《化鉀等,及可視霈要使用之鐮包含 例如碉酸氳納,磺酸押,第三丁氧化鉀,氬化銷等。氟 化物或_之用量相當於毎其耳通式[9]或[12]化合物或 其麴分別至少為1莫耳,較佳1.0至3.0莫耳。反應通常 供於0-180 Ό之通度進行5分鏟至30小時時間。 相信通式[3]或[4]化合物其中\/為下式表示基: 中 其 //C02R1 The size of this paper is applicable to China National Standard (CNS) A4 (210X297 mm) • 33 · Printed by ABC Consumer Cooperatives, Central Standards Bureau of the Ministry of Economic Affairs 袈 Α7 Β7 V. Description of the invention (p) As the general formula [2] above, 4], [61, [7], [81, [9], [10], [11] \ / and [12], R1, R2, Re, A, X, X1 and Aik are defined as above; R14 · Represents a carboxyl protecting group as R1; R 24 represents a substituted or unsubstituted 焼 16, ** group, schenyl group, aryl group or heteroschenyl group as R2; 〆 is a group represented by the formula: 'N 〆 or 夂 C〆T a where Ya represents a hydrogen atom, a tooth atom, a substituted or unsubstituted alkyl group, an alkyl group or an alkylthio group, or a protected or unprotected hydroxyl group; and X2 represents a ® atom . The salts of the compounds of the general formulas [6], [7], [8], [9], [10], [1 II and [1 2] include the same compounds as those of the compounds of the general formula [1]. The steps are explained as follows: (U general formula [VII compound or its salt or general formula [1II compound or its hydrazine is generally known in the industry via the general formula [61 compound or its general formula [10] compound or its salt, respectively. (A) For example, according to the method described in Angewant C Henie, Internati na 1 Edition in English, vol. 18, page 72 (1 979), a compound of the general formula [6] or a salt thereof The carboxyl group of the compound of the general formula [10] or a salt thereof, such as N,! Γ-carbonyldiimidazole, converts the compound into an active acid amine, and then the active acid amine and malonate The magnesium salt can be converted to a compound of the general formula [7! Or a salt thereof or a compound of the general formula [11] or an active acid sulfonium amine and a malonic acid monoester magnesium sulfide.醮 can be any solvent and contains, for example, aromatic tobaccos such as benzene, toluene, xylene, etc .; ethers such as dioxane, tetrahydrofuran, diethyl ether, etc .; halogenated hydrocarbons such as dicyano-3 4-This paper is in accordance with China's national standards ( CNS) Α4 specification (2 丨 0 × 297 mm) -------- f -install -------- 訏 Ir --- f cable (please read the first Please note this page, please fill in this page) DuPont printed A7 B7 produced by the Central Bureau of Standards and Quarantine of the Ministry of Economic Affairs _ V. Description of the invention (") Methane, cyanoform, ethane, etc .; Methyl methyl B amine, Ν, Ν-dimethyl ethyl amine, etc. These solvols can be used alone or as a mixture of two or more. H, (T-carbonyldiazole and malonate The amount of the magnesium salt of the ester is at least 1 mole, preferably 1 to 2 moles, relative to the compound of the general formula [6] or [10] of the mole. The reaction is usually 僳 0-100 * 0, Preferably, the temperature is 10-80eC for 5 minutes to 30 hours. (B) As for another method, the compound of the general formula [6] or a carboxyl group of the * or the compound of the general U0] carboxyl group is modified. For example, the sulfur saccharyl group is converted into an acid halide and subsequently the acid halide is a metal salt of a malonic acid diester such as the malonate diester or the reaction of "magnesium", and the reaction mixture is then hydrated. In the dissolution, p-toluene acid or triacetic acid was used for partial removal and decarboxylation of the carboxyl protecting group, and thus the general formula [Ήcompound or its] or the general formula [Π] compound or its. The cocoon used in the reaction of the compound with the malonate diester gold osmium salt can be any solvent as long as it does not adversely affect the reaction, and it must additionally contain the same solvent as the aforementioned U) (a) _ βmalonate diester metal The amount of salt is at least 1 ear, preferably 1 to 3 ears, relative to the general formula [61 or [101] compound or its salt per ear. This reaction is usually carried out at a temperature of -50 to 10 (TC). 5 minutes to 30 hours. (2) (a &gt; A compound of the general formula [9] or a salt thereof or a compound of the general formula [12] or a salt thereof may be passed through the compound of the general formula [71 or a salt thereof or a general formula 丨 11], respectively. The compound or its hydrazone is reacted with an orthoester such as methyl orthoformate and ethyl orthoformate equal to acetic acid, and then reacted with a compound of the general formula [8] or its ". Solvents used in these reactions _ as long as there is no adverse effect on the reaction, it can be any solvent containing, for example, aromatic smoke such as benzene, toluene, xylene, etc .; such as -35- This paper is applicable to Chinese national standards ( CNS) A4 specification (210X297mm) I ------- 丨 installed, ----- ordered --i ---- A line (please read the precautions on the back before filling out this note) Printed A7 B7__ Printed by the Shellfish Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of the Invention (4) Di-Isoane, Tetrahydrofuran, Phenylmethyl «, Dioxane Diethyl«, Dimethyl Solvent Fermentation, such as formazan, acetic fermentation, propionate, etc .; halogenated halogens such as di «methane, cyanoform, dicyanoethane, etc .; amines such as N, N-dimethylformamide, Ν, Ν -di Methyl ethylamine, etc .; such as dimethylene, etc .; etc. These solvents can be used alone or in combination of two or more. The amount of ortho-acid sugar is relative to the general formula [毎 or [11] The compound or its stupid is at least 1 ear, preferably 1 to 10 moles. The reaction is usually carried out at a temperature of 0-15 (TC, preferably 50-1 50 ° C for 20 minutes to 50 hours In the reaction with the compound of the general formula U] or its reaction after time ❶, the general formula [8] The use of the compound or its salt is at least 1 mole relative to the general formula [Ή or [11] of the compound or its salt. These reactions are usually inferior to O-iWC, preferably 10-60 · 0. (B) As for another method, the compound of the general formula (Ή compound or its 鼸 or the formula [11] or its "and acetal such as Ν, Ν-dimethylmethylose according to two Methyl acetals, η, N-dimethylformamide diethyl aldehydes, etc., are reacted in the presence or absence of acetic anhydride, such as acetic anhydride, etc., and then converted into the following general reactions [8] or their salts. The compound of the general formula [9] or a salt thereof, or the compound of the general formula [12 丨 or a salt thereof. The solvent used in the foregoing reaction can be any solvent as long as it does not cause an adverse color reaction, and further includes the above (2) & lt a) The same amount of the same solution is at least 1 mole relative to the compound of the general formula [7] or [11] or its salt, and about 1 to 5 deciles compared to 。. Reaction with S Usually you carry out the reaction for 20 minutes to 50 hours at a temperature of 0-100 eC, preferably 20-85 °. Afterwards, the compound of the general formula [81 or its compound], the compound of the general formula [8] or its The amount of tincture relative to tincture The compound of formula [7] or its color is at least 1 mole, and these reactions are usually carried out at a temperature of preferably 10-6 D eC for a period of 20 minutes to 30 hours. (3) General formula [ 21 The compound or its salt or the compound of the general formula [41] or its salt can be identified through the compound of the general formula [9] or its crocodile or the compound of the general formula [12] or its salt in the presence or absence of fluoride salt or age, respectively. It can be obtained by reaction. Soluble in reaction _ as long as it does not cause adverse color response to the reaction, it can be any solvent containing, for example, sugar amines such as Ν, Ν-dimethylformamide, Ν, Ν-dimethylacetamide Amines, etc .; ethers such as dioxane, phenylmethyl ether, dioxalyl dimethyl ether, dimethyl lysolysine, etc .; fluorene, such as dimethylarsine, etc .; etc. These solvents can be used alone or in combination of two or more. Visible Fluoride-3 to be used-6-This paper size is applicable to China National Standard (CNS) A4 (210 × 297 mm) --------- f 1 Packing -------- Order-- --f line (please read the note on the back before filling in this). Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 _ _ _B7___ V. Description of the invention (β) The surface contains such as sodium fluoride, potassium Etc., and the sickle to be used includes, for example, sodium oxalate, sulfonic acid, potassium third butoxide, argon pin and the like. The amount of fluoride or _ is equivalent to at least 1 mol, preferably 1.0 to 3.0 mol, of the compound of the general formula [9] or [12], respectively. The reaction is usually provided at a range of 0-180 ° F for 5 minutes to 30 hours. It is believed that the compound of the general formula [3] or [4] where // is the following formula:

CIY 基 示 表 式 下 成 生 2 R 舆 其中B及R7之定義如上 可特別根據日本特許公開案第2-85,255號等所述方法製 備。 通式[10]芳基錫化合物或其鹽,通式[11 ]芳基錫化合 物或其鹽或通式[4]芳基錫化合物或其鹽可分別經由通 式I 6 ]鹵化芳基化合物或其鹽,通式[7 1曲化芳基化合物 或其邇,或通式[2]鹵化芳基化合物或其鼸使用耙錯合 物催化薄根鐮例如日本化學會公報56期3855-3856頁( 1386)所述方法輿六烷基二鐳烷反鼴而得使用之溶雨及 把銪合物催化翔可為對反應不會産生不良影響者且無待 殊限制。其特例傜與前述裂法1相同。六烷基二錫烷用 量相對於每莫耳通式[6][7】或[2]®化芳基化合物或其鹽 至少為1莫耳較佳1 . 〇 - 3 · 0莫耳。反慝通常像於4 0 - 1 6 0 -C -37- -------ii裝------訂—t---Γ線 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度遑用中國國家標準( CNS ) A4g ( 210X297公釐) 經濟部中央標隼局員工消费合作社印裝 A7 ( _____; B7 ___ 五、發明説明(4 ) 之溫度進行1 - 7 2小時時間β 生産路徑中當通式[2], [4], [6], [7], [8], [9], [10],[11]或[12】化合物或其鹽含有胺基,羥基或羧基 時,可使用習知保讃基預先保護此基,並於反應完成後 以已知方式去除保護基。 當前述製法使用之通式[2], [4], [6], [7], [8], [9], [10], [11】或[12]之化合物或其鹽具有異構物(例 如光學異構物,幾何異檐物,互變異構物等),此等異 構物可取而代之。又前述化合物或其鹽可以溶劑合物或 水合物或所需結晶形使用。反應完成後,反隳混合物可 於随後之反應中就此使用而無需分離目揉化合物。 通式[6]化合物或其鹽及通式[2】化合物或其鹽(生産 本發明化合物起始物料之一)可由已知化合物合成,合 成方法傜將其藉例如日本特許公開案第1-100 ,166號所 述方法轉成含所痛X’之方法,亦即利用桑徳梅爾反躔。 随後通式[3】有機錫化合物或其鹽可根據例如下述合 成方法合成: R4 R4Under the CIY basic expression, the generation 2 R is public, where the definitions of B and R7 can be prepared according to the methods described in Japanese Patent Laid-open No. 2-85,255 and the like. An aryl tin compound of the general formula [10] or a salt thereof, an aryl tin compound of the general formula [11] or a salt of the aryl tin compound of the general formula [4], or an aryl tin compound of the general formula [4] may be respectively halogenated through an aryl compound through the general formula I 6] Or a salt thereof, a compound of the general formula [71] or a halogenated aryl compound, or a halogenated aryl compound of the general formula [2] The method described in (1386) can be used as a solvent for the reaction of hexaalkyl diradane, and the catalyst can be used as the catalyst without any adverse effect on the reaction. The special case 傜 is the same as the aforementioned cracking method 1. The amount of hexaalkyldistannane is at least 1 mole, preferably 1.0 to 3.0 moles per mole of the general formula [6] [7] or [2] ® aryl compound or a salt thereof. The response is usually like 4 0-1 6 0 -C -37- ------- ii installation -------- order- t --- Γ line (please read the precautions on the back before filling in this (Page) This paper is in Chinese National Standard (CNS) A4g (210X297 mm). It is printed on A7 (_____; B7 ___) by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs. 5. The temperature of the description of invention (4) is 1-7 2 Hour time β When the general formula [2], [4], [6], [7], [8], [9], [10], [11] or [12] in the production route contains an amine In the case of a hydroxyl group, a hydroxyl group or a carboxyl group, the conventional protecting group can be used to protect the group in advance, and the protecting group can be removed in a known manner after the reaction is completed. When the general method [2], [4], [6], [ 7], [8], [9], [10], [11] or [12] or their salts have isomers (such as optical isomers, geometric isomers, tautomers, etc.), These isomers may be substituted. The aforementioned compounds or their salts may be used in solvates or hydrates or in the desired crystal form. After the reaction is complete, the reaction mixture may be used for this purpose in subsequent reactions without the need to isolate the compound. A compound of the general formula [6] or Salts and compounds of the general formula [2] or their salts (one of the starting materials for the production of the compounds of the present invention) can be synthesized from known compounds. The synthesis method can be converted by the method described in, for example, Japanese Patent Laid-Open No. 1-100,166 The method containing the pain X ', that is, using mulberry mel to reverse the reaction. Subsequently, the organotin compound or its salt of the general formula [3] can be synthesized according to, for example, the following synthesis method: R4 R4

[5]或其鹽 [3】或其鹽 其中R 3 ,R 4,R s ,Χ 1及Aik之定義如上。 通式【3]化合物或其翬可經由通式[5]化合物或其鹽根 _ 3 8 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) (請先間讀背面之注意事項再填寫本頁) -裝^[5] or a salt thereof [3] or a salt thereof wherein R 3, R 4, R s, X 1 and Aik are as defined above. The compound of the general formula [3] or its hydrazone can pass through the compound of the general formula [5] or its salt root_ 3 8-This paper size applies to the Chinese National Standard (CNS) A4 specification (210 × 297 mm) (please read the note on the back first) (Fill in this page again)-Pack ^

*1T* 1T

X A7 B7 五、發明説明U! 據上述方法使用耙錯合物催化劑與六烷基二矽烷反應而 得。 上述製法中,當通式[3】或丨5]化合物或其盥具有異構 物(例如光舉異構物,幾何異構物,互變異構物等)時, 此等異構物可取而代之。又上述化合物或其鹽可以溶劑 $牲合物或所箱結晶形使用。 當通式[3]或[5]化合物具有胺基或羥基時,可事先使 用習知保護基保護此基並於反應完成後以已知方式去除 保護基。 通式[5]表示之異吲呤咻鹵化物或其蘧腯於本發明化 合物生産用之起始物料之一,可藉下列合成方法合成, 例如根據有機合成第5冊,1064-106 6頁之方法,日本 特許公開案第63-179,872號,日本特許公两案第2-62,8Ϊ5 號或日本待許公開案第3-52,888號或4^1116111-?(^811./ Drug Res.3〇(ll),1487-1493(1980)等陳述之方法。 --------^ ·裝 ---- (請先閱讀背面之注意事項再填寫本頁)X A7 B7 V. Description of the invention U! It is obtained by reacting hexaalkyldisilazane with rake complex catalyst according to the above method. In the above production method, when the compound of the general formula [3] or 丨 5] or its isomers (such as light isomers, geometric isomers, tautomers, etc.), these isomers may be replaced. . The above compounds or their salts can be used in a solvent or in a crystal form. When the compound of the general formula [3] or [5] has an amine group or a hydroxyl group, this group can be protected in advance with a conventional protecting group and the protecting group can be removed in a known manner after completion of the reaction. The isoindolinium halide represented by the general formula [5] or one of the starting materials used in the production of the compound of the present invention can be synthesized by the following synthetic methods, for example, according to Organic Synthesis Book 5, 1064-106 6 The method is described in Japanese Patent Publication No. 63-179,872, Japanese Patent Publication No. 2-62,8Ϊ5, or Japanese Patent Publication No. 3-52,888 or 4 ^ 1116111-? (^ 811./ Drug Res. 3〇 (ll), 1487-1493 (1980), etc. -------- ^ · Equipment ---- (Please read the precautions on the back before filling this page)

*1T* 1T

S级 經濟部中央橾準局員工消費合作社印製 [13]或其鹽Class S Printed by the Consumer Cooperatives of the Central Government Bureau of the Ministry of Economic Affairs [13]

14 1或其鹽14 1 or its salt

本紙張尺度適用中國國家標準(CNS &gt; A4規格(210X297公釐)This paper size applies to Chinese national standards (CNS &gt; A4 size (210X297 mm)

經濟部中央榡準局員工消費合作社印製 A7 B7 五、發明説明(4 )Printed by the Employees' Cooperatives of the Central Government Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description

U5]或其鹽 其中R3,1^及^之定義如上,及γ表示去除基。 通式[13]’ [141,[15]及[5a]化合物之鹽包含如對通 式[1]化合物所述之鹽。Y之去除基包含鹵原子如氣原 子,溴原子等》 通式[5]或其鹽可經由通式[13]化合物或其鹽舆rS(JH2 反應,或經由通式[14】化合物或其鹽進行脱水反匾而得, 另一方面,通式[5aj化合物或其鹽,其含亞胺基,可經 由通式[15]化合物或其鹽進行閉琛反應而得。此外通 式[13], [14]或[15]化合物或其鹽及由通式[13], [14] 或[15]化合物或其鹽衍生之有機錫化合物可與通式[4] 或[2]化合物或其鹽根據如上製法製法1之相同方法進 行偶合反應,所得化合物根據前述柑同方法進行異丨3丨時 啉環之生成反應獲得通式[1]化合物或其鹽。 前述製法中,當通式[13],[14], [15]或[5a]化合物 或其鹽具有異構物(例如光學異構物,幾何異構物,互 受異構物等)時,此等異構物可取而代之。又前述化合 物或其鹽可以溶劑合物或水合物或多種結晶形使用。 當通式[13],[14], [15】或[5a】化合物或其鹽具有胺基 或羥基時,可事先使用習知保護基保護此基,並於反應 後以已知方式去除保護基。 通式[1]化合物或其鹽也可藉下示任一種製法生産。 -40- 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X297公釐) (請先聞讀背面之注意事項再填寫本页)U5] or a salt thereof wherein R3, 1 ^ and ^ are as defined above, and γ represents a removing group. The salt of the compound of the general formula [13] '[141, [15] and [5a] includes the salt as described for the compound of the general formula [1]. The removing group of Y contains a halogen atom such as a gas atom, a bromine atom, etc. "The general formula [5] or a salt thereof can be reacted via a compound of the general formula [13] or a salt thereof via the rS (JH2 reaction, or via a compound of the general formula [14] or The salt is obtained by dehydration. On the other hand, the compound of the general formula [5aj or its salt, which contains an imine group, can be obtained by a closed reaction of the compound of the general formula [15] or its salt. In addition, the general formula [13 ], [14] or [15] compounds or their salts, and organotin compounds derived from compounds of the general formula [13], [14] or [15] or their salts can be combined with the compounds of the general formula [4] or [2] or The salt is subjected to a coupling reaction according to the same method as in Production Method 1 above, and the obtained compound is subjected to the isocyanate ring formation reaction according to the aforementioned method to obtain a compound of the general formula [1] or a salt thereof. In the aforementioned production method, when the general formula When [13], [14], [15] or [5a] compounds or their salts have isomers (such as optical isomers, geometric isomers, mutual isomers, etc.), these isomers may be Instead, the aforementioned compounds or their salts may be used in solvates or hydrates or in multiple crystal forms. When the compounds of the general formula [13], [14], [15] or [5a] or When the salt has an amine group or a hydroxyl group, this group can be protected in advance with a conventional protecting group, and the protecting group can be removed in a known manner after the reaction. The compound of the general formula [1] or a salt thereof can also be produced by any of the production methods shown below. -40- This paper size applies to China National Standard (CNS) A4 (210X297mm) (Please read the precautions on the back before filling this page)

A7 B7 五、發明説明(神 〔製法2〕 R6 0A7 B7 V. Description of the invention (God [Method 2] R6 0

C02Rla 16]或其鹽 1) 原酸酯或縮醛2) R 2¾ -JJH 2 [8]或其鹽 R6 0C02Rla 16] or its salt 1) orthoester or acetal 2) R 2¾ -JJH 2 [8] or its salt R6 0

ί ——---I 1— - -I —^n nn - --: I ·---- -ΪΙ (锖先閱讀背面之注意事項再填寫本頁) 、?τ 線 經濟部中央標準局員工消費合作社印製 R6 0ί ——--- I 1—--I — ^ n nn--: I · ---- -ΪΙ (锖 Please read the notes on the back before filling this page),? τ Central Bureau of Standards, Ministry of Economic Affairs Printed by Employee Consumer Cooperative R6 0

CO2R1 1 ]或其鹽 -41 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) A7 B7 五、發明説明(和) 其中 R1 ,Ria ,R2 ,R221,R3,R4 ,RS ,R6,A〆 Λα1, X 及X 2定義如上。 通式[16]或[17]化合物之鹽包含如前就通式[1]化合 物所述之相同鹽。 通式[1]化合物或其鹽可由通式[16]化合物或其鹽根 據前述方法(通式[2]或[4】化合物或其鹽由通式[7】或 [Η]化合物或其鹽之合成)播得。換言之,通式[1]化 合物或其鹽可經由通式U6】化合物或其鹽與原酸酯或縮 醛於有或無酸酐如乙酸酐存在下反應,然後與通式[8] 或其盏反應,随後通式[17]化合铷或其薄於有或無氟化 物鹽或_存在下進行閉琛反應而得。 如此所得通式[1]化合物或其鹽可經由前者接受已知 反應如氣化,通原,重排,取代,齒化,脱水,水解等 或進行此等反應之迪當組合而轉成Β —種通式[1]化合 物。 前述製法中,當通式丨8], [16]或[17]化合物或其鹽 具有異構物(例如光學異構物,幾何異携物,互變異構 物等)時,此等異構物可取而代之。又前述化合物或其 鹽可以溶爾合物或水合物或所需結晶形使用ό 經濟部中央標隼局員工消費合作社印裂 --------Γ裝-- (請先閲讀背面之注意事項再填寫本頁) 當通式[8】,[161,[17]或[1]化合物或其鹽具有胺基 ,羥基或羧基時可事先使用習知保護基保護該基及於反 應完成後以習知方式去除保護基。反應完成後反應混合 物可未分離目標化合物而就此用於後縝之反應中。 其次,通式[16]化合物或其鹽,其乃生産本發明化合 物之起始物料之一,將説明如下》通式[16]化合物或其 鼸為新穎,可根據例如如下製法合成。 ___ _________- 4 _________ 本紙張尺度適用中國國家標準(CNS ) Α4規格(2丨〇 X 297公釐) A7 B7 五、發明説明(4,) 經濟部中央標準局員工消費合作社印製 R6CO2R1 1] or its salt-41 This paper size applies to Chinese National Standards (CNS) A4 specifications (210 × 297 mm) A7 B7 V. Description of the invention (and) Among them R1, Ria, R2, R221, R3, R4, RS, R6 , A〆Λα1, X and X 2 are defined as above. The salt of the compound of the general formula [16] or [17] includes the same salt as previously described for the compound of the general formula [1]. A compound of the general formula [1] or a salt thereof can be prepared from a compound of the general formula [16] or a salt thereof according to the aforementioned method (a compound of the general formula [2] or [4] or a salt thereof from a compound of the general formula [7] or [Η] Synthesis). In other words, the compound of the general formula [1] or its salt can be reacted with the orthoester or acetal in the presence or absence of an acid anhydride such as acetic anhydride via the compound of the general formula U6] or its salt, and then reacted with the general formula [8] or its salt. The reaction is obtained by a compound of the general formula [17] or a thinner than a thin-walled reaction in the presence or absence of a fluoride salt or _. The compound of the general formula [1] or a salt thereof thus obtained can be converted to B via a known reaction such as gasification, passogen, rearrangement, substitution, toothing, dehydration, hydrolysis, etc. -A compound of the general formula [1]. In the aforementioned production method, when the compound of the general formula 丨 8], [16] or [17] or its salt has isomers (such as optical isomers, geometric isomers, tautomers, etc.), these isomers Things can be replaced. The aforementioned compounds or their salts can be used in the form of solvates or hydrates or the desired crystal form. The Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs prints -------- Γ-- (Please read the Note: Please fill in this page again) When the compound of the general formula [8], [161, [17] or [1] or its salt has an amine group, a hydroxyl group or a carboxyl group, a conventional protecting group may be used to protect the group in advance and complete the reaction. The protecting group is then removed in a conventional manner. After completion of the reaction, the reaction mixture may be used in the subsequent reaction without isolating the target compound. Next, the compound of the general formula [16] or a salt thereof, which is one of the starting materials for producing the compound of the present invention, will be described below. The compound of the general formula [16] or hydrazone is novel and can be synthesized according to, for example, the following production method. ___ _________- 4 _________ This paper size applies to Chinese National Standards (CNS) A4 specifications (2 丨 〇 X 297 mm) A7 B7 V. Description of the invention (4) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs R6

【16】或其a -43- I-------Γ 裝1 (·請先閲讀背面之注意事項再填寫本頁)[16] or a -43- I ------- Γ Pack 1 (· Please read the precautions on the back before filling this page)

、1T 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作杜印掣 A7 B7 五、發明説明(Ο ) 上式中[6】,[7],[10],[11】,[16]及[18],!{1,11^, K3,K4,R5,Re ,X,X1,X2 及 Uk定義如上。 通式[18】化合物之鼸包含前述通式丨1]相同之廉。 通式[16]化合物或其鹽可由通式[7]或[11】化合物或· 其鹽根據如上製法1所述之相同方法合成或者也可經由 將通式[18]化合物或其鹽根據前述方法進行睡酯化反應 生産。 通式[7]化合物或其鹽或通式【11】化合物或其鹽,可 分別經由通式[6 ]化合物或其鹽或通式[1 Q ]化合物或其鹽 ,分別根據前述方法進行酮酯化反醮而得。另一方面, 通式[18]化合物或其鹽可由通式[6]或[10】化合物或其 鹽根據前述製法1之相同方法製備。 當通式[6], [7] ,[10], [11】,[16]或[18]化合物或其鹽 具有胺基,羥基或羧基時可事先使用習知保護基保護該 基,並於反應後以已知方式去除該基。 前述製法中,當通式U], [7], [10],丨11], [16]或[18] 化合物或其鹽具有異構物(光學異構物,幾何異構物, 互變異構物等)時,此等異構物可取而代之,又前述化 合物或其鹽可以溶劑合物或水合物或所需結晶使用。完 成反應後,反應混合物可未經分離目標化合物而就此用 於後缠之反應。 如此所得通式[I]化合物或其鹽可根據習知方转如萃 取,結晶,程式雇析等分離及鈍化》 當本發明化合物用作蕖物時,化合物可舆製劑佐爾如 -4 4 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) I--------^ -I (請先閱讀背面之注意事項再填寫本頁) 、-'0 經濟部中央標準局員工消費合作杜印製 A7 _ B7_ '__ 五、發明説明(G ) 賦形劑,習知醫藥製劑用之載劑或稀釋劑混合且可以錠 劑,膠囊,粉劑,糖漿薄I,粒薄I,九剤,分散液劑,乳 液劑,溶液薄I,栓薄I,軟膏劑,注射劑等剤型經口或滕 外投藥。投藥途徑、劑量及次數可随病人之年齡,體重 及症狀適當改變。通常以〇.卜lOOaig/kg/日之比辦分成 —份至數份經口或賭外投藥(例如藉注射、滴注、直膜 内投藥等)將化合物投予病人即足夠。 其次説明本發明之代表性化合物之藥理活性。 抗菌活性 試驗方法 根據日本化學治療協會之方法〔CHEMOTHERARY,V〇1.、 1T This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297mm). Du Yinshu A7 B7, employee cooperation of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (0) In the above formula [6], [7], [10], [11], [16] and [18],! {1,11 ^, K3, K4, R5, Re, X, X1, X2 and Uk are defined as above. The compounds of the general formula [18] include the same compounds as the general formula [1]. The compound of the general formula [16] or a salt thereof can be synthesized from a compound of the general formula [7] or [11] or a salt thereof according to the same method as described in the production method 1 above, or can also be prepared by subjecting a compound of the general formula [18] or a salt thereof according to the foregoing Methods Production was carried out by esterification. The compound of the general formula [7] or a salt thereof or the compound of the general formula [11] or a salt thereof can be respectively subjected to the ketone through the compound of the general formula [6] or a salt thereof or the compound of the general formula [1 Q] or a salt thereof according to the aforementioned method. Obtained from esterification. On the other hand, the compound of the general formula [18] or a salt thereof can be prepared from the compound of the general formula [6] or [10] or a salt thereof according to the same method as in the aforementioned production method 1. When the compound of the general formula [6], [7], [10], [11], [16] or [18] or a salt thereof has an amine group, a hydroxyl group or a carboxyl group, the conventional protecting group may be used to protect the group in advance, and This group is removed in a known manner after the reaction. In the foregoing preparation method, when the compound of the general formula U], [7], [10], 丨 11], [16] or [18] has a isomer (optical isomer, geometric isomer, mutual variation) Structures, etc.), these isomers may be used instead, and the aforementioned compounds or their salts may be used as solvates or hydrates or desired crystals. After the reaction is completed, the reaction mixture can be used for the post-reaction reaction without isolating the target compound. The compound of the general formula [I] or its salt thus obtained can be isolated and passivated according to conventional methods such as extraction, crystallization, formula analysis, etc. When the compound of the present invention is used as a mash, the compound can be formulated as Zorru-4 4 -This paper size applies Chinese National Standard (CNS) A4 specification (210X297mm) I -------- ^ -I (Please read the precautions on the back before filling this page), -'0 Central of the Ministry of Economic Affairs Standards Bureau's consumer cooperation Du printed A7 _ B7_ '__ 5. Description of the invention (G) Excipients, carriers or diluents used in conventional pharmaceutical preparations can be mixed and can be tablets, capsules, powders, thin syrups, granules Thin I, Jiujing, dispersing liquid, emulsion, solution thin I, suppository I, ointment, injection and other 剤 type oral or external administration. The route, dosage and frequency of administration can be appropriately changed according to the age, weight and symptoms of the patient. It is usually divided into a ratio of 0.1 to 100 aig / kg / day-one to several portions of the compound administered to the patient by oral or external gambling (for example, by injection, drip, intramucosal administration, etc.). Next, the pharmacological activities of the representative compounds of the present invention will be described. Antibacterial activity test method According to the method of the Japanese Chemotherapy Association [CHEMOTHERARY, V〇1.

' I 29,Νο·1,page 7 6 - 7 9 ( 1 9 8 1)〕,一掴接種環之細菌溶 液(經由於米勒行頓營養汁(D if co製造)於37*C培餐20小 時並調整至1Q6細胞/平板(1Q8細胞/毫升)濃度而得) 接種於含試驗化合物之米勒行頓瓊脂培餐基(Difco製迪) ,及於37 eC培餐20小時,及随後觀察細饈的生長拥定細 菌生長受抑制的最低潺度,該濃度以ΜΙΜ#8/·1)表示。 試驗結果示於表U 表1之星號定義如下: *: /5-内醯胺酶-生産性細豳 MRSA(美西西林—抗性金黄蕕萄球菌) 試驗化合物A : 1-環丙基-6-氟-7-(異吲哼啉-5-基)-8-甲基-1,4-二氫-4-氧基!- 3-羧酸 對照化合物B: 1-琛丙基-6-氟- 7- (1-六氫吡阱基)-1, -45* 本紙張尺度適用中國國家榡準(CNS丨八4規格(2ι.οχ297公釐) ----------裝«— (請先閱讀背面之注意事項再填寫本頁·) 訂 A7 B7 五、發明説明(私) 4-二氫-4-氧基H$啉-3-羧酸(賽普洛笑沙辛) 表1 MIC ( μ g /m 1) A B 金黃蕕萄球菌 FDA 2 0 9 P έ 0 . 0 5 0 . 2 金黃葡萄球菌F-137* S 0 . 0 5 0.39 金黃®萄球菌 F- 5 9 7 ** ^0.05 6.25 大賭桿菌NIH J JC-2 έ 0 . 05 έ 0 . 0 5 --------(裝-I (請先閱讀背面之注意事項再填寫本頁) 由前逑結果可知本發明化合物具有絶佳抗菌活性。 進行本發明之最佳模式 以下將參照參考例及實例説明本發明之進一步細節, 但本發明絶非視為局限於此。 溶離劑之混合比除非另行規定苔則像以體積計β柱式 層析所用載劑為矽膠60,7 7 3 4號(HER 0 &amp; Co.,INC.製造 )。又於參考例與實例中,&quot;di-TFA&quot;·^詞表示三氣乙酸 -d !及” d 6 - D M S 0 ”表示二甲亞明-d e。 參考例1 於3〇1〇1甲苯内溶解3.04§乙基3-溴-2,4,5-三氟苯甲 酸酯,及於溶液内加入5.11 g三丁基乙烯基錫及0.25 g肆 (三苯瞵)把(0),隨後所得混合物於氮氣氛下加熱2小時 -46- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -11 K4 經濟部中央標準局員工消費合作社印製 .經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(u) 。反應混合物於減壓下濃縮,及所得殘餘物藉柱式層析 純化(溶離剤:正己烷:乙酸乙酯=100: 1)獲得無色油 狀乙基2,4,5 -三氟-3-乙烯基苯甲酸酯。如此所得油狀 産物溶解於62b1甲酵及12b1二氯甲烷之混合溶劑,及随 後於- 5CTC次入臭氣氣體歴時3小時,及随後吹入氮氣歴 時30分鐘。溶液溫度升高至-20eC及随後加入〇.81g硼氳 化鈉,其後所得混合物於室溫攪拌12小時。反應混合物 加人400b1乙酸乙酯及600b1冰水之混合溶劑及PH以6N氫 氣酸調整至1,随後分皤生成的有機層以飽和鹽水溶液洗 滌然後以以無水硫酸隸脱水。然後於滅壓下蒸皤去除溶 劑。如此所得的殘餘物藉柱式層析純化(溶解薄I :正-己 烷:乙酸乙酯=4: 1)獲得1.70 g無色油狀乙基)-羥甲基 -2 ,4 ,5-三氟苯甲酸酯。 IR (淨)cm-i: υ〇〇 1720 NMR (CDC13) δ 值:1.38 (3Η, t, J=6.8Hz), 2.60 (lH,t,J=5.0Hz),4.39(2H,q,J=6.8Hz),4.65-4.95 (2Hf m), 7.40-8.00 (1H, m) 參考例2 (1〉溶解61. 7g乙基2,4, 5-三氟-3-甲基苯甲酸酯於3 08b1 二甲亞硪中及4 2.3g叠氮化納加至該溶液,随後所得混 合物於55°C攪拌14土時。反應混合物冷卻至室溫及随後 4 加至乙酸乙酯500ffll及1200B1水之混合溶_。生成的有 機靥經分離.以水洗滌然後以無水硫酸鎂脱水^然後於 減懕下蒸餾去除溶劑獲得65.3g淡黄色油狀乙基4-*氘- -47- 本紙張尺度適用中國國家橾準(CNS ) Α4規格(210Χ297公釐) ---------Γ 裝·:— (請先閱讀背面之注意事項再填寫本萸)'I 29, Νο · 1, page 7 6-7 9 (1 9 8 1)], a loop of bacterial solution of inoculation loop (via Miller's nutritional juice (manufactured by D if co) at 37 * C 20 hours and adjusted to a concentration of 1Q6 cells / plate (1Q8 cells / ml)) Inoculated on the Miller rowton agar culture base (Difco Di) containing the test compound, and cultured at 37 eC for 20 hours, and with Later, the growth of the larvae was observed to determine the minimum degree of growth inhibition. The concentration was expressed as MIM # 8 / · 1). The test results are shown in Table U. The asterisks in Table 1 are defined as follows: *: / 5-lactamase-productive MRSA (methicillin-resistant Staphylococcus aureus) Test compound A: 1-cyclopropyl- 6-fluoro-7- (isoindhenyl-5-yl) -8-methyl-1,4-dihydro-4-oxy! -3-carboxylic acid reference compound B: 1-Cyclopropyl-6-fluoro-7- (1-hexahydropyridyl) -1, -45 * This paper size is applicable to China National Standard (CNS 丨 8-4 specifications) (2ι.οχ297 mm) ---------- Installation «— (Please read the notes on the back before filling in this page ·) Order A7 B7 V. Description of the Invention (Private) 4-Dihydro-4 -Oxy H $ line-3-carboxylic acid (Cyproxaxin) Table 1 MIC (μ g / m 1) AB Staphylococcus aureus FDA 2 0 9 P 0. 0 5 0. 2 Staphylococcus aureus F-137 * S 0. 0 5 0.39 Staphylococcus aureus F- 5 9 7 ** 0.05 Pack-I (Please read the notes on the back before filling this page) From the previous results, we can know that the compound of the present invention has excellent antibacterial activity. The best mode for carrying out the present invention Hereinafter, further details of the present invention will be described with reference to reference examples and examples. However, the present invention is by no means limited to this. Unless otherwise specified, the mixing ratio of the dissolving agent is like the silica gel 60, 7 7 3 4 (HER 0 & Co., INC.). Also in reference examples and examples, &quot; di-TFA &quot; · ^ means triacetic acid -d! and "d 6-DMS 0" means dimethylarmine-de. Reference Example 1 3.04 §ethyl 3-bromo-2 was dissolved in 3,001 toluene. 4,5-trifluorobenzoate, and 5.11 g of tributylvinyltin and 0.25 g of tris (triphenylphosphonium) were added to the solution (0), and then the resulting mixture was heated under a nitrogen atmosphere for 2 hours-46 -This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) -11 K4 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economics A7 B7. ). The reaction mixture was concentrated under reduced pressure, and the obtained residue was purified by column chromatography (isocyanate: n-hexane: ethyl acetate = 100: 1) to obtain ethyl 2,4,5-trifluoro- as a colorless oil. 3-Vinyl benzoate. The oily product thus obtained was dissolved in a mixed solvent of 62b1 formazan and 12b1 dichloromethane, and then odor gas was added at -5CTC for 3 hours, and then nitrogen was blown in. After 30 minutes, the temperature of the solution was raised to -20eC and 0.881 g of sodium borosulfide was subsequently added, after which the resulting mixture was stirred at room temperature for 12 hours. Mixture and addition of a mixed solvent of ethyl acetate and 400b1 PH 600b1 of ice-water and adjusted to 1 to 6N-hydrochloric acid gas, and then the resulting organic layer was BU washed with saturated saline solution and then dried over anhydrous sulfate scribe dehydration. The solvent was then removed by distillation under reduced pressure. The residue thus obtained was purified by column chromatography (dissolved in thin I: n-hexane: ethyl acetate = 4: 1) to obtain 1.70 g of ethyl as a colorless oil) -hydroxymethyl-2,4,5-tri Fluorobenzoate. IR (net) cm-i: υ〇〇1720 NMR (CDC13) δ value: 1.38 (3Η, t, J = 6.8Hz), 2.60 (lH, t, J = 5.0Hz), 4.39 (2H, q, J = 6.8Hz), 4.65-4.95 (2Hf m), 7.40-8.00 (1H, m) Reference Example 2 (1> Dissolved 61.7 g of ethyl 2,4, 5-trifluoro-3-methylbenzoate To this solution was added in 3 08b1 dimethylarsine and 4 2.3 g of sodium azide, and the resulting mixture was then stirred at 55 ° C. for 14 hours. The reaction mixture was cooled to room temperature and then added to ethyl acetate 500ffll. And mixed with 1200B1 water. The generated organic tritium is separated. It is washed with water and then dehydrated with anhydrous magnesium sulfate. Then the solvent is distilled off under reduced pressure to obtain 65.3 g of ethyl 4- * deuterium in the form of light yellow oil. -47- The size of this paper is applicable to China National Standard (CNS) A4 specification (210 × 297 mm) --------- Γ Packing ::-(Please read the notes on the back before filling in this card)

*1T K線 經濟部中央標準局員工消費合作杜印製 A7 B7 五、發明説明(4 ) 2 , 5-二氟-3-甲基笨酸酯。 (2) 於60b1甲酵懸浮14.2 g氣化亞錫並於此懸浮液内於 室溫以1小時時間逐滴加入10. Og乙基4-疊氡-2 ,5-二氟 -3-甲基苯甲酸酷於20·1甲酵之溶液,随後所得混合物, 於同溫攪拌3 0分鐘β於減壓下蒸皤去除甲酵,及於所得 殘餘物内加入30ml乙醚及ΐ〇〇Β1水,随後pH以2Ν氳氣化 納水液諝整至12.5。生成的有機層經分離,然後以水洗 滌及以無水硫酸鎂脱水。然後於減壓下蒸皤去除溶劑獲 得8.91g黃色油狀乙基4 -胺基-2,5 -二氟-3-甲基苯甲酸 酯β (3) 溶解8.91g乙基4 -疊氮-2 ,5 -二氟-3-甲基苯甲酸_ 於50ml乙酵内及添加50b1 2N氫氣化納水溶液至該溶液 ,随後所得混合物於室溫攪拌3小時。反應混合物内加 入50ml 2NBI酸及所得結晶藉過濾收集獲得5.45g無色结 晶性4 -胺基-2, 5 -二氟-3-甲基苯甲酸。 IR (KBr) cm-i: υ〇〇 1701, 1636 NMR (άχ-TFA) δ 值:2.50 (3H, s), 7.86 (1H, dd, J=5.4Hz, J=9.3Hz) 參考例3 (1)溶解13.2g乙基3-二氟甲氣-2,4,5-三氟苯甲酸酯於 66b1二甲亞碘中及於此溶液内加入7.3 g*氮化納,随後 所得混合物於室溫攪拌5小時。反應混合物加入150ml 乙酸乙酯及150b1冰水之混合溶_及?11以2NH酸緦整至 2,然後生成之有機層經分離然後依次以水及飽和鹽水 -4 8 - 本紙張尺度適用中國國家榇準(CNS ) A4規格(210X297公釐) --------C ,裝^— (請先閱讀背面之注意事項再填寫本頁) 訂* 1T K line Consumption cooperation by employees of the Central Bureau of Standards, Ministry of Economic Affairs, Du printed A7 B7 V. Description of the invention (4) 2, 5-difluoro-3-methyl stearic acid ester. (2) Suspend 14.2 g of stannous gas in 60b1 formazan and dropwise add 10.10 g of ethyl 4-azido-2,5-difluoro-3-form in this suspension at room temperature over 1 hour. A solution of benzoic acid in 20.1 formazan, and then the resulting mixture was stirred at the same temperature for 30 minutes β to remove the formazan under reduced pressure, and 30 ml of ether and 〇〇〇Β1 were added to the obtained residue. Water, and then the pH was adjusted to 12.5 with 2N 氲 gasified sodium water solution. The resulting organic layer was separated, washed with water and dehydrated with anhydrous magnesium sulfate. Then, the solvent was distilled off under reduced pressure to obtain 8.91 g of ethyl 4-amino-2,5-difluoro-3-methylbenzoate β as a yellow oil (3) 8.91 g of ethyl 4-azide was dissolved -2,5-difluoro-3-methylbenzoic acid_ In 50 ml of acetic acid and add 50b1 2N sodium hydrogenated aqueous solution to the solution, and then the resulting mixture was stirred at room temperature for 3 hours. 50 ml of 2NBI acid was added to the reaction mixture and the resulting crystals were collected by filtration to obtain 5.45 g of colorless crystalline 4-amino-2,5-difluoro-3-methylbenzoic acid. IR (KBr) cm-i: υ〇〇1701, 1636 NMR (άχ-TFA) δ value: 2.50 (3H, s), 7.86 (1H, dd, J = 5.4Hz, J = 9.3Hz) Reference example 3 ( 1) Dissolve 13.2g of ethyl 3-difluoromethane-2,4,5-trifluorobenzoate in 66b1 dimethyl iodide and add 7.3 g * sodium nitride to this solution, and then obtain the mixture Stir at room temperature for 5 hours. Add 150ml of ethyl acetate and 150b1 ice water to the reaction mixture. 11 is adjusted to 2 with 2NH acid, and the resulting organic layer is separated and then sequentially with water and saturated brine-4 8-This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) ----- --- C, install ^ — (Please read the precautions on the back before filling this page) Order

X 經濟部中央標準局員工消費合作社印製 A7 B7 · , 五、發明説明(47) 溶液洗滌,随後以無水硫酸鈉脱水〇然後於滅壓下蒸皤 去除溶劑。所得殘餘物藉柱式層析純化(溶離雨:正-己 烷:乙酸乙酯=10: 1)獲得13.9g無色油狀乙基-4-疊氮 -2,5 -二氟-3-甲氣苯甲酸酯β (2) 於210ml乙酵及70nl乙酸乙酯中溶解13.8g乙基4-疊 氮-2, 5-二氟-3-二氟甲氣笨甲酸酯,及添加138g 5%耙 -磺至該溶液,随後所得混合物於5fleC於氫氣流下攪拌6 小時。反應混合物經過濾及所得濾液於減壓下濃縮獲得 12.3g無色結晶乙基4-胺基-2,5-二氟-3-二氟甲氣苯酸 酯。 (3) 於61ml乙醇中懸浮12.3g乙基4-胺基-2,5-二氟- 3-二氟甲氣苯甲酸酯,及添加31bI 2U氩氣化納水溶液至 該懸浮液,随後所得混合物於40 ·0攪拌1小時。反應混 合物内加入35 Bl 2Ν氳氮酸及藉過濾收集生成之沈濺物 ,獲得l〇.6g無色結晶性4-胺基-2 ,5 -二氟-3-二氣甲氣苯 甲酸。 IR (KBr) cm-1: υ〇-〇 1703, 1636 NMR {CDCI3-CD3OD) 6 值 i 6.62 (1H, tf J=74Hz)f 7.49 (1H, ddf J=6.3Hz, J=11.7Hz) 以相同方式獲得下列化合物e .4-胺基-2,5-二氟-3-氟苯甲酸 IR (KBr) cm-l: uc=〇 1705, 1637 NMR (d6-DMSO) δ 值:5.60 (1H, d, J=54HZ), 6.05 (2H, brs), 7.32 (1H, dd, J=6.lHz, J=11.7Hz) -49- 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX297公董) (請先閱讀背面之注意事項再填寫本頁) .裝‘ 線 經濟部中央標準局員工消費合作社印製 A7 ΒΊ_'五、發明説明(〇 ) • 4-胺基-2,5-二氟-3-羥甲基苯甲酸 IR (KBr) cm-i: υ〇β〇 1717, 1639 NMR (CDCI3-CD3OD) δ 值:4.72 (2Η, d, J=2.0Hz), 7.48 (1H, dd, J=6.8Hz, J=11.7Hz) 參考例4 於658|«14.7%氫溴酸内懸浮26.3|4-胺基-2,5-二氟 -3-甲基苯甲酸,及161g溴化鋦加至懸浮液。以1小時 時間逐滴加入16.5g亞硝酸納於165β1水之溶液於此懸浮 液内並伴以冰冷卻,及所得混合物於同溫攪拌1小時然 後於同溫攪拌2小時。反應混合物内加入700Β1甲苯及 生成的有機層經分離,以瀑鹽酸洗濂,然後以無 水硫酸鎂脱水。然後於減壓下蒸皤去除溶劑。所得殘餘 物内加入正己烷及藉過濾收集所得结晶«得29.5g無色 結晶性4-溴-2, 5-二氟-3-甲基苯甲酸。 IR (KBr) cm-i: υ〇·ο 1699 NMR (CDC13) δ 值:2.41 (3H, d, J=2.9Hz), 7.57 (1H, άά, J=6.3Hzf J=7.8Hz) 以相同方式獲得下列化合物〇 .4-溴-2,5-二氟-3-二氟甲氧苯甲酸 IR (KBr) cm-l: υ〇=ο 1718, 1698 NMR (CDCI3-CD3OD) δ 值:6.65 (1Η, t, J=74Hz), 7.66 (1H, dd, J=5.9Hz, J=8.3Hz) • 4-溴-2, 5-二戴-3-氟甲氣苯甲酸 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公嫠) ---------C 裝--- (請先閲讀背面之注意事項再填寫本頁)X Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. V. Description of the invention (47) The solution was washed and then dehydrated with anhydrous sodium sulfate. Then the solvent was removed by evaporation under reduced pressure. The obtained residue was purified by column chromatography (dissolution: n-hexane: ethyl acetate = 10: 1) to obtain 13.9 g of ethyl-4-azido-2,5-difluoro-3-formaldehyde as a colorless oil. Gas benzoate β (2) Dissolve 13.8 g of ethyl 4-azido-2,5-difluoro-3-difluoromethaneformate in 210 ml of acetic acid and 70 nl of ethyl acetate, and add 138 g 5% rake-sulfur was added to the solution, and the resulting mixture was then stirred at 5fleC for 6 hours under a stream of hydrogen. The reaction mixture was filtered and the resulting filtrate was concentrated under reduced pressure to obtain 12.3 g of colorless crystalline ethyl 4-amino-2,5-difluoro-3-difluoromethanebenzoate. (3) Suspend 12.3 g of ethyl 4-amino-2,5-difluoro-3-difluoromethanebenzoate in 61 ml of ethanol, and add 31bI 2U argon sodium aqueous solution to the suspension. The resulting mixture was stirred at 40 · 0 for 1 hour. 35 Bl 2N nitrogen acid was added to the reaction mixture, and the resulting splatter was collected by filtration to obtain 10.6 g of colorless crystalline 4-amino-2,5-difluoro-3-digasmethylbenzoic acid. IR (KBr) cm-1: υ〇-〇1703, 1636 NMR {CDCI3-CD3OD) 6 value i 6.62 (1H, tf J = 74Hz) f 7.49 (1H, ddf J = 6.3Hz, J = 11.7Hz) to In the same manner, the following compound e. 4-amino-2,5-difluoro-3-fluorobenzoic acid IR (KBr) cm-1 was obtained: uc = 〇1705, 1637 NMR (d6-DMSO) δ value: 5.60 (1H , d, J = 54HZ), 6.05 (2H, brs), 7.32 (1H, dd, J = 6.lHz, J = 11.7Hz) -49- This paper size applies to China National Standard (CNS) A4 specification (21 OX297 (Public Director) (Please read the precautions on the back before filling this page). Install '7 printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Online Economics Ⅴ. Description of the invention (〇) • 4-Amino-2,5- Difluoro-3-hydroxymethylbenzoic acid IR (KBr) cm-i: υ〇β〇1717, 1639 NMR (CDCI3-CD3OD) δ value: 4.72 (2Η, d, J = 2.0Hz), 7.48 (1H, dd, J = 6.8Hz, J = 11.7Hz) Reference Example 4 26.3 | 4-Amino-2,5-difluoro-3-methylbenzoic acid was suspended in 658 | «14.7% hydrobromic acid, and 161 g of bromine Add hydrazone to the suspension. A solution of 16.5 g of sodium nitrite in 165? 1 water was added dropwise to this suspension over 1 hour with ice cooling, and the resulting mixture was stirred at the same temperature for 1 hour and then at the same temperature for 2 hours. To the reaction mixture was added 700B1 toluene and the resulting organic layer was separated, washed with waterfall hydrochloric acid, and then dehydrated with anhydrous magnesium sulfate. The solvent was then removed by evaporation under reduced pressure. To the obtained residue was added n-hexane and the obtained crystals were collected by filtration to obtain 29.5 g of colorless crystalline 4-bromo-2,5-difluoro-3-methylbenzoic acid. IR (KBr) cm-i: υ〇 · ο 1699 NMR (CDC13) δ value: 2.41 (3H, d, J = 2.9Hz), 7.57 (1H, άά, J = 6.3Hzf J = 7.8Hz) In the same way The following compound 0.4-bromo-2,5-difluoro-3-difluoromethoxybenzoic acid IR (KBr) cm-1 was obtained: υ〇 = ο 1718, 1698 NMR (CDCI3-CD3OD) δ value: 6.65 ( 1Η, t, J = 74Hz), 7.66 (1H, dd, J = 5.9Hz, J = 8.3Hz) • 4-bromo-2, 5-didai-3-fluoromethanebenzoic acid Standard (CNS) A4 specification (210X297 male) --------- C Pack --- (Please read the precautions on the back before filling this page)

、1T, 1T

XX

A 經濟部中央標準局員工消費合作杜印製 A7 B7 五、發明説明(49 ) IR (KBr) cm-l: uc=〇 1703 NMR (CDCI3) δ 值:5.72 (2Η, d, J=53Hz), 6.33 (1Η, brs), 7.63 (1H, dd, J=5.8Hzf J=8.3Hz) • 4 -溴-2, 5 -二氟-3-羥甲基苯甲酸 IR (KBr) cm-l: υ〇=〇 1718 NMR (CD3OD) δ 值:4.83 (2H, d, J=2,4Hz), 7.68 (lHf dd, J=6.lHz, J=8.5Hz) 參考例5 於8ml硫酸溶解2. Og 4-溴-2, 5-二概-3-甲氣苯甲酸 及逐滴加入4m 1硝至該溶液中並伴以冰冷卻,随後所得 混合物於室溫摟拌1小時。反應混合物加入5Db1乙醚 及50b1冰水之混合溶劑,及生成的有機層經分離,以飽 和鹽水溶液洗滌然後以無水硫酸鎂乾燥。然後減壓蒸餾 去除溶劑。如此所得殘餘物内加入正己烷及所得結晶藉 過濾收集獲得1.9g淡黃色結晶性4-漠-2 ,5-二氟-3-甲 氣-6-硝基苯甲酸。 IR (KBr) cm-l: υ〇=〇 1718 NMR (CDC13) δ 值:4.16 (3H, d, J〒2.9Hz), 8.75 (1H, brs) 參考例6 於100ml無水四氫呋喃中溶解10 · Og 溴-2,5-二輻-3-甲基苯甲酸及9.69g fi,Ν'-羰基二眯唑加至該溶液並伴以 冰令卻,隨後所得混合物於室溫攪拌1小時。隨後添 加8.56g乙氣羰基乙酸鎂至混合物及所得混合物於該溫 -5 1- 本紙張尺度適用中國國家橾準(CNS ) A4規格(210X297公釐) --------裝 *-- (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 A7 B7 ’五、發明説明(β ) 下攪拌20小時β反應混合物加至200βι1乙酸乙酯及300B1 水之混合物,且ΡΗ以6 Ν鹽酸調整至1。随後分離生成之有 機層,依次以飽和硪酸氫鈉水溶液。水及飽和鹽水溶液 洗滌,然後以無水硫酸鎂乾燥。然後減壓蒸皤去除溶劑 β如此所得殘餘物藉柱式層析純化(溶離劑=正己烷: 乙酸乙酯=10 : 1)獲得8. 9.5g無色結晶性乙基4-溴- 2,5-二氟-3-甲基苯甲醒基乙酸酯β IR (KBr) cm-l: v&gt;c=0 1644 NMR (CDCI3) δ 值:1.00-1.70 (3H, m), 2.41 (3H, d, J=2.9Hz), 3.70-4.70 (3.2Hf m), 5.84 (0.4H, s)f 7.30-7.75 (1H, m), 12.5 (0.4H, brs) 以相同方式獲得下列化合物。 •乙基 4-溴-2,5-二纒-3-二氟甲氣苯甲酵基乙酸酯 IR (KBr) cm-i: uc=〇 1670 NMR (CDCI3) δ 值:0.70-1.40 (3Η, m), 3.60-4.50 (3.2H, m), 5.85 (0.4H, s), 6.62 (1H, t, J=73Hz), 7.30-7.70 (1H, m), 12.7 (0.4H, s) •乙基4-溴-2,5-二氟-3-氟甲氣苯甲醛基乙酸酯 IR (KBr) cra-l: υ〇=〇 1654 NMR (CDCI3) 6 值:1.00-1.50 (3Η, m), 3.60-4.50 (3.2H, m)f 5.69 (2H, d, J=53Hz), 5.83 (0.4Hr s), 7.20-7.70 (1H, m), 12.6 (0.4H, s) 參考例7 1.8084-溴-2,5-二氟-3-羥甲基苯甲酸懸浮於181111二 -52- ---------Γ -裝*-- (請先閱讀背面之注意事項再填寫本頁) '1Τ· Κ 線 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 經濟部中央標準局員工消費合作社印製 A7 ___^_, B7__ 五、發明説明(β ) 氣甲烷内及於懸浮液内於冰冷卻下加入1.64 g三乙胺及: 0.84 g乙酸辭,随後懸浮液攪拌1小時。然後懸浮液之 溫度升高至室溫,此時混合物又攪拌12小時。反«混合 物加至20ml二氣甲烷及50·1水之混合溶劑及pH以6Ν鹽酸 調整至1。随後分離有搛層,以鉋和鹽水溶液洗滌及然 後以無水硫酸錢脱水。減壓蒸鳙去除溶薄。所得之殘餘 物藉柱式層析純化(溶離劑:氰仿:乙酵=9: 1)獲得無 色油狀3 -乙睡氣甲基-4-溴-2,5 -二氬苯甲酸。所得油狀 産物溶解於42·1無水四氳呋喃中,及以冰冷卻下加下 1.64g Ν,Ν1-羰基二眯唑。所得混合物於室溫攪拌1小 時。随後將1.45 g乙氣羰基乙酸鎂加入其中及所得混合 物於同溫下攪拌2(ϊ小時。反應混合物加至8〇Β1乙酸乙酯 及lODnl水之混合溶剤中及pH以6N鹽酸調整至1。随後分 離有機層,以飽和鹽水溶液洗滌然後以無水硫酸鎂乾燥 »随後減壓蒸皤去除溶劑。如此所得殘餘物藉柱式層析 純化(溶離劑:正己烷:乙酸乙酯=20 : 1)獲得1.3 2g無 色結晶性乙基3-乙醒氧甲基-4-溴-2,5-二氟苯甲醯基乙 酸酯》 IR (KBr) cm-i: uc=〇 1742, 1654 NMR (CDC13) δ 值:1.00-1.50 (3Η, m), 2.08 (3Η, s), 3.80-4.50 (3_2H, m), 5.32 {2H, d, J=2.4Hz), 5.87 (0.4Hr s)f 7.40-7.90 (lHr m)r 12.3 (0.4H, brs) -53- 本紙張尺度適用中國國家標準(CNS ) Α4規格(2丨0Χ297公釐) ---------c 裝-— (請先閱讀背面之注意事項再填寫本頁)A Consumption cooperation by employees of the Central Bureau of Standards, Ministry of Economic Affairs, printed A7 B7 V. Description of the invention (49) IR (KBr) cm-1: uc = 〇1703 NMR (CDCI3) δ value: 5.72 (2Η, d, J = 53Hz) , 6.33 (1Η, brs), 7.63 (1H, dd, J = 5.8Hzf J = 8.3Hz) • 4-bromo-2, 5-difluoro-3-hydroxymethylbenzoic acid IR (KBr) cm-1: υ〇 = 〇1718 NMR (CD3OD) δ value: 4.83 (2H, d, J = 2, 4Hz), 7.68 (lHf dd, J = 6.1 Hz, J = 8.5 Hz) Reference Example 5 Dissolved in 8 ml sulfuric acid 2. Og 4-bromo-2,5-diiso-3-methylbenzoic acid and 4 ml of 1 nitrate were added dropwise to the solution with ice cooling, and the resulting mixture was then stirred at room temperature for 1 hour. The reaction mixture was added with a mixed solvent of 5Db1 ether and 50b1 ice water, and the resulting organic layer was separated, washed with a saturated saline solution and then dried over anhydrous magnesium sulfate. The solvent was then removed by distillation under reduced pressure. To the residue thus obtained was added n-hexane and the resulting crystals were collected by filtration to obtain 1.9 g of pale yellow crystalline 4-aque-2,5-difluoro-3-methyl-6-nitrobenzoic acid. IR (KBr) cm-1: υ〇 = 〇1718 NMR (CDC13) δ value: 4.16 (3H, d, J〒2.9Hz), 8.75 (1H, brs) Reference Example 6 Dissolved in 100 ml of anhydrous tetrahydrofuran 10 · Og Bromo-2,5-difluoro-3-methylbenzoic acid and 9.69 g of fi, N'-carbonyldioxazole were added to the solution with ice quenching, and the resulting mixture was then stirred at room temperature for 1 hour. Subsequently, 8.56g of magnesium acetylacetate was added to the mixture and the resulting mixture was at -5 1- This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) -------- packing *- -(Please read the precautions on the back before filling this page) Order A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs' V. Description of the invention (β) Stir for 20 hours β reaction mixture is added to 200βι1 ethyl acetate and 300B1 A mixture of water and pH was adjusted to 1 with 6 N hydrochloric acid. The resulting organic layer was then separated, followed by saturated aqueous sodium hydrogen acetate solution. It was washed with water and a saturated saline solution, and then dried over anhydrous magnesium sulfate. Then, the solvent β was distilled off under reduced pressure, and the residue thus obtained was purified by column chromatography (eluent = n-hexane: ethyl acetate = 10: 1) to obtain 8. 9.5 g of colorless crystalline ethyl 4-bromo-2,5 -Difluoro-3-methylbenzoyl acetate β IR (KBr) cm-1: v &gt; c = 0 1644 NMR (CDCI3) δ value: 1.00-1.70 (3H, m), 2.41 (3H, d, J = 2.9Hz), 3.70-4.70 (3.2Hf m), 5.84 (0.4H, s) f 7.30-7.75 (1H, m), 12.5 (0.4H, brs) The following compounds were obtained in the same manner. • Ethyl 4-bromo-2,5-difluoren-3-difluoromethanebenzyl acetate IR (KBr) cm-i: uc = 〇1670 NMR (CDCI3) δ value: 0.70-1.40 ( 3Η, m), 3.60-4.50 (3.2H, m), 5.85 (0.4H, s), 6.62 (1H, t, J = 73Hz), 7.30-7.70 (1H, m), 12.7 (0.4H, s) • Ethyl 4-bromo-2,5-difluoro-3-fluoromethylbenzaldehyde acetate IR (KBr) cra-1: υ〇 = 〇1654 NMR (CDCI3) 6 Value: 1.00-1.50 (3Η , m), 3.60-4.50 (3.2H, m) f 5.69 (2H, d, J = 53Hz), 5.83 (0.4Hr s), 7.20-7.70 (1H, m), 12.6 (0.4H, s) Reference examples 7 1.8084-bromo-2,5-difluoro-3-hydroxymethylbenzoic acid suspended in 181111 di-52- --------- Γ -pack *-(Please read the precautions on the back before (Fill in this page) '1T · K line paper size is applicable to Chinese National Standard (CNS) Α4 size (210 × 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 ___ ^ _, B7__ 5. Description of the invention (β) 1.64 g of triethylamine and 0.84 g of acetic acid were added to the gaseous methane and in the suspension under ice cooling, and the suspension was stirred for 1 hour. The temperature of the suspension was then raised to room temperature, at which time the mixture was stirred for another 12 hours. The reverse mixture was added to a mixed solvent of 20 ml of digas methane and 50 · 1 water, and the pH was adjusted to 1 with 6N hydrochloric acid. The radon layer was subsequently separated, washed with a planer and a saline solution, and then dehydrated with anhydrous sulfuric acid. Remove the solvent by evaporating under reduced pressure. The obtained residue was purified by column chromatography (eluent: cyanoform: acetic acid = 9: 1) to obtain 3-ethylacetoxymethyl-4-bromo-2,5-diargonbenzoic acid as a colorless oil. The obtained oily product was dissolved in 42.1 anhydrous tetramethylfuran, and 1.64 g of N, N1-carbonyldioxazole was added under ice-cooling. The resulting mixture was stirred at room temperature for 1 hour. Subsequently, 1.45 g of magnesium acetylacetate was added thereto, and the resulting mixture was stirred at the same temperature for 2 hours (ϊ hours. The reaction mixture was added to a mixed solution of 80B1 ethyl acetate and 10 Nl water and the pH was adjusted to 1 with 6N hydrochloric acid. The organic layer was then separated, washed with a saturated saline solution and then dried over anhydrous magnesium sulfate. Then the solvent was removed by distillation under reduced pressure. The residue thus obtained was purified by column chromatography (eluent: n-hexane: ethyl acetate = 20 : 1) Obtained 1.3 2 g of colorless crystalline ethyl 3-ethoxymethyl-4-bromo-2,5-difluorobenzylidene acetate. IR (KBr) cm-i: uc = 〇1742, 1654 NMR (CDC13) δ value: 1.00-1.50 (3Η, m), 2.08 (3Η, s), 3.80-4.50 (3_2H, m), 5.32 (2H, d, J = 2.4Hz), 5.87 (0.4Hr s ) f 7.40-7.90 (lHr m) r 12.3 (0.4H, brs) -53- This paper size applies to China National Standard (CNS) Α4 size (2 丨 0 × 297 mm) --------- c pack -— (Please read the notes on the back before filling this page)

*1T Κ4 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明() 參考例8 於l.Og 4-溴-2 ,5-二氟-3-甲氣-6-硝基苯甲酸内加入 3ml氣化硫醯基及〇.3β1 Ν,Ν -二甲基甲醛胺,所得混合 物回流加熱1小時。反應混合物於減壓下濃縮播得醯氨 〇另外〇.4g 60%氫化鈉懸浮於30Β1四氫呋喃中,1.8g 丙二酸第三丁酯乙酯以冰冷卻逐滴加入懸浮液.随後懸 浮液於同溫攪拌2小時。所得反應混合物内於-20 eC逐 滴加人前述所得醛氮於lOnl四氳呋喃之溶液,所得混合 物以冰冷卻攪拌30分鐘然後於室溫攪拌1小時。反應混 合物加至50nl乙酸乙酯及50b1水之混合溶液,及PH以6H 鹽酸調整至1。生成的有機靥經分離,依次以水及飽和 鹽水溶液洗滌然後以無水硫酸鎂乾燥。然後減壓蒸皤去 除溶劑β如此所得殘餘物内加入1〇»1二氯甲烷及三氟乙 酸,及所得混合物於室溫攪拌2小時。反鼴混合物經減 壓濃縮及所得殘餘物藉柱式層析純化(溶離爾:甲苯)獲 得〇.9g無色結晶性乙基4-溴-2,5-二氟-3-甲氣-6-硝基 苯甲酵基乙酸酯。 IR (KBr) cm-1: υ〇=ο 1737r 1718 NMR (CDCI3) δ 值:1·25 (3H, t, J=7.3Hz), 3.60-4.40 (7H, m) 參考例9 (1)於15〇1«1二氣甲烷溶解30.08乙基4-溴-2,5-二氟 -3-甲基苯甲醯基乙酸酯,及19.1g乙酸酐及22.3g N, N-二甲基甲醛胺二甲基縮醛加至溶液,随後所得混合物 -54- 本紙張尺度適用中國國家楳準(CNS ) Α4規格(210X297公釐) — i —I . I l·— I (請先閱讀背面之注意事項再填寫本頁) 、?τ 經濟部中央標準局貝工消費合作杜印裂 A7 B7 五、發明説明(β) 於室溫攪拌1小時。然後於減壓下蒸餾去除溶劑。所得 殘餘物溶解乙醇及5.90 g琛丙胺加至其中,随後所得 混合物於室溫攪拌30分鐘。然後於減壓下蒸皤去除溶劑 »所得殘餘物内加入正己烷及生成的結晶藉過濾播得 35.7g無色結晶性乙基2-(4-溴-2,5-二氟-3-甲基苯甲 醯基)-3-環丙胺基丙烯酸酷。 (2)於 175ml二甲亞 1¾ 溶解 35.〇g 乙基 2-(4 -溴-2 ,5 -二 氰-3-甲基苯甲睡基)-3-璨丙胺基丙烯酸酯,及27.4g硪 酸鉀加至該溶液,随後所得混合物於lD0eC攪拌3D分鐘。 反應混合物冷卻至室溫,然後將lDDOml水加至其中,随 後藉過濾收集生成之結晶獲得30.0g無色結晶性乙基7-溴-1-環丙基-6-氟-8-甲基-1,4-二氫-4-氧塞Iff啉-3-羧 酸酯》 IR (KBr) cm-l: uc=〇 1731 NMR (CDC13) δ 值:0.70-1.70 (7Η, m), 2.91 (3Η, s), 3.70-4.10 (1H, m), 4.38 (2Hf qf J=7.3Hz), 8.01 (1H, dr J=8.3Hz)/ 8.65 (1H, s) 以相同方式獲得下列化合物。 •乙基7-溴-卜璟丙基-8-二氟甲氣-6-氟-1,4-二氲-4-氧基Ilf啉-3-羧酸酯 IR (KBr) cm-l: υ〇=〇 1723 NMR (CDCI3) 5 值:0.90-1.60 (7Hr m), 3,80-4.15 (1H, m), 4.39 (2H, q, J=7.3Hz)f 6.59 (1H, tr J=74Hz), 8.16 (1H, d, J=8.3Hz), 8.61 (1H, s) ~ 5 5 - 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇Χ:297公釐) ---------C、裝— (請先閱讀背面之注意事項再填寫本頁) -1T.* 1T Κ4 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the invention () Reference Example 8 In 1.0 g of 4-bromo-2,5-difluoro-3-methane-6-nitrobenzoic acid 3 ml of vaporized thiosulfanyl group and 0.3β1 N, N-dimethylformamide were added thereto, and the resulting mixture was heated under reflux for 1 hour. The reaction mixture was concentrated under reduced pressure to obtain ammonia. Another 0.4 g of 60% sodium hydride was suspended in 30B1 tetrahydrofuran, and 1.8 g of ethyl tert-butyl malonate was added dropwise to the suspension under ice cooling. The suspension was then suspended. Stir at the same temperature for 2 hours. To the obtained reaction mixture was added dropwise a solution of the aforementioned aldehyde nitrogen in 10 l tetramethylenefuran at -20 eC, and the resulting mixture was stirred under ice-cooling for 30 minutes and then at room temperature for 1 hour. The reaction mixture was added to a mixed solution of 50nl of ethyl acetate and 50b1 of water, and the pH was adjusted to 1 with 6H hydrochloric acid. The resulting organic hydrazone was separated, washed successively with water and a saturated saline solution and then dried over anhydrous magnesium sulfate. Then, the solvent β was removed by distillation under reduced pressure, and the residue thus obtained was added with 10 »1 dichloromethane and trifluoroacetic acid, and the resulting mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure, and the obtained residue was purified by column chromatography (solvent: toluene) to obtain 0.9 g of colorless crystalline ethyl 4-bromo-2,5-difluoro-3-methane-6- Nitrobenzyl acetate. IR (KBr) cm-1: υ〇 = ο 1737r 1718 NMR (CDCI3) δ value: 1.25 (3H, t, J = 7.3Hz), 3.60-4.40 (7H, m) Refer to Example 9 (1) in 15〇1 «1 digas methane dissolved 30.08 ethyl 4-bromo-2,5-difluoro-3-methylbenzylidene acetate, and 19.1 g of acetic anhydride and 22.3 g of N, N-dimethyl Formaldehyde dimethyl acetal was added to the solution, and the resulting mixture was -54- This paper size applies to China National Standard (CNS) A4 (210X297 mm) — i —I. I l · — I (Please read first Note on the back, please fill in this page again.),? Τ Aye B7, B7, Consumer Cooperation of the Central Bureau of Standards of the Ministry of Economic Affairs, A7 B7 5. Description of Invention (β) Stir at room temperature for 1 hour. The solvent was then distilled off under reduced pressure. The obtained residue was dissolved in ethanol and 5.90 g of benzylamine was added thereto, and then the resulting mixture was stirred at room temperature for 30 minutes. Then, the solvent was distilled off under reduced pressure. To the resulting residue was added n-hexane and the resulting crystals were filtered to obtain 35.7 g of colorless crystalline ethyl 2- (4-bromo-2,5-difluoro-3-methyl). Benzamidine) -3-cyclopropylaminoacrylic acid. (2) Dissolve 35.0 g of ethyl 2- (4-bromo-2,5-dicyano-3-methylbenzyl) -3-gallylamino acrylate in 175 ml of dimethylidene 1¾, and 27.4 g of potassium osmate was added to the solution, and the resulting mixture was then stirred at 10 ° C for 3D minutes. The reaction mixture was cooled to room temperature, and 1DDOml water was added thereto, and the resulting crystals were collected by filtration to obtain 30.0 g of colorless crystalline ethyl 7-bromo-1-cyclopropyl-6-fluoro-8-methyl- 1,4-dihydro-4-oxetine Iffline-3-carboxylic acid ester "IR (KBr) cm-1: uc = 01731 NMR (CDC13) δ value: 0.70-1.70 (7Η, m), 2.91 ( 3Η, s), 3.70-4.10 (1H, m), 4.38 (2Hf qf J = 7.3Hz), 8.01 (1H, dr J = 8.3Hz) / 8.65 (1H, s) The following compounds were obtained in the same manner. • Ethyl 7-bromo-bupropion-8-difluoromethane-6-fluoro-1,4-difluoren-4-oxyIlfline-3-carboxylic acid ester IR (KBr) cm-1: υ〇 = 〇1723 NMR (CDCI3) 5 values: 0.90-1.60 (7Hr m), 3,80-4.15 (1H, m), 4.39 (2H, q, J = 7.3Hz) f 6.59 (1H, tr J = 74Hz), 8.16 (1H, d, J = 8.3Hz), 8.61 (1H, s) ~ 5 5-This paper size applies to China National Standard (CNS) A4 (21〇 ×: 297mm) ---- ----- C 、 装 — (Please read the notes on the back before filling this page) -1T.

X 經濟部中央標準局員工消費合作杜印製 A 7 :B7五、發明説明(β ) .乙基 7-溴-卜璟丙基-6-氟-8-氟甲氣-1,4-二氫-4-氣 基IFf啉-3-羧酸酯 IR (KBr) cm-i: υ〇=〇 1684, 1644 NMR (CDC13) 6 值:0.90-1.60 (7Η, m), 3.80-4.60 (3H, m), 5.69 (2H, df J=54Hz), 8.11 (1H, d, J=8.3Hz), 8.61 (1H, s) •乙基 8 -乙醯氣甲基-7-溴-1-環丙基-6-氟-1,4 -二氫 -4 -氧基睹啉-3-羧酸酯 IR (KBr) cm-i: υ〇=〇 1745, 1728, 1692 NMR {CDCI3) δ 值:〇.70-1·55 (7Η, m), 2.07 (3Η, s), 3.70-4.60 (3Η, m), 5.88 (2Η, s), 8.18 (1Η, d, J=7.8Hz), 8.64 (1H, s) 參考例1 0 1.46g乙基 8-乙醯氧甲基-7-溴-1-環丙基-6-氟-1,4-二氫-4-氣基睹啉-3-羧酸酯懸浮於58b1乙醇中,及將19 ng甲氣化納加至懸浮液,隨後所得混合物於室溫攪拌7 小時。反應混合物内加入60ml水及pH以1N鹽酸調整至 7,隨後藉過濾收集生成之結晶糢得1.28g無色結晶性乙 基 7 -溴-1-環丙基-6-氟-8-羥甲基-1,4-二氫-4-氧基晻 啉-3-羧酸酯 IR (KBr) cm-i: υ〇=〇 1718 NMR (di-TFA) δ 值:1.0S-1.90 (7H, m), 4.45-5.30 (3Hr m)f 5.99 (2H, s), 8.38 (1H, d, J=6.8Hz), 9.52 (1H, s) -56- (請先閱讀背面之注意事項再填寫本頁) 裝-X Consumption cooperation by employees of the Central Bureau of Standards of the Ministry of Economic Affairs, Du printed A 7: B7 V. Description of invention (β). Ethyl 7-bromo-bupropion-6-fluoro-8-fluoromethyl-1,4-di Hydrogen-4-amino IFfline-3-carboxylic acid ester IR (KBr) cm-i: υ〇 = 〇1684, 1644 NMR (CDC13) 6 Value: 0.90-1.60 (7Η, m), 3.80-4.60 (3H , m), 5.69 (2H, df J = 54Hz), 8.11 (1H, d, J = 8.3Hz), 8.61 (1H, s) • Ethyl 8-acetamidine methyl-7-bromo-1-ring Propyl-6-fluoro-1,4-dihydro-4 -oxoline-3-carboxylic acid ester IR (KBr) cm-i: υ〇 = 〇1745, 1728, 1692 NMR {CDCI3) δ value: 〇.70-1 · 55 (7Η, m), 2.07 (3Η, s), 3.70-4.60 (3Η, m), 5.88 (2Η, s), 8.18 (1Η, d, J = 7.8Hz), 8.64 ( 1H, s) Reference Example 1 1.46 g of ethyl 8-acetamidomethyl-7-bromo-1-cyclopropyl-6-fluoro-1,4-dihydro-4-carbamoline-3- The carboxylic acid ester was suspended in 58b1 ethanol, and 19 ng of sodium formazan was added to the suspension, and the resulting mixture was then stirred at room temperature for 7 hours. 60 ml of water was added to the reaction mixture and the pH was adjusted to 7 with 1N hydrochloric acid, and the resulting crystal mold was collected by filtration to obtain 1.28 g of colorless crystalline ethyl 7-bromo-1-cyclopropyl-6-fluoro-8-hydroxymethyl -1,4-dihydro-4-oxydacryline-3-carboxylic acid ester IR (KBr) cm-i: υ〇 = 〇1718 NMR (di-TFA) δ value: 1.0S-1.90 (7H, m ), 4.45-5.30 (3Hr m) f 5.99 (2H, s), 8.38 (1H, d, J = 6.8Hz), 9.52 (1H, s) -56- (Please read the precautions on the back before filling this page ) Loading-

、1T .K4 本紙張尺度適用中國國家標隼(CNS ) A4規格(210 X297公釐) 經濟部中央標準局員工消費合作社印裝 Α7 Β7 五、發明説明(《) 參考例Π 1.27g乙基7 -澳-1-環丙基-6-氟-8-經甲基-1,4-二 氫-4-氧基I®啉-3-耧酸酯懸浮於127ml二氣甲烷,及 1 . 3 3 g三氟化二乙胺基硫於-4 Q°C逐滴加至懸浮液,随 後所得混合物於-2(TC攪拌1小時然後於0°C攪拌3小時 〇反應混合物加至冰水及以飽和联酸氣納水丨容液 將pH調整至8。随後分離有機層,以飽和鹽水洗條,然 後以無水硫酸鎂乾燥。然後於減歷下蒸腺去除溶劑。如 此所得殘餘物藉柱式層析純化(溶離劑:氮仿;乙醇二 1 0 0 : 1)獲得1 · 〇 5 g無色結晶性乙基卜溴-1 -環丙基-6 -氟-8-氟甲基-1,4 -二氫-4-氣基睡啉-3-羧酸酯。 IR (KBr) cm-li υ〇=〇 1723, 1694 NMR (CDCI3) δ 值:0.60-1.75 (7Η, m), 3.65-4.65 (3Hf m), 6.11 (2H, d, J=47Hz), 8.21 (1H, ddr J=2.2Hzr J=8.1Hz)f 8.64 (1H, s) 參考例1 2 5.00g乙基7-溴-1-環丙基”6-氟-8-甲基-1,4-二氫 -4 -氧基睡啉-3-羧酸酯懸浮於50ml甲苯,及15.8g贰(三 丁基錫)及95Bg氦化贰(三苯瞵)耙(II)加至懸浮液,随 後所得混合物回流加熱24小時。反應混合物減壓濃编, 及如此所得殘餘物藉柱式層析純化(溶離劑:甲苯:乙 酸乙酯=10·· 1)獲得5.10g無色結晶性乙基1-琛丙基-6_ 氟-8-甲基-7_三丁基錫烷基-14 -二氲-4-氧基1¾啉- 3-羧酸酿。 -57- 本紙張技適财關家縣(CNS) A4· (21GX297公羡) ---------C 裝— (請先閲讀背面之注意事項再填寫本頁) 訂 Κ 經濟部中央橾隼局員工消費合作杜印裝 A7 B7 五、發明説明(A ) IR (KBr) cm-l: uc=〇 17 24 NHR (CDC13) 6 值:0.30-2.30 (34H, m), 2.79 (3H, s), 3.60-4.10 (1H, m)f 4.38 (2H, q, J=6.8Hz), 7.83 (1H, df J=6.3Hz)r 8.63 (1H, s) 以相同方式獲得下列化合物。 •乙基1-環丙基-6-氟-7-三丁基錫烷基-1,4 -二氩-4-氣 基暗啉-3 -羧酸酯 IR (KBr) cm-1: Vq-o 1725 NMR (CDCI3) 6 值:0.50-1.80 .(34Η, m), 3.10-3,70 (1H, m), 4.40 (2H, q, J=6.8Hz)f 7.96 (1H, d, J=2.0Hz), 8.03 (1H, df J = 6.3H7.), 8.56 (1H, s) •乙基 (S)-9-氟-3-甲基-7-氧基-10-三丁基錫烷基-2 , 3 -二氫- 7H -吡啶駢〔l,2,3-de〕 〔1,4〕苯駢鸣阱- 6- 羧酸酯 IR (KBr) cm-l: υ〇=〇 1718 NMR (CDC13) δ 值:0.30-2.30 (33H, m), 4.00-4.60 (5H, m), 7.60 (1H, d, J=6.8Hz), 8.30 (1H, s) •乙基1-環丙基-6-氟-7-三丁基錫院基-1,4 -二氫- 4- 氣基-1,8-萊啶-3-羧酸酯 IR (KBr) cm-l: uc=o 1729 NMR (CDCI3) θ 值:0 · 60-1 · 90 ( 34Η, in), 3.40-3 · 95 (1H, m), 4.40 (2Hf q, J=6.8Hz), 8.16 (1H, d, J=5.9Hz), 8.66 (1H, s) -58- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) —---------C -裝*— (請先閱讀背面之注意事項再填寫本頁) tr- 線 1、發明説明(〇) A7 B7 經濟部中央榡準局員Η消費合作杜印裂 *乙基8-m-l-環丙基-6-氟-7-三丁基錫烷基-1,4-二 氳-4-氣基1¾啉-3-羧酸酯 NMR (CDCI3) δ 值:0.60-1.90 (34Η, Π1), 3.90-4.60 (3Η, m), 7.93 (1H, d, J=6.3Hz)f 8.63 (1H, s) •乙基1-琛丙基-6-氟-8-甲基-7-三丁基錫烷基-1,4-二氳-4-氣基睹淋-3-接酸_ IR (KBr) cm-i: υ〇〇 1731 NMR (CDC13) δ 值.〇 * °·4〇-2.0 (34Hf m)f 3.50-4.05 (4Η, m), 4.27 (2Η, q, J=7.〇Hz), 7·84 (1Η, d, J=6.4Hz), 8.57 (XHf S) 參考例1 3 (1) 溶解19.Dg 1-溴-3,4-二(羥甲基)苯於38〇1|1乙醚内 及添加112g三溴化磷以冰冷卻至此溶液,随後任何所得 混合物放置3日。反應混合物加SioooBi冰水及pH以碩 酸氫納調整至7,随後混合物以lOOOul乙酸乙酯萃取。 所得有機層以飽和鹽水洗截然後以無水硫酸鎂乾燥。然 後藉減壓蒸皤去除溶劑獲得28.5 g無色結晶性卜溴- 3,4-二(溴甲基)苯。 (2) 3.97g氳化納(純度:60%懸浮於7〇Bl N,N -二甲基 甲醯胺内及加入50ml含8.49g對-甲笨磺醯胺之二甲 基甲醯胺溶液,随後所得混合物於60 Ό攪拌3D分鏟。反 應混合物内於6(TC加入17.〇g卜溴3,4-二(溴甲基')苯於 50ul N,N -二甲基甲醏胺之溶液,及所得混合物於6〇ec 攪拌1小時。所得反應混合物加至500ml冰水及藉過灌 -59- (請先閱讀背面之注意事項再填寫本頁) 裝卜 ,1Τ Κ 經濟部中央標準局員工消費合作社印製 A7 ;B7五、發明説明(Η ) 收集沈澱並以柱式層析純化(溶離劑:氣仿)獲得1 5 . 2 g 結晶性5-溴-2-(對甲苯磺醯基)異吲呤啉。 IR (KBr) cm-l: us〇2 1347, 1164 NMR (CDCI3) δ 值:2·39 (3Η, s), 4·56 (4Η, brs), 6.75-7.90 (7Η, m) 以相同方式獲得下列化合物。 .5 -溴-1 -甲基-2 -(對-甲苯磺酵基)異吲呤啉 IR (淨)cnrl: us〇2 1347, 1164 NMR (CDCI3) δ 值:1.60, 1.66 (3Η, each, d, J=6.0Hz), 2.34, 2.39 (3H, each, s), 4.50-5.15 (3H, m), 6.70-7.95 (7H, m) • 5 -溴-3-甲基- 2- (對-甲苯磺醛基)異吲昤啉 IR (淨)cm-i: us〇2 1346, 1165 NMR (CDCI3) θ 值:1.62 (3Η, d, J=6.3Hz), 2.38 (3H, s), 4.35-5.15 (3H, m), 6.65-7.90 (7H, m) .5 -溴-4 ,7 -二氟- 2- (對-甲苯磺酴基)異吲跺啉 IR (KBr) cm-l: us〇2 1348, 1163 'NMR (CDC13) δ 值·· 2.42 (3H, s), 4,66 (4H, s)r 6.88 (lHf tf J=6.0Hz), 7.33 (2H, d, J=8.0Hz), 7.78 (2Hf d, J=8.0Hz) 參考例1 4 (1)於8 5 0ing 1-(1-胺基環丙基)-4-溴-2-羥甲基苯及 8.5ml甲醇之混合物内加入1.24 g三氟乙酸乙酯及所得混 合物於室溫攪拌24小時。減壓蒸皤去除溶劑及所得殘餘 -6 0 - (請先閱讀背面之注意事項再填寫本頁) -裝. 訂 K4 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 經濟部中央標準局負工消費合作杜印製 A7 _; B7 _五、發明説明(β ) 物藉柱式層析純化(溶離劑:氛仿:乙酵= 30: 1)獲得 l.〇2g無色结晶性4 -溴-2-羥甲基-1-(1-三氟乙醒胺基環 丙基)苯。 IR (KBr) cm小· υ〇〇 1717, 1702 NMR (CDC13) 5 值:1.05-1.60 (4Η, 2.50 &lt;1Η, brs)f 4.95 (2Η, s), 7.15-7.70 (3H, m)f 8.06 (1H, brs) (2) 9 50ng(l)所得4-溴-2-羥甲基-1-(1-三氟乙B胺基 瓌丙基)苯懸浮於2GB1苯内,及68Geg三-正丁瞵及85〇Bg 1,厂-偶氮二羰基-二(六氫咄啶)以此順序添加加至懸浮 液並伴以冰冷卻,随後所得混合物租度升高至室溫,此 時混合物攪拌3小時。遇濾去除不溶物,然後減K蒸皤 去除溶削。所得殘餘物藉柱式層析純化(溶離雨:正己 烷:乙酸乙酯=15·· 1)獲得720b g無色結晶性5-澳-2-三 氟乙挺基-嫘〔異吲哚啉-1,1夂環丙烷〕p IR (KBr) cm-1: υ〇=〇 1697 NMfi (CDCI3) δ 值:0.75-1.20 (2Η, m), 2.30-2.75 (2H, m), 5.08 (2H, s), 6.56 (1H, d, J=9.0Hz), 7.15-7.65^2H71n) 參考例15 於25·1 47%氲溴酸内5.Og 2-(對-甲苯磺醯基)-5-溴 異吲呤淋懸浮,及添加4. Og酚及15·1丙酸至懸浮液,随 後所得混合物回流加熱4小時。反應混合物於減壓下囊 縮,及乙醇加至所得殘餘物,随後所得结晶藉過濾收集 -6 1 _ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) (請先閱讀背面之注意事項再填寫本頁) •裝' 、1Τ Κ、 1T .K4 The size of this paper is applicable to China National Standard (CNS) A4 (210 X297 mm) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the invention (") Reference example Π 1.27g ethyl 7 -Ao-1-cyclopropyl-6-fluoro-8- via methyl-1,4-dihydro-4-oxyl® phthaloline-3-phosphonate suspended in 127 ml of digas methane, and 1.3 3 g of diethylaminosulfur trifluoride was added dropwise to the suspension at -4 Q ° C, and the resulting mixture was then stirred at -2 ° C for 1 hour and then at 0 ° C for 3 hours. The reaction mixture was added to ice water And adjust the pH to 8 with a saturated diacid soda water. The organic layer was then separated, the strips were washed with saturated brine, and then dried over anhydrous magnesium sulfate. The solvent was then evaporated under reduced pressure to remove the solvent. The residue thus obtained Purification by column chromatography (eluent: azoform; ethanol 2 100: 1) to obtain 1.05 g of colorless crystalline ethylbenzene bromide-1 -cyclopropyl-6 -fluoro-8-fluoromethyl -1,4-dihydro-4-aminopyroline-3-carboxylic acid ester IR (KBr) cm-li υ〇 = 〇1723, 1694 NMR (CDCI3) δ value: 0.60-1.75 (7Η, m) , 3.65-4.65 (3Hf m), 6.11 (2H, d, J = 47Hz), 8.21 (1H, ddr J = 2.2Hzr J = 8.1 Hz) f 8.64 (1H, s) Reference Example 1 2 5.00 g of ethyl 7-bromo-1-cyclopropyl "6-fluoro-8-methyl-1,4-dihydro-4 -oxoline- The 3-carboxylic acid ester was suspended in 50 ml of toluene, and 15.8 g of rhenium (tributyltin) and 95 Bg of rhenium (triphenylsulfonium) rake (II) were added to the suspension, and the resulting mixture was then heated under reflux for 24 hours. The reaction mixture was decompressed Concentrated, and the thus-obtained residue was purified by column chromatography (eluent: toluene: ethyl acetate = 10 ·· 1) to obtain 5.10 g of colorless crystalline ethyl 1-benzyl-6-fluoro-8-methyl -7_Tributylstannyl-14-dioxo-4-oxy1¾line-3-carboxylic acid. -57- This paper is suitable for Guanjia County (CNS) A4 · (21GX297 public envy) --- ------ C equipment— (Please read the precautions on the back before filling this page) Order KK Consumer Cooperation with the Central Bureau of the Ministry of Economic Affairs Du printed equipment A7 B7 V. Description of the invention (A) IR (KBr) cm -l: uc = 〇17 24 NHR (CDC13) 6 Value: 0.30-2.30 (34H, m), 2.79 (3H, s), 3.60-4.10 (1H, m) f 4.38 (2H, q, J = 6.8Hz ), 7.83 (1H, df J = 6.3Hz) r 8.63 (1H, s) The following compounds were obtained in the same manner. • Ethyl 1-cyclopropyl-6-fluoro-7-tributylstannyl-1,4-diargon-4-amino dark morpholine-3 -carboxylic acid ester IR (KBr) cm-1: Vq-o 1725 NMR (CDCI3) 6 Value: 0.50-1.80. (34Η, m), 3.10-3,70 (1H, m), 4.40 (2H, q, J = 6.8Hz) f 7.96 (1H, d, J = 2.0 Hz), 8.03 (1H, df J = 6.3H7.), 8.56 (1H, s) • Ethyl (S) -9-fluoro-3-methyl-7-oxy-10-tributyltin alkyl-2 , 3 -dihydro-7H-pyridine hydrazine [1,2,3-de] [1,4] benzene sulfonium trap-6-carboxylic acid ester IR (KBr) cm-1: υ〇 = 〇1718 NMR (CDC13 ) δ value: 0.30-2.30 (33H, m), 4.00-4.60 (5H, m), 7.60 (1H, d, J = 6.8Hz), 8.30 (1H, s) • Ethyl 1-cyclopropyl-6 -Fluoro-7-tributyltinyl-1,4-dihydro-4-airyl-1,8-eryridine-3-carboxylic acid ester IR (KBr) cm-1: uc = o 1729 NMR (CDCI3) θ value: 0 · 60-1 · 90 (34Η, in), 3.40-3 · 95 (1H, m), 4.40 (2Hf q, J = 6.8Hz), 8.16 (1H, d, J = 5.9Hz), 8.66 (1H, s) -58- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) —--------- C -Packing * — (Please read the note on the back first Please fill in this page for further information) tr- line 1. Description of invention (〇) A7 B7 Ministry of Economic Affairs榡 Associate Bureau MembersΗConsumer Cooperation Du Yincai * Ethyl 8-ml-cyclopropyl-6-fluoro-7-tributyltin alkyl-1,4-difluoren-4-amino 1¾line-3-carboxylate NMR (CDCI3) δ value: 0.60-1.90 (34Η, Π1), 3.90-4.60 (3Η, m), 7.93 (1H, d, J = 6.3Hz) f 8.63 (1H, s) Methyl-6-fluoro-8-methyl-7-tributylstannyl-1,4-difluoren-4-ylamino-methyl-3-carboxylic acid_ IR (KBr) cm-i: υ〇〇1731 NMR (CDC13) δ value. 〇 * ° · 4.0-2.0 (34Hf m) f 3.50-4.05 (4Η, m), 4.27 (2Η, q, J = 7.〇Hz), 7.84 (1Η, d, J = 6.4Hz), 8.57 (XHf S) Reference Example 1 3 (1) Dissolve 19.Dg 1-bromo-3,4-bis (hydroxymethyl) benzene in 38〇1 | 1 ether and add 112g of tribromo Phosphorus was cooled to this solution with ice, and then any resulting mixture was left for 3 days. The reaction mixture was added with SioooBi ice water and the pH was adjusted to 7 with sodium hydrogen sulfate, and then the mixture was extracted with 100 ul of ethyl acetate. The obtained organic layer was washed with saturated brine and then dried over anhydrous magnesium sulfate. Then, the solvent was removed by distillation under reduced pressure to obtain 28.5 g of colorless crystalline bromo-3,4-bis (bromomethyl) benzene. (2) 3.97g sodium sulfonamide (purity: 60% suspended in 70Bl N, N-dimethylformamide and 50ml of dimethylformamide solution containing 8.49g p-toluidinesulfonamide Then, the resulting mixture was stirred at 60 ° C for 3D scooping. The reaction mixture was added with 17.0 g of bromo 3,4-bis (bromomethyl ') benzene in 50ul of N, N-dimethylformamidine at 6 (TC). Amine solution, and the resulting mixture was stirred at 60 ec for 1 hour. The obtained reaction mixture was added to 500 ml of ice water and borrowed -59- (please read the precautions on the back before filling this page) Loading, 1Τ Κ Ministry of Economy Printed by the Consumer Standards Cooperative of the Central Bureau of Standards A7; B7 V. Description of the invention (Η) Collect the precipitate and purify it by column chromatography (eluent: aerosol) to obtain 15.2 g of crystalline 5-bromo-2- (pair Tosylsulfonyl) isoindolin. IR (KBr) cm-1: us〇2 1347, 1164 NMR (CDCI3) δ value: 2.39 (3Η, s), 4.56 (4Η, brs), 6.75 -7.90 (7Η, m) The following compounds were obtained in the same manner.. 5-Bromo-1 -methyl-2-(p-toluenesulfonyl) isoindolinoline IR (net) cnrl: us〇2 1347, 1164 NMR (CDCI3) δ value: 1.60, 1.66 (3Η, each, d, J = 6.0Hz), 2.34, 2. 39 (3H, each, s), 4.50-5.15 (3H, m), 6.70-7.95 (7H, m) • 5-bromo-3-methyl-2- (p-toluenesulfonyl) isoindinoline IR (net) cm-i: us〇2 1346, 1165 NMR (CDCI3) θ value: 1.62 (3Η, d, J = 6.3Hz), 2.38 (3H, s), 4.35-5.15 (3H, m), 6.65 -7.90 (7H, m). 5-Bromo-4,7-difluoro-2- (p-toluenesulfonyl) isoindioline IR (KBr) cm-1: us〇2 1348, 1163 'NMR ( CDC13) δ value 2.42 (3H, s), 4,66 (4H, s) r 6.88 (lHf tf J = 6.0Hz), 7.33 (2H, d, J = 8.0Hz), 7.78 (2Hf d, J = 8.0Hz) Reference Example 14 (1) To 1.50 g of 1- (1-aminocyclopropyl) -4-bromo-2-hydroxymethylbenzene and 8.5 ml of methanol was added 1.24 g of trifluoroacetic acid. The ethyl ester and the resulting mixture were stirred at room temperature for 24 hours. Remove the solvent and the remaining residue under reduced pressure -6 0-(Please read the precautions on the back before filling this page)-Packing. Order K4 This paper size is applicable to China National Standard (CNS) A4 size (210 X 297 mm) Duty-printing and consumer cooperation of the Central Bureau of Standards, Ministry of Economic Affairs, Du printed A7 _; B7 _ V. The description of the invention (β) was purified by column chromatography (eluent: fluoroform: ethyl fermentation = 30: 1) to obtain 1.02 g Colorless crystalline 4-bromo-2-hydroxymethyl-1- (1-trifluoroethoxyaminocyclopropyl) benzene. IR (KBr) cm small υ〇〇1717, 1702 NMR (CDC13) 5 value: 1.05-1.60 (4Η, 2.50 &lt; 1Η, brs) f 4.95 (2Η, s), 7.15-7.70 (3H, m) f 8.06 (1H, brs) (2) 9 50ng (l) of 4-bromo-2-hydroxymethyl-1- (1-trifluoroethylBaminomethylpropyl) benzene suspended in 2GB1benzene, and 68Geg three -N-butyrazine and 850Bg 1, plant-azodicarbonyl-bis (hexahydropyridine) were added in this order to the suspension and cooled with ice, and then the resulting mixture was raised to room temperature, The mixture was stirred at this time for 3 hours. The insoluble matter is removed by filtration, and then K is removed to remove the solvent. The obtained residue was purified by column chromatography (dissociation rain: n-hexane: ethyl acetate = 15 ·· 1) to obtain 720b g of colorless crystalline 5-o-2-trifluoroethylidene-fluorene [isoindoleline- 1,1 夂 cyclopropane] p IR (KBr) cm-1: υ〇 = 〇1697 NMfi (CDCI3) δ value: 0.75-1.20 (2Η, m), 2.30-2.75 (2H, m), 5.08 (2H, s), 6.56 (1H, d, J = 9.0Hz), 7.15-7.65 ^ 2H71n) Reference Example 15 5.Og 2- (p-toluenesulfonyl) -5- in 25 · 47% osmium bromide-5- Bromoisoindin was leached and suspended, and 4.0 g of phenol and 15.1 propionic acid were added to the suspension, and the resulting mixture was then heated under reflux for 4 hours. The reaction mixture was capsulated under reduced pressure, and ethanol was added to the obtained residue, and the obtained crystals were collected by filtration. 6 1 _ This paper size is applicable to China National Standard (CNS) A4 (210 × 297 mm) (please read the back first) Note for this page, please fill out this page) • installed ', 1Τ Κ

經濟部中央標準局員工消費合作杜印製 A7 B7 五、發明説明(w) 獲得3.5g 5 -溴異吲氣溴酸鹽》所得氲溴酸蘧懸浮 於50ml二氣甲烷,及添加2.8g三乙胺至懸浮液内,随後 2. 4 g苯甲_基氯以冰冷卻逐滴加至其中。随後所得混合 物於室溫攪拌1小時。反應混合物加入50·1水中及pH以 6N鹽酸諝整至U睡後,生成的有機層經分離,以飽和 鹽水溶液洗滌然後以無水硫酸鎂乾燥。然後於減壓下蒸 餾去除溶劑。如此所得殘餘物内加入正己烷,所得結晶 藉過濾收集獲得3.8 g無色結晶性2-苄氣玻基-5-溴異吲· P朵啉。 IR (KBr) cm-i: uc=〇 1705 NMR (CDC13) δ 值:4.69 ΜΗ, s), 5.20 (2Η, s), 6.70-7.40 (8H, m) 參考例16 1.20g 2-(對-甲苯磺醯基-5-溴異吲哚啉懸浮於24b1 甲苯内,及添加3 . 95g六丁基二鐲烷及39 4mg肆(三苯胯) 耙(0)至懸浮液,随後所得混合物於氰氣氛下回流加熱24 小時。反應混合物於減壓下濃維,及所得殘餘物藉柱式1 層析純化(溶離爾:己烷:乙酸乙酯=1〇: 1)播得0.92g 油狀2-(對-甲苯磺醛基)-5-三丁基錫烷異吲丨榮啉 IR {淨 J cm-l: us〇2 1349 f 1166 NMR (CDCI3) δ 值:0·20-2_00 (27Η, m), 2.40 (3Hr s), 4·61 (4H, brs), 6·50-8·00 {7H, m) 以相同方式獲得下列化合物。 • 1-甲基- 2-(對-甲苯磺醯基)-5-三氟丁基錫烷基-異11引 -62- 本紙張尺度適用中國國家榇準(CNS ) ΑΊ規格(210X297公釐) ---------「批衣^-I (請先閲讀背面之注意事項再填寫本頁)Consumption cooperation with employees of the Central Bureau of Standards, Ministry of Economic Affairs, Du printed A7 B7 V. Description of the invention (w) Obtained 3.5 g of 5-bromoisoindane bromate. The "bromide" obtained in suspension was suspended in 50 ml of digas methane, and 2.8 g of three were added. Ethylamine was added to the suspension, and then 2.4 g of benzyl chloride were added dropwise thereto under ice-cooling. The resulting mixture was then stirred at room temperature for 1 hour. After the reaction mixture was added to 50 · 1 water and the pH was adjusted to 6 with hydrochloric acid 6N, the resulting organic layer was separated, washed with a saturated saline solution and then dried over anhydrous magnesium sulfate. The solvent was then removed by distillation under reduced pressure. To the residue thus obtained was added n-hexane, and the obtained crystals were collected by filtration to obtain 3.8 g of colorless crystalline 2-benzylgasoyl-5-bromoisoindole-P-doline. IR (KBr) cm-i: uc = 〇1705 NMR (CDC13) δ value: 4.69 Μ, s), 5.20 (2Η, s), 6.70-7.40 (8H, m) Reference example 16 1.20g 2- (pair- Tosylsulfonyl-5-bromoisoindololine was suspended in 24b1 toluene, and 3.95 g of hexabutyldibrane and 39 4 mg of triphenylhydrazone were added (0) to the suspension, and the resulting mixture was then obtained. The mixture was heated at reflux under a cyanide atmosphere for 24 hours. The reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by column 1 chromatography (eluent: hexane: ethyl acetate = 10: 1) to obtain 0.92 g of an oil. The shape of 2- (p-toluenesulfonyl) -5-tributylstannane isoindole and wingline IR {Net J cm-1: us〇2 1349 f 1166 NMR (CDCI3) δ value: 0 · 20-2_00 (27Η , m), 2.40 (3Hr s), 4.61 (4H, brs), 6.50-8 · 00 {7H, m) The following compounds were obtained in the same manner. • 1-Methyl-2- (p-toluenesulfonyl) -5-trifluorobutylstannyl-iso-11-62- This paper size applies to China National Standard (CNS) Α size (210X297 mm)- -------- 「Approve ^ -I (Please read the precautions on the back before filling this page)

*tT A7 _ B7_ 五、發明説明(Η ) 時啉 IR (淨)cm-ι: υ5〇2 1349, 1165 NMR (CDC13) δ 值:0.70-1.80 (30Η, m), 2.38 (3Η, s), 4.55-5.15 (3H, τη), 6.90-7.90 (7Η, m) • 3-甲基-2-(對-甲苯磺醛基)-5-三丁基錫烷基-異吲 時啉 IR (淨} cm_1: uS〇2 1349, 1165 NMR (CDCI3) δ 值:' 0.60-1.90 (30H, Π〇, 2·37 (3H, s)r 4.30-5.20 (3Η, m), 6.80-7.90 (7H, m) .5-三丁基錫烷基-2-三氟乙醯基-螺〔異吲呤啉-1,1'-環丙烷〕 IR (淨.)cirri: Dc=〇 1694 NMR (CDCI3) δ 值:0.70-2.10 (29Η, m), 2.35-2.75 (2H, m)r 5.16 (2H, s), 6.60-7.70 (3H, m) • 苄氧羰基-5-三丁基錫烷基異吲昤啉 IR (淨)cm-i: vjc=〇 1718, 1709 NMR (CDCI3) δ 值:0.30-1.70 (27Η, m), 4.73 (4Η, s), 5.15 (2H, s), 6.80-7.40 (8H, in) 參考例17 經濟部中央標準局員工消費合作社印製 --------{^ 裝-- (請先閱讀背面之注意事項再填寫本頁) K4 於27»1甲苯内,溶解3.55g 2-(對-甲苯磺醯基)-5 -三 丁基錫烷基異吲呤啉,及添加1 . 35g乙基4-溴-2 , 5-二 氟-3-甲基苯甲醯乙酸酯及〇.29g氣化貳(三苯瞵)耙(II) 至溶液,随後所得混合物於氮氣氛下回流加熱8小時。 反應混合物於減壓下濃縮,所得殘餘物藉柱式層析純化 -63-本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明() (溶離劑:苯:乙酸乙酯= 70: 1)獲得1.25g無色結晶性 乙基2,5-二氟-3-甲基-4-〔2-(對-甲苯磺醛基)異ϋ引呤 啉-5-基]笨甲醯基乙酸酯。 IR (KBr) cnr!: i&gt;c=〇 1746 NMR (CDC13) δ 值:1.10-1.70 (3Η, m), 2.07 (3Η, d, J-2_9Hz), 2·41 (3H, Sr m), 3·80_4·50 (3·4π, m), 4.67 (4H, s), 5.88 (0.3H, s), 6.80-8.00 (8H, m), 12.6 (0.3Hr brs) 以相同方式獲得下列化合物。 •乙基 2,5-二氟-4-〔2-(對-甲苯磺醯基)-異吲丨朵啉- 5-基〕苯甲醛基乙酸酯 IR (KBr) cm-i: υ〇=〇 17 47 NMR (CDCI3) δ 值:1.10-1.70 (3Η, m), 2.40 (3Η, s), 3.90-4.50 (3.2H, m), 4.66 (4H, s), 5.89 (0.4H, s), 7.00- 8.00 {9H, m), 12.7 (0.4H, brs) •乙基4-〔 2-(苄氣羰基)-異吲昤啉-5-基〕-2, 5-二覦 -3-甲氣-6-硝基苯甲鹾基乙酸酷 IR (KBr) cm-l: uc=〇 1751, 1707 NMR (CDC13) δ 值:1.00-1.60 (3H, m), 3.60-4,.50 (6.2H, m), 4.81 (4H, s), 5.22 (2H, s), 5.50 (0.4H, s), 7.10-7.40 (8H, m), 12.2 (0.4H, brs) 參考例1 8 -64- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------^裝--- (請先閱讀背面之注意事項再填寫本頁) 丁 -*° 經濟部中央標準局員工消費合作杜印裝 A7 B7 '五、發明説明(Η ) 700mg乙基 7 -溴-卜環丙基-6-氟-8-甲氣-1,4 -二氫 -4-氧基IH啉-3-羧酸酯,88 9 mg 1-氰基-2-甲基-4-三丁 基錫烷基苯及13{Ug氣化貳(三苯瞵)鼦(II)懸浮於21ml 二甲苯内,及所得懸浮液回流加熱2小時。反應混合物 冷卻至室溫,及藉過濾收集沈澱之結晶。所得粗結晶藉 柱式層析純化(溶離劑:氣仿)獲得49Gmg無色結晶性乙 基7-(4 -氰基-3-甲基)苯基-1-環丙基-6-氟-8-甲氣-1,4 _二氫-4-氣基睹淋-3-耧酸酯。 IR (KBr) cm-l: υ〇=〇 1726 NMR (CDC13) δ 值:0.90-1.70 (7Η, m), 2.64 (3Η, s), 3.37 (3H, s), 3.65-4.15 (1H, m), 4.40 (2Hf q, J=7.〇Hz), 7.20-7.90 (3H, m), 8.03 (1H, d, J=9.5Hz), 8.64 (1H, s) 實例1 於25ml Ν,Ν -二甲基甲醛胺溶解2.30g 2-(對-甲苯磺 醯基)-5 -溴異吲昤啉,及添加1 . 5 1 g氧化銀(I )及0 · 7 5 g 肆(三苯膦)钯(0)至溶液中,隨後所得混合物於1D(TC氮 氣氛下攪拌5分鐘。隨後反應混合物内加人1.54g乙基 1-環丙基-6-氟-8-甲基-7-三丁基錫烷基-1,4-二氫- 4-氧基眩啉-3-羧酸酯溶解於5ml Ν,Ν -二甲基甲醯胺,及 所得混合物於l〇〇°C攪拌15分鐘。反應混合物加至50ml 乙酸乙酯及l〇〇ml水之混合溶劑中及pH以2 N鹽酸調整至 2,隨後藉過濾去除不溶物。生成的有機層經分離,以 -6 5- (請先閲讀背面之注意事項再填寫本頁) 裝卜* tT A7 _ B7_ V. Description of the invention (Η) Timeline IR (net) cm-ι: υ5〇2 1349, 1165 NMR (CDC13) δ Value: 0.70-1.80 (30Η, m), 2.38 (3Η, s) , 4.55-5.15 (3H, τη), 6.90-7.90 (7Η, m) • 3-methyl-2- (p-toluenesulfonyl) -5-tributyltinalkyl-isoindolinoline IR (net) cm_1: uS〇2 1349, 1165 NMR (CDCI3) δ value: '0.60-1.90 (30H, Π〇, 2.37 (3H, s) r 4.30-5.20 (3Η, m), 6.80-7.90 (7H, m ) .5-Tributyltinalkyl-2-trifluoroacetamidino-spiro [isoindolin-1,1'-cyclopropane] IR (net.) Cirri: Dc = 0 1694 NMR (CDCI3) δ value: 0.70-2.10 (29Η, m), 2.35-2.75 (2H, m) r 5.16 (2H, s), 6.60-7.70 (3H, m) • Benzyloxycarbonyl-5-tributyltin alkyl isoindioline IR ( Net) cm-i: vjc = 〇1718, 1709 NMR (CDCI3) δ value: 0.30-1.70 (27Η, m), 4.73 (4Η, s), 5.15 (2H, s), 6.80-7.40 (8H, in) Reference Example 17 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -------- {^ Pack-(Please read the precautions on the back before filling out this page) K4 in 27 »1 toluene, dissolve 3.55g 2- (p-toluenesulfonyl) -5-tributyltin alkyl isoindolinoline, and addition 1. 35 g of ethyl 4-bromo-2, 5-difluoro-3-methylbenzidine acetate and 0.29 g of gaseous thallium (triphenylhydrazone) were raked (II) to the solution, and the resulting mixture was then The mixture was heated under reflux in a nitrogen atmosphere for 8 hours. The reaction mixture was concentrated under reduced pressure, and the obtained residue was purified by column chromatography.-63- This paper is in accordance with Chinese National Standard (CNS) A4 (2 丨 0X297 mm). Printed by A7 B7, Consumer Cooperatives of the Bureau of Standards V. Description of the invention () (Dissolving agent: benzene: ethyl acetate = 70: 1) Obtain 1.25 g of colorless crystalline ethyl 2,5-difluoro-3-methyl-4 -[2- (p-toluenesulfonyl) isoamidinepyridin-5-yl] benzylideneacetate. IR (KBr) cnr !: i &gt; c = 〇1746 NMR (CDC13) δ value: 1.10-1.70 (3Η, m), 2.07 (3Η, d, J-2_9Hz), 2.41 (3H, Sr m), 3.80_4 · 50 (3 · 4π, m), 4.67 (4H, s), 5.88 (0.3H, s), 6.80-8.00 (8H, m), 12.6 (0.3Hr brs) The following compounds were obtained in the same manner. • Ethyl 2,5-difluoro-4- [2- (p-toluenesulfonyl) -isoindoline-2-yl] benzaldehyde acetate IR (KBr) cm-i: υ〇 = 〇17 47 NMR (CDCI3) δ value: 1.10-1.70 (3Η, m), 2.40 (3Η, s), 3.90-4.50 (3.2H, m), 4.66 (4H, s), 5.89 (0.4H, s ), 7.00- 8.00 {9H, m), 12.7 (0.4H, brs) • Ethyl 4- [2- (benzylcarbonyl) -isoindinoline-5-yl] -2, 5-difluorene-3 -Methane-6-nitrobenzylideneacetic acid IR (KBr) cm-1: uc = 〇1751, 1707 NMR (CDC13) δ value: 1.00-1.60 (3H, m), 3.60-4, .50 (6.2H, m), 4.81 (4H, s), 5.22 (2H, s), 5.50 (0.4H, s), 7.10-7.40 (8H, m), 12.2 (0.4H, brs) Reference example 1 8- 64- The size of this paper is applicable to Chinese National Standard (CNS) A4 (210X297 mm) --------- ^ pack --- (Please read the precautions on the back before filling this page) 丁-* ° Consumption cooperation between employees of the Central Bureau of Standards of the Ministry of Economic Affairs, printed A7 B7 'V. Description of the invention (Η) 700mg ethyl 7-bromo-cyclopropyl-6-fluoro-8-methyl-1,4-dihydro-4 -Oxy IH phthaloline-3-carboxylic acid ester, 889 mg of 1-cyano-2-methyl-4-tributyltin alkylbenzene and 13 {Ug gaseous scandium (triphenylhydrazone) scandium (II) Floating in 21ml of xylene, and the resulting suspension was heated at reflux for 2 hours. The reaction mixture was cooled to room temperature, and the precipitated crystals were collected by filtration. The obtained crude crystals were purified by column chromatography (eluent: aerosol) to obtain 49Gmg of colorless crystalline ethyl 7- (4-cyano-3-methyl) phenyl-1-cyclopropyl-6-fluoro-8. -Methane-1,4_dihydro-4-airyl molybdenyl-3-phosphonate. IR (KBr) cm-1: υ〇 = 〇1726 NMR (CDC13) δ value: 0.90-1.70 (7Η, m), 2.64 (3Η, s), 3.37 (3H, s), 3.65-4.15 (1H, m ), 4.40 (2Hf q, J = 7.0 Hz), 7.20-7.90 (3H, m), 8.03 (1H, d, J = 9.5Hz), 8.64 (1H, s) Example 1 in 25ml Ν, Ν- Dimethylformamide dissolves 2.30g of 2- (p-toluenesulfonyl) -5-bromoisoindioline, and adds 1.51 g of silver (I) oxide and 0.75 g of triphenylphosphine ) Palladium (0) into the solution, and the resulting mixture was stirred under a 1D (TC nitrogen atmosphere for 5 minutes. Then 1.54 g of ethyl 1-cyclopropyl-6-fluoro-8-methyl-7- was added to the reaction mixture. Tributylstannyl-1,4-dihydro-4-oxoroline-3-carboxylic acid ester was dissolved in 5 ml of Ν, Ν-dimethylformamide, and the resulting mixture was stirred at 100 ° C for 15 minutes The reaction mixture was added to a mixed solvent of 50 ml of ethyl acetate and 100 ml of water and the pH was adjusted to 2 with 2 N hydrochloric acid, and then the insoluble matter was removed by filtration. The resulting organic layer was separated by -6 5- (Please (Please read the notes on the back before filling out this page)

、1T Κ4 本纸張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐) 經濟部中央樣準局員工消費合作社印製 A7 B7 五、發明説明(〆) 飽和鹽水溶液洗滌然後以無水硫酸鎂乾燥。然後於減壓 下蒸餾去除溶劑。所得之殘餘物藉柱式層析純化(溶離 劑:甲苯:乙酸乙酯=3: 1),及随後加入乙醚,随後 藉過濾收集生成之結晶獲得0.5 5 g無色結晶性乙基1-環 丙基-6-氟-8-甲基-7-〔2-(對-甲苯磺醛基)異吲呤啉- 5-基〕-1,4 -二氫-4-氣基陉啉-3-羧酸酯。 IR (KBr) cm-i: υ〇〇 1733, 1693 NME (CDC13) δ 值:0.70-1.60 (7Η, m,), 2.42 (3ΗΓ s), 2.50 (3H, s), 3.70-4.10 (1H, m), 4.40 (2Hf q, J=7.3Hz), 4.69 (4H, s), 6.90-8.20 (8H, m), 8.70 (1H, s) 以相同方式獲得下列化合物。 •乙基1-環丙基-6-氟-7-〔2-(對-甲苯磺醯基)異吲It朵 啉-5-基〕-1,4 -二氫-4-氣基瞪啉-3-羧酸酯 IR (KBr) cm-1: υ〇=ο 1728, 1693 NMR (CDCI3) δ 值:0.90-1.55 (7Η, m), 2.41 (3Η, s), 3.20-3.70 (1H, m), 4.40 (2H, q, J=6.8Hz), 4.69 (4H, s), 7.00-8.25 (9H, m), 8.57 (1H, s) .乙基 (S)-9-氟-3-甲基-7-氣基-10-〔 2-(對-甲苯磺 醯基)異吲哚啉-5-基〕-2,3-二氫-7H-吡啶駢〔1,2,3-de〕-〔1,4〕苯駢枵阱-6-羧酸酯 IR (KBr) cm-i: uc=〇 1721 NMR (CDCI3) δ 值:1.00-1 · 55 ( 6Η, in) , 2 · 41 ( 3Η, s), 4.00-4.80 (9H, m), 6.90-7.90 (8H, m), 8.32 (1H, s) 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) --------r 裝I — (請先閱讀背面之注意事項再填寫本頁) 訂 .K4 經濟部中央標準局員工消費合作杜印製 A7 B7 五、發明説明(β) .乙基 -1-環丙基-6-氟-7-〔2-(對-甲苯磺酵基)-異吲 Ϊ朵啉-5-基〕-1,4-二氫-4-氣基-1,8-萘碇-3-羧酸酯 IR (KBr) cm-i: υ〇=〇 1719, 1679, 1651 NMR (di-TFA) δ 值:1.10-1.90 (7H, m), 2.47 (3H, s), 4.10-5.10 (7Hf m), 7.20-8.80 (8Hf m), 9.45 (1H, s) •乙基 8-氯-1-環丙基-6-氟-7- [2-(對-申苯磺醯基) 異吲昤啉-5-基〕-1 , 4-二氫-4-氧基授啉-3-羧酸酯 IR (KBr) cm-i: υ〇=〇 1726 NMR (CDCI3) δ 值..:0.70-1.70 (7H, m), 2.41 (3H, s), 3.80-4.80 (7H, m), 6.90-8.25 (8Hf m), 8.69 (1H, S) •乙基1-環丙基-7-〔 4 , 7-二氟-2-(對-甲苯磺醛基)異 吲呤啉-5-基〕-ΰ-氟-1,4-二氫-4-氧基丨i啉-3-羧酸酯 IR (KBr) cm-i: υ〇=〇 1728, 1690 NMR (CDCI3) δ 值:1.00-1.60 (7Η, m), 2.42 (3Η, s), 3.15-3.65 (1H, m), 4.39 (2H, q, J=6.8Hz)f 4.74 (4H, s), 6.90-8.00 (6H, m), 8.20 (1H, d, J=10.0Hz), 8.57 (1H, s) .乙基1-環丙基-7-〔4,7-二氟- 2-(對-甲苯磺醒基)異 吲鸣啉-5 -基]-6 -氟-8 -甲氣-1,4 -二氫-4 -氣基if啉-3 -羧酸酯 IR (KBr) cm-i: uc=0 1729, 1691 NMR (CDC13)S 值:lu {7H, m), 2·44 {3H, s), 3.43 (3H, s), 3.70-4.95 (7H, m), 6.80-8.15 (6H, m)f 8.57 (1H, s) __-67-_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------Γ 裝 l· — (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(讣) 實例2 47mg乙基 7-溴-1-瓖丙基-6-氟-8-甲基-1,4-二氫- 4-氣基_啉-3-羧酸酯懸浮於lml甲苯内,及於此懸浮液内 加入74ng 2-(對-甲苯磺醛基)-5-三丁基錫烷基異吲峥啉 及1.5mg肆-(三苯勝)耙(0),随後所得混合物於氮氣氛 下回流加熱18小時。反應混合物於減壓下濃缩,及所得 殘餘物藉柱式層析純化(溶離劑:正己烷:乙酸乙酯= 1: 1),然後加入乙醚,随後藉遇濾收集生成之結晶獲 得27m g無色結晶性乙基卜環丙基-6-氟-8-甲基-7-〔 2-(對-甲苯磋醛基)異吲哚啉-5 -基〕-1,4 -二氫-4 -氣基桂 啉-3-羧酸酯。 此種化合物之物理性質與實例1所得;ffc合物完金相同。 以相同方式獲得下列化合物。 •乙基1-環丙基-6,8-二氟-7-〔2-(對-甲苯磺醛基)異 吲呤啉-5-基〕-1,4-二氫-4-氣基晬啉-3-羧酸酯 IR (KBr) cm-1: uc=〇 1731, 1696 NMR (CDC13) 6 值:0.90-1.80 (7H, m), 2.41 (3H, s), 3.60-4.10 (lHr m)f 4.10-4.90 (6H, m)f 6.80-8.30 (8H, m), 8.59 (1H, s) •乙基 1-(2,4-二氟苯基)-6-氟-7-〔2-(對-甲苯磺醛 基)異吲哚啉-5-基〕-1,4-二氫-4-氣基-1,8-萊啶-3-羧 酸酯 _ 6 8 - 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) (讀先閲讀背面之注意事項再填寫本頁) 裝 訂 經濟部中央標準局負工消費合作社印製 A7 B7__ 五、發明説明(K ) IR (KBr) cra-l: uc=〇 1675, 1655 NMR (CDC13) 6 值:1.40 (3H, t, J=6.8Hz), 2.39 (3H, s), 4.41 (2H, q, J=6.8Hz), 4·63 (4H, s), 6.80-7.90 (10H, m), 8.48 (1H, d, J=10.〇Hz)r 8.58 (1H, s) .乙基7-〔 2-(苄氣数基)異吲呤啉_5~基〕-卜環丙基 -6-氟-8-氟甲基-1,4-二氳-4-氣基睹啉-3-羧酸酯 IR (KBr) cm-ι: υ〇=〇 1732, 1718 NMR (CDC13) δ 值:0.85-1.75 (7H, m), 3.85-4.65 (3H, m)f 4.81 (4H, s), 5.21 (2H, s)r 5.61 (2H, d, J=48Hz), 7.05-7.55 (8H, m), 8.23 (1H, dd, J=2.〇Hz, 8.8Hz), 8.66 (1H, s) 實例3 〇.25g乙基7-i吳·_1-琛丙基氟-8-甲氣-1,4-二氫 -4 -氣基if啉-3-羧酸酯懸浮於5ml甲苯内,及於此懸浮 液加入D.55g 2-(對-甲笨磺醯基卜5 -三丁基錫烷基異吲 昤麻及〇.〇9g氱化贰(三苯R)耙(II),隨後所得混合物 於氫流下回流加熱8小時。反應混合物於減應下濃缩, 及所得殘餘物藉柱式層析純化(溶離薄:氣仿),随後加 入乙過濾收集生成之結晶獲得0.19g無色結晶性乙 基乙基1-瑪丙基-6-氟-8-甲氣-7-〔2-(對-甲苯礙睡 基)異吲呤啉-5-基〕-1,4-二氫-4-氧基β淋-3·接酸_。 -69- 本紙張尺度適用中國國家標準(CNS ) A4g ( 210 Χ297公釐) (請先閱讀背面之注意事項再填寫本頁) f、 1T Κ4 The size of this paper is applicable to Chinese National Standard (CNS) A4 specification (210 X 297 mm) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 5. Description of the invention (〆) Saturated saline solution and then washed with anhydrous Dry over magnesium sulfate. The solvent was then distilled off under reduced pressure. The obtained residue was purified by column chromatography (eluent: toluene: ethyl acetate = 3: 1), and then ether was added, and the resulting crystals were collected by filtration to obtain 0.5 5 g of colorless crystalline ethyl 1- Cyclopropyl-6-fluoro-8-methyl-7- [2- (p-toluenesulfonyl) isoindolinolin-5-yl] -1,4-dihydro-4-aminopyridin- 3-carboxylic acid ester. IR (KBr) cm-i: υ〇〇1733, 1693 NME (CDC13) δ value: 0.70-1.60 (7Η, m,), 2.42 (3ΗΓ s), 2.50 (3H, s), 3.70-4.10 (1H, m), 4.40 (2Hf q, J = 7.3Hz), 4.69 (4H, s), 6.90-8.20 (8H, m), 8.70 (1H, s) The following compounds were obtained in the same manner. • Ethyl 1-cyclopropyl-6-fluoro-7- [2- (p-toluenesulfonyl) isoindolin Itorolin-5-yl] -1,4 -dihydro-4-amino azolin 3-carboxylic acid ester IR (KBr) cm-1: υ〇 = ο 1728, 1693 NMR (CDCI3) δ value: 0.90-1.55 (7Η, m), 2.41 (3Η, s), 3.20-3.70 (1H, m), 4.40 (2H, q, J = 6.8Hz), 4.69 (4H, s), 7.00-8.25 (9H, m), 8.57 (1H, s). Ethyl (S) -9-fluoro-3- Methyl-7-amino-10- [2- (p-toluenesulfonyl) isoindololin-5-yl] -2,3-dihydro-7H-pyridinium [1,2,3-de ]-[1,4] Benzene-6-carboxylic acid ester IR (KBr) cm-i: uc = 〇1721 NMR (CDCI3) δ value: 1.00-1 · 55 (6Η, in), 2 · 41 (3Η, s), 4.00-4.80 (9H, m), 6.90-7.90 (8H, m), 8.32 (1H, s) This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm)- ------- r Pack I — (Please read the notes on the back before filling this page) Order. K4 Consumption Cooperation with Employees of the Central Standards Bureau of the Ministry of Economic Affairs Du A7 B7 5. Invention Description (β). Ethyl -1-cyclopropyl-6-fluoro-7- [2- (p-toluenesulfonyl) -isoindiodoline-5-yl] -1,4-dihydro-4-amino-1, 8-naphthalenepyrene-3-carboxylic acid ester IR (KBr) cm-i: υ〇 = 〇1719, 1679, 1651 NMR (di-TFA) δ values: 1.10-1.90 (7H, m), 2.47 (3H, s), 4.10-5.10 (7Hf m), 7.20-8.80 (8Hf m), 9.45 ( 1H, s) • Ethyl 8-chloro-1-cyclopropyl-6-fluoro-7- [2- (p-s-benzenesulfenyl) isoindioline-5-yl] -1, 4-di Hydrogen-4-oxoline-3-carboxylate IR (KBr) cm-i: υ〇 = 〇1726 NMR (CDCI3) δ value: 0.70-1.70 (7H, m), 2.41 (3H, s ), 3.80-4.80 (7H, m), 6.90-8.25 (8Hf m), 8.69 (1H, S) Ethyl 1-cyclopropyl-7- [4, 7-difluoro-2- (p-toluene Sulfonyl) isoindolinolin-5-yl] -fluorene-fluoro-1,4-dihydro-4-oxyl-iline-3-carboxylic acid ester IR (KBr) cm-i: υ〇 = 〇 1728, 1690 NMR (CDCI3) δ value: 1.00-1.60 (7Η, m), 2.42 (3Η, s), 3.15-3.65 (1H, m), 4.39 (2H, q, J = 6.8Hz) f 4.74 (4H , s), 6.90-8.00 (6H, m), 8.20 (1H, d, J = 10.0Hz), 8.57 (1H, s). Ethyl 1-cyclopropyl-7- [4,7-difluoro- 2- (p-toluenesulfonyl) isoindoline-5 -yl] -6 -fluoro-8 -methane-1,4-dihydro-4 -aminoifolin-3 -carboxylic acid ester IR ( KBr) cm-i: uc = 0 1729, 1691 NMR (CDC13) S values: lu {7H, m), 2.44 (3H, s), 3.43 (3H, s), 3.70-4.95 (7H, m) , 6.80-8.15 (6H, m) f 8.57 (1H, s) __- 67-_ This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) --------- Γ Installation l · — (Please read the back first Please note this page, please fill in this page) Order A7 B7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the Invention (讣) Example 2 47mg ethyl 7-bromo-1-fluorenyl-6-fluoro-8-methyl -1,4-dihydro-4-airyl-line-3-carboxylic acid ester was suspended in 1 ml of toluene, and 74 ng of 2- (p-toluenesulfonyl) -5-tributyltin was added to the suspension. Alkyl isoindoxaline and 1.5 mg of tris- (triphenylene) rake (0), and the resulting mixture was then heated under reflux under a nitrogen atmosphere for 18 hours. The reaction mixture was concentrated under reduced pressure, and the obtained residue was purified by column chromatography (eluent: n-hexane: ethyl acetate = 1: 1), then ether was added, and the resulting crystals were collected by filtration to obtain 27 m. g colorless crystalline ethylbucyclopropyl-6-fluoro-8-methyl-7- [2- (p-tolylaldehyde) isoindoline-5-yl] -1,4-dihydro- 4-Gauryl cyanoline-3-carboxylic acid ester. The physical properties of this compound are the same as those obtained in Example 1; The following compounds were obtained in the same manner. • Ethyl 1-cyclopropyl-6,8-difluoro-7- [2- (p-toluenesulfonyl) isoinolinolin-5-yl] -1,4-dihydro-4-yl Periline-3-carboxylic acid ester IR (KBr) cm-1: uc = 〇1731, 1696 NMR (CDC13) 6 Value: 0.90-1.80 (7H, m), 2.41 (3H, s), 3.60-4.10 (lHr m) f 4.10-4.90 (6H, m) f 6.80-8.30 (8H, m), 8.59 (1H, s) • Ethyl 1- (2,4-difluorophenyl) -6-fluoro-7- [ 2- (p-toluenesulfonyl) isoindololin-5-yl] -1,4-dihydro-4-amino-1,8-eryridine-3-carboxylic acid ester 6 8-This paper Standards are applicable to China National Standard (CNS) A4 specifications (210X297 mm) (read the precautions on the back before filling this page) Binding Printed by the Central Standards Bureau of the Ministry of Economic Affairs and Consumer Cooperatives A_B7__ 5. Description of the invention (K) IR (KBr) cra-1: uc = 〇1675, 1655 NMR (CDC13) 6 value: 1.40 (3H, t, J = 6.8Hz), 2.39 (3H, s), 4.41 (2H, q, J = 6.8Hz) , 4.63 (4H, s), 6.80-7.90 (10H, m), 8.48 (1H, d, J = 10.〇Hz) r 8.58 (1H, s). Ethyl 7- [2- (benzyl gas Number group) Isoinline_5 ~ yl] -bucyclopropyl-6-fluoro-8-fluoromethyl-1,4-difluoren-4-ylamino-3-carboxylate IR (KBr ) cm-ι: υ〇 = 〇1732, 1718 NMR (CDC13) δ value: 0.85-1.75 (7H, m), 3.85-4.65 (3H, m) f 4.81 (4H, s), 5.21 (2H, s) r 5.61 (2H, d, J = 48Hz), 7.05-7.55 (8H, m), 8.23 (1H, dd, J = 2.0Hz, 8.8Hz), 8.66 (1H, s) Example 3 0.25g ethyl 7-i Wu-1-chenpropylpropyl fluoride -8-Methane-1,4-dihydro-4 -amino ifolin-3-carboxylic acid ester was suspended in 5ml of toluene, and D.55g of 2- (p-methylbenzylsulfonyl) was added to the suspension. (B) 5-Tributyltin alkyl isoindane ramie and 0.09 g of trifluoride (triphenyl R) halide (II), and the resulting mixture was then heated under reflux for 8 hours under a hydrogen stream. The reaction mixture was concentrated under reduced stress, and The obtained residue was purified by column chromatography (thinning: aerosol), and then filtered by adding B to collect the resulting crystals to obtain 0.19 g of colorless crystalline ethylethyl 1-methylpropyl-6-fluoro-8-methyl gas. -7- [2- (p-toluene stilbyl) isoindolinolin-5-yl] -1,4-dihydro-4-oxyβ-lyl-3. -69- This paper size applies to Chinese National Standard (CNS) A4g (210 x 297 mm) (Please read the precautions on the back before filling this page) f

、1T 經濟部中央標準局員工消費合作杜印製 A7 B7 ’ 五、發明説明uo IR (KBr) cm-1: Uc=〇 1731 NMR (CDC13) 5 值:0.80-1.70 (7H, m), 2.41 (3H, s), 3.32 (3H, s), 3.60-4.20 (1H, m) , 4.40 (2H,· q, J=6.8Hz), 4.68 (4H, s), 7.10-7.50 (5H, m)r 7.60-8.15 (3H, m), 8.61 (1H, s) 以相同方式獲得下列化合物e •乙基:l -環丙基-6 -氟-8 -甲氣-7 -〔 1 -甲基-2 -(對-甲 苯磺醯基)異吲昤啉-5-基〕-1,4-二氳-4-氣基丨f啉-3-羧酸酯 IR (KBr) cm-l: υ〇〇 1732 NMR (CDCI3) δ 值:0.80-2.00 (10Η, m), 2.40 (3Η, s), 3.30 (3H, s), 3.75-5.30 (6H, m), 7.10-8.15 {8H, m)f 8.65 (1H, s) .乙基 1-環丙基-6-覦-8-甲氣-7-〔3-甲基- 2-(對-甲 苯磺醯基)異吲昤啉-5-基〕-1 ,4-二氫-4-氣基丨f啉- 3-羧酸酯 IR (KBr) cm-l: \Jc=〇 1729 NMR (CDCI3) S 值:0.90-1.80 (10H, m), 2.39 (3H, s), 3.31 (3H, s)f 3.75-5.10 (6H, ro), 7.05-8.10 (8Hf m), 8.61 (1H, s) •乙基 1-環丙基-6-氟-8-甲氧-7-〔2-三氟乙酵基〕-螺〔異吲嘌啉-1 , 1 '-環丙烷〕-5 -基〕-1 , 4 -二氫-4 -氣基睹啉-3 -羧酸酯 -70&quot; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------C 裝 l·— (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 A7 B7 '五、發明説明(W ) IR (KBr) cm-1: υ〇〇 1731, 1697 NMR (CDCI3) δ 值:0.70-1.90 (9Η, in) , 2.20-2.90 (2Hf m), 3.38 (3Hf s), 3.60-4.70 (3H, m)r 5.21 (2H, s), 6.55-8.20 (4H, m), 8.59 (1H, s) •乙基卜環丙基-8-二氟甲氣-6-氟-7-〔 2-(對-甲苯横 醛基)異吲呤啉-5-基〕-1,4-二氳-4-氧基If啉-3-羧酸酯 IR (KBr) cm-1: υ〇=〇 1730 NMR (CDCI3) δ 值:0.90-1.70 (7Η, m), 2.40 (3Hr s), 3.70-4.85 (7H, m), 5.8.3 (1H, t, J=75Hz), 7.00-8.30 (8H, m), 8.62 (1H, s) •乙基卜環丙基-8 -二氟甲氣-6-氟-7-〔3 -甲基- 2- (對 -甲苯磺醯基)異吲呤啉-5-基〕-1,4-二氫-4-氣基睹啉 -3-羧酸酯 IR (KBr) cm-i: υ〇=〇 1732 NMR (CDCI3) δ 值:0.70-1.80 (10Η, m), 2.39 (3Η, s), 3.60-5.30 (6H, m), 5.80 (1H, t, J=75Hz), 6.80-8.30 (8H, m), 8.64 (1H, s) •乙基卜環丙基-8-二氟甲氣-6-氟-7-〔2-三纒乙醯基 -螺〔異吲哚啉-1,1、環丙基-5-基〕-1,4 -二氫-4-氣基 瞍啉-3-羧酸酯 IR (KBr) cm-i: υ〇〇 1729, 1701 NMR (CDCI3) δ 值:0.80-1.65 (9Η, m), 2.40-2.80 (2Η, m), 3.80-4.70 (3Η, m), 5.20 (2H, n)r 5.BB (1H, t, J=74Hz), 6.70-7.60 (3Hf m)f 8.15 (1H, d, J=9.0Hz), 8.61 (1H, s) -7 1 - (請先閲讀背面之注意事項再填寫本頁) 裝 訂 K4 本紙張尺度適用中國國家梂準(CNS ) A4规格(210X297公釐) 經濟部中央標準局員工消費合作社印聚 A7 五、發明説明(W ) •乙基 1-環丙基-6-氟-8-氟甲氣-7-〔2-(對-甲苯磺醯 基)異吲呤啉-5-基〕-1,4-二氫-4-氧基if啉-3-羧酸酯 IR (KBr) cm-ι: υ〇=〇 1727 NMR (CDCI3) δ 值:0.90-1.60 (7Η, m), 2.41 (3Η, s), 3.75-4.80 (7H, m), 5.02 (2Hr d, J=54Hz), 7.00- 7.85 (7H, m),8.10 {1H, d, J=9.3Hz), 8.62 (1H, s) •乙基卜環丙基-6-氟-7-〔1-甲基- 2-(對-甲苯磺醯基) 異吲呤啉-5-基〕-1 , 4-二氫-4-氣基if啉-3-羧酸酯 IR (KBr) cm-l: Uc=〇 1727 NMR (CDCI3) 6 值:1.00-1.90 (10Η, m), 2.38 (3Hr s), 3.20-3.70 (1H, m), 3.90-5.20 (5H, m), 7.00- 8.25 (9Hf m), 8.54 (lHf s) •乙基1-環丙基-6-氟-7-〔3-甲基- 2-(對-甲苯磺醯基) 異吲呤啉-5-基〕-1 , 4-二氫-4-氣基睹啉-3-羧酸酯 IR (KBr) cm-i: uc=〇 1727, 1708, 1695 NMR (CDCI3) δ 值·· 0.80-1.90 (10Η, m) , 2.39 (3H, s), 3.10-3.70 (1H, m), 3.90-5.20 (5H, m), 6.80-8.25 (9Hf m), 8.55 (1H, s) •乙基 7-〔 2 -(苄氧羰基)異吲昤啉-5-基〕-8-氣-6-氟 -1-〔(lR,2S)-2 -氟環丙基〕-1,4-二氫-4-氣基睹淋- 3-羧酸酯 -72- 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝· 、1Τ 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(W ) IR (KBr) cm-i: υ〇=〇 1726, 1709 NMR (CDCI3) δ 值:0.80-1.70 (5Η, ra), 3.80-4.90 (7.5H, m), 5.00-5.50 (2.5H, m), 6.90-7.90 (8H, m), 8.18 (1H, d, J=8.8Hz), 8.59 (1H, d, J=2.4Hz) 實例4 於21»1二氣甲烷溶解20〇1»£乙基2,5-二氟-3-甲基-4-〔2-(對-甲苯磺醯基)異吲啤啉-5-基〕苯甲醯基乙酸酯 ,及於此溶液内加入76ing乙酸酐及9〇Bg -二甲基甲 醛胺二甲縮醛,隨後所得混合物於室溫攪拌2小時。其 後於減壓下蒸餾去除溶劑。所得殘餘物溶解於lml乙酵 及添加58mg 2-氟乙胺鹽酸鹽及27mg甲氧化納於1b1乙 醇之溶液至該溶液,随後所得混合物於室溫攪拌2 0分鐘 。反應混合物於減壓下濃縮及所得混合物溶解於2b1 N, N-二甲基甲醯胺,随後添加65bg碩酸鉀至溶液中。所得 混合物於100 °C攪拌1小時。反應混合物冷卻至室溫及 随後加水至混合物。所得沈澱藉過濾收集,及所得淡黃 色固體藉柱式層析純化(溶離剤:正己烷:乙酸乙酯= 2: 1)。其後二異丙醚加至其中,其後藉過濾收集生成 的結晶,獲得1 2 6 m g無色結晶性乙基-1 - ( 2 -氟乙基)-8 -甲基-7-〔2-(對-甲苯磺醛基)異吲呤啉-5-基〕-1,4-二 氫-4-氧基授啉-3-羧酸酯。 -7 3 ~ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) S1· ---------(裝 l· - (請先閲讀背面之注意事項再填寫本頁) 訂 k4 經濟部中央標,準局員工消費合作杜印製 A7 :B7 五、發明説明(p) IR (KBr) cm-l: υ〇〇 1724, 1696 NMR (CDCI3) δ 值:1.40 {3Η, t, J=7.3H7:), 2.2η (3H, s), 2.41 (3H, s), 4.00-5.10 (10H, m)f 6.90-7.90 (7H, m), 8.10 (1H, d, J=9.3Hz), 8.48 (1H, s) 以相同方式獲得下列化合物。 .乙基 1-乙基-G-氟-8-甲基-7-〔 2-(.對-甲笨磺醢基) 異吲咬啉-5 -基〕-1,4 -二氫-4 -氣基HS啉-3 -羧酸酯 IR (KBr) cm-i: i&gt;c=〇 1725, 1686 NMR (CDCI3) 6 值:1.10-1.80 (6Η, m), 2.30 (3Η, s), 2.39 (3H, s), 4.10-4.90 (8Hr m), 7.00-8.00 (7H, m), 8.10 (1H, d, J=9.3Hz), 8.46 (lHf s) •乙基 6-氟-卜〔(lR,2S)-2-氟環丙基〕-8-甲基- 7-〔2-(對-甲苯磺醯基)異吲P呆啉-5-基〕-1,4-二氳-4-氣 基挖啉-3 -羧酸酯 IR (KBr) cm-i: υ〇=〇 1725, 1690 NHR (CDCI3) δ 值:1.00-1.90 (5Η, m), 2.42 (6Η, s), 3.30-4.80 (7.5H, m) , 5.10-5.5U (0.5!if m), 6.80-8.20 (8H, m), 8.57 (1H, d, J=2.9Hz) •乙基 1-(2,4-二氟苯基)-6-氟-8-甲基-7-〔 2-(對-甲 苯磺酷基)異吲哚啉-5-基〕-1,4 -二氬-4 -氣基丨f啉- 3-羧酸酯 IR (KBr) cm-l: υ〇=〇 1734, 1700 本紙張尺度適用中國國家標準(CNS〉A4規格(210X297公釐) 裝-=-I (請先閲讀背面之注意事項再填寫本頁) -Γ 五、發明説明(w .乙基 1-(4-苄氧苯基)-6-氟-8-甲基-7-〔2-(對-甲苯 磺醯基)異吲哚啉-5-基〕-1,4-二氫-4-氣基啉-3-羧 酸酯 IR (KBr) cm-i: uc=〇 1728, 1694 NMR (CDC13) δ 值卜 1.10-1.80 (6H, m)r 2.36 (3H, S), 4.35 (2H, q, J=7.3Hz), 4.60 (4Hr s)r 5.08 (2H, s), 6.80-7.90 (16H, m), 8.11 (1H, d, J=9.3Hz), 8.43 (1H, s) 請 先 閱 讀 背 之 注 意 事 項 養 經濟部中央標準局員工消費合作社印製 •乙基6-氟-1-(2-氟乙基)-7-〔2-(對-甲苯磺醛基)異 吲昤啉-5-基〕-1,4-二氫-4-氧基眭啉-3-羧酸酯 IR (KBr) cm-i: υ〇=〇 1724 MHR (CDCI3) δ.值:1.40 (3Η, t, J=7.3Hz), 2.41 (3H, s), 4.10-5.35 (10H, m), 7.00-7.90 (8Hf id), 8·20 (1H, df J-10.3Hz), 8.46 (1H, s) •乙基1-(2, 4-二氟苯基)-6-氟-7-〔 2-(對-甲苯磺醯 基)異吲呤啉-5-基〕-1,4 -二氫-4-氧基ϊί啉-3-羧酸酯 IR (KBr) cm-l: uc=〇 1725 NMR (CDC13) δ 值:1.40 (3H, t, J=7.3Hz), 2.39 (3H, s), 4.10-4.70 (6H, m), 6.90-7.90 (11H, m)f 8.23 (1H, d, J=10.3Hz)r 8.38 (1H, s) 7 5 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 A7 B7_— —五、發明説明(μ ) 實例5 於〇.71g原甲酸乙酯及0.49g乙酸酐中溶解〇.66g乙 基4-〔2-(苄氣羰基)異吲II朵啉-5-基〕-2,5-二氟-3-甲 氣-6-硝基苯甲醯基乙酸酯,及溶解於回流加熱30分鐘 。反應混合物於減壓下濃縮,及所得殘餘物溶解於3.3al 乙醇及2b1二氯甲烷中。溶液内加入0.08 g琛丙胺,及所 得混合物於室溫攪拌30分鐘。反應混合物於減壓下灌縮 ,及所得殘餘物溶解於l〇Bl四氫呋喃。溶液内加入〇.〇5g 60%氫化納,及所得混合物於室溫攪拌30分鐘。反應混 合物加入lOinl 1N鹽酸及藉過濾收集沈澱出之結晶獲得 0 . 33g無色結晶性乙基7-〔 2 -(苄氣羰基)異吲呤啉-5-基〕 -1-環丙基-6-氟-8-甲氣-5-硝基-1,4-二氫-4-氣基技啉 -3-羧酸酯。 IR (KBr) cm-i: uc=〇 1728, 1709 tJMR (CDC13) δ 值:0.90-1.60 (7H, m), 3·42 ΠΗ, s), 3.70-4.10 (1H, m), 4.34 (2H, q, J=6.8H7,), 4.84 (4Hr s), 5.23 (2H, s), 7.05-7.55 (8H, m)f 8.61 (1H, s) 實例6 (1) 470mg乙基7-(4 -氰基-3-甲基)苯基-l-環丙基- 6-氟-8-甲氧-1,4 -二氳-4-氣基睹淋-3-搂酸酯,230 ng N-溴丁醯亞胺及50mg過苯甲酸懸浮於20b1四氦化硪中,懸 浮液间流加熱2小時。反應混合物内加入llOagfi -溴 -76- (請先閱讀背面之注意事項再填寫本頁) Γ. 裝. 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐〉 經濟部中央標準局員工消費合作社印製 A7 _l_B7_ 五、發明説明(# ) 丁二醯亞胺及20aig過苯甲酸及所得混合物又回流加熱2 小時〇操作重覆一次。於減壓下蒸餾去除溶劑,及所得 殘餘物内加入20β1氣仿及l〇Bl水任混合物分離成兩層。 生成的有機層經分離以無水硫酸鎂乾燥。隨後於減歷下 蒸餾去除溶劑獲得37〇Bg乙基7-(3-溴甲基-4-«基)苯 基1-琛丙基-6-氟-8-甲氣-1,4-二氫-4-氧基眭啉-3-羧 酸酯之粗晶。 (2) 如上(1)所得化合物76m g叠氮化納及13mg四-正丁基 溴化銨溶解於2ml水及2hi1二氯甲烷之混合劑中,及溶液 於室溫攪拌15小時。於減壓下蒸皤去除溶剤及於所得殘 餘物内加入2G ml乙酸乙酯及ΙΟβΙ水任混合物分離成兩層 β生成的有機層經分離,依次以水及飽和鹽水溶液洗滌 ,然後以無水硫酸鎂乾燥。然後於減壓下蒸皤去除溶劑 ,及將乙醚加至所得殘餘物。藉遒濾收集生成之結晶播 得270mg無色結晶性乙基7-(3-叠氰甲基-4-氰基)苯基-卜 環丙基-6-氟-8-甲氣-1,4-二氫-4-氣基喹啉-3-羧酸酯。 IR (KBr) cm-1: -N3 2103, υ〇=ο 1728 HMR (CDCI3) 6 值:0.80-1.70 (7Η, m}, 3.3.7 (3Η, s), 3.70-4.10 (1H, m)f 4.40 (2Hr q, J=7.0Hz), 4.70 (2H, s)f 7.15-8.20 (4H, m)f 8.64 (1H, s) (3) 室溫下以約1小時畤間逐滴加入3ml 210ieg如上(2) 所得化合物之甲醇溶液於3〇2»g氣化亞錫於2»1甲醇之懸 浮液内,所得混合物於同溫攪拌30分鐘。於減壓下蒸梅 去除溶劑及所得殘餘物内加入l〇ml氯仿及lQal飽和硝酸 -77- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐〉 ---------1 裝-- (請先閲讀背面之注意事項再填寫本頁) -&quot; 經濟部中央標準局員工消費合作社印裝 A7 _^__B7_ 五、發明説明(# Γ 鉀水溶液,隨後經西來特(Celite)過濾去除不溶物。所 得濾液任其分離成兩雇及生成的有機層依次以飽和硝酸 鉀水溶液及飽和鹽水溶液洗滌及然後以無水硫酸鎂乾燥 。於減壓下蒸餾去除溶劑,及所得殘餘物藉柱式層析純 化〔溶離劑:(氯仿:乙醇:濃舞水=150: 25: 1)之有 機層〕獲得l〇〇mg卜環丙基-6-氟-7-(1-亞胺基異吲呤 啉-5-基)-8-甲氧-1,4-二氫-4-氣基Pf啉-3-羧酸之甲 基酯及乙基酯之混合物。 (4)於lOOing如上(3&gt;所得混合物|於2ml乙醇及2 ml二P等 烷之懸浮液内加入1b1 1N氫氣化鈉水溶液及所得混合物 於室溫攪拌2小時。於減壓下蒸皤去除溶劑,及所得殘 餘物加入2il水,随後藉過濾去除不溶物。二氣化碩氣體 體吹送入所得濾液及沈澱出之結晶藉過濾收集獲得56ιπg 無色結晶晶性1-璟丙基-6-氟-7-(1-亞胺基異吲昤啉- 5-基)-8 -甲氧-1,4 -二氫-4-氧基if啉-3-羧酸。 IR (KBr) cm-l: uc=〇 1617、 1T Consumption cooperation between employees of the Central Bureau of Standards of the Ministry of Economic Affairs, Du printed A7 B7 ′ 5. Description of invention uo IR (KBr) cm-1: Uc = 〇1731 NMR (CDC13) 5 Value: 0.80-1.70 (7H, m), 2.41 (3H, s), 3.32 (3H, s), 3.60-4.20 (1H, m), 4.40 (2H, q, J = 6.8Hz), 4.68 (4H, s), 7.10-7.50 (5H, m) r 7.60-8.15 (3H, m), 8.61 (1H, s) In the same manner, the following compound e is obtained: ethyl: l-cyclopropyl-6-fluoro-8-methyl-7- [1-methyl- 2- (p-toluenesulfonyl) isoindioline-5-yl] -1,4-difluoren-4-yl group fline-3-carboxylic acid ester IR (KBr) cm-1: υ〇 〇1732 NMR (CDCI3) δ value: 0.80-2.00 (10Η, m), 2.40 (3Η, s), 3.30 (3H, s), 3.75-5.30 (6H, m), 7.10-8.15 (8H, m) f 8.65 (1H, s). Ethyl 1-cyclopropyl-6-fluorene-8-methyl gas-7- [3-methyl-2- (p-toluenesulfonyl) isoindioline-5-yl ] -1,4-dihydro-4-amino group f-line-3-carboxylic acid ester IR (KBr) cm-1: \ Jc = 〇1729 NMR (CDCI3) S value: 0.90-1.80 (10H, m) , 2.39 (3H, s), 3.31 (3H, s) f 3.75-5.10 (6H, ro), 7.05-8.10 (8Hf m), 8.61 (1H, s) Ethyl 1-cyclopropyl-6-fluoro -8-methoxy-7- [2-trifluoroethionyl] -spiro [isoindine -1, 1 '-cyclopropane] -5 -yl] -1, 4 -dihydro-4 -amino-based phosphino-3 -carboxylate-70 &quot; This paper size applies to China National Standard (CNS) A4 specifications ( 210X297 mm) --------- C Pack l · — (Please read the notes on the back before filling this page) Order A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs W) IR (KBr) cm-1: υ〇〇1731, 1697 NMR (CDCI3) δ values: 0.70-1.90 (9Η, in), 2.20-2.90 (2Hf m), 3.38 (3Hf s), 3.60-4.70 ( 3H, m) r 5.21 (2H, s), 6.55-8.20 (4H, m), 8.59 (1H, s) Ethylbucyclopropyl-8-difluoromethane-6-fluoro-7- 〔2 -(P-toluene aldehyde) isoinolinolin-5-yl] -1,4-bisfluoren-4-oxy If chloro-3-carboxylate IR (KBr) cm-1: υ〇 = 〇 1730 NMR (CDCI3) δ value: 0.90-1.70 (7Η, m), 2.40 (3Hr s), 3.70-4.85 (7H, m), 5.8.3 (1H, t, J = 75Hz), 7.00-8.30 (8H , m), 8.62 (1H, s) • Ethylbucyclopropyl-8-difluoromethane-6-fluoro-7- [3-methyl-2- (p-toluenesulfonyl) isoindolin Porphyrin-5-yl] -1,4-dihydro-4-pyridyl-3-carboxylate IR (KBr) cm-i: υ〇 = 〇1732 NMR (CDCI3) δ value: 0.70- 1.80 (10Η, m), 2.39 (3Η, s), 3.60-5.30 (6H, m), 5.80 (1H, t, J = 75Hz), 6.80-8.30 (8H, m), 8.64 (1H, s) • Ethylbucyclopropyl-8-difluoromethane-6-fluoro-7- [2-trimethylacetino-spiro [isoindolin-1,1, cyclopropyl-5-yl] -1 , 4-dihydro-4-aminopyridin-3-carboxylic acid ester IR (KBr) cm-i: υ〇〇〇1729, 1701 NMR (CDCI3) δ value: 0.80-1.65 (9Η, m), 2.40- 2.80 (2Η, m), 3.80-4.70 (3Η, m), 5.20 (2H, n) r 5.BB (1H, t, J = 74Hz), 6.70-7.60 (3Hf m) f 8.15 (1H, d, J = 9.0Hz), 8.61 (1H, s) -7 1-(Please read the precautions on the back before filling in this page) Binding K4 This paper size is applicable to China National Standard (CNS) A4 size (210X297 mm) Economy Ministry of Central Standards Bureau Consumers' Cooperative Printing Poly A7 V. Description of Invention (W) • Ethyl 1-cyclopropyl-6-fluoro-8-fluoromethane-7- [2- (p-toluenesulfonyl) iso Indolinolin-5-yl] -1,4-dihydro-4-oxyifline-3-carboxylic acid ester IR (KBr) cm-ι: υ〇 = 〇1727 NMR (CDCI3) δ value: 0.90- 1.60 (7Η, m), 2.41 (3Η, s), 3.75-4.80 (7H, m), 5.02 (2Hr d, J = 54Hz), 7.00- 7.85 (7H, m), 8.10 {1H, d, J = 9.3Hz), 8.62 (1H, s) • Ethylbucyclopropyl-6-fluoro-7- [1-methyl-2- (p-toluenesulfonyl) isoindolinolin-5-yl] -1, 4-dihydro-4 -Gas ifyl-3-carboxylate IR (KBr) cm-1: Uc = 〇1727 NMR (CDCI3) 6 Value: 1.00-1.90 (10Η, m), 2.38 (3Hr s), 3.20-3.70 (1H , m), 3.90-5.20 (5H, m), 7.00- 8.25 (9Hf m), 8.54 (lHf s) Ethyl 1-cyclopropyl-6-fluoro-7- [3-methyl-2- 2- ( P-toluenesulfonyl) isoinolinolin-5-yl] -1,4-dihydro-4-aminomethylphosphino-3-carboxylic acid ester IR (KBr) cm-i: uc = 〇1727, 1708 , 1695 NMR (CDCI3) δ values 0.80-1.90 (10Η, m), 2.39 (3H, s), 3.10-3.70 (1H, m), 3.90-5.20 (5H, m), 6.80-8.25 (9Hf m ), 8.55 (1H, s) • Ethyl 7- [2-(benzyloxycarbonyl) isoindioline-5-yl] -8-gas-6-fluoro-1-[(lR, 2S) -2- Fluorocyclopropyl] -1,4-dihydro-4-amino-based hydrochloride-3-carboxylic acid ester-72- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) (please first Read the notes on the back and fill in this page.) 1 、 Printed A7 B7 by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of Invention (W) IR (KBr) cm-i: υ〇 = 〇1726, 1709 NM R (CDCI3) δ value: 0.80-1.70 (5Η, ra), 3.80-4.90 (7.5H, m), 5.00-5.50 (2.5H, m), 6.90-7.90 (8H, m), 8.18 (1H, d , J = 8.8Hz), 8.59 (1H, d, J = 2.4Hz) Example 4 Dissolved in 21 »1 digas methane 20〇1» £ ethyl 2,5-difluoro-3-methyl-4- [ 2- (p-toluenesulfonyl) isoinducline-5-yl] benzylidene acetate, and in this solution were added 76ing acetic anhydride and 90Bg-dimethylformamide dimethyl acetal Then, the resulting mixture was stirred at room temperature for 2 hours. The solvent was then distilled off under reduced pressure. The obtained residue was dissolved in 1 ml of acetic acid, and a solution of 58 mg of 2-fluoroethylamine hydrochloride and 27 mg of sodium methoxide in 1b1 ethanol was added to the solution, and then the resulting mixture was stirred at room temperature for 20 minutes. The reaction mixture was concentrated under reduced pressure and the resulting mixture was dissolved in 2b1 N, N-dimethylformamide, followed by the addition of 65bg of potassium persulfate to the solution. The resulting mixture was stirred at 100 ° C for 1 hour. The reaction mixture was cooled to room temperature and then water was added to the mixture. The resulting precipitate was collected by filtration, and the resulting pale yellow solid was purified by column chromatography (isocyanate: n-hexane: ethyl acetate = 2: 1). Thereafter, diisopropyl ether was added thereto, and the resulting crystals were collected by filtration to obtain 126 mg of colorless crystalline ethyl-1-(2-fluoroethyl) -8-methyl-7- [2- (P-toluenesulfonyl) isoinolinolin-5-yl] -1,4-dihydro-4-oxoline-3-carboxylic acid ester. -7 3 ~ This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) S1 · --------- (install l ·-(Please read the precautions on the back before filling this page) Ordered the central standard of the Ministry of Economic Affairs of the Ministry of Economic Affairs, and printed by the employees of the quasi bureau A7: B7 V. Description of the invention (p) IR (KBr) cm-1: υ〇〇1724, 1696 NMR (CDCI3) δ value: 1.40 {3Η, t, J = 7.3H7 :), 2.2η (3H, s), 2.41 (3H, s), 4.00-5.10 (10H, m) f 6.90-7.90 (7H, m), 8.10 (1H, d, J = 9.3Hz), 8.48 (1H, s) The following compounds were obtained in the same manner. .Ethyl 1-ethyl-G-fluoro-8-methyl-7- [2-(. P-methylbenzylsulfonyl) isoindoline-5 -yl] -1,4-dihydro-4 -Gas-based HS phthaloline-3 -carboxylic acid ester IR (KBr) cm-i: i &gt; c = 〇1725, 1686 NMR (CDCI3) 6 values: 1.10-1.80 (6Η, m), 2.30 (3Η, s), 2.39 (3H, s), 4.10-4.90 (8Hr m), 7.00-8.00 (7H, m), 8.10 (1H, d, J = 9.3Hz), 8.46 (lHf s) (LR, 2S) -2-fluorocyclopropyl] -8-methyl-7- [2- (p-toluenesulfonyl) isoinP-Pinolin-5-yl] -1,4-difluorenyl- 4-Gaurinoline-3 -carboxylic acid ester IR (KBr) cm-i: υ〇 = 〇1725, 1690 NHR (CDCI3) δ value: 1.00-1.90 (5Η, m), 2.42 (6Η, s), 3.30-4.80 (7.5H, m), 5.10-5.5U (0.5! If m), 6.80-8.20 (8H, m), 8.57 (1H, d, J = 2.9Hz) Ethyl 1- (2,4 -Difluorophenyl) -6-fluoro-8-methyl-7- [2- (p-tosylsulfonyl) isoindololin-5-yl] -1,4-diargon-4 -amino丨 f-line-3-carboxylic acid ester IR (KBr) cm-l: υ〇 = 〇1734, 1700 This paper size is applicable to Chinese national standard (CNS> A4 specification (210X297 mm))-=-I (Please read first Note on the back then fill out this page) -Γ V. Description of the invention (w. Ethyl 1- (4- (Oxyphenyl) -6-fluoro-8-methyl-7- [2- (p-toluenesulfonyl) isoindololin-5-yl] -1,4-dihydro-4-carbamoline- 3-carboxylic acid ester IR (KBr) cm-i: uc = 〇1728, 1694 NMR (CDC13) δ value 1.10-1.80 (6H, m) r 2.36 (3H, S), 4.35 (2H, q, J = 7.3Hz), 4.60 (4Hr s) r 5.08 (2H, s), 6.80-7.90 (16H, m), 8.11 (1H, d, J = 9.3Hz), 8.43 (1H, s) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs and Economics • Ethyl 6-fluoro-1- (2-fluoroethyl) -7- [2- (p-toluenesulfonyl) isoindioline-5-yl ] -1,4-dihydro-4-oxyfluoroline-3-carboxylic acid ester IR (KBr) cm-i: υ〇 = 〇1724 MHR (CDCI3) δ. Value: 1.40 (3Η, t, J = 7.3Hz), 2.41 (3H, s), 4.10-5.35 (10H, m), 7.00-7.90 (8Hf id), 8.20 (1H, df J-10.3Hz), 8.46 (1H, s) 1- (2, 4-difluorophenyl) -6-fluoro-7- [2- (p-tosylsulfonyl) isoinolinolin-5-yl] -1,4-dihydro-4-oxo Fluoroline-3-carboxylate IR (KBr) cm-1: uc = 〇1725 NMR (CDC13) δ value: 1.40 (3H, t, J = 7.3Hz), 2.39 (3H, s), 4.10-4.70 (6H, m), 6.90-7.90 (11H, m) f 8.23 (1H, d, J = 10.3Hz) r 8.38 (1H, s) 7 5 This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm). Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs. And 0.49 g of acetic anhydride were dissolved in 0.66 g of ethyl 4- [2- (benzylcarbonyl) isoindole II dorolin-5-yl] -2,5-difluoro-3-methane-6-nitrobenzene Formamyl acetate, and dissolved in reflux and heated for 30 minutes. The reaction mixture was concentrated under reduced pressure, and the resulting residue was dissolved in 3.3al ethanol and 2b1 dichloromethane. To the solution was added 0.08 g of benzylamine, and the resulting mixture was stirred at room temperature for 30 minutes. The reaction mixture was shrunk under reduced pressure, and the obtained residue was dissolved in 10 Bl of tetrahydrofuran. 0.05 g of 60% sodium hydride was added to the solution, and the resulting mixture was stirred at room temperature for 30 minutes. The reaction mixture was added with 10 inl 1N hydrochloric acid and the precipitated crystals were collected by filtration to obtain 0.33 g of colorless crystalline ethyl 7- [2- (benzylcarbonyl) isoindolinolin-5-yl] -1-cyclopropyl-6 -Fluoro-8-methyl-5-nitro-1,4-dihydro-4-amino-tetraline-3-carboxylic acid ester. IR (KBr) cm-i: uc = 〇1728, 1709 tJMR (CDC13) δ value: 0.90-1.60 (7H, m), 3.42 ΠΗ, s), 3.70-4.10 (1H, m), 4.34 (2H , q, J = 6.8H7,), 4.84 (4Hr s), 5.23 (2H, s), 7.05-7.55 (8H, m) f 8.61 (1H, s) Example 6 (1) 470mg ethyl 7- (4 -Cyano-3-methyl) phenyl-l-cyclopropyl-6-fluoro-8-methoxy-1,4-difluoren-4-ylsulfonium-3-phosphonate, 230 ng N -Bromobutyriminium and 50 mg of perbenzoic acid were suspended in 20b1 thorium helium helium, and the suspension was heated by interflow for 2 hours. Add llOagfi-bromo-76- to the reaction mixture (please read the precautions on the back before filling this page) Γ. Packing. The size of the paper is applicable to China National Standard (CNS) A4 (2 丨 0X297 mm) Central Ministry of Economy Printed by the Consumer Bureau of Standards Bureau A7 _l_B7_ V. Description of the invention (#) Succinimide and 20aig perbenzoic acid and the resulting mixture were heated under reflux for 2 hours. Repeat the operation. The solvent was distilled off under reduced pressure and the resulting 20β1 aeroform and 10B1 water were added to the residue to separate into two layers. The resulting organic layer was separated and dried over anhydrous magnesium sulfate. The solvent was then distilled off under reduced pressure to obtain 37.0Bg ethyl 7- (3- Crude crystals of bromomethyl-4- «yl) phenyl 1-propenyl-6-fluoro-8-methyl-1,4-dihydro-4-oxyfluoroline-3-carboxylic acid ester. 2) The compound (76 mg) of sodium azide and 13 mg of tetra-n-butylammonium bromide obtained in (1) above were dissolved in a mixture of 2 ml of water and 2hi1 dichloromethane, and the solution was stirred at room temperature for 15 hours under reduced pressure. The solvent was removed by evaporation and 2G ml of ethyl acetate and 10βΙ water were added to the resulting residue to separate into two layers of β. The organic layer was separated, washed successively with water and a saturated saline solution, and then dried over anhydrous magnesium sulfate. Then, the solvent was distilled off under reduced pressure, and diethyl ether was added to the obtained residue. The resulting crystals were collected by filtration to obtain 270 mg. Colorless crystalline ethyl 7- (3-azidomethyl-4-cyano) phenyl-bucyclopropyl-6-fluoro-8-methyl-1,4-dihydro-4-aminoquinoline 3-carboxylic acid ester. IR (KBr) cm-1: -N3 2103, υ〇 = ο 1728 HMR (CDCI3) 6 Value: 0.80-1.70 (7Η, m}, 3.3.7 (3Η, s), 3.70 -4.10 (1H, m) f 4.40 (2Hr q, J = 7.0Hz), 4.70 (2H, s) f 7.15-8.20 (4H, m) f 8.64 (1H, s) (3) at room temperature, about 1 After 3 hours, 3 ml of 210ieg of the compound obtained in (2) above was added dropwise in a methanol solution of 302 »g of stannous vaporized in 2» 1 methanol, and the resulting mixture was stirred at the same temperature for 30 minutes. Under reduced pressure Remove the solvent from steamed plums and add 10ml of chloroform and lQal saturated nitric acid to the residue. -77- This paper applies the Chinese National Standard (CNS) A4 specification (210X297 mm) --------- 1 pack- -(Please read the notes on the back before filling out this page)-&quot; Employees of Central Bureau of Standards, Ministry of Economic Affairs Means cooperative printing fee A7 _ ^ __ B7_ V. invention is described (# Γ aqueous potassium to Unexamined West subsequently (of Celite) insolubles were removed by filtration. The resulting filtrate was allowed to separate into two layers and the resulting organic layer was washed successively with a saturated potassium nitrate aqueous solution and a saturated saline solution and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography [eluent: (chloroform: ethanol: concentrated water = 150: 25: 1) organic layer] to obtain 100 mg of cyclopropyl Methyl ester of 6-fluoro-7- (1-iminoisoinolinolin-5-yl) -8-methoxy-1,4-dihydro-4-airyl Pfline-3-carboxy And ethyl ester mixture. (4) In 100ing as above (3> Resulting mixture | Into a suspension of 2 ml of ethanol and 2 ml of dioxane and the like, add 1b1 1N aqueous sodium hydride solution and stir the resulting mixture at room temperature for 2 hours. Remove under reduced pressure The solvent and the obtained residue were added with 2 il of water, and then the insoluble matter was removed by filtration. The digasified gas was blown into the obtained filtrate and the crystals precipitated from the precipitate were collected by filtration to obtain 56 μm of colorless crystalline 1-propylpropyl-6. -Fluoro-7- (1-iminoisoindioline-5-yl) -8-methoxy-1,4-dihydro-4-oxyifolin-3-carboxylic acid IR (KBr) cm -l: uc = 〇1617

NfdR (di-TFA) δ 值:1.20-1.80 ( 4H, m) , 3.61 { 3ί1, s), 4.35-5.20 (3H, m), 7.70-8.5Q (4H, m), 9.53 (1H, s) 實例7 〇.30g乙基卜環丙基-6-氟-8-甲基-7-〔2-(對-甲苯 磺醛基)異吲昤啉-5-基〕-1,4-二氫-4-氧基睹啉-3-羧 酸酯懸浮於3ml乙醇中,及添加3ml 1N氫氣化納水溶液 及3ιπ1二鸣烷至懸浮液,随後所得混合物於室溫攪拌2小 -7 8 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐) --------V 裝— (請先閲讀背面之注意事項再填寫本頁) 汰 Γ 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(^ ) 時。反應混合物内加入3al 1HS酸及如此生成的結晶藉 遇濾收集播得〇.27g無色結晶性卜琛丙基-6-氟-8-甲 基-7-〔2-(對-甲苯磺醯基)異吲呤啉-5-基〕-1,4-二氫 * -4-氣基挂啉-3-羧酸。 IR (KBr) cm-l: υ〇=〇 1726 ilMR (t-TFA) δ 值:1.10-1.90 (4Η, m), 2.48 (3Η, s), 2.89 (3H, s), 4.50-5.00 (5H, m) , 6.90-8.00 (7H, m), 8.30 (1H, df J=7.8Hz), 9.62 (lHr s) 以相同方式獲得下列化合物e •卜琢丙基-6-氟-7-〔 2-(對-甲苯磺醯基)異吲哚啉- 5-基〕-1,4-二氫-4-氧基瞍啉-3-羧酸 IR (KBr) cm-l: u〇〇 1724 NMR (di-TFA) 6 值:1.X0-1.90 (4Hf m), 2.47 (3H, s)f 3.80-4.45 (1H, m), 4.87 (4H, s), 7.10-8.00 (7H, m), 8.44 (1H, d, J=9.3Hz)f 8.74 {1H, df J=5.9Hz), 9.46 (1H, s) • (S)-9-氟-3-甲基-7-氧基-10-〔 2-(對-甲苯磺醯基) 異吲哚啉-5-基〕-2,3-二 « -7H-吡啶駢〔1,2,3-de〕〔 1,4〕苯駢枵阱-6-羰酸 IR (KBr) cm-l: uc=〇 1723 NMR (dx-TFA) δ 值:1.83 (3H, d, J=6.8Hz), 2.47 (3H, s), 4.40-5.50 (7H, m), 7.00-8.30 (8H, m), 9.35 (1H, s) -79- 本紙張尺度逋用中國國家橾準(_'CNS ) A4規格(210X297公釐〉 (請先閲讀背面之注意事項再填寫本頁) 裝' 訂-NfdR (di-TFA) δ value: 1.20-1.80 (4H, m), 3.61 {3ί1, s), 4.35-5.20 (3H, m), 7.70-8.5Q (4H, m), 9.53 (1H, s) Example 7 0.30 g of ethylbucyclopropyl-6-fluoro-8-methyl-7- [2- (p-toluenesulfonyl) isoindioline-5-yl] -1,4-dihydro -4-Oxylan-3-carboxylic acid ester was suspended in 3 ml of ethanol, and 3 ml of a 1 N aqueous sodium hydrogen solution and 3 μm of dioxane were added to the suspension, and the resulting mixture was then stirred at room temperature for 2 hours. 7 8- This paper size is applicable to China National Standard (CNS) Α4 size (210 X 297 mm) -------- V Pack— (Please read the notes on the back before filling this page) Γ Central Standards Bureau of the Ministry of Economic Affairs A7 B7 printed by employee consumer cooperatives V. Invention description (^). 3al 1HS acid and the crystals thus formed were added to the reaction mixture, and 0.27 g of colorless crystalline buchenpropyl-6-fluoro-8-methyl-7- [2- (p-toluenesulfonyl) was collected and collected by filtration. ) Isoinolinolin-5-yl] -1,4-dihydro * -4-aminopyridin-3-carboxylic acid. IR (KBr) cm-l: υ〇 = 〇1726 ilMR (t-TFA) δ value: 1.10-1.90 (4Η, m), 2.48 (3Η, s), 2.89 (3H, s), 4.50-5.00 (5H , m), 6.90-8.00 (7H, m), 8.30 (1H, df J = 7.8Hz), 9.62 (lHr s) In the same manner, the following compound e was obtained: -(P-toluenesulfonyl) isoindololin-5-yl] -1,4-dihydro-4-oxyfluorolin-3-carboxylic acid IR (KBr) cm-1: u〇〇1724 NMR (di-TFA) 6 values: 1.X0-1.90 (4Hf m), 2.47 (3H, s) f 3.80-4.45 (1H, m), 4.87 (4H, s), 7.10-8.00 (7H, m), 8.44 (1H, d, J = 9.3Hz) f 8.74 {1H, df J = 5.9Hz), 9.46 (1H, s) • (S) -9-fluoro-3-methyl-7-oxy-10- [2- (p-toluenesulfonyl) isoindololin-5-yl] -2,3-di «-7H-pyridinium [1,2,3-de] [1,4] benzene -6-Carboxylic acid IR (KBr) cm-1: uc = 〇1723 NMR (dx-TFA) δ value: 1.83 (3H, d, J = 6.8Hz), 2.47 (3H, s), 4.40-5.50 (7H , m), 7.00-8.30 (8H, m), 9.35 (1H, s) -79- This paper size uses China National Standard (_'CNS) A4 size (210X297 mm) (Please read the note on the back first Matters refill this page) Pack 'Order-

A 經濟部中央橾準局員工消費合作社印製 A7 B7_ 五、發明説明(% ) •卜琛丙基-6-氰-7-〔 2-(對-甲苯磺醯基)異吲B朵啉- 5-基〕-1,4 -二氫-4-氧基-1.,8 -萊陡-3-袋酸 IR (KBr*) cm-i: uc=〇 1718 NMR (di-TFA) δ 值:1 ·20-1·90 (4H, m), 2.47 (3H, s), 4.20-4.70 (1H, m), 4.89 (4H, s), 7.20-8.90 (8Hr m)f 9.53 (1H, s) • 1-環丙基-6 ,8-二氟-7-〔 2-(對-甲苯磺醯基)異吲呤 啉-5-基〕-1,4-二氫-4-氣基S啉-3-羧酸 IR (KBr) cm-l: υ〇=〇 1729 NMR (CDC13) δ 值:0.90-1.80 (4H, m}, 2.38 (3H, s), 3.60-4.30 (1H, m), 4.67 (4H, s)f 7.00-8.30 (8H, m), 8.83 (1H, s), 14.0 (lHr brs) • 8-氰-1-環丙基-6-氟-7-〔 2 -(對-甲苯磺醯基)異吲I朵 啉-5-基〕-1,4-二氳-4-氣基ϋ啉-3-羧酸 IR (KBr) cm-i; υ〇=〇 1728 NMR (CDCI3) δ 值:0.70-1.50 (4Η, m)r 2.39 (3Η, s)f 4.00-4.50 (1H, m)f 4.67 (4H, s), 6.80-7.90 (7H, m), 8.13 (1H, d, J=8.8Hz), 8.93 (1H, 5), 14·0 (1H, brs) • 1-環丙基-7-〔4,7-二氟- 2-(對-甲苯磯醯基)異吲》朵 淋-5-基〕-6-齦-1,4 -二篇-4-氧基授淋-3-竣酸 _ 8 0 _ 本紙張尺度適用中國國家梂準(tNS &gt; A4规格(210X297公釐) ----------f .裝,------II--------(k (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標隼扃負工消費合作社印装 A 7 B7 _ 五、發明説明(w) IR (KBr) cm-l: υ〇=〇 1734 NMR (di-TFA) 6 值:1.10-1.85 (4H, m), 2.49 (3H, s), 4.00-4.45 (1H, m), 4.92 (4H, s), 7.10-8.10 (5H, m), 8.47 (1H, d, J=8.5Hz), 8.77 (1H, d, J=5.5Hz), 9.49 (1H, s) • 1-環丙基-7-〔4, 7 -二氟- 2- (對-甲苯《醯基)異吲i采 啉-5-基〕-6-氟-8-甲氣-1,4-二氫-4-氧基授啉-3-羧酸 IR (KBr) cm-l: uc=〇 1730 NMR (CDCI3) δ 值:0.90-1.70 (4Η, m), 2.40 (3H, s), 3.47 (3H, s), 3.80-4.30 (1H, m), 4.81 (4H, s)f 6.80-8.20 (6H, m), 8.85 (1H, s), 14.2 (1H, brs) • 1-( 2, 4-二氰苯基)-6-氟-7-〔 2-(對-甲苯磺酵基)異 吲呤咻-5-基〕-1,4-二氫-4-氣基-1,8-萘啶-3-羧酸 IR (KBr) cm-l: uc*〇 1724 NMR (di-TFA) 6 值:2·46 (3H, s), 4.78 (4H, s), 7.05-8.15 (10H, m), 8.71 (lHf d, J=l〇.〇Hz)f 9.50 (1H, s) • 7-〔 2-(苄氣羰基)異吲呤琳-5-基〕-1-琛丙基-6-氰 -8-氟甲基-1,4-二氩-4-氧基桂啉-3-羧酸 IR (KBr) cra-i: υ〇=〇 1713 NMR (CDC13) δ 值:0.75-1.60 (4H, m), 4.00-4.50 (1H, m), 4.85 (4H, s), 5.23 (2H, s), 5.70 (2H, d, J=47Hz)f 6.80-7.75 (8H, m), 8.28 (1H, d, J=7.5Hz), 8.95 (1H, s), 14.1 (1H, brs) _ 8 1 - 本紙張尺度逋用國國家標準('CNS )A4規格(210X297公釐) ---------'裝 τ------訂--·----Γ i (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(0) • 1-環丙基-6-氟-8-甲氣-7-〔2-(對-甲苯磺癱基)異吲 Ϊ荣W-5 -基〕-1,4 -二氦-4 -氣基· β淋-3-袋酸 IR (KBr) cm-i: υ〇〇 1727 NMR (CDCI3) 5 值·· 1.00-1.50 (4Η, m), 2.40 (3Η, s), 3.34 (3H, s), 3.80-4.40 (1H, m), 4.69 (4Hf brs), 6.90-8.20 (8Hf m), 8.86 (1H, s), 14.3 (1H, brs) • 1-璣丙基-6-«-8-甲《-7- [1-甲基- 2-(對-甲苯雇酵 基)異吲丨朵啉-5-基〕-1,4-二氫-4-氣基枝啉-3-羧酸 IR (KBr) cm-l: υ〇=〇 1734 NMR (di-TFA) δ 值:1.20-2·00 (7H, m), 2.45 (3H, s), 3.54 (3H, s), 4.35-5.45 (4H, m), 7.00-7.95 (7H, m), 8.20 (1H, d, J=8.5Hz), 9.49 (1H, s) • 1-琢丙基-6-籲-8-甲氧-7-〔 3-甲基-2-(對-、甲苯磺醛 基)異吲呤啉-5-基〕-1 ,4-二氫-4-氣基吱啉-3-羧酸 IR (KBr) cnr1: υ〇ο 1728 NMR (CDCI3-D2O) δ 值:0.90-1.45 (4Η, m), 1.68 (3H, d, J=6.5Hz), 2.39 (3H, s}, 3.34 (3H, s), 3.80-4.30 (1H, m)f 4.55-5.25 (3H, m), 7.05-8.10 (8H, m), 8.85 (1H, s) •卜環丙基-8-二氟甲氧-6-氟-7-〔 2-(對-甲苯磺醛基) 異吲呤啉-5-基〕-1,4 -二氳-4-氣基IFf啉-3-羧酸 -82- 本紙朵又度適用中國國家梯準(_CNS ) A4C4M 210X297公釐) ---------C ·裝··— (請先閲讀背面之注意事項再填寫本頁) ΐχ • S-- - imtw 瀘 B7__ 五、發明説明(心) IR (KBr) cm-l: υς=〇 1732 NMR (CDCI3+CD3OD) 6 值:0.90-1.50 (4马,m), 2.42 (3H, s), 3.90-4.35 (1H, m), 4.70 (4H, s), 5.91 (1H, t, J=75Hz), 7.15-7.95 .(7H, m) , 8.18 (1H, d, J=9.0Hz), 8.92 (1H, s) • 1-琛丙基-8-二氟甲氣-6-氟-7-〔3-甲基- 2-(對-甲苯 磺醯基)異吲哚咻-5-基〕-1,4 -二氬-4-氧基丨f啉-3-羧酸 IR (KBr) cm-l: υ〇=〇 1732 NMR (CDCI3) 6 值·· 0.80-1.95 (7Η, m), 2.39 (3Η, S), 3.85-4.35 (1H, m), 4.45-5.25 (3H, m), 5.82 (1H, t, J=74Hz), 7.10-7.50 (5Hf m), 7.55-7.90 (2H, m)f 8.18 (1H, d, J=8.8Hz), 8.91 (1H, s)f 14.0 (1H, brs) • 1-琛丙基-6-氟-8-氟甲《-7-〔 2-(對-甲篆基磺醯基)異 吲哚啉-5-基〕-1,4-二氫-4-氣基晻啉-3-羧酸 IR (KBr) cm-l: υ〇*〇 1732 經濟部中央標牟局負工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) NMR (CDC13) δ 值:0.80-1.50 (4H, m), 2.42 (3H, s), 3.90-4.40 (1H, m), 4.69 &lt;4H, s), 5.06 (2H, d, J=53Hz)f 7.00-7.80 (7H, m)f 8.12 (1H, d, J=8.8Hz), 8.91 (1H, s), 14.2 (1H, brs) • 1-琛丙基-6-氟-7-〔卜甲基- 2-(對-甲苯磺酵基)異吲 _ 8 3 _ 本紙張尺度適用中國國家標準(fcNS ) A4規格(210X297公釐) B7 _ 五、發明説明(P) P采啉-5-基〕-1,4-二氫-4-氣基β啉-3-羧酸 IR (KBr) cm-i: υ〇=〇 1751, 1734 NMR (di-TFA) δ 值:1·20-2·10 (7H, m), 2.45 (3H, s), 3.90-4.50 (1H, m), 4.60-5.50 (3H, m), 7.10-8.05 (7H, m), 8.42 (1H, d, J=9.5Hz), 8.74 (1H, d, J=6.0Hz), 9.46 (1H, s) • 1-琛丙基-6-氟-7-〔3-甲基- 2-(對-甲苯礙醯基)異吲 呤啉-5-基〕-1,4-二氳-4-氣基晻啉-3-羧酸 IR (KBr) cm-i: υ〇*〇 1754, 1736 NMR (di-TFA) 6 值:1.25-2.00 (7H, m), 2.46 (3H, s), 3.95-4.45 {1H, m)r 4.65-5.50 (3H, m), 7.20-8.10 (7H, m), 8.44 (1H, d, J=9.5Hz)f 8.74 (1H, d, J=6.0Hz), 9.46 (1H, s) • 7-〔 2-(苄氣羰基)異吲呤啉-5-基〕-8-氛-6-氟-1-〔 (lR,2S)-2-氟丙基〕-1,4-二氫-4-氣基丨i啉-3-羧酸 IR (KBr) cm-1·: υ〇=ο 1708 經濟部中央標準局員工消费合作社印製 (請先閱讀背面之注意事項存填寫本頁) NMR (CDC13) δ 值:0.90-2.20 {2Η, σι),3.80-5.00 (5·5Η, m), 5.00-5.50 (2.5Η, m), 6.90-7.50 (8Η, n〇, 8.20 (1H, d, J=7.8Hz), 8.88 (1H, brs), 13.7 (1H, brs) -8 4 _ 本紙張尺度適用中國國家標準(tNS ) A4规格(210 X 297公釐) A7 B7 五、發明説明(衫) _ 6-氟-1-(2-氟乙基)-8-甲氧-7-〔 2-(對-甲苯磺醛基) 異吲丨朵啉-5-基〕-1,4-二氳-4-氧基睹啉-3-羧酸 IR (ΚΒζ) cm-i: υς=〇 1718 NMR (di-TFA) δ 值:2.47 (3H, s}, 2.65 (3H, s), 3.70-6.00 (8H, m), 7.00-8.10 (7H, m), 8.36 (1H, d, J=8.0Hz), 9.46 (1H, s) • 1-乙基-6-鼉-8-甲基-7-〔 2-(對-甲苯磺酵基)異吲呤 啉-5-基〕-1,4-二氬-4-氧基桂啉-3-羧酸 IR (KBr) cm-l: uc=〇 1720 NMR (CDC13) δ 值:1.46 (3H, t, J=7.3 Hz), 2.41 (6H, s), 4.15-4.90 (6H, m), 6.90-7.90 (7Hf m), 8.14 (1H, d, J=9.3Hz), 8.74 (1H, s), 14.4 (1H, brs) •6-鑛-1-〔(111,23)-2-«琛丙基〕-8-甲基-7-〔2-(對 -甲苯磺醛基)異吲呤啉-5-基〕-1,4-二氫-4-氧基睹啉 -3-羧酸 IR (KBr) cm-l: υ〇=〇 1726 NMR (CDC13) δ 值.:0.80-2.30 (2Hf m), 2.42 (3Hf * 經濟部中央標準局貝工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) s)f 2.51 (3H, s), 3.70-4.90 (5.5Hf m), 5.10-5.60 (0.5H,.m), 6.80-8.15 {8Hf m), 8.83 (1H, d, J=2.9Hz) • 1-(2,4-二氟苯基)-6-氟-8-甲基-7-〔 2-(對-甲苯磺 醯基)異吲哚啉-5-基〕-1,4 -二藎-4 -氧基ΪΪ啉-3-羧酸 -85- / ’ 本紙張尺度適用中國國家揉準('七奶)人4規格(210';&lt;297公釐) 經濟部中央標準局員工消費合作社印製 A7 _B7__ 五、發明説明(糾) IR (KBr) cm-i: υ〇=〇 1734 .1-(4-苄氧苯基)-6-氟-8-甲基-7-〔 2-(對-甲苯磺醛 基)異吲吁啉-5-基〕-1,4_二氬_4_氣基丨f啉_3_羧酸 IR (KBr) cra-l: υ〇»〇 1728 NMR (di-TFA) δ 值:1.81 (3Η, s), 2.46 (3Η, s), 4.60-5.70 (6H, m), 6.90-8.20 (16Hf m), 8.41 (1H, d, J=8.3Hz)f 9.32 (lHr S) • 6-氟-1- (2-氟乙基-7-〔 2 -(對-甲笨磷醯基)異吲哚啉 -5-基〕-1,4-二氳-4-«基歧啉-3-羧酸 IR (KBr) cm-i: υ〇=〇 1719 NMR (di-TFA) δ 值:2.47 (3Hf s), 4.40-5.60 (8H, m), 7.10-8.60 (9H, m), 9·45 (1H, s) • 1-( 2, 4-二氰苯基)-6-氰-7-〔 2-(對-甲苯磺酵基)異 吲》$啉-5-基〕-1,4-二氳-4-氣基II啉-3-羧酸 IR (KBr) cm-i: υ〇=〇 X719 • 7-〔 2-(苄氣羰基)異吲呤啉-5-基〕卜璨丙基-6-氟- 8-甲氣-5-硝基-1,4-二氫-4-氣基喹啉-3-羧酸 IR (KBr) cm-l: uc*〇 1736, 1702 NMR (CDCI3) δ 值:0.80-1.80 (4H, m), 3.45 (3H, s), 3.80-4.30 (1H, m), 4.86 (4H, s), 5.23 (2Hf S), 7.10-7.50 (8H, m), 8.92 (1H, s), 13.3 (1H, brs) -86- 本紙張尺度逋用中國國家梯準(CNS ) A4規格(210X297公釐) ----------裝'— (請先閲請背面之注意事項再填寫本頁) ,-° -ο 經濟部中央揉準扃負工消費合作社印製 A7 B7 _ 五、發明説明(打) 實例8 0.53g 1-琢丙基-6-戴-8-甲基-7-〔 2-(對-甲苯雄睡 基)異吲$咻-5-基〕-1,4-二氫-4-氧基H啉-3-羧酸懸 浮於5.3·1 47%氫溴酸中,及添加0.28g酚及3.2·1丙 酸至懸浮液,随後所得混合物於《流下回流加熱1小時 。反應混合物於減壓下》雄,及乙酵加至所得殘餘物, 随後生成之结晶藉過濾收集得0.38 g無色结晶性1-琛丙 基-6-氟-8-甲基- 7-(異吲I朵啉-5-基)-1,4-二氳-4-氛基 歧啉-3-羧酸氳溴酸鹽。所得之氳溴酸91驗浮於3.8·1乙 酵中及然後溶解於7.6·1 0.5Ν氬氧化銷水溶液,其後二 氧化硪吹送入溶液内。遇濾收集生成的結晶獲得〇.2 7g 無色結晶性1-環丙基-6-氟-8-甲基- 7-(異吲哚啉-5-基) •1,4 -二氫-4-氧基授Ift - 3-竣酸·。 IR (KBr) cm-i: uc=〇 1643 NMR (di-TPA) 6 值:0.90-2.00 (4Hf m), 2.94 (3H, s), 4.40-5.30 (5H, m), 7.10-7.85 (3H, m)f 8.35 (lHf d, J=7.8Hz)r 9.63 (1H, s) 以相同方式獲得下列化合物》 • 1-琿丙基- δ-覦 - 7-(異吲哚咻-5-基)-1,4-二氫-4-氣 基B啉-3-羧酸 IR (KBr) cm-i: υ〇〇 1615 NMR (di-TFA) δ 值:1.20-2.10 (4Hf m)r 4.00-4.60 (1H, m), 5.04 (4H, s), 7.40-8.10 (3H, m), 8.49 (1H, d, J=9.3Hz), 8.74 (1H, d, J=5.9Hz), 9.49 (1H, s) -87- &gt; 1 本紙法尺度逋用中國國家揲準(_CNS ) A4規格(210X297公釐) ---------{&quot;装------訂'--.----Γ i (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印裝 A7 B7五、發明説明(S&quot; .(S〉-9-氟-3-甲基-10-(異吲呤啉-5-基)-7-氧基-2 , 3-二氲-7H-吡啶駢〔1,2,3-de〕 〔1,4 〕苯駢啤阱-6-羧酸 IR (KBr) cm-i: υ〇=〇 1717 NMR (di-TFA) 6 值·· 1.85(lHld,J=6.8Hz),4.10- 5.50 (7H, m), 7.64 (3H, s), 8.12 (1H, d, J=8.8Hz), 9.37 (1H, s) • 1-璨丙基-6-氟-7-(異吲丨朵W - 5-基)-1,4-二氫-4-氣 基-1,8-萊啶-3-羧酸 IR (KBr) cm-i: υ〇=〇 1617 NMR (di-TFA) δ 值:1.00-2.00 (4H,m), 4.10-4.70 (1H, m), 5.03 (4H, s), 7.30-9.00 (4H, m), 9.53 (1H, s) .1-環丙基-6 ,8-二氟- 7-(異吲呤啉-5-基)-1 ,4-二氫- 4-氧基_f啉-3-羧酸 IR (KBr) cm-l: υ〇=〇 1616 NMR (di-TFA) δ 值:1.30-2.00 (4H, m), 4.30-5.30 (5H, m), 7.71 (3Hf s)f 8.37 (1H, d, J=7.8Hz), 9.52 (1H, s) • 8-氰-1-琛丙基-6-氟- 7-(異吲呤酥-5-基)-1,4-二M - 4-氣基枝啉-3-羧酸 IR (KBr) cm-i: υ〇〇 1636 NMR (di-TFA) δ 值:1.10-1.90 (4H, m), 4.60-5.20 (5H, m), 7.30-7.80 (3H, m), 8.43 (1H, d, J=6.8Hz), 9.63 (1H, s) -8 8 _ (請先閲讀背面之注意事項再填寫本頁) 裝. ,--°A Printed by A7 B7_, a consumer cooperative of the Central Bureau of Quasi-Economic Bureau of the Ministry of Economic Affairs V. Description of the invention (%) • Buchen Propyl-6-cyano-7- [2- (p-toluenesulfonyl) isoindole B-doline- 5-yl] -1,4-dihydro-4-oxy-1., 8-leso-3-saccharic acid IR (KBr *) cm-i: uc = 〇1718 NMR (di-TFA) δ value : 1 · 20-1 · 90 (4H, m), 2.47 (3H, s), 4.20-4.70 (1H, m), 4.89 (4H, s), 7.20-8.90 (8Hr m) f 9.53 (1H, s ) • 1-Cyclopropyl-6,8-difluoro-7- [2- (p-tosylsulfonyl) isoindolinolin-5-yl] -1,4-dihydro-4-amino S Porphyrin-3-carboxylic acid IR (KBr) cm-1: υ〇 = 〇1729 NMR (CDC13) δ value: 0.90-1.80 (4H, m), 2.38 (3H, s), 3.60-4.30 (1H, m) , 4.67 (4H, s) f 7.00-8.30 (8H, m), 8.83 (1H, s), 14.0 (lHr brs) • 8-cyano-1-cyclopropyl-6-fluoro-7- [2-( P-toluenesulfonyl) isoindolinylidolin-5-yl] -1,4-difluoren-4-ylpyridin-3-carboxylic acid IR (KBr) cm-i; υ〇 = 〇1728 NMR (CDCI3) δ value: 0.70-1.50 (4Η, m) r 2.39 (3Η, s) f 4.00-4.50 (1H, m) f 4.67 (4H, s), 6.80-7.90 (7H, m), 8.13 (1H , d, J = 8.8Hz), 8.93 (1H, 5), 14.0 (1H, brs) • 1-cyclopropyl-7- [4,7-difluoro-2-(p-A Isopropyl) Isoindole "Dorin-5-yl] -6-gingival-1,4 -two-piece-4-oxysporin-3-conjugic acid _ 8 0 _ This paper size applies to China National Standards ( tNS &gt; A4 specification (210X297 mm) ---------- f. equipment, -------- II -------- (k (Please read the precautions on the back before (Fill in this page) Printed by the Central Ministry of Economic Affairs and Consumer Cooperatives A 7 B7 _ V. Description of the invention (w) IR (KBr) cm-1: υ〇 = 〇1734 NMR (di-TFA) 6 Value: 1.10 -1.85 (4H, m), 2.49 (3H, s), 4.00-4.45 (1H, m), 4.92 (4H, s), 7.10-8.10 (5H, m), 8.47 (1H, d, J = 8.5Hz ), 8.77 (1H, d, J = 5.5Hz), 9.49 (1H, s) • 1-cyclopropyl-7- [4, 7 -difluoro-2- (p-toluene} isopropyl) Phenolin-5-yl] -6-fluoro-8-methyl-1,4-dihydro-4-oxoline-3-carboxylic acid IR (KBr) cm-1: uc = 〇1730 NMR (CDCI3 ) δ value: 0.90-1.70 (4Η, m), 2.40 (3H, s), 3.47 (3H, s), 3.80-4.30 (1H, m), 4.81 (4H, s) f 6.80-8.20 (6H, m ), 8.85 (1H, s), 14.2 (1H, brs) • 1- (2, 4-dicyanophenyl) -6-fluoro-7- [2- (p-toluenesulfonyl) isoindolinium -5-yl] -1,4-dihydro-4-airyl-1,8-naphthyridin-3-carboxylic acid IR (KBr) cm-1 uc * 〇1724 NMR (di-TFA) 6 values: 2.46 (3H, s), 4.78 (4H, s), 7.05-8.15 (10H, m), 8.71 (lHf d, J = l〇.〇Hz ) f 9.50 (1H, s) • 7- [2- (benzylcarbonyl) isoindolinline-5-yl] -1-chenpropyl-6-cyano-8-fluoromethyl-1,4-di Argon-4-oxylaurin-3-carboxylic acid IR (KBr) cra-i: υ〇 = 〇1713 NMR (CDC13) δ value: 0.75-1.60 (4H, m), 4.00-4.50 (1H, m) , 4.85 (4H, s), 5.23 (2H, s), 5.70 (2H, d, J = 47Hz) f 6.80-7.75 (8H, m), 8.28 (1H, d, J = 7.5Hz), 8.95 (1H , s), 14.1 (1H, brs) _ 8 1-This paper uses the national standard ('CNS) A4 specification (210X297 mm) ---------' installation τ ----- -Order-· ---- Γ i (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (0) • 1-cyclopropyl- 6-fluoro-8-methane-7- [2- (p-toluenesulfonyl) isoindole W-5 -yl] -1,4-dihelium-4 -gasyl β β-3- Pouch acid IR (KBr) cm-i: υ〇〇1727 NMR (CDCI3) 5 values 1.00-1.50 (4Η, m), 2.40 (3Η, s), 3.34 (3H, s), 3.80-4.40 (1H , m), 4.69 (4Hf brs), 6.90-8.20 (8Hf m), 8.86 (1H, s), 14.3 (1H, brs) • 1-Hydroxypropyl-6-«-8-methyl <<-7- [1-methyl-2-((p-toluenethio) isoindolinol-5-yl] -1,4-dihydro-4-aminobromoline-3-carboxylic acid IR (KBr) cm-1: υ〇 = 〇1734 NMR (di-TFA) δ value: 1.20-2 · 00 (7H, m ), 2.45 (3H, s), 3.54 (3H, s), 4.35-5.45 (4H, m), 7.00-7.95 (7H, m), 8.20 (1H, d, J = 8.5Hz), 9.49 (1H, s) • 1-Cyclopropyl-6-co-8-methoxy-7- [3-methyl-2- (p-, tosyl) isoindolinolin-5-yl] -1,4 -Dihydro-4-air cyline-3-carboxylic acid IR (KBr) cnr1: υοο 1728 NMR (CDCI3-D2O) δ value: 0.90-1.45 (4Η, m), 1.68 (3H, d, J = 6.5Hz), 2.39 (3H, s), 3.34 (3H, s), 3.80-4.30 (1H, m) f 4.55-5.25 (3H, m), 7.05-8.10 (8H, m), 8.85 (1H, s) • Bucyclopropyl-8-difluoromethoxy-6-fluoro-7- [2- (p-toluenesulfonyl) isoinolinolin-5-yl] -1,4 -difluorene-4 -Gas-based IFfline-3-carboxylic acid-82- This paper is suitable for China National Standard (_CNS) A4C4M 210X297 mm) --------- C · Install ·· — (Please read the back first Please note this page before filling in this page) ΐχ • S---imtw 泸 B7__ 5. Description of the invention (heart) IR (KBr) cm-l: υς = 〇1732 NMR (CDCI3 + CD3OD) 6 Values: 0.90-1.50 (4 horses, m), 2.42 (3H, s), 3.90-4.35 (1H, m), 4.70 (4H, s), 5.91 (1H, t, J = 75Hz), 7.15-7.95. (7H, m), 8.18 (1H, d, J = 9.0Hz), 8.92 (1H, s) • 1-chenpropyl-8-difluoromethane-6 -Fluoro-7- [3-methyl-2- (p-toluenesulfonyl) isoindolyl-5-yl] -1,4-diargon-4-oxy 丨 fline-3-carboxylic acid IR (KBr) cm-1: υ〇 = 〇1732 NMR (CDCI3) 6 value · 0.80-1.95 (7Η, m), 2.39 (3Η, S), 3.85-4.35 (1H, m), 4.45-5.25 ( 3H, m), 5.82 (1H, t, J = 74Hz), 7.10-7.50 (5Hf m), 7.55-7.90 (2H, m) f 8.18 (1H, d, J = 8.8Hz), 8.91 (1H, s ) f 14.0 (1H, brs) • 1-Ceryl-6-fluoro-8-fluoromethyl "-7- [2- (p-methylamidosulfonyl) isoindoline-5-yl]- 1,4-dihydro-4-amino cyanoline-3-carboxylic acid IR (KBr) cm-l: υ〇 * 〇1732 Printed by the Ministry of Economic Affairs Central Standards Bureau Bureau of Work Consumer Cooperatives (please read the note on the back first) Please fill in this page again) NMR (CDC13) δ value: 0.80-1.50 (4H, m), 2.42 (3H, s), 3.90-4.40 (1H, m), 4.69 &lt; 4H, s), 5.06 (2H, d, J = 53Hz) f 7.00-7.80 (7H, m) f 8.12 (1H, d, J = 8.8Hz), 8.91 (1H, s), 14 .2 (1H, brs) • 1-Ceryl-6-fluoro-7-[[Bromyl-2- (p-toluenesulfonyl) isoindole] 8 3 _ This paper is in accordance with China National Standard (fcNS) A4 Specifications (210X297 mm) B7 _ 5. Description of the invention (P) P-Colinolin-5-yl] -1,4-dihydro-4-airyl β-line-3-carboxylic acid IR (KBr) cm-i: υ〇 = 〇1751, 1734 NMR (di-TFA) δ value: 1.20-2 · 10 (7H, m), 2.45 (3H, s), 3.90-4.50 (1H, m), 4.60-5.50 (3H , m), 7.10-8.05 (7H, m), 8.42 (1H, d, J = 9.5Hz), 8.74 (1H, d, J = 6.0Hz), 9.46 (1H, s) • 1-chenpropyl- 6-fluoro-7- [3-methyl-2- (p-toluenesulfonyl) isoinolinolin-5-yl] -1,4-difluoren-4-yloxyquinolin-3-carboxylic acid IR (KBr) cm-i: υ〇 * 〇1754, 1736 NMR (di-TFA) 6 Value: 1.25-2.00 (7H, m), 2.46 (3H, s), 3.95-4.45 {1H, m) r 4.65 -5.50 (3H, m), 7.20-8.10 (7H, m), 8.44 (1H, d, J = 9.5Hz) f 8.74 (1H, d, J = 6.0Hz), 9.46 (1H, s) • 7- [2- (benzylcarbonyl) isoinolinolin-5-yl] -8-ammonia-6-fluoro-1-[(lR, 2S) -2-fluoropropyl] -1,4-dihydro-4 -Gas-based i-line-3-carboxylic acid IR (KBr) cm-1 ·: υ〇 = ο 1708 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ( Please read the notes on the back and fill in this page first) NMR (CDC13) δ value: 0.90-2.20 (2Η, σι), 3.80-5.00 (5 · 5Η, m), 5.00-5.50 (2.5Η, m), 6.90 -7.50 (8Η, n〇, 8.20 (1H, d, J = 7.8Hz), 8.88 (1H, brs), 13.7 (1H, brs) -8 4 _ This paper size applies to the Chinese National Standard (tNS) A4 specifications ( 210 X 297 mm) A7 B7 V. Description of the invention (shirt) _ 6-fluoro-1- (2-fluoroethyl) -8-methoxy-7- [2- (p-toluenesulfonyl) isoindole丨 Porphyrin-5-yl] -1,4-difluoren-4-oxoline-3-carboxylic acid IR (κΒζ) cm-i: υς = 〇1718 NMR (di-TFA) δ value: 2.47 ( 3H, s}, 2.65 (3H, s), 3.70-6.00 (8H, m), 7.00-8.10 (7H, m), 8.36 (1H, d, J = 8.0Hz), 9.46 (1H, s) • 1 -Ethyl-6-fluorene-8-methyl-7- [2- (p-toluenesulfonyl) isoindolinolin-5-yl] -1,4-diargon-4-oxylaurin- 3-carboxylic acid IR (KBr) cm-1: uc = 〇1720 NMR (CDC13) δ value: 1.46 (3H, t, J = 7.3 Hz), 2.41 (6H, s), 4.15-4.90 (6H, m) , 6.90-7.90 (7Hf m), 8.14 (1H, d, J = 9.3Hz), 8.74 (1H, s), 14.4 (1H, brs) • 6-ore-1-[(111,23) -2- «Ceryl] -8-methyl-7- [2- (p-toluenesulfonyl) Indolinolin-5-yl] -1,4-dihydro-4-oxoline-3-carboxylic acid IR (KBr) cm-1: υ〇 = 〇1726 NMR (CDC13) δ value .: 0.80- 2.30 (2Hf m), 2.42 (3Hf * Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) s) f 2.51 (3H, s), 3.70-4.90 (5.5Hf m), 5.10-5.60 (0.5H, .m), 6.80-8.15 (8Hf m), 8.83 (1H, d, J = 2.9Hz) • 1- (2,4-difluorophenyl) -6-fluoro -8-methyl-7- [2- (p-toluenesulfonyl) isoindololin-5-yl] -1,4-difluorene-4 -oxyfluorin-3-carboxylic acid-85- / 'This paper size applies to Chinese national standard (' Seven Milk ') 4 specifications (210'; &lt; 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 _B7__ V. Description of the invention (correction) IR (KBr ) cm-i: υ〇 = 〇1734 .1- (4-benzyloxyphenyl) -6-fluoro-8-methyl-7- [2- (p-toluenesulfonyl) isoindoline-5 -Yl] -1,4_diargon_4_amino group fline_3_carboxylic acid IR (KBr) cra-1: υ〇 »〇1728 NMR (di-TFA) δ value: 1.81 (3Η, s ), 2.46 (3Η, s), 4.60-5.70 (6H, m), 6.90-8.20 (16Hf m), 8.41 (1H, d, J = 8.3Hz) f 9.32 (lHr S) • 6-fluoro -1- (2-fluoroethyl-7- [2-(p-methylbenzylphosphonium) isoindololin-5-yl] -1,4-bisfluoren-4- «yl bismorpholine-3- Carboxylic acid IR (KBr) cm-i: υ〇 = 〇1719 NMR (di-TFA) δ value: 2.47 (3Hf s), 4.40-5.60 (8H, m), 7.10-8.60 (9H, m), 9 · 45 (1H, s) • 1- (2, 4-dicyanophenyl) -6-cyano-7- [2- (p-toluenesulfonyl) isoindolin >> $ line-5-yl] -1, 4-Difluoren-4-ylamino-2-line-3-carboxylic acid IR (KBr) cm-i: υ〇 = 〇 × 719 • 7- [2- (benzylcarbonyl) isoindolinline-5-yl] b Cannyl-6-fluoro-8-methyl-5-nitro-1,4-dihydro-4-aminoquinoline-3-carboxylic acid IR (KBr) cm-1: uc * 〇1736, 1702 NMR (CDCI3) δ values: 0.80-1.80 (4H, m), 3.45 (3H, s), 3.80-4.30 (1H, m), 4.86 (4H, s), 5.23 (2Hf S), 7.10-7.50 (8H , m), 8.92 (1H, s), 13.3 (1H, brs) -86- This paper size adopts China National Standard (CNS) A4 specification (210X297 mm) ---------- install '— (Please read the precautions on the back before filling in this page),-° -ο Printed by the Central Ministry of Economic Affairs of the Central Working Group Consumer Cooperative A7 B7 _ 5. Description of the invention (type) Example 8 0.53g 1-zhuo Propyl-6-dai-8-methyl-7- 〔2- (p-toluene Pyridyl) iso-indolyl-5-yl] -1,4-dihydro-4-oxyH-line-3-carboxylic acid suspended in 5.3.1 47% hydrobromic acid, and 0.28 g of phenol and 3.2 -1 propionic acid to suspension and the resulting mixture was heated under reflux for 1 hour. The reaction mixture was added to the residue under reduced pressure, and acetic acid, and the resulting crystals were collected by filtration to obtain 0.38 g of colorless crystalline 1-propenyl-6-fluoro-8-methyl-7- ( Isoindolyl-5-yl) -1,4-diamidino-4-aminobimorpholine-3-carboxylic acid phosphonium bromate. The obtained osmium bromide 91 was floated in 3.8.1 acetic acid and then dissolved in 7.6.1 0.5N argon-oxidized pin aqueous solution, and then osmium dioxide was blown into the solution. The resulting crystals were collected by filtration to obtain 0.2 7 g of colorless crystalline 1-cyclopropyl-6-fluoro-8-methyl-7- (isoindololin-5-yl) • 1,4-dihydro-4 -Oxygen Ift-3-complete acid. IR (KBr) cm-i: uc = 〇1643 NMR (di-TPA) 6 Value: 0.90-2.00 (4Hf m), 2.94 (3H, s), 4.40-5.30 (5H, m), 7.10-7.85 (3H , m) f 8.35 (lHf d, J = 7.8Hz) r 9.63 (1H, s) The following compounds were obtained in the same manner "• 1-fluorenyl- δ-fluorene-7- (isoindolyl-5-yl ) -1,4-Dihydro-4-amino-Bolin-3-carboxylic acid IR (KBr) cm-i: υ〇〇1615 NMR (di-TFA) δ Value: 1.20-2.10 (4Hf m) r 4.00 -4.60 (1H, m), 5.04 (4H, s), 7.40-8.10 (3H, m), 8.49 (1H, d, J = 9.3Hz), 8.74 (1H, d, J = 5.9Hz), 9.49 ( 1H, s) -87- &gt; 1 Paper size, using China National Standard (_CNS) A4 size (210X297 mm) --------- {&quot; 装 -------- Order ' --.---- Γ i (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (S &quot;. (S> -9-Fluoro- 3-methyl-10- (isoindolinolin-5-yl) -7-oxy-2, 3-difluorene-7H-pyridine [1,2,3-de] [1,4] benzene Beer trap-6-carboxylic acid IR (KBr) cm-i: υ〇 = 〇1717 NMR (di-TFA) 6 value 1.85 (lHld, J = 6.8Hz), 4.10-5.50 (7H, m), 7.64 (3H, s), 8.12 (1H, d, J = 8.8Hz), 9.37 (1H, s) • 1-Cannyl-6-fluoro-7- (isoindone W-5-yl) -1,4-dihydro-4-amino-1,8-eryridine-3-carboxylic acid IR (KBr) cm-i: υ〇 = 0〇1717 NMR (di-TFA) δ value: 1.00-2.00 (4H, m), 4.10-4.70 (1H, m), 5.03 (4H, s), 7.30-9.00 (4H, m), 9.53 (1H, s). 1-cyclopropyl-6,8-difluoro-7- (isoinolinolin-5-yl) -1,4-dihydro-4-oxyl f-line-3-carboxylic acid IR (KBr) cm-1: υ〇 = 〇1616 NMR (di-TFA) δ value: 1.30-2.00 (4H, m), 4.30-5.30 (5H, m), 7.71 ( 3Hf s) f 8.37 (1H, d, J = 7.8Hz), 9.52 (1H, s) • 8-cyano-1-chenpropyl-6-fluoro-7- (isoindolin crisp-5-yl)- 1,4-DiM-4-aminobromoline-3-carboxylic acid IR (KBr) cm-i: υ〇〇1636 NMR (di-TFA) δ value: 1.10-1.90 (4H, m), 4.60- 5.20 (5H, m), 7.30-7.80 (3H, m), 8.43 (1H, d, J = 6.8Hz), 9.63 (1H, s) -8 8 _ (Please read the precautions on the back before filling this page ) Installed.,-°

A 本紙張又度適用中國國家榇準(_CNS ) A4規格(210X297公釐) A7 B7___ 五、發明説明(打) .1-琛丙基- 7-(4 ,7-二氟異吲呤啉-5-基卜6-氟-1,4-二 氫-4-氣基睡啉-3-羧酸 IR (KBr) cm-i: υ〇»〇 1720 NMR (di-TFA) δ 值』:1.15-1.95 (4H, m) f 3.95-4.60 (1H, m), 5·13 (4H, s), 7.15-7.65 (1H, m), 8.51 (1H, d, J=8.8Hz), 8.84 (1H, d, J=5.4Hz), 9.51 (1H, s) • 1-琛丙基-7- (4,7-二氟異吲I荣囀-5-基)-6-氟-8-甲氧 -1,4-二氳-4-氣基丨奎啉-3-羧酸 IR (KBr) cm-l: υ〇=〇 1734 NMR (di-TFA) δ 值:1.20-1.80 (4H, m), 3.75 (3H, s), 4.45-4.95 (1H, m), 5.15 (4Hf s)f 7.20-7.55 (1H, m), 8.24 (1H, d, J=8.5Hz), 9.50 (1H, s) • 1- (2 , 4-二氟苯基)-6-氟-7-(異吲呤啉-5-基)-1 , 4-二 氳-4-氣基-1,8 -葉萌-3-袋酸 IR (KBr) cm-l: uc=〇 1654 NMR (di-TFA) δ 值:4·99 (4H, brs&gt;, 6.90-8.40 (6H, m), 8.78 (1H, d, J=9.5Hz), 9.50 (1H, s) ---------^装-------訂'--_----C .i (請先閱讀背面之注意事項再填寫本莨) 經濟部中央標準局員工消費合作社印製 0 覼- 6 I 基 丙 琛 啉 睡 基 氧 采 β »3| 異 S (酸 7-羧 基 氣 甲 二 IR (KBr) cm-ι: u〇=〇 1637 NMR (di-TFA) 6 值:1.20-1.80 (4H, m), 3.62 (3H, s), 4.40-5.20 (5Hf m), 7.73 (3H, brs)f 8.26 (lHf d, J=8.3Hz), 9.50 (1H, s) -89- 本紙張尺度適用中國國家標fr'dNS ) A4规格(210X297公釐) 經濟部中央標準局員工消費合作杜印製 A7-B7 五、發明説明(衫) • 1-琛丙基-6-氟-8-甲氣- 7-(1-甲基異吲昤啉-5-基)- 1.4- 二氪-4-氣基授啉-3-羧酸 IR (KBr.) cm-1: uc=〇 1726 NMR (di-TFA) 6 值:1.30-2.20 (7H, m), 3.60 (3H, s), 4.50-5.60 (4H, m), 7.30-8.00 (3H, m), 8.26 (lHf dr J=8.3Hz)r 9.51 (1H, s) • 1-琢丙基-δ-戴-8-甲氣-7-(3 -甲基異丨3丨丨呆淋-5-基)- 1.4- 二氬-4-氣基枝啉-3-羧酸 IR (KBr) cm-1: uc=〇 1629 NMR (di-TFA) δ 值:1·10-2·10 (7H, m), 3.62 (3H, s), 4.30-5.65 (4H, m), 7.20-7.80 (3H, m), 8.29 (1H, d, J=8.3Hz), 9·50 (1H, s) • 1-琛丙基-8-二氟甲氧-6-氟- 7-(異I引呤啉-5-基)-1, 4- 二氳-4-氣基技啉-3-羧酸 IR (KBr) cm-l: υ〇=〇 1636 NMR (di-TFA) δ 值:1.00-2.00 (4Hf m), 4.30-5.20 (5H, m), 6.20 (lHf t, J=72Hz)f 7.72 (3Hf brs)f 8.46 (1H, df J=8.3Hz)f 9.58 (1H, s) • 1-琿丙基-8-二氰甲氧-6-氰- 7-(3-甲基異13丨昤啉-5-基) -1,4-二氫-4-氣基丨f啉-3-羧酸 IR (KBr) cm-l: uc=〇 1638 NMR (di-TFA) δ 值:1.15-2.15 (7H, m), 4.45-5.15 (3H, m), 5.15-5.70 (1H, m), 6.20 (1H, t, J=72Hz), 7.30-7.95 (3H, m), 8.46 {1H, d, J=8.3Hz), 9.59 (1H, s) -9 0 - — i______ 本紙張尺度適用中國國家標準〔CNS ) A4規格(210X29?公釐) ---------C 裝— (請先閱讀背面之注意事項再填寫本頁) 訂-A This paper is again applicable to China National Standard (_CNS) A4 specification (210X297 mm) A7 B7___ V. Description of the invention (type) .1-chenpropyl-7- (4,7-difluoroisoindolinoline 5- (6-fluoro-1,4-dihydro-4-aminopyroline-3-carboxylic acid) IR (KBr) cm-i: υ〇 »〇1720 NMR (di-TFA) δ value": 1.15 -1.95 (4H, m) f 3.95-4.60 (1H, m), 5.13 (4H, s), 7.15-7.65 (1H, m), 8.51 (1H, d, J = 8.8Hz), 8.84 (1H , d, J = 5.4Hz), 9.51 (1H, s) • 1-Ceryl-7- (4,7-difluoroisoindole I-Ran-5-yl) -6-fluoro-8-methoxy -1,4-Difluoren-4-yl group quinoline-3-carboxylic acid IR (KBr) cm-1: υ〇 = 〇1734 NMR (di-TFA) δ value: 1.20-1.80 (4H, m) , 3.75 (3H, s), 4.45-4.95 (1H, m), 5.15 (4Hf s) f 7.20-7.55 (1H, m), 8.24 (1H, d, J = 8.5Hz), 9.50 (1H, s) • 1- (2, 4-difluorophenyl) -6-fluoro-7- (isoinolinolin-5-yl) -1, 4-difluoren-4-yl-1,8-叶 萌- 3-bag acid IR (KBr) cm-1: uc = 〇1654 NMR (di-TFA) δ value: 4.99 (4H, brs &gt;, 6.90-8.40 (6H, m), 8.78 (1H, d, J = 9.5Hz), 9.50 (1H, s) --------- ^ Installation ------- Order '--_---- C .i (Please read the precautions on the back before Fill out this ) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 0 6-6 I-propylpropanylpyridine oxygen collection β »3 | isoS (acid 7-carboxymethylformaldehyde IR (KBr) cm-ι: u〇 = 〇 1637 NMR (di-TFA) 6 values: 1.20-1.80 (4H, m), 3.62 (3H, s), 4.40-5.20 (5Hf m), 7.73 (3H, brs) f 8.26 (lHf d, J = 8.3Hz ), 9.50 (1H, s) -89- This paper size is applicable to the Chinese national standard fr'dNS) A4 size (210X297 mm) Employees of the Central Standards Bureau of the Ministry of Economic Affairs and Consumer Cooperation Du printed A7-B7 V. Description of the invention (shirt) • 1-Ceryl-6-fluoro-8-methane- 7- (1-methylisoindolin-5-yl)-1.4-bispyridin-4-ylsulfonyl-3-carboxylic acid IR (KBr.) Cm-1: uc = 〇1726 NMR (di-TFA) 6 Values: 1.30-2.20 (7H, m), 3.60 (3H, s), 4.50-5.60 (4H, m), 7.30-8.00 ( 3H, m), 8.26 (lHf dr J = 8.3Hz) r 9.51 (1H, s) • 1-Chloropropyl-δ-dai-8-methyl gas-7- (3-methyliso 丨 丨 3 丨Phenyl-5-yl) -1.4-Diargon-4-aminobromoline-3-carboxylic acid IR (KBr) cm-1: uc = 〇1629 NMR (di-TFA) δ value: 1 · 10-2 · 10 (7H, m), 3.62 (3H, s), 4.30-5.65 (4H, m), 7.20-7.80 (3H, m), 8.29 (1H, d, J = 8.3Hz), 9.50 (1H, s) • 1-chen Propyl-8-difluoromethoxy-6-fluoro-7- (iso-isopyridin-5-yl) -1,4-bisfluoren-4-yloxyline-3-carboxylic acid IR (KBr) cm-l: υ〇 = 〇1636 NMR (di-TFA) δ value: 1.00-2.00 (4Hf m), 4.30-5.20 (5H, m), 6.20 (lHf t, J = 72Hz) f 7.72 (3Hf brs) f 8.46 (1H, df J = 8.3Hz) f 9.58 (1H, s) • 1-fluorenyl-8-dicyanomethoxy-6-cyano-7- (3-methyliso13 丨 fluorin-5 -Group) -1,4-dihydro-4-amino group f-line-3-carboxylic acid IR (KBr) cm-1: uc = 〇1638 NMR (di-TFA) δ value: 1.15-2.15 (7H, m), 4.45-5.15 (3H, m), 5.15-5.70 (1H, m), 6.20 (1H, t, J = 72Hz), 7.30-7.95 (3H, m), 8.46 {1H, d, J = 8.3 Hz), 9.59 (1H, s) -9 0-— i______ This paper size applies Chinese National Standard (CNS) A4 (210X29? Mm) --------- C Pack— (Please read the back first (Notes to fill out this page)

M A7 _B7___ 五、發明説明(扔) • 1-琛丙基-6-氟-8-氟甲氣-7-(異吲呤W - 5-基)-1 , 4-二氳-4-氧基睡啉-3-羧酸 IR (KBr) cm-i: υ〇=〇 1732 NMR (di-TFA) δ 值:1.00-2.00 (4H, m), 4.50-5.25 (5Hf m), 5.28 (2H, d, J=52Hz), 7.20-7.90 (3Hr m)f 8.39 (1H, dr J=8.3Hz), 9.56 (1H, s) • 1-琛丙基-6-氟- 7-(1-甲基異13丨呤淋-5-基)-1 ,4-二氳 -4-氣基吱啉-3-羧酸M A7 _B7___ V. Description of the invention (throw) • 1-Ceryl-6-fluoro-8-fluoromethyl-7- (isoindolin W-5-yl) -1, 4-difluoren-4-ox Benzylline-3-carboxylic acid IR (KBr) cm-i: υ〇 = 〇1732 NMR (di-TFA) δ value: 1.00-2.00 (4H, m), 4.50-5.25 (5Hf m), 5.28 (2H , d, J = 52Hz), 7.20-7.90 (3Hr m) f 8.39 (1H, dr J = 8.3Hz), 9.56 (1H, s) • 1-chenpropyl-6-fluoro-7- (1-form Iso-13-pyridin-5-yl) -1,4-difluoren-4-ylamino-3-carboxylic acid

IR (KBr) cm-i: υ〇»〇 1618 I NMR (di-TFA) δ 值:1.30-2.20 (7H, m), 4.00-4.50 (1H, m)f 4.80-5.70 (3H, m), 7.40-8.00 (3H, m)fl 8.49 (1H, d, J=9.0Hz), 8.79 (lHf d, J=6.0Hz), 9.49 (1H, s) •卜琛丙基-6-氣- 7-(3-甲基異吲基)-1,4-二氬 -4-氣基歧啉-3-羧酸 IR (KBr) cm-i: υ〇=〇 1618 經濟部中央標準局員工消费合作社印裝 (請先閲讀背面之注意事項再填寫本頁) NMR (djL-TFA) δ 值:1.20-2.15 (7H, m), 3.95-4.50 (1H, m)f 4.70-5.70 (3ΗΛ m), 7.40-8.05 (3H, m)f 8.15-9.00 (2H, m), 9.44 (1H, s) • 6-氟-1-(2-氟乙基)-7-(異吲呤啉-5-基)-8-甲基-1/4 -二氲-4-氣基歧啉-3-羧酸 IR (KBr) cm-i: υ〇=〇 1628 NMR (di-TFA) δ 值:2.73 {3H, s), 4.00-6.00 (8H, m), 7.00-7.90 (3H, m), 8.44 (1H, d, J=7.3Hz), 9.53 (1H, s) -91 - 本紙張尺度適用中國國家標準(tNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 A7 B7___ 五、發明説明(9。) • 1-乙基-6-氟- 7-(異吲II朵啉-5-基)-8-甲基-1,4-二氫 -4-氣基睹啉-3-羧酸酯 IR {KBr) cm-i: υ〇»〇 1633 NMR (d!-TFA) δ 值:1·76 (3H, t, J=7.3Hz), 2.78 (3Hf s), 4.80-5.50 (6H, m)f 7.30-7.70 {3H, m), 8.41 (1H, d, J=7.8Hz), 9.45 (1H, s) • 6-氟-卜〔(1R,2S )-2-氟琢丙基〕-7-(異吲哚啉-5-基) -8 -甲基-1,4 -二氫-4-氣基H淋-3-錢酸 IR (KBr) cm-i: υ〇*〇 1634 NMR (di-TFA) δ 值:1.20-2.40 (2H, m), 2.88 (3H, s), 4.30-5.90 (6H, m)f 7.10-7.90 (3H, m), 8.35 (1H, d, J=7.3Hz), 9.53 (1H, s) .1-(2,4-二氟苯基)-6-氟- 7-(異吲昤啉-5-基)-8-甲基 1 , 4-二簠-4-氣基β啉-3-羧酸 IR (KBr) cm-i: uc=〇 1636 NMR (di-TFA) δ 值:1·90 (3H, s), 4·50-5·20 (4H, m), 6.80-8.00 (6H, m)f 8.45 (1H, d, J=7.8Hz), 9.35 (1H, s) .6-驀-1-(4-趣苯基)-7-(異S3丨Ϊ朵淋-5-基)-8 -甲基-1,4 -二氳-4-氧基丨f啉-3-羧酸 IR (KBr) cm-l: υ〇=〇 1622 NMR (drTFA) δ 值:1.95 (3Η, s), 4.98 (4Η, brs), 6.50-7.80 (7H, m), 8.48 (1H, d, J=7.7Hz), 9.32 (lHr s) . -92- 本紙張尺度適用中國國家標準(fcNS ) A4規格(210X297公釐) ---------r 裝 f------¾--_----(梦 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央搮準局貝工消费合作社印製 A7 B7 五、發明説明(V ) • 6-氟-1-(2-氟乙基)-7-(異吲Ϊ朵啉-5-基)-1,4-二氲- 4- 霣基Kf啉-3-羧酸 IR (KBr) cm-i: uc-〇 1618 NMR (di-TFA) .δ 值:4·40-5·80 (8H, m)r 7·50-8·10 (3H, m), 8.20-8.80 (2H, m), 9.48 (lHf s) • 1-(2,4-二氟苯基)-6-氟-7-(異吲呤啉-5-基)-1, 4-二 S -4-氧基睡啉-3-羧酸 IR (KBr) cm-i: uc.〇 1622 NMR (di-TFA) δ 值 4.96 (4H, brs), 7.00-8.00 (7Hr m), 8.56 (1H, d, J=9.3Hz), 9.38 (1H, s) 實例9 50ag 1-環丙基-6-氰-8-甲«-7-〔 2-(對-甲苯裹醯基) 異吲昤啉-5-基〕-1,4-二氳-4-氣基β啉-3-羧酸懸浮於 0.5b1 47¾氳溴酸,且懸浮液内加入26Μ酚及0.3·1丙 酸,随後所得混合物於13JTC攪拌6小時。反應混合物 於減歷下濃结,及於所得殘餘物加入0.3*1乙醇,0.3·1 1Η氩氣化納水溶液及0.3·1水以溶解殘餘物。随後二氣化 硪吹送入溶液,及藉遇濾收集沈濺出之结晶獲得12eg淡 黄色结晶性1-璨丙基-6-氟-8-羥- 7-(異吲哚_ - 5-基) -1,4-二氳-4-氣基技啉-3-羧酸。 IR (KBr) cm-1: uc*〇 1613 NMR (di-TFA) δ 值:1.00-1.80 (4H, m)f 4.50-5.20 (5H, m), 7.66 (3H, brs), 8.00 (1H, d, J=8.6Hz}f 9.44 (1H, s) -93- 本紙張尺度適用中國國家揉準(CNS ) Λ4Β ( 210X297公釐) (請先閲讀背面之注意事項再填寫本頁) -裝- 1T- A7 B7 五、發明説明(9&gt; ) 實例1〇 / 於210·«乙基1-瓌丙基-6-氟-8-甲氧-7-〔2-三氟乙 醵基螵〔,異吲呤啉璨丙烷-5-基〕-1.4-二氫-4-«基睡啉羧酸酯於4.2el乙酵之懸浮液内加入2.1al 1N 氲氟化銷水溶液及4.2·1二掙烷,随後所得混合物於40*C 攪拌加熱3小時β反應混合物冷郤至室溫,随後藉遇濾 去除不溶物,其後二氧化硪氣鵲吹送入所得之濾液。沈 箱出之結晶藉遇濾收集獲得14 Oig淡黄色结晶性1-琛丙 基-6-氟-8-甲氣-7-〔螺〔異吲呤啉-1,1·-琢丙基〕-5-基〕-1,4 -二氫-4-氣基技淋-3-袋酸β IR (KBr) cm-i: υ〇=〇 1618 NMR (d6-DMSO) δ 值:0.80-1.50 (6Η, m), 2.40-2.80 (2Η, m), 3.43 (3Hf s), 4.00-4.40 (3H, m)f 6.90-7.60 (3Hf m)f 7.90 (1H, df J=9.0Hz), 8.85 (1H, s) 以相同方式籀得下列化合物e •卜琿丙基-8-二氟甲氣-6 -氟-7-〔《〔異吲呤啉- ΐ,ι·-琛丙基〕-5 -基〕-1,4 -二簠-4 -氣基技淋-3-袋酸 經濟部中央棣準局男工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) IR (KBr) cm-i: υ〇=〇 1636 NMR (d6-DMSO) δ 值:0.90-1.40 (6H, m), 2.40-2.60 (2H, m), 3.50-4.40 (3H, m), 6.67 (1H, t, J=73Hz), 6.80-7.50 (3H, m), 8.11 (1H, d, J=9.0Hz), 8.88 (1H, s) -94- 本&amp;張適用中國國家標準(fcNS ) ( 21GX297公嫠) &quot; 經濟部中央標準局貝工消費合作社印製 A7 B7 五、發明説明(9〇 實例11 1 5 0 b g 7 -〔 2 -(苄氧羰基)異吲丨朵啉-5 -基〕-8 -氣-6-氟-1-〔(lR,2S)-2-氟琛丙基〕-1,4-二氫-4-氣基K啉 -3-羧酸懸浮於25·1乙酸及50ig 556把硪内,及懸浮液 於氫流下於室溫攪拌2小時。反應混合物經過濾及隨後 添加2il 6N鹽酸至所得濾液,其後於滅懕下濃縮混合物 〇所得殘餘物加入乙辞,及遇濾收集生成的结晶。於所 榑结晶内加入0.7*1乙酵,0.7·1 1N氳氣化納水溶掖及 0.7ml水以溶解結晶,及隨後加入稀乙酸而調整溶液ΡΗ 至箱通濾收集沈澱出之结晶獲得45ag無色结晶性8-«-6-戴-卜〔(11?,23&gt;-2-氟琢丙基〕-7-(異吲哚啉-5-基)-1,4-二氳-4-氣基睹啉-3-羧酸。 IR (KBr) cm-i: υ〇=〇 1641 NMR (di-TFA) δ 值:1·30-2.30 (2H, ra), 4.30-5·90 (6Hr m), 7.20-7.80 (3H, m), 8.46 (1H, d, J=7.3Hz), 9.56 (1H, S) 賣例12 於10·1乙酸及60ng 5%耙磺内懸浮85*g 7-〔2-(苄氧 羰基)異吲哚啉-5-基〕_卜琛丙基-6-氟-8-甲氧-5-硝基 -1,4-二氳-4-氣基授啉-3-羧酸,及懸浮液於室租於氳 流下攪拌2小時。反應混合物過濾,及隨後添加2·1 6N 鹽酸至所得濾液,其後所得混合物於減壓下瀵缩。於所 得殘餘物加入乙酵,及生成的結晶藉過濾收集。所得结 晶加入〇·5ιβ1乙醇,0.5nl 1Ν氫氣化納水溶液及0.5*1水 -95- 本紙張尺度適用中國國家標準(亡NS ) A4:%# ( 210X297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝!. 經濟部中央橾準局員工消費合作社印製 A7 B7 五、發明説明(μ ) 以溶解結晶。«後,二氧化磺氣饑吹送入溶掖,及藉遇 $收集沈澱出的結晶獾得Hng淡黄色結晶性5-胺基_1_ 瓌丙基-6-氟- 7-(異吲呤啉-5-基)-8-甲氣-1,4-二氫- 4-氧基喹醵-3-羧酸 IR (KBr) cm-i: υ〇=〇 1716 NMR (h-TFA) δ 值:0.70-1.70 (4H, m), 3.58 (3Η, s), 4.00-4.70 (lHf m), 5.02 (4Hr brs), 7.70 (3H, brs), 9.29 (1H, s) 實例13 0.16g 7-〔2-(苄氣羰基)異吲呤W:-5-基〕-1-琢丙基 -6-氟-8-氟甲氣-1,4-二氫-4-氧基技啉-3-羧酸懸浮於 3.2ι«130%溴化Μ -乙酸溶液内,及懸浮液於室粗播拌40 分鐘。反應混合物於減壓下潰结及於殘餘物内加入乙酵 ,過濾收集生成的結晶》所得結晶溶解於稀氳氧化納水 溶液及ΡΗ以稀鹽酸讕整至7»遇濾收集沈澱出之結晶獲 得68mg無色結晶性1-琢丙基-6-氟- 8-*甲基- 7-(異吲 哚_ - 5-基)-1,4-二氳- 4-«基歧啉-3-羧酸。 IR (KBr) cm~l: 〇c=o 1638 NMR (di-TFA) δ 值:1.10-2.05 (4Hf m), 4.65-5.25 {5H, m), 5.96 (2H, &lt;3, J=47Hz), 7.25-7.85 (3H, m), 8·52 (1H, d, J=7.8Hz), 9.65 (1H, s) 實例14 5 0 g 1 -琛丙基-6 -氟-7 -(異吲丨朵啉-5 -基)-1 , 4 -二氫 -4-縝基挂_-3-羧酸氫澳酸鹽懸浮於0.5〇·1甲酸中, -96- 本紙张尺度逋用中國國家標準(0NS ) Α4规格(210X297公釐) ---------Γ -裝*------IX--.----(, (請先閱讀背面之注意事項再填寫本頁) 經濟部中央樣準局員工消費合作社印裝 A7 B7 五、發明説明(π )IR (KBr) cm-i: υ〇 »〇1618 I NMR (di-TFA) δ value: 1.30-2.20 (7H, m), 4.00-4.50 (1H, m) f 4.80-5.70 (3H, m), 7.40-8.00 (3H, m) fl 8.49 (1H, d, J = 9.0Hz), 8.79 (lHf d, J = 6.0Hz), 9.49 (1H, s) (3-methylisoindyl) -1,4-diargon-4-amino bisphospholine-3-carboxylic acid IR (KBr) cm-i: υ〇 = 〇1618 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the notes on the back before filling this page) NMR (djL-TFA) δ value: 1.20-2.15 (7H, m), 3.95-4.50 (1H, m) f 4.70-5.70 (3ΗΛ m), 7.40 -8.05 (3H, m) f 8.15-9.00 (2H, m), 9.44 (1H, s) • 6-fluoro-1- (2-fluoroethyl) -7- (isoindolinolin-5-yl) -8-Methyl-1 / 4-difluoren-4-aminobimorpholine-3-carboxylic acid IR (KBr) cm-i: υ〇 = 〇1628 NMR (di-TFA) δ value: 2.73 {3H, s), 4.00-6.00 (8H, m), 7.00-7.90 (3H, m), 8.44 (1H, d, J = 7.3Hz), 9.53 (1H, s) -91-This paper size applies to Chinese national standards ( tNS) A4 size (210X297 mm) A7 B7___ printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (9.) • 1-Ethyl-6-fluoro-7- (isoindole II dorolin-5- base -8-Methyl-1,4-dihydro-4-ylamino-3-carboxylate IR {KBr) cm-i: υ〇 »〇1633 NMR (d! -TFA) δ value: 1 · 76 (3H, t, J = 7.3Hz), 2.78 (3Hf s), 4.80-5.50 (6H, m) f 7.30-7.70 (3H, m), 8.41 (1H, d, J = 7.8Hz), 9.45 ( 1H, s) • 6-Fluoro-bu [(1R, 2S) -2-Fluoropropyl] -7- (isoindololin-5-yl) -8-methyl-1,4-dihydro- 4-Gas-H-L-3--3-carboxylic acid IR (KBr) cm-i: υ〇 * 〇1634 NMR (di-TFA) δ value: 1.20-2.40 (2H, m), 2.88 (3H, s), 4.30 -5.90 (6H, m) f 7.10-7.90 (3H, m), 8.35 (1H, d, J = 7.3Hz), 9.53 (1H, s) .1- (2,4-difluorophenyl) -6 -Fluoro-7- (isoindioline-5-yl) -8-methyl1,4-difluoren-4-ylaminoβline-3-carboxylic acid IR (KBr) cm-i: uc = 〇1636 NMR (di-TFA) δ value: 1.90 (3H, s), 4.50-5 · 20 (4H, m), 6.80-8.00 (6H, m) f 8.45 (1H, d, J = 7.8Hz ), 9.35 (1H, s). 6-fluoren-1- (4-triphenyl) -7- (isoS3 丨 fluorid-5-yl) -8-methyl-1,4-difluorene- 4-oxylfline-3-carboxylic acid IR (KBr) cm-1: υ〇 = 〇1622 NMR (drTFA) δ value: 1.95 (3Η, s), 4.98 (4Η, brs), 6.50-7.80 ( 7H, m), 8.48 (1H, d, J = 7.7Hz), 9.32 (lHr s). -92- Paper size Use Chinese National Standard (fcNS) A4 specification (210X297 mm) --------- r Install f ------ ¾ --_---- (Dream (Please read the notes on the back first (Fill in this page again) Printed A7 B7 printed by the Shellfish Consumer Cooperative of the Central Bureau of Quasi-Ministry of Economic Affairs V. Description of the invention (V) • 6-fluoro-1- (2-fluoroethyl) -7- (isoindiodoline- 5-yl) -1,4-bisfluorene-4-fluorenyl Kfline-3-carboxylic acid IR (KBr) cm-i: uc-〇1618 NMR (di-TFA). Δ value: 4.40-5 · 80 (8H, m) r 7.50-8 · 10 (3H, m), 8.20-8.80 (2H, m), 9.48 (lHf s) • 1- (2,4-difluorophenyl) -6 -Fluoro-7- (isoindolinolin-5-yl) -1,4-bisS-4-oxoline-3-carboxylic acid IR (KBr) cm-i: uc.〇1622 NMR (di- TFA) δ value 4.96 (4H, brs), 7.00-8.00 (7Hr m), 8.56 (1H, d, J = 9.3Hz), 9.38 (1H, s) Example 9 50ag 1-cyclopropyl-6-cyano- 8-methyl «-7- [2- (p-toluenesulfonyl) isoindolin-5-yl] -1,4-difluoren-4-ylaminoβ-line-3-carboxylic acid suspended in 0.5b1 47¾ 氲 bromic acid, and 26M phenol and 0.3 · 1 propionic acid were added to the suspension, and the resulting mixture was then stirred at 13JTC for 6 hours. The reaction mixture was concentrated under reduced pressure, and 0.3 * 1 ethanol, 0.3 · 1 1 Torr argon sodium aqueous solution and 0.3 · 1 water were added to the obtained residue to dissolve the residue. Then the digassed tritium was blown into the solution, and the precipitated crystals were collected by filtration to obtain 12eg of pale yellow crystalline 1-canyl-6-fluoro-8-hydroxy-7- (isoindole_-5 -Yl) -1,4-difluoren-4-ylaminopyridin-3-carboxylic acid. IR (KBr) cm-1: uc * 〇1613 NMR (di-TFA) δ value: 1.00-1.80 (4H, m) f 4.50-5.20 (5H, m), 7.66 (3H, brs), 8.00 (1H, d, J = 8.6Hz} f 9.44 (1H, s) -93- This paper size is applicable to the Chinese National Standard (CNS) Λ4B (210X297 mm) (Please read the precautions on the back before filling this page) -pack- 1T- A7 B7 V. Description of the invention (9 &gt;) Example 10 / In 210 · «ethyl 1-fluorenyl-6-fluoro-8-methoxy-7- [2-trifluoroethylfluorenylfluorene [, Isoindinolinylpropan-5-yl] -1.4-dihydro-4- «ylpyroline carboxylate was added to the suspension of 4.2el acetic acid with 2.1al 1N fluorinated pin solution and 4.2.1 Alkane, and the resulting mixture was stirred and heated at 40 * C for 3 hours. The β reaction mixture was cooled to room temperature, and then insoluble matter was removed by filtration, and then radon dioxide was blown into the obtained filtrate. The crystals were collected by filtration to obtain 14 Oig pale yellow crystalline 1-benzyl-6-fluoro-8-methyl gas-7- [spiro [isoindolin-1,1 · -propylpropyl] -5-yl ] -1,4 -Dihydro-4-air-based technology leaching-3-bag acid β IR (KBr) cm-i: υ〇 = 〇1618 NMR (d6-DMSO) δ value: 0.80-1.50 (6Η, m ), 2.40-2.80 (2Η, m), 3. 43 (3Hf s), 4.00-4.40 (3H, m) f 6.90-7.60 (3Hf m) f 7.90 (1H, df J = 9.0Hz), 8.85 (1H, s) In the same manner, the following compound e is obtained:珲 propyl-8-difluoromethane-6-fluoro-7-[[[Isoinolino-pyrene, ι · -chenpropyl] -5 -yl] -1,4 -difluorene-4 -qi Printed by the Male Worker Consumer Cooperative of the Central Bureau of Quasi-Economy Bureau of the Ministry of Economic Affairs of Jijilin 3-Pack Acid (please read the precautions on the back before filling this page) IR (KBr) cm-i: υ〇 = 〇1636 NMR (d6- DMSO) δ value: 0.90-1.40 (6H, m), 2.40-2.60 (2H, m), 3.50-4.40 (3H, m), 6.67 (1H, t, J = 73Hz), 6.80-7.50 (3H, m ), 8.11 (1H, d, J = 9.0Hz), 8.88 (1H, s) -94- This & Zhang applies to China National Standards (fcNS) (21GX297 public address) &quot; Shellfish Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs Printing A7 B7 V. Description of the invention (90 Example 11 1 50 0 bg 7-[2-(benzyloxycarbonyl) isoindolino-doline-5 -yl] -8 -gas-6-fluoro-1-[( lR, 2S) -2-fluorosynyl] -1,4-dihydro-4-amino-Kolinolin-3-carboxylic acid was suspended in 25.1 acetic acid and 50ig 556 amidines, and the suspension was under a stream of hydrogen Stir at room temperature for 2 hours. The reaction mixture was filtered and then 2 μl of 6 N hydrochloric acid was added to the obtained filtrate, and then the mixture was concentrated under reduced pressure. The obtained residue was added with ethyl acetate, and the resulting crystals were collected by filtration. Add 0.7 * 1 acetic acid, 0.7 · 1 1N hydration sodium hydroxide solution and 0.7ml water to dissolve the crystals, and then add dilute acetic acid to adjust the solution P to the box-pass filter to collect the precipitated crystals to obtain 45ag Colorless crystallinity 8-«-6-Da-bu [(11?, 23 &gt; -2-Fluoropropyl] -7- (isoindololin-5-yl) -1,4-difluorene-4- Gasoline phthaloline-3-carboxylic acid. IR (KBr) cm-i: υ〇 = 〇1641 NMR (di-TFA) δ value: 1.30-2.30 (2H, ra), 4.30-5 · 90 (6Hr m), 7.20-7.80 (3H, m), 8.46 (1H, d, J = 7.3Hz), 9.56 (1H, S) Selling Example 12 Suspended in 10 · 1 acetic acid and 60ng 5% rake 85 * g 7 -[2- (benzyloxycarbonyl) isoindololin-5-yl] _Phenyl-6-fluoro-8-methoxy-5-nitro-1,4-difluoren-4-yl Porphyrin-3-carboxylic acid, and the suspension were stirred under a turbulent stream for 2 hours. The reaction mixture was filtered, and then 2.16 N hydrochloric acid was added to the resulting filtrate, after which the resulting mixture was shrunk under reduced pressure. The product is added with acetic acid, and the resulting crystals are collected by filtration. The obtained crystals are added with 0.55β1 ethanol, 0.5nl 1N sodium hydrogenated aqueous solution and 0.5 * 1 water-95- This paper size applies Chinese national standards (Death NS) A4:% # (210X297 mm) (Please read the precautions on the back before filling out this page)-Install !. Printed by A7 B7, Consumer Cooperatives of the Central Procurement Bureau of the Ministry of Economic Affairs 5. Description of Invention (μ) To dissolve the crystals. «After that, sulphur dioxide gas is blown into the solvent, and the crystals precipitated by collecting $ to obtain Hng light yellow crystalline 5-amino_1_ propyl-6-fluoro-7- (Isoinolinolin-5-yl) -8-methyl-1,4-dihydro-4-oxyquinoline-3-carboxylic acid IR (KBr) cm-i: υ〇 = 〇1716 NMR (h -TFA) δ value: 0.70-1.70 (4H, m), 3.58 (3Η, s), 4.00-4.70 (lHf m), 5.02 (4Hr brs), 7.70 (3H, brs), 9.29 (1H, s) 13 0.16 g of 7- [2- (benzylcarbonyl) isoindolin W: -5-yl] -1-chloropropyl-6-fluoro-8-fluoromethane-1,4-dihydro-4-oxo Gyroline-3-carboxylic acid was suspended in a 3.2 mil 130% bromide-acetic acid solution, and the suspension was coarsely seeded in the chamber for 40 minutes. The reaction mixture was decomposed under reduced pressure and ethyl acetate was added to the residue The resulting crystals were collected by filtration. The resulting crystals were dissolved in dilute aqueous sodium oxide solution and diluted with dilute hydrochloric acid to 7. The precipitated crystals were collected by filtration to obtain 68 mg of colorless crystals. Cyclopropyl-6-fluoro-1- cut --8- * methyl --7- (isoindole _ --5-yl) -1,4-Yun --4- «manifold yl-3-carboxylic acid. IR (KBr) cm ~ l: 〇c = o 1638 NMR (di-TFA) δ value: 1.10-2.05 (4Hf m), 4.65-5.25 (5H, m), 5.96 (2H, &lt; 3, J = 47Hz ), 7.25-7.85 (3H, m), 8.52 (1H, d, J = 7.8Hz), 9.65 (1H, s) Example 14 5 0 g 1 -Ceryl-6-fluoro-7-(iso Indoline-5-yl) -1,4-dihydro-4-fluorenyl-3-carboxylic acid hydrogen aluminate suspended in 0.50.1 formic acid, -96- This paper uses China National Standard (0NS) Α4 Specification (210X297 mm) --------- Γ -Installation * ------ IX --.---- (, (Please read the precautions on the back before (Fill in this page) A7 B7 printed by the Consumer Cooperatives of the Central Procurement Bureau of the Ministry of Economic Affairs 5. Description of the invention (π)

及添加27ag福暍啉至該懸浮液,随後該混合物画流 2小時。於減壓下蒸皤去除溶薄。所得殘餘物加入5·1水及PH 以飽和硪声氳納水溶掖謂整至7,隨後所得混合物以5份 5通1«仿萃取β所得《仿層以無水硫酸鎂乾燥然後於減 S下蒸»去除溶蘭0乙酵加至所得殘餘物及遇濾收集生 成的結晶獲得23ig淡黄色结晶性1-琛丙基-6-氟- 7-(2- 甲基異吲呤啉-5-基)-1,4-二氬-4-氣基技啉-3-羧酸 IR (KBr) cm-1: υ〇=〇 1730 NMR (di-TFA) 6 值:1.20-2.05 (4H, m), 3.39 (3H, s), 4.00-5.60 (5Hf m), 7.45-8.05 (3H, m), 8.50 (1H, d, J=9.2Hz), 8.80 (1H, d, J=5.9Hz)f 9.50 (1H, S) 以相同方式«得下列化合物》 • 1-環丙基-6-氟-8-甲基- 7-(2-甲基異吲呤啉-5-基)-1 ,4-二篇:-4-氣基ϋ啉-3-羧酸 IR (KBr) cm-i: υ〇=ο 1725 NMR (di-TFA) δ 值:1.05-2.00 (4H, m), 2.93 (3H, s), 3.38 (3Hf s), 4.30-5.50 (5H,. m), 7.20-7.80 (3H,in),8.34 (1H,d' J=7.3Hz),9.63 (1H, s) • (S) - 9-氟-3-甲基-10 - (2-甲基異吲呤_ - 5-基)-7-氣 基-2,3-二氫-7H-吡啶駢〔1,2,3-de〕 〔 1,4 -〕苯駢啤 阱-6 -袋酸 IR (KBr) cm-1: υ〇=〇 1716 NMR (di-TFA) 6 值:1.50-2.20 (3H, m)r 3.35 (3H, brs), 4.10-5.80 (7Hf m)f 6.90-8.30 (4H, m), 9.35 (1H, brs) -97_ 本紙張尺度適用中國國家梯準(亡NS ) A4規格(210x297公釐) ---------f -裝*------1T---^--1^ ^ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央橾準局員工消費合作社印策 A7 B7_. 五、發明説明() • 1-環丙基-6-氟- 7-(2-甲基異吲呤啉-5-基)-1,4-二氫 -4-氣基-1,8-萊啶-3-羧酸 IR (KBr,) cm-i: υ〇〇 1727 NMR (CDC13) δ 值 ‘:0.90-1.55 (4Η, m&gt;, 2.63 (3Η, s), 3.50-4.20 (5H, m}, 7.36 (1H, d, J=8.3Hz), 7.80-8.20 (2H, m), 8.44 (1H, d, J=10.7Hz)r 8.93 (1H, s) • 1-琛丙基-6 ,8-二瓤-7-(2-甲基異吲昤麻-5-基&gt;-1,4- 二氳-4-氣基it _ - 3-箱酸 IR (KBr) cm-l: uc=0 1648 NMR (CDCI3) δ : 0.90-1.50 (4Hf m) f 2.60 (3H, brs), 3.50-4.40 (5H, m), 7.25 (3H, s), 8.07 (1H, d, J=8_5Hz), 8.87 {1H, s) • 1-琛丙基-6-氣-8-甲氣-7- (2-甲基-異吲》朵啉-5-基) -1,4 -二氫-4-氣基If淋-3-錢酸 IR (KBr) cm-l: uc=〇 1732 NMR (drTFA) δ 值:1.20-1.80 (4H, m), 3.39 (3H, s), 3.63 (3H, s)f 4.30-5.60 (5Hf m)f 7.73 (3Hf brs), 8.26 (1H, d, J=8.5Hz), 9.52 (1H, s) ' •卜琛丙基-8-二氟甲氣-6-瓤-7-(2-甲基異吲呤啉-5-基) -1 ,4-二氫-4-氣基丨- 3-羧酸 IR (KBr) cm-i: υ〇-〇 1723 NMR (di-TFA) δ 值:1.00-2.00 (4H, m), 3.34 (3H, s), 4.30-5.50 (5H, ra), 6.23 (1H, t, J=72Hz), 7.73 (3H, brs)f 8.47 (1H, d, J=8.3Hz), 9.60 (1H, S) _l___ 9 8 -___ 本紙ϋ適用中國國^橾準(_CNS ) A4規格(210X297公釐) I-------1 裝.------、tT--^----c·^ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標率局員工消費合作社印製 A7 _B7_ 五、發明説明(97 ) • 6-氣-1-(2-氟乙基〉-8-甲基-7-(2-甲基異I引呤啉- 5-基)-1,4-二氫-4-氧基授啉-3-羧酸 IR (KBr) cm-1; 〇c=o 1718 工業用途 本發明化合物其中異吲呤啉琛之硪原子鍵結至授啉酮 -或萊啶酮-羧酸主幹之位置7-者可用作抗薗劑。 -99- 本紙張尺度適用中國國家揉準('CNS ) A4規格(210X297公釐) I-------C ‘裝*------IX--;---- (請先閱讀背面之注意事項再填寫本頁) C;' !:' O'wi i. ^ -r 大勝桿菌NIHJJ02 ! I 71 I m g T3 5 室 m m D&gt; 萏 0.012 0.025 0.006 0.012 03 4 靈 0.0121 ρ mmk 0.012 0.05 00 &gt;-Cf〇 o § &lt;0.006 0.05 &lt;0.006 0.012 00 I \ \ &lt;0.006 ρ 0.012 0.025 00 s 1.56 〇 p 00 fttVcooh ΗΝ〇Γϊί ^ M· CHjCHaF 0.05 0.39 0.05 0.05 00 0 F-y^A^COOH 0.025 ο r〇 0.051 0.0251 CO o ^xr$; #And 27ag of fentholine was added to the suspension, and then the mixture was drawn for 2 hours. The solvent was removed by evaporation under reduced pressure. The obtained residue was added with 5 · 1 water and pH to saturate the water and dissolved in water. The whole mixture was then scaled to 7 and then the obtained mixture was extracted with 5 parts of 5 through 1 «imitation extraction β. The imitation layer was dried over anhydrous magnesium sulfate and then reduced under S. Steaming »Remove the lysocyanine and add ethyl acetate to the obtained residue and collect the crystals collected by filtration to obtain 23ig pale yellow crystalline 1-benzyl-6-fluoro-7- (2-methylisoindolinline-5- Radical) -1,4-diargon-4-aminopyridin-3-carboxylic acid IR (KBr) cm-1: υ〇 = 〇1730 NMR (di-TFA) 6 Value: 1.20-2.05 (4H, m ), 3.39 (3H, s), 4.00-5.60 (5Hf m), 7.45-8.05 (3H, m), 8.50 (1H, d, J = 9.2Hz), 8.80 (1H, d, J = 5.9Hz) f 9.50 (1H, S) in the same way «to the following compounds" • 1-cyclopropyl-6-fluoro-8-methyl-7- (2-methylisoinolinolin-5-yl) -1,4 -Two articles: 4-Aminopyridin-3-carboxylic acid IR (KBr) cm-i: υ〇 = ο 1725 NMR (di-TFA) δ value: 1.05-2.00 (4H, m), 2.93 (3H , s), 3.38 (3Hf s), 4.30-5.50 (5H, .m), 7.20-7.80 (3H, in), 8.34 (1H, d 'J = 7.3Hz), 9.63 (1H, s) • (S )-9-fluoro-3-methyl-10-(2-methylisoindin_-5-yl) -7-amino-2,3-dihydro-7H-pyridinium [1,2,3 -de] [1, 4-]骈 Beer trap-6-bagic acid IR (KBr) cm-1: υ〇 = 〇1716 NMR (di-TFA) 6 value: 1.50-2.20 (3H, m) r 3.35 (3H, brs), 4.10-5.80 ( 7Hf m) f 6.90-8.30 (4H, m), 9.35 (1H, brs) -97_ This paper size is applicable to the Chinese national standard (NS NS) A4 size (210x297 mm) --------- f -Equipment * ------ 1T --- ^-1 ^ ^ (Please read the notes on the back before filling out this page) The Central Consumers' Bureau of the Ministry of Economic Affairs, Consumer Cooperatives, India A7 B7_. V. Description of the invention () • 1-Cyclopropyl-6-fluoro-7- (2-methylisoinolinolin-5-yl) -1,4-dihydro-4-amino-1,8-eryridine-3 -Carboxylic acid IR (KBr,) cm-i: υ〇〇1727 NMR (CDC13) δ value ': 0.90-1.55 (4Η, m &gt;, 2.63 (3Η, s), 3.50-4.20 (5H, m), 7.36 (1H, d, J = 8.3Hz), 7.80-8.20 (2H, m), 8.44 (1H, d, J = 10.7Hz) r 8.93 (1H, s) • 1-chenpropyl-6,8-two瓤 -7- (2-methylisoindole ramie-5-yl &gt; -1,4-diamidino-4-carbyl it _-3-box acid IR (KBr) cm-1: uc = 0 1648 NMR (CDCI3) δ: 0.90-1.50 (4Hf m) f 2.60 (3H, brs), 3.50-4.40 (5H, m), 7.25 (3H, s), 8.07 (1H, d, J = 8_5Hz), 8.87 { 1H, s) • 1-chenpropyl-6-gas-8-methylgas-7- (2-methyl-isoindole (Dorolin-5-yl) -1,4-dihydro-4-airyl If leaching-3-carboxylic acid IR (KBr) cm-1: uc = 〇1732 NMR (drTFA) δ value: 1.20-1.80 (4H , m), 3.39 (3H, s), 3.63 (3H, s) f 4.30-5.60 (5Hf m) f 7.73 (3Hf brs), 8.26 (1H, d, J = 8.5Hz), 9.52 (1H, s) '• Berchen propyl-8-difluoromethane-6-fluorene-7- (2-methylisoindolinline-5-yl) -1, 4-dihydro-4-amino group 丨-3- Carboxylic acid IR (KBr) cm-i: υ〇-〇1723 NMR (di-TFA) δ value: 1.00-2.00 (4H, m), 3.34 (3H, s), 4.30-5.50 (5H, ra), 6.23 (1H, t, J = 72Hz), 7.73 (3H, brs) f 8.47 (1H, d, J = 8.3Hz), 9.60 (1H, S) _l___ 9 8 -___ This paper is applicable to China ^ 橾 standard (_CNS ) A4 size (210X297mm) I ------- 1 pack .------, tT-^ ---- c · ^ (Please read the precautions on the back before filling this page) Printed A7 _B7_ by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs V. Description of the Invention (97) • 6-Ga-1- (2-fluoroethyl> -8-methyl-7- (2-methylisopropyl) Porphyrin- 5-yl) -1,4-dihydro-4-oxoline-3-carboxylic acid IR (KBr) cm-1; oc = o 1718 Industrial use The compound of the present invention is isoindoline硪 atom is bonded to linolinone- or eryridone- 7- position of the acid are useful as anti trunk Sonogashira agent. -99- This paper size is applicable to China National Standard ('CNS) A4 (210X297mm) I ------- C' Packing * ------ IX-; ---- (Please Read the precautions on the back before filling this page) C; '!:' O'wi i. ^ -R victorius NIHJJ02! I 71 I mg T3 5 chamber mm D &gt; 萏 0.012 0.025 0.006 0.012 03 4 Ling 0.0121 ρ mmk 0.012 0.05 00 &gt; -Cf〇o § &lt; 0.006 0.05 &lt; 0.006 0.012 00 I \ \ &lt; 0.006 ρ 0.012 0.025 00 s 1.56 〇p 00 fttVcooh ΗΝ〇Γϊί ^ M · CHjCHaF 0.05 0.39 0.05 0.05 00 0 Fy ^ A ^ COOH 0.025 ο r〇0.051 0.0251 CO o ^ xr $; #

:¾騰#菌 NIHJJC~2 I 1 1 w I T 1 1 T1 § Ό 1 fr 蓉' 0.003 0.025 0.006 0.006 00 卜Q。 0 0 0.012 &lt;0.006 &lt;0.006 &lt;0.006 00 i \ 0 § 1 0.05 &lt;0.012 &lt;0.012 &lt;0.012 CO ffv^Vcooh ΗΝ〇φτΧ^ F 0.05 〇 ho p p CO 々1。 1 &lt;0.006! 0.025 &lt;0.006 ( 0.012 00 OMe^ 0.025 0.05 0.025 0.025 00 〇 Me 0.051 0.051 0.051 0.051 CO 1大腸桿菌NIHJJ02 1 1 1 雪 71 莒 % 1 τι g 1 m 缂 化合物 1 3.13 1,56 ο fo ' 0.39: σ&gt; fXjCVc〇〇h NH 丨 3.13 0.012 0.012 0.012 i § 0.006 ο fo 0.012 0.012 00 i § 0.025 0.78 0.025 0.05 CO k 0 丨 0.006 ο FO 0.025 0.012 00 % o § . &lt;0.006 0.05 &lt;0,006 &lt;0.006 CO O § 99a 387838: ¾ 腾 # 菌 NIHJJC ~ 2 I 1 1 w I T 1 1 T1 § Ό 1 fr Rong '0.003 0.025 0.006 0.006 00 BU Q. 0 0 0.012 &lt; 0.006 &lt; 0.006 &lt; 0.006 00 i \ 0 § 1 0.05 &lt; 0.012 &lt; 0.012 &lt; 0.012 CO ffv ^ Vcooh ΗΝ〇φτχ ^ F 0.05 〇 ho p p CO 々1. 1 &lt; 0.006! 0.025 &lt; 0.006 (0.012 00 OMe ^ 0.025 0.05 0.025 0.025 00 〇Me 0.051 0.051 0.051 0.051 CO 1 E. coli NIHJJ02 1 1 1 snow 71 莒% 1 τι g 1 m 缂 compound 1 3.13 1,56 ο fo '0.39: σ &gt; fXjCVc〇〇h NH 丨 3.13 0.012 0.012 0.012 i § 0.006 ο fo 0.012 0.012 00 i § 0.025 0.78 0.025 0.05 CO k 0 丨 0.006 ο FO 0.025 0.012 00% o §. &lt; 0.006 0.05 &lt; 0,006 &lt; 0.006 CO O § 99a 387838

^M#aNIHJJC-2 1 1 1 1 -π g n〇 g 蠢 m 化合物 p p p 0.05 1 \ ιΐ I 大腸桿菌NIHJJ02 w i 1 I I -n g D I 1 化合物 0.006 0.05 0.025 0.0251 i § 0.025 0.025 0.012 0.0251 f § 0.025 0.05 0.05 0.0251 § I 0.05 0.05 0.05 0.05 0 c〇〇H -ccrx/ 0.012 0.05 0.025 0.025 i &amp; n § I 0.012 0.025 0.012 0.012 0 § p 0.05 0.025 0.051 s :¾ 1 菌 NIHJJ02 ! | I T 裒 1 1 1 *O 塞: 鼷. 化合物 p 3.13 o ho ' 0.39 CO ^/XtVcooh CHjCHaF &lt;0.006 -0.39 0.05 0.05 00 \ 0Ό12 0.012 0.003 omz ο § X 0.025 &lt;0.006 &lt;0.006 &lt;0.006 ο % § X 0.012 p mm*. &lt;0.006 0.0121 /¾0 § &lt;0.006 0.012 &lt;0.006 0.012 ro 0 § &lt;0.006 0.05 &lt;0.006| &lt;0.006| 05 0 F^YKrCOOH -a〇y/ f^ M # aNIHJJC-2 1 1 1 1 -π gn〇g compound m ppp 0.05 1 \ ι I I E. coli NIHJJ02 wi 1 II -ng DI 1 compound 0.006 0.05 0.025 0.0251 i § 0.025 0.025 0.012 0.0251 f § 0.025 0.05 0.05 0.0251 § I 0.05 0.05 0.05 0.05 0 c〇〇H -ccrx / 0.012 0.05 0.025 0.025 i &amp; n § I 0.012 0.025 0.012 0.012 0 § p 0.05 0.025 0.051 s: ¾ 1 bacteria NIHJJ02! | IT 裒 1 1 1 * O Plug: 鼷. Compound p 3.13 o ho '0.39 CO ^ / XtVcooh CHjCHaF &lt; 0.006 -0.39 0.05 0.05 00 \ 0Ό12 0.012 0.003 omz ο § X 0.025 &lt; 0.006 &lt; 0.006 &lt; 0.006 ο% § X 0.012 p mm * . &lt; 0.006 0.0121 / ¾0 § &lt; 0.006 0.012 &lt; 0.006 0.012 ro 0 § &lt; 0.006 0.05 &lt; 0.006 | &lt; 0.006 | 05 0 F ^ YKrCOOH -a〇y / f

99b99b

Claims (1)

Α8 Bg C8 387838 D8 六、申請專利範圍 第84108286號「新穎畦_酮-或桊啶酮-耧酸衍生物或其鹽 j專利案申覆窨 (88年1¾ 巧申請專利範圔: I 月_|〇1|正I 1穸正I I 一種下式表示之新潁喹啉酮-或桊啶羧酸衍生物或 其翳蕖容許鹽: R6 〇Α8 Bg C8 387838 D8 VI. Application scope of patent No. 84108286 "Novel ketone- or pyridone- acetic acid derivative or its salt j Patent application (1882 of 1998) Patent application scope: I month_ 〇1 | n-I 1 穸 n-II A new quinolinone- or pyridinecarboxylic acid derivative represented by the following formula or its permissive salt: R6 〇 C02R1 經濟部中央棣準局βζ工消费合作社印装 焼基、通化Cl - 4焼基、C3 - β琢焼基\趙化C3 -β環烷基或視情況由鹵原子、羥基或苄氣基取代之 苯基;R3表示趣自下列之至少一者:氫原子及齒原子 :R4表示遵自下列之至少一者:氳原子,鹵原子, Ci - 4烷基,亞胺基及與R*键結之碘原子生成 C3 - β琛焼琛之基;Μ表示氳原子,“ -4烷基, 甲苯磺醣基、鹵化Ci.4醯基或苄氧羰基:R6表示氫原 子、胺基或硝基:、Α^表示、/或、。/ I Υ ,其中Υ表示籯原子,鹵原子,CU - 4烷基、鹵化Ci -4烷基、烷氣基、齒化Ci-*烷氣基或羥 --------^ 裝------訂------f冰 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中困國家梯準(CNS U4规格(210X297公嫠) Α8 Bg C8 387838 D8 六、申請專利範圍 第84108286號「新穎畦_酮-或桊啶酮-耧酸衍生物或其鹽 j專利案申覆窨 (88年1¾ 巧申請專利範圔: I 月_|〇1|正I 1穸正I I 一種下式表示之新潁喹啉酮-或桊啶羧酸衍生物或 其翳蕖容許鹽: R6 〇C02R1 Printed by the Central Associated Bureau of the Ministry of Economic Affairs βζIndustrial Cooperative Cooperative, Tonghua Cl-4, C3, β3, and C3, β cycloalkyl or optionally halogen, hydroxyl, or benzyl Substituted phenyl; R3 represents at least one of the following: hydrogen atom and tooth atom: R4 represents at least one of the following: fluorene atom, halogen atom, Ci-4 alkyl group, imino group and R * The bonded iodine atom forms a C3-β sulphonium group; M represents a fluorene atom, "-4 alkyl, tosyl, halogenated Ci.4 fluorenyl or benzyloxycarbonyl: R6 represents a hydrogen atom, an amine or Nitro :, A ^ represents, / or, ./ I Υ, where Υ represents a fluorene atom, a halogen atom, CU-4 alkyl group, a halogenated Ci-4 alkyl group, an alkane group, and a dentified Ci- * alkane group Or hydroxyl -------- ^ Loading ------ order ------ f ice (Please read the precautions on the back before filling this page) CNS U4 Specification (210X297) 嫠 A8 Bg C8 387838 D8 6. Application for Patent Range No. 84108286 "Novel ketone_ or pyridone- acetic acid derivative or its salt j Patent application (1¾ in 1998) Patent application : I _ month | 〇1 | n n I I a representation of the formula I 1 Xi novelty quinolinone - or Juan piperidine carboxylic acid derivative or its salt fog lotus allowable: R6 billion C02R1 經濟部中央棣準局βζ工消费合作社印装 焼基、通化Cl - 4焼基、C3 - β琢焼基\趙化C3 -β環烷基或視情況由鹵原子、羥基或苄氣基取代之 苯基;R3表示趣自下列之至少一者:氫原子及齒原子 :R4表示遵自下列之至少一者:氳原子,鹵原子, Ci - 4烷基,亞胺基及與R*键結之碘原子生成 C3 - β琛焼琛之基;Μ表示氳原子,“ -4烷基, 甲苯磺醣基、鹵化Ci.4醯基或苄氧羰基:R6表示氫原 子、胺基或硝基:、Α^表示、/或、。/ I Υ ,其中Υ表示籯原子,鹵原子,CU - 4烷基、鹵化Ci -4烷基、烷氣基、齒化Ci-*烷氣基或羥 --------^ 裝------訂------f冰 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中困國家梯準(CNS U4规格(210X297公嫠) 經濟部中央標隼局貝工消费合作社印策 387888 I •D8 六、申請專利範圍 基,或與R2生成下式表示之基:C02R1 Printed by the Central Associated Bureau of the Ministry of Economic Affairs βζIndustrial Cooperative Cooperative, Tonghua Cl-4, C3, β3, and C3, β cycloalkyl or optionally halogen, hydroxyl, or benzyl Substituted phenyl; R3 represents at least one of the following: hydrogen atom and tooth atom: R4 represents at least one of the following: fluorene atom, halogen atom, Ci-4 alkyl group, imino group and R * The bonded iodine atom forms a C3-β sulphonium group; M represents a fluorene atom, "-4 alkyl, tosyl, halogenated Ci.4 fluorenyl or benzyloxycarbonyl: R6 represents a hydrogen atom, an amine or Nitro :, A ^ represents, / or, ./ I Υ, where Υ represents a fluorene atom, a halogen atom, CU-4 alkyl group, a halogenated Ci-4 alkyl group, an alkane group, and a dentified Ci- * alkane group Or hydroxyl -------- ^ Loading ------ order ------ f ice (Please read the precautions on the back before filling this page) CNS U4 specification (210X297 public money) Sealed by the Bayer Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 387888 I • D8 6. The scope of patent application, or the basis of the following formula with R2: 其中RT表示選自下列之至少一者:氫原子,Ci - 4 烷基,及B表示氧原子;及X表示豳原子。 a如申謫專利範困第1項之峰嗡酮-或蒹啶酮-羧酸衍生物 或其醫藥容許s,其中R4為選自下列之至少一者:氫 原子,Ci - 4烷基,及與R4鍵結之硪原子生成之c3 -β環烷琛之基。 3.如申請專利範園第1項或第2項之晻_酮-或桊啶酮-羧 酸衍生物或其酱蕖容許鹽,其中R5表示氫原子或Ci -4焼基。 4如申請專利範園第1項或第2項之喹明&gt; 酮-或謇啶酮-羧 酸衍生物或其醫蕖容許鹽,其中Re表示胺基。 5. 如申請專利範圍第1項或第2項之晻嗡酮·羧羧 酸衍生物或其醫藥容許鹽,其中為%,其中Y I γ 之定栽如第1項。 6. 如申妹專利範圍第1項或第2項之#啶酮-羧 羧 酸衍生物或其s蕖容許鹽,其中、/為。 7. 如申請專利範園第1項之__麵-或綦啶酮-羧酸衍生物 或其翳藥容許鹽,其葆選自: I 1-琛丙基-6-氟-7 -(異吲嶸呦-5-基)-8-甲基-1,4-二氫 -2 * 本紙張尺度用中國固家揉準(CNS ) Μ规格(210X297公釐) --------f i------ir-----*〇 (請先聞讀背面之注項再填寫本頁) 387888 8888 ABCD 六、申請專利範圍 -4-氣基喹呦-3-羧酸, (S)-9-氟-3-甲基-10-(2-甲基異吲¢8呦-5-基)-7-氣 基-2,3-二售:-7H-毗啶駢[l,2,3-de][l, 4]苯駢啤畊-6-羧酸, 卜琛丙基-6-氟-7-(異吲哚呦-5-基)-8-甲氣-1, 4-二 氬-4-氣基唼_ -3-羧酸, 卜琛丙基-8-二氟甲氣-6-瓤-7-(異吲哚呦-5-基)-1, 4-二氬-4-氣基喹嗡-3-羧酸,及 5-胺基-1-環丙基-6-氣-7-(異吲1«呦-5-基)-8-甲氣 -1,4-二氳-4-氣基喹- 3-羧酸。 8. —種下式表示之有機錫化合物或其鹽:Wherein RT represents at least one selected from the group consisting of a hydrogen atom, a Ci-4 alkyl group, and B represents an oxygen atom; and X represents a fluorene atom. a As described in the first paragraph of the patent claim, the peak ketone- or pyridone-carboxylic acid derivative or its pharmaceutically acceptable s, wherein R4 is at least one selected from the group consisting of a hydrogen atom, a Ci-4 alkyl group, And the c3 -β-cycloalkane group formed by the pyrene atom bonded to R4. 3. The dark ketone- or pyridinone-carboxylic acid derivative or its permissible salt, such as item 1 or 2 of the patent application park, wherein R5 represents a hydrogen atom or a Ci-4 fluorenyl group. 4. The quinine of item 1 or item 2 of the patent application park> A ketone- or pyridone-carboxylic acid derivative or a medically acceptable salt thereof, wherein Re represents an amine group. 5. For example, if the humulone · carboxylic acid derivative or the pharmaceutically acceptable salt thereof is the first or the second in the scope of patent application, the percentage is%, and the Y I γ is fixed as in the first item. 6. For example, # 1 or 2 # pyridone-carboxycarboxylic acid derivative or its permissible salt in the scope of Shenmei patent, where / is. 7. If the __face- or pyridone-carboxylic acid derivative or its peony allowable salt of item 1 of the applied patent garden is selected from the group consisting of: I 1-chenpropyl-6-fluoro-7-( Isoindio-5-yl) -8-methyl-1,4-dihydro-2 * This paper size is based on China Gujiazheng (CNS) M specifications (210X297 mm) ------- -f i ------ ir ----- * 〇 (please read the notes on the back before filling this page) 387888 8888 ABCD VI. Application scope of patent Acid, (S) -9-fluoro-3-methyl-10- (2-methylisoindion ¢ 8 呦 -5-yl) -7-amino-2,3-diamine: -7H-pyridine骈 [l, 2,3-de] [l, 4] Benzene-6-carboxylic acid, buchenpropyl-6-fluoro-7- (isoindolyl-5-yl) -8-formaldehyde Gas-1, 4-diargon-4-ylhydrazone_-3-carboxylic acid, buchenpropyl-8-difluoromethane-6-fluorene-7- (isoindolyl-5-yl)- 1,4-Diargon-4-aminoquino-3-carboxylic acid, and 5-amino-1-cyclopropyl-6-gas-7- (isoin1 «呦 -5-yl) -8 -Methyl-1,4-diamidino-4-aminoquino-3-carboxylic acid. 8. —Organic tin compounds or their salts represented by the formula: Sn(Alk); 經濟部中央標準局貞工消費合作社印装 其中R3 , R*及1{8係如申請專利範圃第1項所定義,及 Aik表示直鏈或支鎗h - 4烷基β 9. 一種下式表示之喹啉醑-或綦啶酮-羧酸衍生物或其翳 藥容許鹽 R6 〇 C02R1Sn (Alk); printed by Zhengong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs, where R3, R * and 1 {8 are as defined in item 1 of the patent application garden, and Aik represents a linear or rifle h-4 alkyl group β 9. A quinolinium fluorene-or pyridone-carboxylic acid derivative represented by the following formula or its peony permissible salt R6 〇C02R1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) --------d------IT------f ¥ (請先聞讀背面之注意事項再壤寫本頁)This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) -------- d ------ IT ------ f ¥ (Please read the notes on the back first Write this page again) 387838 b8 D8 六、申請專利範圍 其中R1 ,R2 , Re , X及A係如申請專利範圍第1項所定 義,Aik表示直鏈或支鍵C! *烷基。 10 —種下式表示之衍生物或其鹽: R6 Ο CO2R1 R3 其中R1 , R3 , , Rs , Re , X及A係如申請專利範圍 第1項所定義。 11 一種用作抗豳爾之組成物,其包含翳藥,效置之 如申誚專利範困第1項之《埘酮-或綦啶酮-羧酸衍生物 或其轚藥容許鼸及醫藥容許製備佐剤。 --------^ i------tr-----〇 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央梂準局員工消費合作社印製 本紙張尺度適用中國國家揉準(CNS ) A4規格(210X297公釐)387838 b8 D8 6. Scope of patent application Among them, R1, R2, Re, X and A are as defined in the first scope of patent application, and Aik represents a linear or branched C! * Alkyl group. 10—A derivative or a salt thereof represented by the formula: R6 Ο CO2R1 R3 where R1, R3,, Rs, Re, X and A are as defined in the first scope of the patent application. 11 A composition for use as an anti-drug, which comprises a peony, and is effective as described in the "Patentone- or Piridone-Carboxylic Acid Derivatives or their Peony Drugs" It is allowed to prepare Zoam. -------- ^ i ------ tr ----- 〇 (Please read the precautions on the back before filling out this page) Printed Paper Size by the Employees' Cooperatives of the Central Procurement Bureau of the Ministry of Economic Affairs Applicable to China National Standard (CNS) A4 (210X297 mm)
TW84108286A 1995-08-09 1995-08-09 Novel quinolone-or naphthylidone-carboxylic acid derivatives or their salts TW387888B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW84108286A TW387888B (en) 1995-08-09 1995-08-09 Novel quinolone-or naphthylidone-carboxylic acid derivatives or their salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW84108286A TW387888B (en) 1995-08-09 1995-08-09 Novel quinolone-or naphthylidone-carboxylic acid derivatives or their salts

Publications (1)

Publication Number Publication Date
TW387888B true TW387888B (en) 2000-04-21

Family

ID=21624855

Family Applications (1)

Application Number Title Priority Date Filing Date
TW84108286A TW387888B (en) 1995-08-09 1995-08-09 Novel quinolone-or naphthylidone-carboxylic acid derivatives or their salts

Country Status (1)

Country Link
TW (1) TW387888B (en)

Similar Documents

Publication Publication Date Title
JP6367366B2 (en) 4-amino-imidazoquinoline compounds
US5935952A (en) Quinolone- or naphthylidone-carboxylic acid derivates or their salts
TW502022B (en) 4-amino substituted-2-substituted-l,2,3,4- tetrahydroquinolines
JP5926793B2 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
US9067936B2 (en) 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
TWI258475B (en) Novel benzoimidazole derivatives useful as antiproliferative agents
TW402595B (en) Indazole derivatives
AU2014294866B2 (en) Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same
US20210206758A1 (en) Naphthyridines as integrin antagonists
TW201217371A (en) Quinoline and quinoxaline derivatives as kinase inhibitors
JP2010506851A (en) Bicyclic heteroaromatic compounds
TW201215605A (en) Manufacturing process for pyrimidine derivatives
JP2009534456A (en) Pharmaceutical compounds
HU228567B1 (en) Quinolonecarboxylic acid derivatives or salts thereof
TWI242012B (en) (R)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid methanesulfonate, its monohydrate and anti-bacterially pharmaceutical composition comprising the same as active ingredient
ES2273479T3 (en) DERIVATIVES OF CHINOLONACARBOXYL ACIDS OR SALTS OF THE SAME.
JPH082896B2 (en) 7-[[3- (aminomethyl) -3-alkyl] -1-pyrrolidinyl] -quinoline-carboxylic acid
WO2020224626A9 (en) Compound used as kinase inhibitor and application thereof
CN101124229B (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
IE912801A1 (en) Novel tricyclic compound or salts thereof, method for¹producing the same and antimicrobial agent containing the¹same
TW491849B (en) Tricyclic amine derivatives and method for preparing quinolone compound
US7745459B2 (en) Quinolizinone compound and use thereof as HIV integrase inhibitor
TW387888B (en) Novel quinolone-or naphthylidone-carboxylic acid derivatives or their salts
CN114585621B (en) Imidazoquinoline amine derivative, pharmaceutical composition and application thereof
WO2020192129A1 (en) Method for preparing 2-(3-(azetidin-3-yl)piperidin-1-yl)ethyl-1-ol and use thereof

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent